etoposide has been researched along with methotrexate in 1310 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 183 (13.97) | 18.7374 |
1990's | 471 (35.95) | 18.2507 |
2000's | 354 (27.02) | 29.6817 |
2010's | 267 (20.38) | 24.3611 |
2020's | 35 (2.67) | 2.80 |
Authors | Studies |
---|---|
Hansch, C; Khwaja, TA; Selassie, CD | 1 |
Allison, DL; Glaser, R; Holliday, JE; Kamat, PL; Liebowitz, SM; Moeschberger, ML; Schaller, JP; Witiak, DT | 1 |
Heijn, M; Hooijberg, JH; Lankelma, J; Scheffer, GL; Szabó, G; Westerhoff, HV | 1 |
Beutler, JA; Kuroda, M; Mimaki, Y; Sashida, Y; Yokosuka, A | 1 |
Belinsky, MG; Chen, ZS; Kruh, GD; Rea, PA; Zeng, H | 1 |
Huang, L; Humphreys, JE; Morgan, JB; Polli, JW; Serabjit-Singh, CS; Webster, LO; Wring, SA | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Belinsky, MG; Chen, ZS; Hopper-Borge, E; Kotova, E; Kruh, GD; Shchaveleva, I | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Benfenati, E; Raska, I; Toropov, AA; Toropova, AP | 1 |
Benet, LZ; Brouwer, KL; Chu, X; Dahlin, A; Evers, R; Fischer, V; Giacomini, KM; Hillgren, KM; Hoffmaster, KA; Huang, SM; Ishikawa, T; Keppler, D; Kim, RB; Lee, CA; Niemi, M; Polli, JW; Sugiyama, Y; Swaan, PW; Tweedie, DJ; Ware, JA; Wright, SH; Yee, SW; Zamek-Gliszczynski, MJ; Zhang, L | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ghosh, I; Manoharlal, R; Prakash, O; Prasad, R; Puri, N; Sharma, M | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
Calvo, A; Font, M; Ibáñez, E; Palop, JA; Plano, D; Prior, C; Sanmartín, C | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Bednarski, PJ; Emmrich, T; Hirt, C; Kiefer, T; Leffler, U; Lemmerhirt, H; Link, A; Schulz, R; Sydow, K | 1 |
Font, M; Ibáñez, E; Lizarraga, E; Palop, JA; Plano, D; Sanmartín, C | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Burckhardt, G; Flörl, S; Hagos, Y; Kühne, A; Marada, VV | 1 |
Du, Y; Guo, H; Li, M; Liu, Y; Ren, L; Wang, L; Yuan, J; Zhang, C; Zhang, H; Zhang, Y; Zhao, L; Zhou, J | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Gao, T; Guo, H; Li, L; Li, S; Liu, Y; Wang, L; Xing, R; Yuan, J; Zhang, C; Zhang, H; Zhang, K; Zhao, L | 1 |
Gao, F; Wang, T; Xiao, J; Zhang, X | 1 |
Xu, Z; Zhang, L | 1 |
Carr, DT; Eagan, RT; Frytak, S; Lee, RE; Rubin, J | 1 |
Grieder, A; Maurer, R; Stähelin, H | 1 |
Bunn, PA; Chretien, PB; Cohen, MH; Fossieck, BE; Ihde, DC; Johnston, AV; Kenady, DE; Lipson, SD; Makuch, R; Matthews, MJ; Minna, JD; Shackney, SE | 1 |
Bunn, PA; Cohen, MH; Fossieck, BE; Ihde, DC; Johnston-Early, A; Makuch, R; Matthews, MJ; Minna, JD; Shackney, SE | 1 |
Abeloff, MD; Ettinger, DS; Khouri, NF; Lenhard, RE | 1 |
Brunner, KW; Cavalli, F; Hasler, E; Martin, J; Ryssel, HJ; Sonntag, RW; Tschopp, L | 1 |
Dombernowsky, P; Nissen, NI | 1 |
Dommann, C; Gebbers, JO; Honegger, HP; Joss, R; Kroner, T; Maurer, R; Peters, J; Pichert, G; Stahel, RA; Sulser, H | 1 |
Bianconcini, G; Candini, R; Dallasta, A; Gobbi, F; Mazzali, F | 1 |
Chabner, BA; Duffey, PL; Longo, DL; Urba, WJ; Wilson, WH; Wittes, R | 1 |
Howells, DW; Hyland, K; Smith, I; Strobel, S | 1 |
Ahlgren, JD; Schulof, RS; Wampler, GL | 1 |
D'Incalci, M; Erba, E; Lorico, A; Sen, S | 1 |
Bao, YH | 1 |
Fryer, JG; Wampler, GL | 1 |
Bakri, YN; Ezzat, A; Pedersen, P | 1 |
Daxenbichler, G; Helweg, G; Hetzel, H; Judmaier, W; Marth, C; Schwegel, P; Wicke, K; Zeimet, AG | 1 |
Lurain, JR; Miller, DS; Rademaker, AW; Schink, JC; Singh, DK | 1 |
Brodin, O; Lamberg, K; Nõu, E | 1 |
Li, LY | 1 |
Gibson, J; Joshua, DE; Kronenberg, H; Mansberg, R | 1 |
Ezaki, K; Hirano, M; Ino, T; Maruyama, F; Matsui, T; Miyazaki, H; Okamoto, M; Shimizu, K; Shinkai, K; Sobue, R | 1 |
Furukawa, S; Inoue, T; Ito, K; Kokatsu, T; Mochimatsu, I; Sawaki, S; Tsukuda, M; Watanabe, S | 1 |
Fujita, T; Ito, M; Matsui, T; Nakao, Y; Natazuka, T; Sugimoto, T | 1 |
Arnold, H; Bross, K; Heidemann, E; Heim, ME; Hoffman, I; Josten, K; Manegold, C; Reinold, HM; Schalk, KP; Steinke, B | 1 |
Green, JA; Husband, DJ | 1 |
Alonso, C; Climent, MA; Germá, JR; Izquierdo, MA; Ojeda, B; Seguí, MA | 1 |
Harrell, JH; Miller, KL | 1 |
Agthe, A; Brittinger, G; Engelhard, M; Griesser, H; Huhn, D; Kuse, R; Lennert, K; Schwerdtfeger, R; Siegert, W; Tiemann, M | 1 |
Ezaki, K; Hirano, M; Maruyama, F; Okamoto, M | 1 |
Mizoguchi, H; Saito, H | 1 |
Calne, R; Clark, PI; Owen, RA; Stebbings, W; Whelan, JS | 1 |
Bergerat, JP; Damonte, JC; Dufour, P; Herbrecht, R; Liu, KL; Maloisel, F; Oberling, F; Ortiz, S | 1 |
Weiss, RB | 1 |
Abella, E; Alvarado, CS; Chauvenet, A; Dubowy, R; Harris, M; Inoue, S; Krischer, JP; Ravindranath, Y; Ritchey, AK; Wiley, J | 1 |
Brämswig, JH; Hörnig-Franz, I; Schellong, G | 1 |
Chisa, M; Hasegawa, S; Katoh, M; Koike, M; Kubomatsu, Y; Kunika, N; Nakamura, K; Sano, F; Takahashi, M; Wakayama, T | 1 |
Crist, WM; Crom, WR; Evans, WE; Groom, S; McLeod, HL; Relling, MV; Rivera, GK; Rodman, JH; Silverstein, K | 1 |
Baba, H; Tomita, K; Tsuchiya, H; Ueda, Y; Yasutake, H; Yokogawa, A | 1 |
Solal-Céligny, P | 1 |
O'Connell, MJ | 1 |
Atiq, OT; Brennan, M; Chapman, D; Ginn, D; Heelan, R; Kelsen, D; Lightdale, C; Niedzwiecki, D; Saltz, L; Vinciguerra, V | 1 |
Horiuti, A; Kakishita, E; Kanamaru, A; Masaoka, T; Miyazaki, E; Nagai, K; Shibata, H; Takemoto, Y; Tsubaki, K; Yonezawa, T | 1 |
Kondo, I; Miura, T; Murai, T; Shimura, H | 1 |
de Dycker, RP; Fechtig, A; Neumann, RL; Schumacher, T; Zajaczkowski, T | 1 |
Fushiki, H | 1 |
Cold, S; Pfeiffer, P; Rose, C | 1 |
Horie, H; Kinugawa, N; Kudoh, F; Miyamoto, S; Okimoto, Y; Oto, S | 1 |
Demirkazik, A; Dinçol, D; Günel, N; Içli, F; Karaoğuz, H | 1 |
Eiro, I; Kanetsuki, I; Nakajo, M; Onohara, S; Takeshita, T; Uchiyama, N; Yano, T | 1 |
Grau, C; Overgaard, J | 1 |
Ash, CM; Geddes, D; Goldman, J; Harper, PG; Souhami, RL; Spiro, SG; Tobias, JS; Twelves, CJ | 1 |
Ahlgren, JD; Ellison, NM; Fryer, JG; Heim, WJ; Wampler, GL | 1 |
Biscottini, B; Cellerino, R; Fatati, G; Guidi, F; Isidori, P; Raspugli, M; Tummarello, D | 1 |
Bagshawe, KD; Begent, RH; Holden, L; Newlands, ES; Rustin, GJ | 1 |
Ashley, S; Holborn, J; Jones, AL; Smith, IE | 2 |
de Jong, S; de Vries, EG; Mulder, NH; Zijlstra, JG | 1 |
Levine, PA; Tabbara, IA | 1 |
Nakamura, T; Ueda, T | 1 |
Bellmunt, J; Bodi, R; Jolis, L; Mur, E; Navarro, M; Rubio, D; Solé, LA | 1 |
Airoma, G; Bianco, AR; Contegiacomo, A; De Placido, S; Ferrante, G; Gentile, M; Gridelli, C; Lauria, R; Perrone, F | 1 |
Miyachi, H; Ohnuma, T; Sekiguchi, S; Takemura, Y | 1 |
Colbeck, RA; Crawford, SM; Williams, G | 1 |
Castañeda, VL; Geiser, CF; Marlin, AE; Mullins, JK; Parmley, RT; Saldivar, VA | 1 |
Harvey, V; Levi, J; Raghavan, D; Thomson, D | 1 |
Bagshawe, KD; Ivory, C; Kelly, MP; Phillips, P; Rustin, GJ | 1 |
Battifora, H; Moncada, A; Purdy, LJ; Sheibani, K; Stroup, RM | 1 |
Dahlberg, S; Eyre, HJ; Files, JC; Fisher, RI; Miller, TP; Pendergrass, KB; Weick, JK | 1 |
Chang, SC; Hsu, JR; Perng, RP | 1 |
Cossman, J; DeVita, VT; Duffey, PL; Fisher, RI; Gilliom, M; Hubbard, SM; Ihde, DC; Jaffe, ES; Longo, DL; Wesley, MN | 1 |
Avilés, A; Díaz-Maqueo, JC; López Vancell, D; Rodríguez, L; Torras, V | 1 |
Greco, FA; Greer, JP; Hainsworth, JD; Hildreth, CR; Johnson, DH; McMaster, ML; Wolff, SN | 1 |
DeAngelis, LM; Gnecco, C; Taylor, L; Warrell, RP | 1 |
Bagshawe, KD; Begent, RH; Bradley, J; Dawson, PM; Kulkarni, RP; Makey, AR; Newlands, ES; Reynolds, KW; Rustin, GJ; Theodorou, NA | 1 |
Dahlberg, S; Fisher, RI; Miller, TP | 1 |
Buscema, J; Currie, JL; McLellan, R; Woodruff, JD | 1 |
Greco, FA; Greer, JP; Hainsworth, JD; Johnson, DH; McMaster, ML; Wolff, SN | 1 |
Connors, JM; Hoskins, P; Klimo, P; O'Reilly, SE | 1 |
Anders, CH; Moritz, T; Nagel-Hiemke, M; Niederle, N; Nowrousian, MR; Schmidt, CG; Seeber, S | 1 |
DeVita, VT; Fisher, RI; Hubbard, SM; Longo, DL; Miller, TP; Young, RC | 1 |
Brack, N; Brittinger, G; Dornoff, W; Engelhard, M; Enne, W; Gassmann, W; Gerhartz, H; Hallek, M; Heise, J; Meusers, P | 1 |
Cousar, JB; Flexner, JM; Greco, FA; Greer, JP; Hainsworth, JD; Johnson, DH; McMaster, ML; Stein, RS; Wolff, SN | 1 |
Capnist, G; Chisesi, T; Contu, A; Coser, P; Porcellini, A; Rancan, L; Rizzoli, V; Salvagno, L; Santini, G; Sertoli, M | 1 |
Abbadessa, V; Avanzini, P; Carotenuto, M; Cavanna, L; Federico, M; Gobbi, PG; Leone, G; Lombardo, M; Moretti, G; Pitini, V | 1 |
Mead, GM; Sweetenham, JW; Whitehouse, JM | 1 |
Bonadonna, G; Bregni, M; Gandola, L; Gianni, AM; Lombardi, F; Siena, S; Valagussa, P | 1 |
Alavi, A; Fox, K; Silfen, D | 1 |
Bastion, Y; Coiffier, B; Tigaud, JD | 1 |
Maca, RD | 1 |
Cartwright, KC; Duncan, MH; Foucar, E; McConnell, TS; Winter, SS | 1 |
Coulombier, DM; Spooner, SF | 1 |
Cao, C; García, H; Gutiérrez, J; Osorio, G; Vacarezza, R | 1 |
Bowman, WP; Buchanan, GR; Jacaruso, D; Kamen, BA; Roach, ES; Rollins, N; Winick, NJ | 1 |
Ogawa, M | 2 |
Carrión, JR; Delgado, JR; Dominguez, S; Flores, E; Garcia, P; Jaen, J; Santos, JA | 1 |
Bakri, YN; Nassar, M; Pedersen, P | 1 |
Akimoto, M; Hattori, T; Nishimura, T; Satoh, M; Terashima, Y | 1 |
Hovi, L; Saarinen, UM; Sariola, H | 1 |
Bender-Götze, C; Dopfer, R; Ebell, W; Ehninger, G; Friedrich, W; Gadner, H; Henze, G; Klingebiel, T; Peters, C; Riehm, H | 1 |
Childers, JM; Surwit, EA | 1 |
Kohorn, EI | 2 |
Dombernowsky, P; Hansen, HH; Hansen, M; Hirsch, FR; Osterlind, K; Pedersen, AG; Sörenson, S | 1 |
Clancy, L; Daly, P; Kelly, P; O'Brien, AA | 1 |
Bastida Vila, P; Giralt López, J; Javier Manchón, G; Olivé Oliveras, T; Ortega Aramburu, JJ; Sánchez, C | 1 |
Avella, M; Bacci, G; Dallari, D; De Cristofaro, R; Ferruzzi, A; Manfrini, M; Marangolo, M; Mercuri, M; Picci, P; Pignatti, G | 1 |
Andriessen, MP; Mulder, JG; Sleijfer, DT | 1 |
Cabanillas, F | 3 |
Airo, I; Helve, O; Hiltunen, KM; Mattila, J | 1 |
Akao, T; Hashimura, T; Nakagawa, T; Okumura, K | 1 |
Bagshawe, KD; Begent, RH; Ledermann, JA; Newlands, ES; Philip, PA; Rustin, GJ | 1 |
Frohmüller, H; Heimbach, D; Wirth, M | 1 |
Close, P; Meister, L; Ruchelli, E | 1 |
Davies, BM; Hopwood, LE; Moulder, JE; Volk, DM | 1 |
Nielsen, H | 1 |
Brincker, H; Mirza, MR | 1 |
Elinder, G; Henter, JI | 1 |
Creutzig, U; Ritter, I; Schellong, G | 1 |
Bacchi, M; Bartolucci, R; Bisagni, G; Boni, C; Ceci, G; Cocconi, G; Colozza, MA; De Lisi, V; Lottici, R; Mosconi, AM | 1 |
Feig, SA; Harris, R; Matthay, KK; Moss, TJ; Ramsay, N; Reynolds, CP; Seeger, RC; Selch, M; Villablanca, JG | 1 |
Blanche, S; Caniglia, M; Fischer, A; Girault, D; Griscelli, C; Landman, J | 1 |
Amato, R; Dexeus, FH; Finn, L; Fitz, K; Logothetis, CJ; Sella, A | 1 |
Harstrick, A; Köhne-Wömpner, CH; Poliwoda, H; Schmoll, HJ; Schöber, C; Wilke, H | 1 |
Ishii, S; Itoh, O; Kariya, Y; Kawaharajo, K; Nagasawa, M; Takeuchi, T; Yamamoto, H | 1 |
Burns, I; Byrne, M; Gill, G; Harvey, V; Levi, JA; Raghavan, D; Sandeman, T; Snyder, R; Tattersall, M; Thomson, D | 1 |
Boiocchi, M; D'Incalci, M; Erba, E; Lorico, A; Rappa, G; Sen, S | 1 |
Abeloff, MD; Aisner, SC; Eggleston, JC; Ettinger, DS; Finkelstein, DM; Ruckdeschel, JC | 1 |
Horiguchi, T; Kawahara, S; Kiura, K; Mima, Y; Moritaka, T; Nishii, K; Numata, T; Ohnoshi, T; Ueoka, H; Yonei, T | 1 |
Cellerino, R; Dazzi, C; Guidi, F; Isidori, P; Rossi, A; Torresi, U; Tummarello, D | 1 |
Arriagada, R; Baldeyrou, P; Cerrina, ML; Chomy, P; De Cremoux, H; le Chevalier, T; Martin, M; Pellae-Cosset, B; Ruffie, P; Tarayre, M | 1 |
Fukuda, M; Matsuno, Y; Morita, M; Noguchi, M; Saijo, N; Sasaki, Y; Tsuchiya, R | 1 |
De Boben, M; Diedrich, H; Freund, M; Ganser, A; Heil, G; Henke, M; Heyll, A; Hiddemann, W; Knauf, U; Koch, P | 1 |
Istvan, L; Marton, E | 1 |
Anasetti, C; Appelbaum, FR; Beatty, P; Doney, K; Martin, P; Pepe, M; Stewart, P; Storb, R; Sullivan, KM; Witherspoon, R | 1 |
Neuhaus, KL; Zeymer, U | 1 |
Barcos, M; Cooper, MR; Gottlieb, AJ; McCarroll, K; Norton, L; Schulman, P | 1 |
Matsukawa, S; Ohta, S; Shimada, M; Taga, T; Yamazaki, S | 1 |
Kitamura, Y; Komatsubara, S; Sakata, Y; Watanabe, M | 3 |
Kaneko, Y; Kawai, S; Kondo, M; Mimaya, J; Tonouchi, T; Toyoda, Y; Ueda, R | 1 |
Csaba, I; Garadnay, B; Göcze, P; Keller, G; Krommer, K | 1 |
Akaza, H; Aso, Y; Kotake, T; Niijima, T | 1 |
Kondo, I; Moriyama, M; Murai, T | 1 |
Fornasier, V; Keystone, EC; Sturgeon, JF; Thomson, GT | 1 |
Arai, K; Mori, H; Ogino, M; Okinaga, S; Sakamoto, T; Yamamoto, T | 1 |
Enblad, G; Glimelius, B; Hagberg, H; Lindemalm, C | 1 |
Howells, DW; Hyland, K; Levinsky, RJ; Smith, I; Strobel, S | 1 |
Bodet, CA; Drutz, DJ; Jorgensen, JH | 1 |
Bron, D; Stryckmans, P; Vandenheule, B | 1 |
Lampkin, BC | 1 |
Bagshawe, KD; Begent, RH; Crawford, SM; Newlands, ES; Rustin, GJ | 2 |
Choo, YC; Ma, HK; Wong, LC | 2 |
Bagshawe, KD; Begent, RH; Crawford, SM; Holden, L; Newlands, ES; Rustin, GJ | 2 |
Markman, M | 1 |
DeVita, VT | 1 |
Bagshawe, KD; Begent, RH; Newlands, ES; Pektasides, D; Rustin, GJ | 2 |
Coltman, CA; Dahlberg, S; Dana, BW; Fisher, RI; Jones, SE; Miller, TP | 1 |
Bagshawe, KD; Begent, RH; Crawford, SM; Ledermann, JA; Newlands, ES; Rustin, GJ; Turkie, W | 1 |
Volberding, PA | 1 |
Dombrowski, H; Drings, P; Hans, K; Harms, V; Havemann, K; Holle, R; Victor, N; Wolf, M | 1 |
Cossman, J; Glatstein, E; Lawrence, TS; Steinberg, SM; Sundeen, JT; Urba, WJ; Young, RC | 1 |
Aalders, JG; Bouma, J; Sleijfer, DT; Willemse, PH | 1 |
Brittinger, G; Dörken, B; Engelhard, M; Engert, W; Enne, W; Fuchs, R; Gerhartz, HH; Hagen-Aukamp, CH; Huhn, D; Thiel, E | 1 |
Brittinger, G; Engelhard, M; Gerhartz, H; Heinz, R; Huhn, D; Meusers, P; Neubauer, A; Siegert, W; Stacher, A; Thiel, E | 1 |
Arnold, H; Busch, FW; Günther, E; Heim, ME; Kraft, H; Krüger, HU; Steinke, B | 1 |
DeVita, VT; Glatstein, E; Ihde, DC; Jaffe, ES; Longo, DL; Young, RC | 1 |
Coltman, CA; Dahlberg, S; Dana, BW; Fisher, RI; Jones, SE; Miller, TP; Weick, JK | 1 |
Clarke, J; Cullen, MH; Harper, PG; Kirkbride, P; Woodroffe, CM | 1 |
Bagshawe, KD; Begent, RH; Hitchins, RN; Newlands, ES; Rustin, GJ; Smith, DB | 1 |
Diehl, V; Schaadt, M; von Kalle, AK | 1 |
Hashimura, T; Hida, S; Kanamaru, H; Nishimura, K; Nishio, Y; Oishi, K; Okada, K; Yamauchi, T; Yoshida, O; Yoshiki, T | 1 |
Alleman, MJ; Peters, WG; Schaafsma, MR; Tham, RT; Willemze, R | 1 |
Bross, K; Heidemann, E; Heim, ME; Hofmann, I; Josten, K; Kraft, A; Löffler, B; Reinold, HM; Richter, C; Steinke, B | 1 |
Brittinger, G; Engelhard, M; Gerhartz, HH; Heinz, R; Huhn, D; Meusers, P; Siegert, W; Stacher, A; Thiel, E; Wilmanns, W | 1 |
Pass, HI; Perry, RR; Rosenberg, RK | 1 |
Kotake, T; Kuroda, M; Miki, T | 1 |
Athanassiou, A; Bafaloukos, D; Barbounis, V; Christodoulou, K; Dimitriadis, M; Pectasides, D | 1 |
Bagshawe, KD; Begent, RH; Dent, J; Newlands, ES; Rustin, GJ | 1 |
Bergerat, JP; Duclos, B; Dufour, P; Garcia, JJ; Herbrecht, R; Oberling, F | 1 |
Kelland, LR; Tonkin, KS | 1 |
Goto, S; Hotta, T; Ichikawa, A; Inoue, C; Murate, T; Nagura, E; Ninomiya, N; Ohnishi, K; Tsushita, K; Utsumi, M | 1 |
Anders, C; Höffken, K; Meier, CR; Nowrousian, MR; Osieka, R; Schmidt, CG; Schoetensack, B | 1 |
Doberauer, C; Ohl, S | 1 |
Goel, R; Howell, SB; Kirmani, S | 1 |
Kashani-Sabet, M; Scanlon, KJ; Sowers, LC | 1 |
Ash, CM; Eraut, D; Geddes, DM; Harper, PG; Partridge, M; Quinn, H; Souhami, RL; Spiro, SG; Tobias, JS | 1 |
Hiraki, S; Kawahara, S; Kiura, K; Kozuka, A; Nishii, K; Numata, T; Ohnoshi, T; Ueoka, H; Yamashta, H; Yonei, T | 1 |
Ouyang, PC | 1 |
Donaldson, ES; Gallion, HH; Higgins, RV; van Nagell, JR | 1 |
Ihde, DC; Viallet, J | 1 |
Chahinian, AP; Comis, RL; Hirsh, V; Holland, JF; Kopel, S; Perry, MC; Propert, KJ; Skarin, A; Ware, JH; Zimmer, B | 1 |
Cullinan, SA; Dalton, RJ; Everson, LK; Gerstner, JB; Jett, JR; Krook, JE; Mailliard, JA; Morton, RF; O'Fallon, JR; Tschetter, LK | 1 |
Benfield, GF; Collins, FJ; Cullen, MH; Matthews, HR; Watson, DC | 1 |
Biscottini, B; Cellerino, R; Fatati, G; Guidi, F; Isidori, P; Porfiri, E; Raspugli, M; Tummarello, D | 2 |
Errington, RD; Green, JA; Hardman, PD; Myint, S; Warenius, HM | 1 |
Bagshawe, KD; Begent, RH; Crawford, SM; Glaser, MG; Newlands, ES; Parker, D; Rustin, GJ; Southcott, BM; Ward, AJ | 1 |
DeVita, VT; Fisher, RI; Longo, D; Young, RC | 1 |
Newlands, ES | 1 |
Wilkinson, PM | 1 |
Janka, GE | 1 |
Blanche, S; Caniglia, M; Fischer, A; Griscelli, C | 1 |
Dopfer, R; Ehninger, G; Einsele, H; Grosse-Wilde, H; Haen, M; Jaschonek, KG; Pawelec, G; Rutayungwa, ET; Schmidt, H; Schneider, W | 1 |
Asada, M; Fujimura, Y; Ishikawa, K; Ito, M; Kimura, T; Miwa, S; Miyazaki, T; Shibata, H; Wu, MC; Yamaguchi, K | 1 |
Barondes, MJ; Hamilton, AM; Hungerford, J; Rustin, GJ | 1 |
Effenberger, T; Henne-Bruns, D; Kremer, B; Weh, HJ | 1 |
Bagshawe, KD; Begent, RH; Boesen, E; Glaser, MG; Ledermann, JA; Newlands, ES; Rustin, GJ; Smith, DB | 1 |
Coe, MA; Errington, RD; Green, JA; Nash, JR; Warenius, HM | 1 |
Abdel-Hadi, S; Adde, M; el-Taneer, O; Gad-el-Mawla, N; Hussein, MH; Magrath, I | 1 |
DeVita, VT; Duffey, PL; Fisher, RI; Gilliom, M; Glatstein, E; Hubbard, SM; Ihde, DC; Jaffe, ES; Longo, DL; Young, RC | 1 |
Kawashima, Y; Maeda, M; Sugimura, M | 1 |
Surwit, EA | 1 |
Bai, L; Feng, FY; Qiu, Q; Song, SZ; Sun, Y; Wang, JW; Wang, QL; Yin, WB; Zhou, JC | 1 |
Brincker, H; Hansen, PV; Hindberg, J | 1 |
Cellerino, R; Guidi, F; Isidori, P; Porfiri, E; Raspugli, M; Tummarello, D | 1 |
Anzanello, F; Boiocchi, M; D'Incalci, M; Lorico, A; Rappa, G | 1 |
Ardizzoni, A; Canobbio, L; Carbone, A; Franceschi, S; Magri, MD; Mazza, F; Rosso, R; Talamini, R; Tirelli, U; Veronesi, A | 1 |
Bolis, G; Bonazzi, C; Landoni, F; Mangili, G; Mangioni, C; Vergadoro, F; Zanaboni, F | 1 |
Grieve, RJ; Harris, RI; Leyland, MJ; Patton, WN; Sangster, G | 1 |
Brecher, ML; Freeman, AI; Green, DM; Sandberg, AA; Simon, JH; Tebbi, CK | 1 |
Abeloff, MD; Berkman, AW; Markman, M; Waterfield, WC | 1 |
Holoye, PY | 1 |
Barber, PV; Carroll, KB; Feinmann, D; James, RD; Lawson, BA; Steward, WP; Thatcher, N | 1 |
Bonomi, P; Bunting, N; Creech, RH; O'Reilly, W; Ruckdeschel, JC; Stolbach, L; Vogl, SE | 1 |
Bassett, H; Carroll, KB; Grötte, G; Smith, DB; Stout, R; Thatcher, N; Winson, M | 1 |
Hansen, HH; Hansen, M; Osterlind, K; Pedersen, AG; Pedersen-Bjergaard, J; Philip, P | 1 |
Bagshawe, KD; Begent, RH; Dent, J; Holden, L; Newlands, ES; Rustin, GJ | 1 |
Coy, P; Fryer, C; Goldie, J; Gudauskas, G; Hadzic, E; Klimo, P; Murray, N; Shah, A; Voss, N; Wilson, K | 1 |
Livingston, RB | 1 |
Calame, JJ; Dijkhuizen, GH; Franke, HR; Stolk, JG; Vermorken, JB; von Kessel, H | 1 |
Ahmedzai, S; Banham, SW; Cunningham, D; Dorward, AJ; Gregor, A; Hutcheon, AW; Kaye, SB; Mackay, NS; Soukop, M; Stack, BH | 1 |
Barkley, HT; Benjamin, RS; Bodey, GP; Frankmann, C; Jeffries, DG; McMurtrey, MJ; Murphy, WK; Valdivieso, M; Welch, SR | 1 |
Kobayashi, O; Matsui, H; Sekiya, S; Takamizawa, H | 1 |
Drings, P; Gropp, C; Hans, K; Havemann, K; Heim, M; Holle, R; Manke, HG; Schroeder, M; Victor, N; Wolf, M | 1 |
Bokemeyer, C; Gabius, HJ; Hellmann, T; Schmoll, HJ | 1 |
Dombernowsky, P; Hansen, HH; Hansen, M; Hirsch, FR; Osterlind, K; Sørensson, S; Vindeløv, LL | 1 |
Chen, TT; Coltman, CA; Crowley, JJ; Grozea, PN; Kies, MS; Livingston, RB; Mira, JG; Pazdur, R; Rivkin, SE; Ward, JH | 1 |
Bien, R; Keohane, M; Papac, RJ; Son, Y; Tiedemann, D; Yesner, R | 1 |
Cabanillas, F; Hagemeister, FB; Jagannath, S; McLaughlin, P; Redman, JR; Rodriguez, MA; Swan, F; Velasquez, WS | 1 |
Brattia, M; Daxenbichler, G; Marth, C; Müller-Holzner, E; Tabarelli, M | 1 |
Ben-Sira, I; Cohen, S; Nissenkorn, I; Stark, B; Wysenbeek, YS; Zaizov, R | 1 |
Krykowski, E; Matusewicz, W; Olszańska-Skorek, T; Robak, T; Urbańska-Ryś, H | 1 |
Buzdar, AU; Fraschini, G; Holmes, FA; Hortobagyi, GN; Hug, V; Jabboury, K; Kau, SW; Theriault, RL | 1 |
Arends, JW; Blijham, GH; Braat, SH; de Haan, J; Hoogland, HJ; van Krimpen, C | 1 |
Imura, H; Ino, T; Ito, N; Kojima, H; Maruyama, F; Matsui, T; Shimizu, K; Shinkai, K; Shirakawa, S; Sobue, R | 1 |
Huijgens, PC; Ossenkoppele, GJ; Reijneke, RM; Thomas, LL; van der Lelie, J; Wijngaarden, MJ | 1 |
Budde, M; Creutzig, U; Riehm, H; Ritter, J; Schellong, G | 1 |
Sevitz, H | 1 |
Aricò, M; Bonetti, F; Burgio, GR; Caselli, D; Maccario, R; Montagna, D; Nespoli, L | 1 |
Fujii, T; Maeda, M | 1 |
Creech, RH; Ettinger, DS; Finkelstein, DM; Joss, RA; Mason, BA; Ruckdeschel, JC; Vogl, S | 1 |
Athanassiades, P; Bacoyiannes, H; Kontoyiannes, D | 1 |
Lampkin, BC; Wong, KY | 1 |
Beard, DB; Haskell, CM | 1 |
Bergsagel, DE | 1 |
Cabanillas, F; Hagemeister, FB; McLaughlin, P; Riggs, S; Salvador, P; Tannir, N; Velasquez, WS | 1 |
Coleman, CN; Horning, SJ; Jacobs, C; Lewis, BJ; Rosenberg, SA; Tseng, A | 1 |
Kobayashi, O; Matsui, H; Takamizawa, H | 1 |
Ettinger, DS; Finkelstein, DM; Ruckdeschel, JC | 1 |
Cheng, YC; Ferguson, PJ | 1 |
Cabanillas, F; Fuller, L; Hagemeister, FB; McLaughlin, P; Riggs, S; Smith, T; Velasquez, WS | 1 |
Horikoshi, N; Imajo, K; Inagaki, J; Inoue, K; Ito, Y; Mukaiyama, T; Nakamura, T; Ogawa, M; Ueno, K; Yamazaki, H | 1 |
Arenzana-Seisdedos, F; Fischer, A; Griscelli, C; Nezelof, C; Perez, N; Virelizier, JL | 1 |
Oliver, RT | 1 |
Abrams, RA; Anderson, T; Baumann, MA; Hansen, R; Hanson, G | 1 |
Arfaei, AH; Asgar, K | 1 |
Brix, F; Dühmke, E; Euler, HH; Gassmann, W; Gremmel, H; Hebbinghaus, D; Kayser, W; Schaub, J; Schmitz, N; Wüstemann, M | 1 |
Grönroos, M; Kangas, L; Mäenpää, J | 2 |
Cavallin-Ståhl, E; Hagberg, H; Lind, J | 1 |
Buccheri, G; Curcio, A; Ferrigno, D; Mattalia, E; Vola, F | 1 |
Herrmann, R; Osswald, H; Youssef, M | 1 |
Drings, P; Gropp, C; Havemann, K; Konrad, RM; Liesenfeld, A; Mahnke, HG; Seifert, W; Thomas, C; Wellens, W; Westerhausen, M | 1 |
Schwarz, MA; Snyder, RD | 1 |
Bagshawe, KD; Newlands, ES | 1 |
Fry, DW; Goldman, ID; Yalowich, JC | 1 |
Bodey, GP; Burgess, MA; Cabanillas, F; Freireich, EJ | 1 |
Bagshawe, KD; Begent, RH; Newlands, ES; Parker, D; Rustin, GJ | 1 |
Crom, WR; Evans, WE; Hutson, PR; Sinkule, JA; Stewart, CF; Yee, GC | 1 |
Kelsen, D | 1 |
Ma, HK; Wong, LC | 1 |
Alberts, DS; Christian, CD; Graham, VE; Surwit, EA | 1 |
Coombs, A; Hanson, J; Moore, JL | 1 |
Aisner, J; Van Echo, DA; Whitacre, M; Wiernik, PH | 1 |
Fearon, F; Geddes, DM; Guimaraes, M; Harper, PG; Smyth, JF; Souhami, RL; Spiro, SG | 1 |
Aroney, RS; Bell, DR; Chan, WK; Dalley, DN; Levi, JA | 1 |
Dillman, RO; Green, MR; Lea, JW; Lehar, TJ; Mendelsohn, J; Rentschler, RE; Royston, I; Seagren, SL; Stanton, W; Taetle, R; Young, JA | 1 |
Denck, H; Karrer, K; Pridun, N; Zwintz, E | 1 |
Boutin, P; Carcassone, Y; Cupissol, D; Michel, FB; Plagne, R; Serrou, B | 1 |
Bitran, JD; DeMeester, TR; Golomb, HM; Hoffman, PC; Newman, SB; Raghavan, V | 1 |
Bremer, K; Krischke, W; Niederle, N; Schmidt, CG; Seeber, S | 1 |
Nakhosteen, JA; Niederle, N | 1 |
Antic, R; Drew, MJ; Gill, PG; McLennan, G; Robinson, PC | 1 |
Barkley, HT; Bodey, GP; Burgess, MA; Cabanillas, F; Chen, T; Frazier, H; Keating, M; Murphy, WK; Valdivieso, M | 1 |
Caracandas, JE; Chen, TY; Lane, WW; Reddy, SK; Regal, AM; Takita, H; Vincent, RG | 1 |
Chen, TT; Costanzi, JJ; Livingston, RB; McGavran, M; Mira, JG; Samson, M | 1 |
Heinz, R; Stacher, A | 1 |
Berard, C; DeVita, VT; Fisher, RI; Hubbard, SM; Jaffe, E; Longo, DL; Wesley, M; Young, RC | 1 |
Chahinian, AP; Green, G; Holland, JF | 1 |
Blatnik, A; Matheny, RB; Niell, HB; Soloway, MS | 1 |
Bellamy, AS; Hill, BT | 1 |
Chabner, BA; DeVita, VT; Fisher, RI; Hubbard, SM; Longo, DL; Wesley, R; Young, RC | 1 |
Berg, C; Bottino, G; Chabner, B; Doyle, LA | 1 |
Flamant, F; Gerbaulet, A; Lemerle, J; Leverger, G | 1 |
Hussain, M; Ruckdeschel, JC; Zimmerman, MS | 1 |
Brennan, MF; Fisher, RI; Popp, MB; Simon, RM | 1 |
Barkley, HT; Benjamin, RS; Bodey, GP; Ertel, M; Freeman, MB; Mountain, CF; Smith, TL; Valdivieso, M | 1 |
Alburquerque Carbuccia, H; Madrigal Alonso, P; Perez Manga, G | 1 |
Demitrish, M; Duffin, H; Enochs, K; Groshko, G; Lockhard, C; Maniscalco-Greb, E; Vaughn, CB | 1 |
Eagan, RT; Jett, JR | 1 |
Bodey, GP; Cabanillas, F; Freireich, EJ; Hagemeister, FB | 1 |
Anderson, G; Bowyer, F; Williams, L | 1 |
Bakker, P; Laan, R; Lammes, FB | 1 |
Almasan, A; Banerjee, D; Bertino, JR; Fan, J; Hochhauser, D; Kelly, R; Li, W; Wahl, GM; Yin, Y; Zielinski, Z | 1 |
Andoh, A; Gemba, K; Harada, M; Hiyama, J; Matsushita, A; Ohnoshi, T; Segawa, Y; Shibayama, T; Tabata, M; Ueoka, H | 1 |
Demachi, H; Konishi, K; Kuroda, Y; Tsugawa, K; Tsuji, M; Yabushita, K | 1 |
Callen, JP; Roth, DJ; Williams, BJ | 1 |
Bleehen, NM; Girling, DJ; Machin, D; Stephens, RJ | 2 |
Chang, J; Crowther, D; Morgenstern, GR; Pettengell, R; Radford, JA; Rowlands, M; Scarffe, JH; Testa, NG; Woll, PJ; Young, R | 1 |
Ishibashi, K; Kawai, T; Kawakami, S; Kokuho, M; Ueda, T; Yamauchi, T; Yonese, J | 1 |
Ino, T; Kojima, H; Maruyama, F; Matsui, T; Miyazaki, H; Nomura, T; Okamoto, M; Sobue, R; Tsuzuki, M; Wakita, M | 1 |
Kawai, T; Kawakami, S; Ohno, Y; Tachibana, Y; Ueda, T; Yamauchi, T; Yonese, J | 1 |
Ezaki, K; Kojima, H; Maruyama, F; Matsui, T; Miyazaki, H; Nomura, T; Okamoto, M; Sobue, R; Tsuzuki, M; Wakita, M | 1 |
Allen, PK; Cabanillas, FF; Fuller, LM; Hagemeister, FB; McLaughlin, P; Rodriguez, MA; Swan, F; Tucker, SL; Velasquez, WS | 1 |
Kawai, T; Kawakami, S; Ohono, Y; Ueda, T; Yamauchi, T; Yonese, J | 1 |
Byrne, A; Carney, DN; Corbally, N; Dervan, PA; Grogan, L | 1 |
Bron, D; Carde, P; de Bock, R; De Wolf-Peeters, C; Delmer, A; Keunig, JJ; Keuning, JJ; Somers, R; Thomas, J; Tirelli, U | 1 |
Coltman, CA; Dahlberg, S; Fisher, RI; Gaynor, ER; Glick, JH; Grogan, TM; Miller, TP; Mize, EM; Oken, MM | 2 |
Chan, T; Cooper, I; Januszewicz, E; Juneja, S; Wolf, M | 1 |
Ciaccia, D; Corey, GR; Peters, W; Thel, MC; Vredenburgh, JJ | 1 |
Chisesi, T; Congiu, AM; Contu, A; Coser, P; Porcellini, A; Rubagotti, A; Salvagno, L; Santini, G; Sertoli, MR; Vespignani, M | 1 |
Baldini, L; Butti, C; Cassi, E; Ceriani, A; Confalonieri, C; De Paoli, A; Lombardi, F; Montalbetti, L; Pisoni, GB; Scandolaro, L | 1 |
Lishner, M; Slingerland, J; Sutcliffe, SB; Theresa, C | 1 |
Advani, SH; Gopal, R; Kurkure, PA; Nair, CN; Nair, R; Pai, SK; Saikia, TK; Sampat, MS | 1 |
Bakri, Y; Berkowitz, RS; Goldstein, DP; Jabbar, FA; Senoussi, M; Subhi, J; von Sinner, W | 1 |
Lurain, JR | 3 |
Biran, H; Blickstein, I; Caspi, B; Dgani, R; Shoham, Z; Weissman, A; Zalel, Y | 1 |
Angus, B; Carey, P; Evans, RG; Jackson, GH; Lennard, AL; Lucraft, H; Proctor, SJ; Taylor, PR | 1 |
Bagshawe, KD; Begent, RH; Brampton, M; Holden, L; Ledermann, JA; Newlands, ES; Rustin, GJ | 1 |
DeVita, VT; Duffey, PL; Fisher, RI; Hubbard, SM; Jaffe, ES; Longo, DL; Raffeld, M; Wittes, RE; Young, RC | 1 |
Fisher, RI | 1 |
Hirano, M | 1 |
Brittinger, G; Engelhard, M; Heinz, R; Huhn, D; Nerl, C; Parwaresch, R; Siegert, W; Tiemann, M | 1 |
Carter, JR; Hartenbach, EM; Saltzman, AK; Twiggs, LB | 1 |
Avilés, A; Díaz-Maqueo, JC; García, EL; Nambo, MJ; Talavera, A | 1 |
Begley, CG; Boyd, AW; Grigg, AP; Lickliter, JD; Szer, J | 1 |
Gabizon, AA; Gorodetsky, R; Mou, X; Vexler, AM | 1 |
Anteby, SO; Meirow, D; Reubinoff, BE; Tanos, V | 1 |
Carpentier, AF; Chantelard, JV; Henin, D; Poisson, M | 1 |
Hahn, J; Herndier, B; Kaplan, LD; McGrath, MS; Meeker, TC; Ng, V; Shiramizu, B; Volberding, PA | 1 |
Andrews, R; Begent, RH; Boshoff, C; Holden, L; Newlands, ES; Oliver, RT; Ong, J; Rustin, GJ; Skelton, M | 1 |
Alberto, P; Bacchi, M; Cerny, T; Hürny, C; Joss, RA; Leyvraz, S; Ludwig, C; Martinelli, G; Stahel, R; Thürlimann, B | 1 |
Cabanillas, F; Cortes, JE; Kurzrock, R; Seymour, JF; Talpaz, M | 1 |
Pandha, HS; Wasan, HS; Waxman, J | 1 |
Chapman, CS; Ghosh, K; Murphy, P; Sivakumaran, M; Wood, JK | 1 |
Akaza, H; Hayashi, H; Koiso, K; Miyanaga, N | 1 |
Ireland, CM; Pittman, SM | 1 |
Fujimoto, N; Higuchi, M; Kawamura, M; Kuni-Eda, Y; Kurosawa, M; Maekawa, I; Morioka, M; Ohmura, T; Okabe, M; Suzuki, S | 1 |
Barnett, MJ; Fairey, RN; Hogge, DE; Klasa, RJ; Klingemann, HG; Nantel, SH; Reece, DE; Shepherd, JD; Sutherland, HJ; Voss, NJ | 1 |
Khan, AA; Rodriguez, JM | 1 |
Dommann-Scherrer, C; Honegger, HP; Jacky, E; Jost, LM; Maurer, R; Sauter, C; Stahel, RA | 1 |
Cardenal, F; Garciá del Muro, X; Vicente, P | 1 |
Postmus, PE; Smit, EF | 1 |
Behm, FG; Boyett, JM; Hancock, ML; Krance, RA; Mahmoud, HH; Pui, CH; Raimondi, SC; Relling, MV; Ribeiro, RC; Sandlund, JT | 1 |
Asano, K; Kawahara, M; Masuda, F; Shirakawa, H | 1 |
Carr, TJ; Costanzo, MR; Fisher, RI; Mullen, GM; Swinnen, LJ | 1 |
Heinz, R; Hopfinger, G; Koller, E; Pittermann, E; Schneider, B | 1 |
Bijnens, L; Hagenbeek, A; Kluin-Nelemans, JC; Meerwaldt, JH; Noordijk, EM; Peeters, CD; Pittaluga, S; Somers, R; Teodorovic, I; van Glabbeke, M | 1 |
Amadori, S; Avvisati, G; Cedrone, M; Cimino, G; Mancini, F; Mandelli, F; Moleti, ML; Testi, AM; Todisco, E | 1 |
Chen, DF; Sun, Y; Yin, WB; Zhang, DW; Zhang, RG; Zhang, XR | 1 |
Bower, M; Brock, C; Fisher, RA; Newlands, ES; Rustin, GJ | 1 |
Aizawa, T; Kawai, T; Kawakami, S; Nakagawa, K; Ohno, Y; Tachibana, Y; Tsuchiya, S; Ueda, T; Yamauchi, T | 1 |
Hagemeister, FB | 1 |
Greco, FA; Greer, JP; Hainsworth, JD; Johnson, DH; McMaster, ML; Stein, RS; Waits, TM; Wolff, SN | 1 |
Kawakami, M; Kobayashi, S; Niwakawa, M; Ogawa, A; Okaneya, T; Tsuruta, T | 1 |
Hosaka, M; Ikeda, I; Kubota, Y; Shuin, T; Yao, M | 1 |
DeVita, VT; Longo, DL; Young, RC | 1 |
Müller, U; Stahel, RA | 1 |
Greco, FA; Greer, JP; Hainsworth, JD; Waits, TM | 1 |
Addante, RR; Daniels, CA; Loomer, L; Schaberg, SJ | 1 |
Ezoe, A; Fujisaki, Y; Hayashi, S; Kohda, K; Nakazawa, O; Takayanagi, N; Takeda, M; Takimoto, R; Tsuji, A; Tsuji, Y | 1 |
Bosly, A; Coiffier, B; Gisselbrecht, C; Haioun, C; Herbrecht, R; Lepage, E; Morel, P; Reyes, F; Sebban, C; Tilly, H | 1 |
Alberto, P; Bleher, EA; Joss, RA; Ludwig, C; Martinelli, G; Sauter, C; Schatzmann, E; Senn, HJ; Siegenthaler, P | 1 |
Hammond, CB; Olt, GJ | 1 |
Ballestrero, A; Basta, P; Brema, F; Ferrando, F; Ghio, R; Gobbi, M; Moraglio, L; Patrone, F; Sessarego, M; Valbonesi, M | 1 |
Fujimoto, T; Kikuchi, M; Shimizu, H; Takaue, Y; Takeda, T; Utsumi, J | 1 |
Andersson, BS; Bellare, N; Gajewski, JL; Giralt, SA; Khouri, IF; McCarthy, P; Mehra, R; Nath, R; Przepiorka, D; van Besien, KW | 1 |
Igawa, M; Kadena, H; Nakamoto, T; Tacho, T; Usui, T | 1 |
Bout, M; Brémond, JL; Dayan, A; Delain, M; Domenech, J; Gihana, E; Linassier, C; Petit, A; Petitdidier, C; Truglio, D | 1 |
Holden, SA; Northey, D; Robinson, MF; Rosowsky, A; Teicher, BA | 1 |
Heinonen, E; Hinkka, SM; Karnani, P; Klemi, PJ; Korpijaakko, TA; Kuoppala, TA; Lähde, MA; Laine, AM; Mäenpää, JU; Nuoranne, EK | 1 |
Carlomagno, C; De Laurentiis, M; De Placido, S; Lauria, R; Marinelli, A; Morabito, A; Pagliarulo, C; Perrone, F; Petrella, G; Varriale, E | 1 |
Bacchi, M; Bernhard, J; Cerny, T; Hürny, C; Joss, RA; Leyvraz, S; Martinelli, G; Senn, HJ; Siegenthaler, P; Stahel, R | 1 |
Chessells, JM; Hirst, WJ; Layton, DM; Mieli-Vergani, G; Pritchard, J; Singh, S; Strobel, S | 1 |
Gadner, H; Henze, G; Ludwig, WD; Müller-Weihrich, S; Parwaresch, R; Reiter, A; Riehm, H; Sauter, S; Schrappe, M; Sykora, KW | 1 |
den Ottolander, GJ; Falkenburg, JH; Fibbe, WE; Kluin-Nelemans, JC; Starrenburg, CW; van der Burgh, JF; Willemze, R; Zijlmans, JM | 1 |
Aglietta, M; Bondesan, P; Caracciolo, D; Falda, M; Gallo, E; Gavarotti, P; Locatelli, F; Novarino, A; Paolino, F; Sanavio, F | 1 |
Green, JA; Pendleton, N | 1 |
Chuchkova, M; Damianov, C; Koleva, P; Terziev, T | 1 |
Archimbaud, E; Auzanneau, G; Cony-Makoul, P; Cordonnier, C; Dombret, H; Dreyfus, F; Fenaux, P; Leblond, V; Stoppa, AM; Troussard, X | 1 |
Broder, LE; Charyulu, KN; Donnelly, EJ; Rao, RK; Raub, WA; Saldana, MJ; Selawry, OS; Sridhar, KS | 1 |
de Pauw, BE; Jongen-Lavrencic, M; Raemaekers, JM; Vreugdenhil, G | 1 |
Kobayashi, H; Obata, K | 1 |
Battista, C; Bevilacqua, N; Chiurazzi, B; Cocorocchio, E; Esposito, G; Iodice, G; Pacilio, G; Panza, N | 1 |
Brown, AE; Crown, JP; Gulati, SC; Jurcic, JG; Koll, B; Yahalom, J | 1 |
Huang, XL; Mei, QD; Yan, M | 1 |
Berchier, MC; Bureau, G; Dabouis, G; Libert, P; Michel, J; Paesmans, M; Ries, F; Sculier, JP; Van Cutsem, O; Vandermoten, G | 1 |
Elliott, WL; Howard, CT; Leopold, WR; Roberts, BJ | 1 |
Nardini, S | 1 |
Friedlander, M; Hammond, I; Jobling, T; Khoo, S; Marsden, D; Murray, J; Quinn, M; Steigrad, S | 1 |
Ito, H; Kimura, Y; Nakamura, H; Nomura, N; Otaka, M; Sakai, N; Shirota, T; Suzuki, A; Toyama, K; Uchida, H | 1 |
Amylon, MD; Chao, NJ; Long, GD; Nademanee, AP; Negrin, RS; O'Donnell, MR; Parker, PM; Smith, EP; Snyder, DS; Stein, AS | 1 |
Baxter, JD; DiNubile, MJ | 1 |
de Jonge, A; Karim, AB; Meyer, OW; Njo, KH; Slotman, BJ | 1 |
Broniek, A; Polowiec, Z; Rowinska-Zakrzewska, E; Wiatr, E; Zych, J | 1 |
Cingil, H; Doğan, B; Harmanyeri, Y; Oztek, I; Sayrak, H | 1 |
Harada, H; Higuchi, T; Maeda, T; Miyoshi, Y; Mori, H; Niikura, H; Okada, S; Shimizu, T; Tada, J; Takahashi, N | 1 |
Gray, RJ | 1 |
Arriagada, R; Chomy, P; de Cremoux, H; Le Chevalier, T; Ruffié, P | 1 |
Elomaa, I | 1 |
Ayass, M; Cassano, W; Dickson, N; Enneking, W; Graham-Pole, J; Heare, M; Heare, T; Marcus, R; Saleh, R; Spanier, S | 1 |
Koshiba, K; Mukai, N; Rokkaku, S; Soh, S; Uchida, T | 1 |
Greco, FA; Hainsworth, JD; Johnson, DH; Lamar, RE; Murphy, PB | 1 |
Godwin, JE; Yuen, BH | 1 |
Kietlińska, Z; Sablińska, B; Zieliński, J | 1 |
Hahn, RG; Hatcher, PA; Richardson, RL; Zincke, H | 1 |
Gadner, H; Gatterer-Menz, I; Grois, N; Heitger, A; Ladisch, S | 1 |
Aricò, M; Egeler, RM; Favara, BE; Heitger, A; Neglia, JP; Nesbit, ME | 1 |
Eguchi, O; Inaba, N; Matsui, H; Takamizawa, H | 1 |
Donaldson, AN; Machin, D; Stephens, R; Whitehead, J | 1 |
Berchuck, A; Clarke-Pearson, DL; Evans, AC; Hammond, CB; Rodriguez, G; Soper, JT | 1 |
Kondoh, M; Miki, T; Nakamura, N; Nakano, E; Nishimura, K; Okuyama, A; Seguchi, T | 1 |
Gramer, EM; Hiremath, V; Howard, LM; Kasimis, BS; Pokorney, ES; Ruddy, P | 1 |
Beuzeboc, P; Dorval, T; Garcia-Giralt, E; Jouve, M; Livartowski, A; Mosseri, V; Palangie, T; Pouillart, P; Scholl, S | 1 |
Ashida, T; Ayabe, T; Maekawa, I; Namiki, M; Shibata, Y; Taruishi, M | 1 |
Bailey, CC; Curzon, ME; Duggal, MS; Hart, P; O'Sullivan, EA | 1 |
Akiyama, T; Kiriyama, M; Kita, I; Kosaka, T; Nakagawa, T; Nakano, Y; Saito, H; Takano, Y; Takashima, S; Tomita, F | 1 |
Babacan, E; Bökesoy, I; Cavdar, AO; Gözdaşoğlu, S; Pamĭr, A; Sunguroğlu, A; Tanindi, S; Türker, A; Unal, E; Yavuz, G | 1 |
Amer, M; Bakri, YN; Ezzat, A; Jabbar, FA; Sinner, W; Subhi, J; Tweijry, A | 1 |
Burgut, R; Doran, F; Erkişi, M; Tunali, C; Unsal, M | 1 |
Chitrathara, K; Gangadharan, VP; Nair, MK; Satishkumar, K; Sivaramakrishnan, R | 1 |
Dorigo, A; Kwan, YL; Mansberg, R | 1 |
Akatsuka, J; Furukawa, T; Nakazawa, S; Nishimura, K; Ohira, M; Okawa, Y; Sugita, K; Tsuchida, M | 1 |
Anderson, JR; Barcos, M; Burns, LJ; Cooper, MR; Gottlieb, AJ; Kirshner, JJ; Parker, B; Peterson, BA | 1 |
Igawa, M; Kadena, H; Matsuura, H; Ohkuchi, T; Ueda, M; Usui, T | 1 |
de Vries, EG; Dolsma, WV; Mulder, NH; Mulder, PO; Sleijfer, DT; van der Ploeg, E; Willemse, PH | 1 |
Gerhartz, HH; Walther, J; Wilmanns, W | 1 |
Ikeda, H; Inoue, T; Masaoka, T; Murayama, S; Ohtani, M; Shibata, H; Song, C; Tang, JT; Teshima, T; Yamazaki, H | 1 |
Fukushima, S; Miyamoto, H; Moriyama, M; Nomura, S | 1 |
Bacci, G; Battistini, A; Ferrari, S; Orlandi, M; Puggioli, C; Sassoli, V; Strazzari, S | 1 |
Bando, T; Fukuse, T; Hirata, T; Hitomi, S; Ike, O; Inui, K; Mizuno, H; Tanaka, F; Wada, H; Yokomise, H | 1 |
Hashimoto, Y; Hayashi, Y; Iwase, Y; Kato, M; Kohri, K; Mogami, T; Sasaki, S; Tugaya, M | 1 |
Bezwoda, WR; Lachter, J; Spencer, D; Stein, ME | 1 |
Anderson, JR; Armitage, JO; Bierman, P; Bishop, MR; Cowles, MK; Kessinger, A; Martin-Algarra, S; Reed, E; Tarantolo, S; Vose, JM | 1 |
Falk, M; Fridrik, MA; Haidinger, R; Hausmaninger, H; Klocker, J; Linkesch, W; Neubauer, M; Pont, J; Radaszkiewicz, T; Raudaschl, G; Schiller, L; Seewann, HL; Sill, H; Stöger, M | 1 |
Cheng, AL | 1 |
Avanzini, P; Carotenuto, M; Cavanna, L; Federico, M; Frassoldati, A; Gobbi, PG; Lombardo, M; Pieresca, C; Silingardi, V; Vallisa, D | 1 |
Ben-Arieh, Y; Ben-Shahar, M; Epelbaum, R; Freidin, N; Haim, N; Leviov, M; Reshef, R | 1 |
Fuzimoto, N; Higuchi, M; Itaya, T; Kawamura, M; Maekawa, I; Morioka, M; Nishi, K; Ohmura, T; Okabe, M; Suzuki, S | 1 |
Elonen, E; Jokipii, A; Lautenschlager, I; Lyytikäinen, O; Ruutu, P; Tiittanen, L | 1 |
Bower, M; Brock, C; Gulliford, T; Newlands, ES; O'Reilly, SM; Smith, DB | 1 |
Mempel, K; Pfetsch, M; Reiter, A; Riehm, H; Schrappe, M; Schwab, G; Welte, K | 1 |
Daxenbichler, G; Lang, T; Marth, C; Müller-Holzner, E; Widschwendter, M | 1 |
Adde, M; Arndt, C; Gootenberg, J; Horak, ID; Jaffe, E; Magrath, I; Neely, J; Nieder, M; Seibel, N; Shad, A; Venzon, D; Wittes, RA | 1 |
Adde, MA; Arndt, C; Gootenberg, J; Horak, ID; Magrath, IT; Neely, JE; Nieder, ML; Seibel, NL; Shad, AT; Venzon, DJ; Weintraub, M | 1 |
Jones, WB; Lewis, JL; Schneider, J; Shapiro, F | 1 |
Dana, A; Doshi, R; Rustin, GJ; Saldanha, GJ | 1 |
Candotti, G; Ferrari, A; Frigerio, L; Garavaglia, E; Mangili, G | 1 |
Cavanagh, D; Fiorica, JV; Gleeson, NC; Hoffman, MS; Roberts, WS | 1 |
Bastit, D; Boulet, D; Fruchart, C; Moncondult, M; Piguet, H; Stamatoullas, A; Tilly, H | 1 |
Calabresi, F; De Sanctis, V; Fiacchini, M; Gherlinzoni, F; Mandelli, F; Martelli, M; Martelli, MF; Meloni, G; Papa, G; Tura, S; Vignetti, M; Zinzani, PL | 1 |
Crowther, D; Deakin, DP; Harris, M; Morgenstern, GR; Pettengell, R; Radford, JA; Ryder, D; Scarffe, JH; Wilkinson, PM; Woll, PJ | 1 |
Enblad, G; Glimelius, B; Hagberg, H | 1 |
Bijnens, L; De Wolf-Peeters, C; Hagenbeek, A; Meerwaldt, JH; Noordijk, EM; Pittaluga, S; Somers, R; Teodorovic, I; Thomas, J | 1 |
Fujita, I; Kitagaki, H; Kono, M; Matsuo, H; Mochizuki, M; Ohashi, M; Takashima, M; Yamasaki, M | 1 |
Anderson, J; Cassileth, P; Glick, J; Gordon, LI; Habermann, TM; Schilder, RJ; Winter, JN | 1 |
Cleary, ML; Davis, RE; Kamel, OW; Soslow, RA; Warnke, RA | 1 |
Bradstock, K; Brisco, J; Enno, A; Hughes, E; McCaul, K; Morley, AA; Neoh, SH; Sykes, PJ; Szer, J | 1 |
Wils, J | 2 |
Asaka, M; Hashino, S; Imamura, M; Kasai, M; Kobayashi, S; Noto, S; Sakurada, K; Tanaka, J | 1 |
Anderson, NR; Lokich, JJ; Moore, CL | 1 |
Asaga, T; Kawahara, S; Osawa, Y; Yanoma, S; Yoshida, A | 1 |
Anderson, L; Cunningham, DC; Gregory, WM; Hancock, BW; Hoskin, PJ; Linch, DC; MacLennan, KA; Milligan, DW; Newland, AC; Stevenson, PA; Vaughan Hudson, B; Vaughan Hudson, G; Wood, JK | 1 |
Nõu, E | 1 |
Bower, M; Fife, K; Holden, L; Newlands, ES; Paradinas, FJ; Rustin, GJ | 1 |
DaSilva, V; Dent, S; Eapen, L; Girard, A; Hugenholtz, H; Stewart, DJ | 1 |
Fisher, RI; Gaynor, ER | 2 |
Gazdar, AF; Ghosh, BC; Ihde, DC; Johnson, BE; Linnoila, RI; Minna, JD; Mulshine, JL; Oie, HK; Pass, HI; Phelps, R; Russell, EK; Shaw, GL; Steinberg, SM | 1 |
Blute, ML; Lerner, SE; Richardson, RL; Zincke, H | 1 |
Flam, F; Kock, E | 1 |
Edwards, CL; Kavanagh, JJ; Kudelka, AP; Malpica, A; Varma, DG; Wright-Browne, V | 1 |
Burke, M; Crawford, DH; Hunt, BJ; Thomas, JA; Walker, H; Yacoub, M | 1 |
Haynes, AP; Iqbal, A; McQuaker, IG; Russell, NH | 1 |
Amigo, ML; Caballero, D; del Cañizo, C; Revilla, R; San Miguel, JF; Sánchez, C | 1 |
Balat, O; Edwards, CL; Kavanagh, JJ; Kudelka, AP; Silva, E; Verschraegen, CF | 1 |
Kemeny, AA; Leslie, MD; Mangili, G; Newlands, ES | 1 |
Bagshawe, KD; Foskett, M; Fuller, S; Hiscox, JG; Holden, L; Lutz, JM; Newlands, ES; Rustin, GJ; Short, D | 1 |
Borowitz, M; Bowman, WP; Buchanan, GR; Farrow, A; Jacaruso, D; Kamen, BA; Shuster, JJ; Winick, N | 1 |
Chong, R; Goh, YT; Lee, LH; Ng, HS; Tan, P; Wong, GC | 1 |
Raez, LE; Saldana, M; Temple, JD | 1 |
Hetzel, DJ; Mortel, R; Olt, GJ; Podczaski, ES; Singapuri, K; Sorosky, JI | 1 |
Higashigawa, M; Kawasaki, H; Ohkubo, T; Ooi, K; Sakurai, M | 1 |
Andersen, J; Bauer, KD; Fisher, RI; Gordon, LI; Jiang, S; Neiman, RS; Oken, MM; Variakojis, D; Winter, JN | 1 |
Kanazawa, K; Moromizato, H | 1 |
Borsi, J; Csáki, C; Ferencz, T; Horváth, J; Paál, K; Schuler, D | 1 |
Berkowitz, RS; Bernstein, MR; Goldstein, DP; Soto-Wright, V | 1 |
Akatsuka, J; Fujisawa, K; Hoshi, Y; Hurusato, M; Kobayashi, H; Maekawa, K; Uchiyama, H; Urashima, M | 1 |
Alcalá, A; Bladé, J; Estapé, J; Faura, MV; Fontanillas, M; García-Conde, J; Hernández-Nieto, L; Llorente, A; López-Guillermo, A; Maldonado, J; Montserrat, E; Viñolas, N; Zubizarreta, A | 1 |
Baba, N; Miyazawa, M; Mizuno, H; Nagatani, T; Okazawa, H; Yanagi, N | 1 |
Ben Othman, T; Binet, JL; Fardeau, C; Gerber, S; Leblond, V; Lehoang, P; Merle-Béral, H; Reux, I; Soussain, C; Sutton, L | 1 |
Behringer, D; Fetscher, S; Finke, J; Kanz, L; Lange, W; Lübbert, M; Mertelsmann, R | 1 |
Barbui, T; Bertini, M; Botto, B; Cinieri, S; Cortellazzo, S; Falda, M; Freilone, R; Grignani, F; Levis, A; Liberati, AM; Locatelli, F; Lovisone, E; Marmont, F; Pizzuti, M; Resegotti, L; Rossi, A; Viero, P; Vitolo, U | 1 |
Avanzini, P; Baldini, L; Cavanna, L; Colombi, M; Federico, M; Gobbi, P; Guffanti, A; Maiolo, AT; Pieresca, C; Silingardi, V | 1 |
Alken, P; Köhrmann, KU; Kreukler, C; Nebe, T; Siegsmund, MJ; Steidler, A | 1 |
Hanada, R; Hongo, T; Horikoshi, Y; Sakurai, M; Yajima, S | 1 |
Aydemir, U; Bierwolf, S; Brittinger, G; Engelhard, M; Gerhartz, HH; Griesser, H; Huhn, D; Lennert, K; Meusers, P; Siegert, W; Thiel, E; Tiemann, M; Wilmanns, W | 1 |
Burnett, AK; Goldstone, AH; Gray, RG; Hann, IM; Rees, JK; Stevens, RF; Wheatley, K | 1 |
Leo, E; Lindemann, A; Schlegel, PG | 1 |
De Filippis, S; Lalli, A; Nuzzo, A; Recchia, F; Torchio, P | 1 |
Golding, PF; Hamilton, CR; Kerr, J; Mead, GM; Milne, AE; O'Callaghan, A; Simmonds, PD; Smartt, P; Sweetenham, JW; Whitehouse, JM | 1 |
Garcia, R; Mass, M; McCormick, CI; Neuwelt, EA; Pearse, HD; Remsen, LG; Roman-Goldstein, S; Sexton, G | 1 |
Allan, DR; Bernstein, CN; Greenberg, H; Johnston, JB; Pimentel, M | 1 |
Baccarani, M; Barillari, G; Cerno, M; Damiani, D; Fanin, R; Geromin, A; Infanti, L; Rinaldi, C; Savignano, C; Silvestri, F; Zaja, F | 1 |
Baek, SY; Choi, GB; Choi, JH; Han, WS; Shim, KN; Sung, SH | 1 |
Baker, KS; DeLaat, CA; Filipovich, AH; Gross, TG; Harris, R; Loechelt, B; Shapiro, RS; Steinbuch, M | 1 |
Kawai, T; Maeda, H; Yamauchi, T; Yoshimura, K | 1 |
Capria, S; Mandelli, F; Meloni, G; Modena, V; Vignetti, M | 1 |
Bagshawe, KD; Begent, RH; Bower, M; Brock, C; Holden, L; Newlands, ES; Rustin, GJ; Short, D | 2 |
Basser, R; Fox, R; Goss, G; Grigg, A; Szer, J | 1 |
Begent, RH; Bower, M; Holden, L; Newlands, ES; Rustin, GJ | 1 |
Basi, GS; Earnshaw, WC; Eischen, CM; Kaufmann, SH; Kottke, TJ; Leibson, PJ; Martins, LM; Tung, JS | 1 |
Grillot, DA; Nuñez, G; Simonian, PL | 1 |
Cramer, MB; Hahne, WF; Kasimis, BS; Schulman, P; Stewart, WH; Tapazoglou, E | 1 |
el-Yazigi, A; Ezzat, A | 1 |
Bayle, C; Corti, C; Cosset, JM; Girinsky, T; Hayat, M; Nasr, F; Ribrag, V; Rougier, P; Theodore, C | 1 |
Droz, JP | 1 |
Bower, M; Brock, C; Holden, L; Makey, AR; Nelstrop, A; Newlands, ES; Rustin, GJ | 1 |
Angus, B; Cameron, DA; Cook, MK; Dawes, PJ; Dawson, AA; Evans, RG; Galloway, MJ; Harris, AL; Heppleston, A; Horne, CH; Krajewski, AS; Lennard, AL; Leonard, RC; Lessells, AM; Lucraft, HH; MacGillivray, JB; Mackie, MJ; Parker, AC; Prescott, RJ; Proctor, SJ; Roberts, JT; Taylor, PR; Thompson, WD; White, JM | 1 |
Brenner, B; Fenig, E; Hana, MB; Katz, A; Rakovsky, E; Sulkes, A | 1 |
Ellison, DW; Katapodis, O; Mead, GM; O'Callaghan, AM; Theaker, JM | 1 |
Hallahan, D; Mundt, AJ; Williams, SF | 1 |
Benaim, E; Blakley, RL; Galipeau, J; Sorrentino, BP; Spencer, HT | 1 |
Cassileth, P; Cooper, BW; Fernandez, H; Kutteh, L; Lazarus, HM; Miller, KB; Morelli, J; Pecora, AL; Roitman, D; Schenkein, DP; Stadtmauer, E | 1 |
Barbui, T; Bellavita, P; Cortelazzo, S; Marchioli, R; Marfisi, RM; Rambaldi, A; Rossi, A; Viero, P | 1 |
Lennard, L; Lilleyman, JS; Welch, JC | 1 |
Azuma, E; Higashigawa, M; Hirayama, M; Hori, H; Ido, M; Kawasaki, H; Sakurai, M | 1 |
Fukuyama, K; Hayashi, S; Kojima, M; Matsubara, S; Nagata, M; Naitoh, K; Nakahara, Y; Tominaga, M | 1 |
Fazeny, B; Fridrik, MA; Greil, R; Hausmaninger, H; Helm, W; Hudec, M; Klocker, J; Krieger, O; Neubauer, M; Oppitz, P; Pont, J; Radaszkiewicz, T; Simonitsch, I; Stöger, M | 1 |
Connors, JM; Gascoyne, RD; Hoskins, PJ; Klasa, R; Le, N; O'Reilly, S; Shenkier, T | 1 |
Bidziñski, M; Drabik, M; Lemieszczuk, B | 1 |
Drescher, CW; Swisher, E | 1 |
Sakata, Y; Tsushima, K | 1 |
Akiyama, Y; Fujino, M; Kawakami, Y; Kirisawa, T; Naya, Y; Ohe, M | 1 |
Hanazawa, T; Kimura, Y; Nagumo, M; Okano, T; Sakamaki, H; Yamaguchi, A | 1 |
Bagshawe, KD; Begent, RH; Bower, M; Holden, L; Newlands, ES; Rustin, GJ; Seckl, MJ; Short, D | 1 |
Camoriano, JK; Habermann, TM; Kurtin, PJ; Schroeder, G; Witzig, TE | 1 |
April, F; Meneghini, V; Perona, G; Pizzolo, G; Ricetti, MM; Solero, P; Tecchio, C; Todeschini, G; Veneri, D; Zanotti, R | 1 |
Araki, S; Asakura, R; Hojo, K; Itoh, A; Kawahara, M; Konishi, T; Nouchi, T; Takeda, Y; Teruya, M | 1 |
Cowie, FJ; Pinkerton, CR; Pritchard-Jones, K; Renshaw, J | 1 |
Okamoto, M | 1 |
Enblad, G; Glimelius, B; Gustavsson, A; Hagberg, H | 1 |
Adde, M; Arndt, C; Gootenberg, J; Horak, ID; Magrath, I; Neely, J; Nieder, M; Owen, W; Seibel, N; Shad, A; Venzon, D; Wilson, W | 1 |
Cheng, AL; Hung, RL; Liu, MY; Uen, WC; Wang, CH; Yeh, KH | 1 |
Buckner, JC; Lewis, JE; McElroy, EA | 1 |
Constine, LS; Hicks, DG; O'Keefe, R; Packman, CH; Rapoport, AP; Rosier, RN; Rowe, JM; Rubin, SJ | 1 |
Cadeo, G; Carosi, G; Casari, S; Donisi, A; Re, A; Rossi, G; Stellini, R | 1 |
Asami, K; Eguchi, H; Hatae, Y; Hirota, T; Iwai, A; Katano, N; Koizumi, S; Kono, Y; Matusita, T; Miyawaki, T; Mugisima, H; Nakayama, M; Nisikawa, K; Osima, K; Sekine, I; Simokawa, T; Suzumiya, J; Tanaka, A; Tsuchiya, T; Tsurusawa, M; Utumi, J; Yamamoto, Y; Yamamura, Y; Yanase, T; Yokota, S | 1 |
Bairey, O; Blickstein, D; Epstein, O; Gabbay, U; Lahav, J; Prokocimer, M; Shaklai, M; Stark, P | 1 |
Aurlien, E; Holte, H; Jakobsen, E; Kvalheim, G; Kvaløy, S; Pharo, A; Smeland, EB | 1 |
Armstrong, MJ; Bradt, CI; Galloway, SM; Greenwood, SK; Hill, RB; Hilliard, CA; Johnson, TE | 1 |
Dreger, P; Glass, B; Kuse, R; Löffler, H; Schmitz, N; Schoch, R; Sonnen, R; Uharek, L; von Neuhoff, N | 1 |
Cabanillas, F; Dong, K; Hagemeister, FB; McLaughlin, P; Moon, T; Rodriguez, MA; Rodriguez-Diaz Pavón, J; Romaguera, JE | 1 |
Anderson, E; Eden, OB; Isaksson, O; Robson, H; Shalet, S | 1 |
Bailey, C; Burrett, J; Chessells, J; Hann, I; Hill, F; Richards, S | 1 |
Bailey, NP; Barnard, DL; Bessell, EM; Child, JA; Cullen, MH; Dunn, J; Farish, J; Fletcher, J; Grieve, RJ; Jack, A; Norfolk, D; Simmons, AV; Stack, C; Stuart, NS; Woodroffe, CM | 1 |
Bloor, AJ; Marcus, RE; Seale, JR | 1 |
Iitsuka, Y; Matsui, H; Seki, K; Sekiya, S | 1 |
Chambers, JT; Cracchiolo, B; Kohorn, EI; Odunsi, KO; Parkash, V; Peck, LL; Taylor, KJ | 1 |
Bando, K; Hasegawa, Y; Ohyama, S; Shirayma, H; Taniguti, M | 1 |
Horiuchi, S; Negishi, T; Tsukamoto, T; Urushibara, M | 1 |
Brehmer, B; Jakse, G; Kapp, T; Rohde, D; Valdor, M | 1 |
Benesch, M; Kerbl, R; Lackner, H; Oberbauer, R; Pakisch, B; Schwinger, W; Urban, C | 1 |
Alla, P; Carloz, E; de Jauréguiberry, JP; Gisserot, O; Jaubert, D; Valance, J | 1 |
Kageyama, S; Ueda, T | 1 |
Hoshino, T; Iwamoto, T; Kuroko, K; Nishida, S; Shirai, C | 1 |
Ben-Bassat, I; Chetrit, A; Dreiher, J; Raamami, P; Raanani, P; Shpilberg, O | 1 |
Astori, C; Bernasconi, C; Bernasconi, P; Lazzarino, M; Orlandi, E | 1 |
Brugières, L; Deley, MC; Delsol, G; Devalck, C; Hartmann, O; Leverger, G; Meguerian-Bedoyan, Z; Pacquement, H; Pondarré, C; Robert, A; Rodary, C; Terrier-Lacombe, MJ | 1 |
Garcia, R; McCormick, CI; Neuwelt, EA; Pearse, HD; Remsen, LG; Sexton, G | 1 |
Adam, Z; Hájek, R; Hejlová, N; Klabusay, M; Korístek, Z; Krahulcová, E; Král, Z; Mayer, J; Müllerová, I; Navrátil, M; Penka, M; Tomíska, M; Vásová, I; Vodvárka, P; Vorlícek, J | 1 |
Avanzini, P; Baldini, L; Brugiatelli, M; Carotenuto, M; Clò, V; Di Renzo, N; Dini, D; Federico, M; Gobbi, PG; Lombardo, M; Silingardi, V; Vallisa, D | 1 |
Bigazzi, C; Bocchia, M; Forconi, F; Lauria, F; Marotta, G | 1 |
Brämswig, JH; Gerres, L; Jürgens, H; Schellong, G; Schlegel, W | 1 |
Enneking, WF; Lindner, NJ; Scarborough, MT; Spanier, SS | 1 |
Bae, SN; Han, KT; Jung, JK; Kim, CT; Kim, JH; Kim, SJ; Lee, JM | 1 |
Borsi, JD; Csáki, C; Ferencz, T; Horváth, J; Paál, K; Schuler, D | 1 |
Bagshawe, KD; Bower, M; Foskett, M; Holden, L; Newlands, ES; Rustin, GJ; Short, D | 1 |
Hibi, S; Imashuku, S; Kasubuchi, Y; Tsunamoto, K | 1 |
Bjarnason, GA; Cripps, C; Dulude, H; Fine, S; Franssen, E; Germond, CJ; Goel, R; Kerr, I; Maroun, JA; Moore, MJ; Oza, AM; Skillings, JR | 1 |
Anami, K; Asami, K; Chin, M; Fujimoto, T; Hatae, Y; Hirota, T; Horikoshi, Y; Ito, M; Iwai, A; Kaneko, Y; Katano, N; Kataoka, S; Kikuchi, M; Koizumi, S; Miyawaki, T; Mugisima, H; Nakayama, M; Nishikawa, K; Osima, K; Suzumiya, J; Taga, T; Tanaka, A; Tsurusawa, M; Watanabe, A; Yanase, T | 1 |
Mrestani, Y; Neubert, R | 1 |
Dobashi, N; Kuraishi, Y; Usui, N | 1 |
Cavalli, F; Ghielmini, M; Sanna, P; Van den Bosch, S | 1 |
Berger, C; Braumann, D; de Witt, M; Erttmann, R; Fiedler, W; Grimm, J; Horstmann, M; Hossfeld, KD; Illiger, HJ; Kabisch, H; Kröger, N; Krüger, W; Kuse, R; Schönrock, P; Stockshläder, M; Weh, HJ; Zander, AR; Zeller, W | 1 |
Chikazawa, H; Fujimoto, S | 1 |
Boerman, RH; Mattijssen, V; Mulder, AH; Raemaekers, JM | 1 |
Bailey, CC; Gattamaneni, HR; Lashford, LS; Lewis, IJ; Michelagnoli, MP | 1 |
Coleman, RE; Gillespie, AM; Hancock, BW; Siddiqui, N | 1 |
Coleman, RE; Dobson, LS; Gillespie, AM; Hancock, BW | 1 |
Chiba, S; Hirai, H; Honda, H; Kanda, Y; Yazaki, Y | 1 |
Chumakov, PM; Kopnin, BP; Semeniak, OIu | 1 |
Alessandri, JL; Attali, T; Dubern, B; Montbrun, A; Pilorget, H; Samperiz, S | 1 |
Drag-Zalesińska, M; Gebarowska, E; Wysocka, T; Zabel, M | 1 |
Gebarowska, E; Kołodziej, J; Majewski, A; Zabel, M | 1 |
Alba, E; Aparicio, J; Barnadas, A; Garcia del Muro, X; Germà-Lluch, JR; Sánchez, M; Tabernero, JM | 1 |
Baas, F; Borst, P; de Haas, M; de Vree, JM; Elferink, RP; Jansen, G; Kool, M; Peters, GJ; Ponne, N; Scheffer, GL; Scheper, RJ; Smith, AJ; van der Linden, M | 1 |
Brocchieri, A; Grignani, G; Maiolo, A; Merlo, EM; Tua, A | 1 |
Manabe, T; Sadahira, Y; Sugihara, T; Yawata, Y | 1 |
Froelich, JJ; Schneller, FR; Zahn, RK | 1 |
Akyol, D; Baltaci, V; Gökmen, O; Kozinoglu, H; Mungan, T; Oguz, S; Oztekin, O | 1 |
Hatzl-Griesenhofer, M; Huber, H; Maschek, W; Pichler, R; Wahl, G; Wimmer, G | 1 |
Daskalakis, A; Lange, W; Musahl, V; von Lintig, F; Waller, CF | 1 |
Alvarez Román, MT; Canales Albendea, MA; del Pozo Pozo, I; Hernández Navarro, F | 1 |
Bargetzi, M; Heitzmann, F; Obeid, L; Schär, B | 1 |
Fushiki, H; Hasegawa, K; Izumi, R; Kono, I; Nishida, M; Noda, K; Noguchi, H; Okuda, H; Sugimori, H; Takizawa, K; Tanaka, T; Udagawa, Y; Umesaki, N; Yamamoto, K | 1 |
Chott, A; Ebell, W; Graf, N; Henze, G; Klingebiel, T; Kremens, B; Ludwig, WD; Mann, G; Müller-Weihrich, S; Plüss, HJ; Reiter, A; Riehm, H; Schrappe, M; Tiemann, M; Yakisan, E; Zimmermann, M; Zintl, F | 1 |
Cassileth, PA; Flynn, P; Ghosh, C; Glick, J; Gordon, LI; Habermann, TM; Weller, E; Winter, JN; Young, M | 1 |
Bonadonna, G; Ferreri, AJ; Giardini, R; Rampinelli, I; Siracusano, L; Tondini, C; Valagussa, P | 1 |
Bisagni, G; Boni, C; Ceci, G; Cocconi, G; De Lisi, V; Di Blasio, B; Morandi, P; Passalacqua, R; Savoldi, L; Zadro, A | 1 |
Acito, L; Anastasi, P; Bella, M; Bisagni, G; Borrini, A; Buzzi, P; Carpi, A; Cocconi, G; Di Costanzo, F; Frassoldati, A; Mosconi, A | 1 |
Abate, G; Bianco, AR; Catalano, G; D'Aprile, M; Dammacco, F; De Lena, M; De Vita, F; Lauta, VM; Lorusso, V; Lucarelli, G; Mantovani, G; Marzullo, F; Palmieri, G; Polimeno, G | 1 |
Fekete-Forgács, K; Kis, B; Lenkey, B; Nagy, G | 1 |
Ozbek, N; Tuncer, AM; Yetgin, S | 1 |
Holden, L; Mulholland, PJ; Newlands, ES; Rustin, GJ; Seckl, MJ | 1 |
Chihara, K; Inoue, R; Iwata, N; Kajimoto, Y; Matsui, T; Matsuoka, H; Natazuka, T; Shimoyama, M; Tamekane, A | 1 |
Ascari, E; Avanzini, P; Baldini, L; Broglia, C; Ghirardelli, ML; Gobbi, PG; Loni, C; Quarta, G; Silingardi, V; Stelitano, C | 1 |
Cunningham, DC; Gregory, WM; Hancock, BW; Hoskin, PJ; Linch, DC; Maclennan, KA; Milligan, D; Newland, AC; Smith, P; Stevenson, PA; Vaughan, B; Vaughan, G; Wood, JK | 1 |
Eden, OB; Gibson, B; Hann, I; Hill, F; Kinsey, S; Lilleyman, J; Mitchell, C; Richards, S; Vora, A | 1 |
Akutsu, M; Bai, L; Furukawa, Y; Ichikawa, A; Kano, Y; Kon, K; Suzuki, K; Tsunoda, S | 1 |
Auclerc, MF; Auvrignon, A; Baruchel, A; Bauduer, F; Berthou, C; Bordigoni, P; Demeocq, F; Lamagnere, JP; Landman-Parker, J; Leblanc, T; Legall, E; Leverger, G; Mathey, C; Michel, G; Pautard, B; Perel, Y; Schaison, G; Schneider, P | 1 |
Huang, J; Sun, Y; Zhang, X | 1 |
Billio, A; Coser, P; Fabris, P; Pescosta, N; Rosanelli, C | 1 |
Caracciolo, D; Corradini, P; Cuttica, A; Gavarotti, P; Ladetto, M; Novero, D; Pileri, A; Rossi, G; Tarella, C; Zallio, F | 1 |
Benz, MS; Kramer, D; Murray, TG; Scott, IU; Toledano, S | 1 |
Bonnefoy-Berard, N; Ferraro, C; Prigent, AF; Quemeneur, L; Revillard, JP; Taverne, C | 1 |
Gillespie, AM; Hancock, BW; Kumar, S | 1 |
Coleman, RE; Dobson, LS; Hancock, BW; Lorigan, PC | 1 |
Lei, S; Ogiso, Y; Omura, S; Tomida, A; Tsuruo, T | 1 |
Balcerzak, SP; Dana, BW; Fisher, RI; Forman, JD; Gaynor, ER; Kjeldsberg, C; LeBlanc, M; Miller, T; Roy, V; Unger, JM | 1 |
Omura, GA | 1 |
Kanazawa, K; Sakumoto, K; Suzuki, T | 1 |
Iitsuka, Y; Matsui, H; Seki, K; Sekiya, S; Suzuka, K | 1 |
Baron, B; Bleiberg, H; Bodenstein, H; Couvreur, ML; Ducreux, MP; Lacave, AJ; Nordlinger, B; Paillot, B; Piedbois, P; Planker, M; Rougier, P; Santos, JG; Schmoll, HJ; Van Cutsem, E; Vanhoefer, U; Wilke, H; Wils, JA | 1 |
Ajani, JA; Yao, JC | 1 |
Bash, R; Hosler, GA; Scheuermann, RH | 1 |
Collins, MK; Gutierrez del Arroyo, A; Palacios, C; Silva, A | 1 |
Luo, Y; Wang, A; Wang, Z | 1 |
Estlin, EJ; Hall, AG; Lowis, SP | 1 |
Ammatuna, E; Barbera, V; Florena, AM; Franco, V; Gerlando, Q; Mariani, G | 1 |
Bosly, A; Brice, P; Brière, J; Coiffier, B; Gaulard, P; Gisselbrecht, C; Haioun, C; Lederlin, P; Lepage, E; Morel, P; Nouvel, C; Reyes, F; Salles, G; Sebban, C; Tilly, H | 1 |
Anthoney, A; de Bono, JS; Graham, J; Kaye, SB; Kirk, D; Paul, J; Simpson, A; Underwood, M | 1 |
Campbell, MJ; George, SL; Julious, SA; Machin, D; Walker, SJ | 1 |
Cazals-Hatem, D; Chevret, S; Clauvel, JP; Dubreuil, ML; Gerard, L; Levy, Y; Matheron, S; Oksenhendler, E | 1 |
Chizzali-Bonfadin, C; Filipits, M; Heinzl, H; Jaeger, U; Pirker, R; Simonitsch, I | 1 |
Ichikawa, Y; Kubo, T; Minami, R; Nishida, M; Nozue, A; Tsunoda, H | 1 |
Behm, FG; Boyett, JM; Campana, D; Coustan-Smith, E; Hancock, ML; Pui, CH; Raimondi, SC; Ribeiro, RC; Rivera, GK; Rubnitz, JE; Sancho, J; Sandlund, JT | 1 |
Sakai, C; Takagi, T; Tamaru, J; Tsujimura, H | 1 |
Hirayama, Y; Koyama, R; Matsunaga, T; Nagai, T; Niitsu, Y; Ohta, H; Sakamaki, S | 1 |
Blume, KG; Hoppe, RT; Horning, SJ; Hu, WW; Johnston, LJ; Negrin, RS; Stockerl-Goldstein, KE | 1 |
Carella, AM; Cavaliere, M; Corsetti, MT; De Stefano, F; Ferrara, R; Lambelet, P; Lerma, E; Loni, C; Pinotti, G; Romanelli, A; Tedeschi, L; Valbonesi, M; Verdiani, S; Vinci, M | 1 |
Bacci, G; Bertoni, F; Campanacci, M; Casadei, R; Fabbri, N; Ferrari, S; Forni, C; Longhi, A; Picci, P; Ruggieri, P; Versari, M | 1 |
Cheng, DK; Ng, TY; Ngan, HY; Wong, LC | 1 |
Bajwa, RP; Reid, MM; Skinner, R; Wariyar, UK; Windebank, KP | 1 |
Achour, E; Azar, N; Belanger, C; Cassoux, N; Delattre, JY; Gerber, S; Hoang-Xuan, K; Leblond, V; Levy, V; Ribrag, V; Soussain, C; Suzan, F | 1 |
Fenstad, GU; Skovlund, E | 1 |
Chan, JK; Cheung, MM; So, JC; Wong, KF | 1 |
Iitsuka, Y; Matsui, H; Seki, K; Sekiya, S; Suzuka, K; Yamazawa, K | 1 |
Weiss, M | 1 |
Artusi, T; Bonacorsi, G; Longo, L; Rivasi, F; Rossi, G | 1 |
Han, S; Xiang, Y; Yang, X | 1 |
Douglas, R; Michael, B; Nabil, S; Thomas, F | 1 |
Azzarà, A; Capochiani, E; Carulli, G; Petrini, M; Rizzuti-Gullaci, A | 1 |
De Marzi, P; Garavaglia, E; Mangili, G; Taccagni, G; Zanetto, F | 1 |
Eden, O; Gibson, B; Hann, I; Harrison, C; Harrison, G; Hill, F; Richards, S; Vora, A | 1 |
Auperin, A; Behrendt, H; Coze, C; Frappaz, D; Leverger, G; Lutz, P; Michon, J; Patte, C; Perel, Y; Raphaël, M; Terrier-Lacombe, MJ | 1 |
Kanda, Y; Mineishi, S; Murakami, J; Ogasawara, T; Saito, T; Seo, S; Shoji, N; Takaue, Y; Tanosaki, R; Tobinai, K | 1 |
Fletcher, BD; Harrison, PL; Kaste, SC; Kennedy, W; Neel, MD; Pui, CH; Razzouk, BI; Relling, MV; Ribeiro, RC; Rubnitz, JE; Sandlund, JT | 1 |
Bernard, M; Casassus, P; Delain, M; Desablens, B; Guilhot, F; Hunault-Berger, M; Ifrah, N; Jouet, JP; Milpied, N; Sadoun, A | 1 |
Ben-Arie, A; Biran, H; Dgani, R; Hagay, Z; Open, M; Piura, B | 1 |
Altintaş, A; Vardar, MA | 1 |
Akiyoshi, K; Ayukawa, H; Eguchi, H; Ishii, E; Kamizono, J; Kawakami, K; Kinukawa, N; Koga, H; Kuroda, H; Matsuzaki, A; Okamura, J; Tamai, Y; Yanai, F | 1 |
Aurlien, E; Holte, H; Jakobsen, E; Kvalheim, G; Kvaløy, S; Rusten, LS | 1 |
Cernilová, I; Doubek, M; Klabusay, M; Korístek, Z; Mayer, J; Navrátil, M; Petráková, K; Vásová, I; Vodvárka, P; Vorlícek, J | 1 |
Croockewit, AJ; Fibbe, WE; Kingma, T; Uyl-de Groot, CA; van Agthoven, M; van Imhoff, GW; van Oers, MH; Vellenga, E; Verdonck, LF; Volkers, CP; Wijermans, PJ | 1 |
Barbui, T; Benedetti, F; Cavalli, F; Cortelazzo, S; Di Nicola, M; Ghielmini, M; Gianni, AM; Oldani, E; Pogliani, E; Rambaldi, A; Rossi, A; Tarella, C; Vitolo, U; Zaglio, F | 1 |
Böhmer, S; Goeschen, K; Gurlit, L; Hartlapp, HJ; Krech, R; Lampe, S | 1 |
Götze, HJ; Lerch, O; Teutenberg, T; Zinn, P | 1 |
Bertino, JR; Cordon-Cardo, C; Elisseyeff, Y; Faircloth, G; Jhanwar, S; Jimeno, J; Li, WW; Takahashi, N | 1 |
Barcos, M; Bloomfield, CD; Freter, CE; Frizzera, G; Johnson, JL; Lee, EJ; Peterson, BA; Petroni, GR; Schiffer, CA | 1 |
Alvarez, E; García, MG; Hajos, SE; Lopes, EC; Vellón, L | 1 |
Bertè, R; Cavanna, L; Civardi, G; Lazzaro, A; Moroni, CF; Vallisa, D | 1 |
Hinterleitner, T; Kerbl, R; Schwinger, W; Smolle Juettner, FM; Urban, C; Zotter, H | 1 |
Chao, TY; Chen, YC; Ho, CL; Hwang, JM; Kao, WY; Sheu, LF | 1 |
Anselmo, AP; Brosteanu, O; Diehl, V; Doelken, G; Duehmke, E; Engert, A; Franklin, J; Georgii, A; Greil, R; Hasenclever, D; Herrmann, R; Josting, A; Kirchner, H; Koch, P; Koch, T; Lathan, B; Loeffler, M; Munker, R; Paulus, U; Pfistner, B; Pfreundschuh, M; Rueffer, U; Schalk, KP; Sieber, M; Tesch, H; Wolf, J | 1 |
Haran, M; Klepfish, A; Lurie, Y; Malnick, S; Shtalrid, M | 1 |
Akiba, M; Bessho, M; Hirashima, K; Itoh, K; Itoh, Y; Kashimura, T; Kawai, N; Kishimoto, K; Matsuda, A; Murohashi, I; Sakata, T; Suzuki, T; Takahashi, T; Tominaga, K; Wakao, D; Yagasaki, F; Yoshida, K | 1 |
Gillmore, R; Kendall, A; Newlands, E | 1 |
Andres-Mateos, E; Arnalich, F; Arnalich, FM; De la Fuente, M; Fernández-Capitán, C; Hernanz, A; López-Maderuelo, D; Montiel, C | 1 |
Bamberg, M; Dieckmann, K; Kortmann, RD; Kühl, J; Meisner, C; Pietsch, T; Timmermann, B | 1 |
Ariatti, C; Bertini, M; Boccomini, C; Botto, B; Calvi, R; Capello, D; Carbone, A; Freilone, R; Gaidano, G; Gallo, E; Gloghini, A; Milan, I; Novero, D; Orsucci, L; Palestro, G; Parvis, G; Pregno, P; Saglio, G; Vitolo, U; Vivenza, D; Zagonel, V | 1 |
Baker, KS; Nagarajan, R; Neglia, J; Ramsay, N | 1 |
Hara, T; Hattori, H; Ishii, S; Matsuzaki, A; Suminoe, A | 1 |
Bergauer, F; Dimpfl, T; Janni, W; Kaestner, R; Linka, F; Rack, B; Rjosk, D; Schindlbeck, C; Sommer, H; Strobl, B | 1 |
Foskett, M; Holden, L; McNeish, IA; Newlands, ES; Rustin, GJ; Seckl, MJ; Strickland, S | 1 |
Agbalika, F; Boulanger, E; Daniel, MT; Grollet, L; Maarek, O; Molina, JM; Oksenhendler, E; Sigaux, F | 1 |
Bordessoule, D; Bosly, A; Coiffier, B; Deconninck, E; Divine, M; Dupriez, B; Fillet, G; Gaulard, P; Gisselbrecht, C; Herbrecht, R; Lepage, E; Nouvel, C; Tilly, H | 1 |
Brooks, SE; Goldstein, DP; Ioffe, O; Knox, S; Meisenberg, B; Wong-You-Cheong, J | 1 |
Hisada, T; Ito, T; Masuda, S; Mochida, A; Morinari, H; Nakahara, K; Nishi, K; Saito, K; Sasaki, S; Tahara, M; Yakumaru, K | 1 |
Döhner, H; Gabler, A; Haas, R; Hartmann, F; Hensel, M; Ho, AD; Jung, W; Schlenk, RF; Trümper, L; Weber-Nordt, R | 1 |
Advani, SH; Banavali, SD; Bhatia, KG; Magrath, I; Naresh, KN; Soman, CS | 1 |
Damon, L; Linker, C; Navarro, W; Ries, C | 1 |
Aggarwal, S; Arora, A; Bhalla, S; Murthy, SA; Singh, B; Vohra, R | 1 |
Armata, J; Balcerska, A; Bogusławska-Jaworska, J; Bubala, H; Dluzniewska, A; Gacka, M; Jaworski, W; Jeleń, M; Kazanowska, B; Kowalczyk, J; Kołecki, P; Kurylak, A; Matysiak, M; Ploszyńska, A; Rokicka-Milewska, R; Sońta-Jakimczyk, D; Sopylo, B; Stańczak, E; Stefaniak, MJ; Stefańska, K; Wróbel, G; Wysocki, M | 1 |
Akaza, H; Hattori, K; Kawai, K; Miyanaga, N; Shimazui, T; Tsukamoto, S; Uchida, K | 1 |
Davies, JH; Evans, BA; Gregory, JW; Jenney, ME | 1 |
Gerrard, M; Hobson, R; Imeson, J; McCarthy, K; Pinkerton, CR; Williams, DM | 1 |
Chen, CL; Chiu, LM; Hung, JH; Wang, PH; Yang, ML | 1 |
Casanova, M; Cefalo, GS; Collini, P; Ferrari, A; Fossati-Bellani, F; Gasparini, M; Luksch, R; Massimino, M; Polastri, D; Spreafico, F; Terenziani, M | 1 |
Amo, S; Bargatze, RF; Benson, E; Cao, J; De Laszlo, SE; Detmers, PA; Egger, LA; Hagmann, WK; Kidambi, U; Kopka, IE; Lanza, T; Lin, LS; Lingham, R; McCauley, E; Mumford, RA; Pikounis, B; Schmidt, JA; Tong, S; Van Riper, G; Warwood, S; Young, DN | 1 |
Ansoborlo, S; Babin-Boilletot, A; Baruchel, A; Pacquement, H; Patte, C; Plouvier, E; Sakiroglu, C | 1 |
Amato, RJ; Daliani, D; Do, KA; Finn, L; Fizazi, K; Kim, J; Logothetis, CJ; Millikan, RE; Pagliaro, LC; Papandreou, CN; Prow, DM; Tu, SM; Wang, X | 1 |
Holden, L; McNeish, I; Newlands, ES; Rustin, GJ; Seckl, MJ; Strickland, S | 1 |
Clemente González, C; García Parés, D; García-Bragado Dalmau, F; Guardia Sánchez, R; Pérez Ayuso, MJ; Porcar Ramells, C | 1 |
Grigg, A; Guarnaccia, C; Hatton, CS; Lewis, MS; McKendrick, J; Mead, GM; Norbert, P; Pescosta, N; Stenning, SP; Sydes, MR; Walewski, J; Wright, D | 1 |
Kellie, SJ; Lockwood, L; Mauger, DC; Pozza, LD; Waters, KD; White, L; Wong, CK | 1 |
Chen, H; Chen, J; Fu, RY; Gu, LJ; Pan, C; Tang, JY; Wang, YP; Wu, Y; Xue, H; Zhao, H | 1 |
Shimizu, T; Yaegashi, N | 1 |
Badgwell, B; Carson, WE; Dierksheide, J; Magro, C; Parihar, R; Russo, T | 1 |
Fukuno, K; Goto, H; Hara, T; Kanemura, N; Kasahara, S; Moriwaki, H; Oyama, M; Sawada, M; Shimizu, M; Takami, T; Tsurumi, H; Yamada, T; Yoshikawa, T | 1 |
Alici, S; Argon, A; Aydiner, A; Basaran, M; Eralp, Y; Saip, P; Topuz, E | 1 |
Aurer, I; Bogdanić, V; Duraković, N; Kovacević-Metelko, J; Labar, B; Mikulić, M; Mrsić, M; Nemet, D; Radman, I; Sertić, D; Zupancić-Salek, S | 1 |
Angrilli, F; Di Lorenzo, R; Di Marzio, A; Fioritoni, G; Liberatore, E; Pennese, E | 1 |
Fenner, MH; Possinger, K | 1 |
Berkow, RL; Hilliard, LM; Watts, RG | 1 |
Kawasaki, T; Nakayama, M; Oka, K; Okane, M; Shiina, H; Tanno, W | 1 |
Hori, M; Koyama, K; Ogasawara, T; Tsubamoto, H; Tsuji, Y | 1 |
Crocci, AJ; Lopes, LF; Minicucci, EM | 1 |
Hino, N; Ishibashi, K; Kanaji, N; Uno, H | 1 |
Boulanger, E; Brière, J; Droz, D; Gaulard, P; Oksenhendler, E | 1 |
Southcott, BM; Stewart, AJ | 1 |
Levine, AM | 1 |
Berry, LR; Chan, AK; Paredes, N; Xu, L | 1 |
Jereb, B; Macedoni-Luksic, M; Todorovski, L | 1 |
Al Awadi, S; Al Shemmari, S; Bajciova, V; Mottl, H; Nemec, J | 1 |
Bar Sela, G; Gaitini, D; Haim, N; Steiner, M; Tsalic, M | 1 |
Iitsuka, Y; Matsui, H; Seki, K; Sekiya, S; Suzuka, K; Tanaka, N; Yamazawa, K | 1 |
Arellano-Rodrigo, E; Bessell, EM; Graus, F; López-Guillermo, A; Montserrat, E; Nomdedeu, B | 1 |
Avilés, A; Calva, A; Fernández, R; Huerta-Guzmán, J; Nambo, MJ; Neri, N | 1 |
Bacci, G; Longhi, A; Macchiagodena, M; Vitali, G | 1 |
Corbacioglu, S; Eber, S; Gungor, T; Hummerjohann, J; Niggli, F | 1 |
Cetin, M; Yetgin, S | 1 |
Lauterbach, I; Mann, G; Niemeyer, C; Parwaresch, R; Reiter, A; Riehm, H; Schrappe, M; Seidemann, K; Simonitsch, I; Stankewitz, K; Tiemann, M; Zimmermann, M | 1 |
Baertschi, E; Bargetzi, MJ; Mironov, A; Notter, M; Wernli, M | 1 |
Hagimoto, T; Kanda, M; Maeda, K; Ohshima, K; Okada, M; Sakamoto, A; Sonoda, T; Suzumiya, J; Tamura, K; Wakamatsu, S | 1 |
Dalrymple, C; Lee, V; Parker, A; Russell, P; Valmadre, S | 1 |
Distel, L; Grabenbauer, G; Holter, W; Neubauer, S; Varon, R | 1 |
Barbui, T; Boccadoro, M; Cortelazzo, S; Coser, P; Cuttica, A; De Crescenzo, A; Di Nicola, M; Di Renzo, N; Federico, M; Gallamini, A; Gallo, E; Gianni, AM; Levis, A; Liberati, M; Musso, M; Pavone, E; Pescarollo, A; Pileri, A; Pregno, P; Romano, R; Rosanelli, C; Rosato, R; Santini, G; Tarella, C; Vitolo, U | 1 |
Doolittle, ND; Kraemer, DF; Lacy, C; Neutwelt, EA; Siegal, T; Tyson, RM | 1 |
Ansink, AC; Lok, CA; ten Kate-Booij, MJ; van der Houwen, C; van Eijkeren, MA | 1 |
Amess, J; Cornelius, V; Delves, T; Fitzgibbon, J; Last, KW; Lister, TA; Norton, A; Rohatiner, AZ; Sieniawska, C; Wilson, A | 1 |
Albertsson, P; Lennernäs, B; Lennernäs, H; Norrby, K | 1 |
Chang, TT; Chang, WH; Chen, RL; Hsiao, TC; Hung, IJ; Lin, DT; Lin, KH; Lin, KS; Lin, MT; Lu, MY; Shu, SG; Wu, CT; Yang, CP; Yang, RS | 1 |
Cole, SP; Deeley, RG; Gu, HM; Muredda, M; Vasa, M; Zhang, DW | 1 |
Boccadoro, M; Caracciolo, D; Cuttica, A; Dell'Aquila, M; Di Nicola, M; Gianni, AM; Ladetto, M; Magni, M; Marinone, C; Pileri, A; Rosace, M; Tarella, C; Zallio, F | 1 |
Mead, G; Woodcock, J; Young, C | 1 |
Goy, A; Hedrick, E; Moskowitz, C; Noy, A; Portlock, C; Qin, J; Straus, DJ; Teruya-Feldstein, J; Wang, ES; Zelenetz, AD | 1 |
Ren, T; Wan, XR; Xiang, Y; Yang, XY; Zhang, ZY | 1 |
BOLLOBAS, B | 1 |
Brunet, S; Esteve, J; Feliu, E; Fernández-Abellán, P; Ribera, JM; Sanz, MA; Xicoy, B | 1 |
Alinari, L; Baccarani, M; Stefoni, V; Vianelli, N; Zinzani, PL | 1 |
Begent, RH; Fuller, S; Gaffan, J; Holden, L; Newlands, ES; Rustin, GJ; Seckl, MJ; Short, D | 1 |
Abrey, LE; Anderson, ND; Caron, D; Correa, DD; Crump, M; DeAngelis, LM; Forsyth, P; Mason, WP; Moskowitz, CH; Nimer, SD; Paleologos, N; Stewart, D; Zelenetz, A | 1 |
Ekinci, C; Günalp, I; Gündüz, K; Taçyildiz, N; Unal, E; Yavuz, G | 1 |
Dekker, AW; Mandigers, CM; Meijerink, JP; Raemaekers, JM; Schattenberg, AV; Verdonck, LF | 1 |
Bilgin, T; Ozan, H; Ozkan, L; Ozuysal, S | 1 |
Bozorgi, K; Escobar, PF; Fishman, DA; Lurain, JR; Singh, DK | 1 |
Davidson, KL; Devaney, MB; Dunlop, DJ; Johnson, PR; Mackie, MJ; Rogers, SY; Thomas, RV; Tighe, JE | 1 |
Arima, N; Arimura, K; Hamada, H; Kukita, T; Matsushita, K; Tei, C | 1 |
Hanioka, K; Maeda, A; Matsushita, A; Nagai, K; Sugimoto, N; Takahashi, T; Watanabe, N | 1 |
Ansink, AC; Lammes, FB; Lok, CA; Rietbroek, RC; Ten Kate-Booij, MJ; van der Houwen, C | 1 |
Ambrosetti, A; Cabras, MG; Di Vito, F; Fioritoni, G; Gabbas, A; Gallamini, A; Gallo, E; Gargantini, L; Gottin, L; Lazzarino, M; Menestrina, F; Morra, E; Orlandi, E; Palestro, M; Pasini, F; Paulli, M; Pizzolo, G; Pizzuti, M; Rossi, G; Secchi, S; Tarella, C; Tecchio, C; Todeschini, G; Vitolo, U | 1 |
Bhala, N; Coleman, JM; Coleman, RE; George, J; Hancock, BW; Hatton, MQ; Horsman, JM; Radstone, CR | 1 |
Abrey, LE; DeAngelis, LM; Lai, R; Rosenblum, MK | 1 |
Cardozo-Pelaez, F; Chan, SL; Chrest, FJ; Emokpae, R; Gorospe, M; Kruman, II; Mattson, MP; Smilenov, L; Wersto, RP | 1 |
Aleksza, M; Gergely, L; Illés, A; Ponyi, A; Sipka, S; Szegedi, G; Váróczy, L | 1 |
Elinder, G; Kimby, E; Sverrisdottir, A | 1 |
Fisher, D; Howard, O; Lacasce, A; Lib, S; Neuberg, D; Shipp, M; Weng, A | 1 |
Behtash, N; Ghaemmaghami, F; Hanjani, P; Soleimani, K | 1 |
Duman, RS | 1 |
Iitsuka, Y; Matsui, H; Mitsuhashi, A; Sekiya, S; Suzuka, K; Yamazawa, K | 1 |
Sun, Z; Wan, X; Xiang, Y; Yang, X | 1 |
Chen, XQ; Guan, ZZ; He, YJ; Huang, HQ; Jiang, WQ; Li, YH; Lin, TY; Liu, DG; Su, YS; Sun, XF; Xia, Y; Xia, ZJ; Zhang, L; Zhen, ZJ; Zhou, ZM | 1 |
Kawaguchi, T; Kumabe, T; Tominaga, T; Watanabe, M | 1 |
Avramis, V; Douglas, JG; Felgenhauer, J; Geyer, JR; Hawkins, DS; Holcenberg, J; Loken, MR; Meshinchi, S; Park, JR; Thomson, B | 1 |
Acquatella, G; Carneiro, M; García, R; Gómez, R; Hernández, M; Insausti, CL; Nouel, A; Santos, S | 1 |
Bonazzi, C; Buda, A; Cantú, MG; Dell'Anna, T; Sacco, S; Urso, M | 1 |
Aragane, Y; Hashimoto, K; Isogai, R; Kanamaru, A; Kawada, A; Maeda, Y; Tezuka, T | 1 |
Ikarashi, Y; Imai, C; Kakihara, T; Tanaka, A; Uchiyama, M; Watanabe, A | 1 |
Al-Izzi, M; Constantinou, J; McNicholas, TA; Nitkunan, T | 1 |
Batchelor, AG; Liddington, MI; Rawlins, JM; Towns, G | 1 |
Baldinger, C; Fridrik, MA; Greil, R; Hausmaninger, H; Klocker, J; Krieger, O; Linkesch, W; Oberaigner, W; Pont, J | 1 |
Eden, OB; Ng, A; Ravetto, PF; Taylor, GM; Wynn, RF | 1 |
Berdel, WE; Diehl, V; Dörken, B; Engert, A; Glossmann, JP; Hossfeld, DK; Josting, A; Kirchner, HH; Kisro, J; Mapara, M; Metzner, B; Rudolph, C; Sieber, M; Sienawski, M; Sieniawski, M | 1 |
Chi, SN; Finlay, JL; Gardner, SL; Knopp, EA; Levy, AS; Miller, DC; Weiner, HL; Wisoff, JH | 1 |
Berta, M; Bertoni, F; del Prever, AB; Fagioli, F; Ferrari, S; Mercuri, M | 1 |
Eren, E; Metindir, J; Ozdilekcan, C; Pak, I | 1 |
Deák, B; Eid, H; Esik, O; Horváth, A; Horváth, GI; Keresztes, S; Lengyel, Z; Lovey, J; Molnár, Z; Rosta, A; Schneider, K; Schneider, T; Tóth, E; Várady, E | 1 |
Alterini, R; Bernardi, F; Bosi, A; Carrai, V; Longo, G; Nassi, L; Rigacci, L | 1 |
Mikami, K; Miki, T; Mizutani, Y | 1 |
Cho, KJ; Cho, SG; Lee, DH | 1 |
Bex, A; Horenblas, S; Kerst, M; Meinhardt, W; Nieuwenhuijzen, JA; Pos, F; van Boven, H | 1 |
Matsui, H; Mitsuhashi, A; Seki, K; Sekiya, S; Suzuka, K; Tanaka, N; Yamazawa, K | 1 |
Hondoh, H; Morii, K; Onda, K; Shinbo, Y; Takahashi, H; Takeuchi, S; Tamura, T; Tanaka, R; Yamanaka, R | 1 |
Benchekroun, S; Benhmiddoune, L; Harif, M; Madani, A; Quessar, A; Zafad, S | 1 |
Bode, U; Deinlein, F; Emser, A; Graf, N; Kortmann, RD; Kuehl, J; Ottensmeier, H; Pietsch, T; Rutkowski, S; Soerensen, N; Warmuth-Metz, M; Wolff, JE | 1 |
Rao, PS | 1 |
Gou, HF; Hou, M; Li, L; Qiu, M; Yan, X; Zhu, J | 1 |
Sun, ZJ; Wan, XR; Xiang, Y; Yang, XY | 1 |
Ren, T; Wan, XR; Xiang, Y; Yang, XY; Zhang, Y | 1 |
Lurain, JR; Nejad, B | 1 |
Filipovich, AH; Gadner, H; Henter, JI; Horne, A; Imashuku, S; Janka, G; Ladisch, S; Locatelli, F; Maarten Egeler, R; Montgomery, SM; Webb, D; Winiarski, J | 1 |
Abella, E; Brunet, S; del Potro, E; Esteve, J; Oriol, A; Ribera, JM | 1 |
Chaudhari, N; Kim, JW; Landin, AM | 1 |
Chaku, J; Kellie, SJ; Lockwood, LR; O'Regan, P; Waters, KD; Wong, CK | 1 |
Donovan, MD; Kandimalla, KK | 1 |
Hobson, R; Morland, B; Ng, A; Williams, D | 1 |
Akçören, Z; Büyükpamukçu, M; Kiratli, H; Köksal, Y; Varan, A | 1 |
Brodsky, I; Rosenbluth, JZ; Styler, MJ; Zak, D | 1 |
Takahashi, H; Tanaka, R | 1 |
Lapeyre-Mestre, M; Montastruc, JL; Pathak, A; Rigal-Huguet, F; Tournamille, JF | 1 |
Danilatou, V; Kalmanti, M; Mantadakis, E; Papadhimitriou, S; Paterakis, G; Stiakaki, E | 1 |
Fisher, RI; LeBlanc, M; Maloney, DG; Miller, TP; Press, OW; Unger, JM | 1 |
Al-Rajhi, N; Connors, JM; Gascoyne, RD; Klasa, R; Paltiel, C; Savage, KJ; Voss, N | 1 |
Im, YH; Jung, CW; Kang, JH; Kang, WK; Kim, K; Kim, WS; Ko, YH; Lee, J; Lee, MH; Lee, SH; Park, BB; Park, JO; Park, K; Park, KW; Park, YS | 1 |
Bosq, J; Casassus, P; Diviné, M; Dupriez, B; Koscielny, S; Le Maignan, C; Pico, JL; Raphaël, M; Ribrag, V; Sebban, C; Stamattoulas, A | 1 |
Hiramatsu, Y; Ishida, M; Masuyama, H; Murakami, K; Sakurai, M | 1 |
Bruns, PK; Daman, M; Doolittle, ND; Fortin, D; Hall, WA; Muldoon, L; Neuwelt, EA | 1 |
King, MM; Osswald, MB | 1 |
Burhenne, J; Foell, JL; Reiss, T; Rengelshausen, J; Staege, MS; Stiefel, M; Wawer, A | 1 |
Chánová, M; Ganevová, M; Kodet, R; Mottl, H; Mrhalová, M; Radvanská, J; Smelhaus, V; Tichý, M | 1 |
Casanova, M; Cefalo, G; Collini, P; Ferrari, A; Fossati-Bellani, F; Gandola, L; Giangaspero, F; Luksch, R; Massimino, M; Meazza, C; Pignoli, E; Podda, M; Poggi, G; Polastri, D; Ravagnani, F; Simonetti, F; Spreafico, F; Terenziani, M | 1 |
Diehl, V; Engert, A; Reiser, M; Rödel, S | 1 |
Ajufo, II; Canty, SH; Lindow, SW | 1 |
Goldstone, A; Hann, I; Mitchell, C; Ramanujachar, R; Richards, S; Rowe, J; Vora, A; Webb, D | 1 |
Fujimaki, K; Fujisawa, S; Fujita, H; Harano, H; Hashimoto, C; Ishigatsubo, Y; Kanamori, H; Kodama, F; Koharazawa, H; Maruta, A; Motomura, S; Sakai, R; Tomita, N | 1 |
Broglia, C; Corazza, GR; Federico, M; Gobbi, PG; Lambelet, P; Lombardo, M; Luminari, S; Mammi, C; Merli, F; Polimeno, G; Riezzo, A; Rovati, A; Valentino, F | 1 |
Hanada, R; Horibe, K; Kobayashi, R; Tawa, A; Tsuchida, M; Tsukimoto, I | 1 |
Antoneli, CB; Arias, VE; Chojniak, MM; Novaes, PE; Ribeiro, Kde C; Sakamoto, LH | 1 |
Amikura, T; Aoki, Y; Banzai, C; Nishikawa, N; Sekine, M; Suzuki, M; Tanaka, K; Yokoo, T | 1 |
Aung, L; Kirk, RC; Liang, S; Quah, TC; Tan, RM; Yeoh, AE | 1 |
Artibani, W; Boscolo Berto, R; El Mazloum, R; Fassina, A; Gottardo, F | 1 |
Bo, J; DA, WM; Li, HH; Wang, QS; Wang, SH; Wu, XX; Yu, L; Zhao, Y | 1 |
Chan, KK; Lam, KW; Ngan, HY; Tam, KF | 1 |
Goyal, HK; Katiyar, D; Mukherjee, U; Pendharkar, D; Thakur, V | 1 |
Wan, X; Xiang, Y; Yang, J; Yang, X | 1 |
Fujioka, H; Honda, M; Matsumiya, K; Satoh, M; Takada, T; Tujimoto, Y | 1 |
Ansink, AC; Grootfaam, D; Lok, CA; ten Kate-Booij, MJ; van der Velden, J; Verheijen, RH | 1 |
Hanada, R; Kigasawa, H; Kinoshita, A; Tabuchi, K; Tomizawa, D; Tsuchida, M; Tsukimoto, I | 1 |
Björkholm, M; Celsing, F; Johansson, E | 1 |
Cantu-Rodríguez, O; Gomez-Almaguer, D; Gonzalez-Llano, O; Gutierrez-Aguirre, H; Herrera-Garza, J; Jaime-Pérez, J; Mancias-Guerra, C | 1 |
Brunetto, AL; Castro, CG; Cruz, LB; Rech, A; Ribeiro, AS; Rosa, LG | 1 |
Chan, GC; Cheuk, DK; Chiang, AK; Ha, SY; Lau, YL; Shek, TW | 1 |
An, R; Han, X; Wang, S; Xue, Y; Zhu, K | 1 |
Asgharzadeh, S; Belasco, J; Chi, SN; Diez, B; Dubowy, R; Dunkel, I; Finlay, J; Gardner, S; Hukin, J; Ji, L; Kellie, S; Levy, A; Miller, DC; Rosenblum, M; Sposto, R; Termuhlen, A; Zacharoulis, S | 1 |
Beitler, B; Chamone, DA; Chaoubah, A; Dulley, FL; Hallack Neto, AE; Llacer, PD; Macedo, MC; Pereira, J | 1 |
Bang, YJ; Heo, DS; Im, SA; Kim, BK; Kim, DW; Kim, NK; Kim, TY; Lee, KW; Park, S; Yoon, SS; Yun, T | 1 |
Bay, JO; Berthou, C; Bertrand, P; Brion, A; Camilleri-Broët, S; Colombat, P; Delepine, R; Delwail, V; Desablens, B; Lamy, T; Lemevel, A; Linassier, C; Rachieru, P | 1 |
Alonso Ojembarrena, A; Contra Gómez, T; Díaz Pérez, MA; García Castro, J; González-Vicent, M; Madero López, L; Pérez Martínez, A; Ramírez Orellana, M | 1 |
Allen, J; Atlas, MP; Dunkel, IJ; Fangusaro, JR; Finlay, JL; Gardner, S; Gonzalez-Gomez, I; Jubran, RF; Miller, D; Rosenblum, M | 1 |
Lam, MS | 1 |
Lurain, JR; Schink, JC; Singh, DK | 2 |
Cagayan, MS; Lu-Lasala, LR | 1 |
Bishton, MJ; Haynes, AP | 1 |
Admirand, JH; Bueso-Ramos, CE; Ford, RJ; Jiang, L; Moran, C | 1 |
Clarke-Pearson, DL; Kirkpatrick, JP; Sampson, JH; Soper, JT; Spillman, M; Wolf, JK | 1 |
Clarke, LE; Goldfeder, KL; James, WD; Katz, KA; Levin, JM; Loren, AW | 1 |
Ahmad, I; André, M; Bennani, J; Bron, D; Dargent, JL; Meuleman, N; Ngirabacu, MC; Ravoet, C; Ysebrant, L | 1 |
Kageji, T; Kanematsu, Y; Matsuzaki, K; Nagahiro, S; Nakatani, M; Okamoto, Y; Watanabe, T | 1 |
Boudrias, M; Fortin, D; Garant, MP; Gendron, C | 1 |
Ling, MT; Wang, X; Wong, YC; Zhang, X | 1 |
Brugières, L; Dupoüy, N; Entz-Werlé, N; Gentet, JC; Guinebretière, JM; Kalifa, C; Le Deley, MC; Marec-Bérard, P; Pacquement, H; Pichon, F; Schmitt, C; Tabone, MD; Vanel, D | 1 |
Akutsu, M; Furukawa, Y; Izumi, T; Kano, Y; Kirito, K; Mano, H; Matsuo, Y; Odgerel, T; Sato, Y; Tsunoda, S; Vu, HA | 1 |
Chen, H; Han, W; Huang, XJ; Liu, DH; Liu, KY; Xu, LP | 1 |
Furue, M; Hara, T; Ichino, K; Ishimura, M; Nishikomori, R; Ohga, S; Takada, H; Urabe, K | 1 |
Frishman, GN; Raughley, MJ | 1 |
Barberi, W; Foa, R; Giona, F; Malandruccolo, L; Mandelli, F; Martino, P; Moleti, ML; Palumbo, G; Paoloni, F; Pescarmona, E; Testi, AM | 1 |
Lv, W; Mao, Y; Wan, X; Xie, X | 1 |
Fujishima, M; Fujishima, N; Hirokawa, M; Inomata, M; Kameoka, Y; Saitoh, H; Saitoh, K; Sawada, K; Takahashi, N; Yamanaka, Y; Yoshioka, T | 1 |
Estella, J; Fernández-Delgado, R; Forns, M; Gallego, S; García-Miguel, P; Indiano, JM; Javier, G; Navajas, A; Pardo, N | 1 |
Avilés, A; Castañeda, C; Cleto, S; Nambo, MJ | 1 |
Akutsu, M; Inoue, K; Izumi, T; Kano, Y; Katano, S; Kobayashi, H; Masuda, Y; Muroi, K; Nagashima, T; Ohmine, K; Ozawa, K; Shirai, T; Takagi, S; Tsunoda, S; Ueda, M; Ueda, T | 1 |
Homma, J; Hondoh, H; Morii, K; Onda, K; Sano, M; Shinbo, Y; Takahashi, H; Tamura, T; Tanaka, R; Tsuchiya, N; Yajima, N; Yamanaka, R | 1 |
Daenen, S; de Wolf, JT; Kluin-Nelemans, HC; van den Berg-de Ruiter, E; van Imhoff, GW; Vellenga, E | 1 |
Ference, SJ; Galor, A; Lee, MS; Peereboom, DM; Perez, VL; Singh, AD; Stevens, GH | 1 |
Borie, R; Daniel, MT; Fieschi, C; Galicier, L; Gérard, L; Meignin, V; Oksenhendler, E | 1 |
Ansell, W; Asterling, S; Berney, D; Joel, SP; Liu, S; Mutsvangwa, K; Oliver, RT; Powles, T; Shamash, J; Stebbing, J; Wilson, P; Wyatt, P | 1 |
Aikawa, K; Arima, F; Fukuda, H; Hanada, S; Hotta, T; Kasai, M; Kobayashi, T; Masanori, S; Mukai, K; Ogura, M; Shirakawa, S; Sueoka, E; Tajima, K; Takeyama, K; Tobinai, K | 1 |
Chiba, S; Izutsu, K; Kako, S; Kanda, Y; Kurokawa, M; Motokura, T; Oshima, K; Sato, H | 1 |
Abromowitch, M; Allen, J; Asgharzadeh, S; Comito, M; Diez, B; Dubowy, R; Dunkel, I; Fangusaro, J; Finlay, J; Gardner, S; Halpern, S; Hukin, J; Ji, L; Kellie, S; Miller, DC; Olshefski, R; Rosenblum, M; Saly, M; Sposto, R; Zacharoulis, S | 1 |
El-Helw, LM; Hancock, BW | 1 |
Chen, Y; Fu, M; Liang, X; Lin, C; Ma, Y; Qian, H; Wang, H; Xiang, Y; Zhan, Q; Zhang, X | 1 |
Akay, OM; Gulbas, Z; Oner, U; Urer, SM | 1 |
Bae, SN; Jung, SG; Kim, CJ; Kim, SJ; Lee, C; Na, YJ | 1 |
Fibbe, WE; Huijgens, PC; Lugtenburg, PJ; van 't Veer, MB; van Imhoff, GW; van Oers, MH; van Putten, WL; Vellenga, E; Verdonck, LF; Wijermans, PW; Zijlstra, JM | 1 |
Goldstein, DA; Tessler, HH | 1 |
Katsicas, MM; Rosenzweig, SD; Russo, RA | 1 |
Jain, S; Mandal, S; Varma, K | 1 |
Bell, S; Doolittle, ND; Fortin, D; Jahnke, K; Knight, KR; Kraemer, DF; Muldoon, LL; Neuwelt, EA | 1 |
Aricò, M; Egeler, RM; Filipovich, AH; Gadner, H; Henter, JI; Horne, A; Imashuku, S; Janka, G; Ladisch, S; Trottestam, H; Webb, D | 1 |
Barbetti, A; Buccoliero, AM; Castiglione, F; Garbini, F; Gheri, CF; Moncini, D; Rossi Degl'Innocenti, D; Taddei, GL; Villanucci, A | 1 |
Anderson, P; Chang, EL; Herzog, CE; Hughes, D; Huh, W; Kornguth, DG; Mahajan, A; Pelloski, CE; Woo, SY | 1 |
Avilés, A; Castañeda, C; Cleto, S; González, M; Huerta-Guzmán, J; Nambo, MJ; Neri, N; Talavera, A | 1 |
Ashrafgangooei, T; Azamolsadat, M; Behroozi, S; Behtash, N; Fatemeh, G; Ghaemmaghami, F; Ghanbari, Z; Gilani, MM; Mitra, MG; Mousavi, A; Nadereh, B; Shohreh, B; Tahereh, A; Zinat, G | 1 |
Hasegawa, Y; Izutsu, K; Kawa, K; Kim, WS; Kwong, YL; Nakamura, S; Okamura, T; Oshimi, K; Suzuki, R; Suzumiya, J; Yamaguchi, M | 1 |
Kono, T; Noguchi, T; Nohara, J; Sakaguchi, Y; Terada, Y | 1 |
McMillan, A; O'Connor, S; Wills, AJ | 1 |
Hsieh, TY; Hsu, KF; Huang, SC; Kuo, PL | 1 |
Homma, J; Hondoh, H; Kakuma, T; Morii, K; Sano, M; Shinbo, Y; Takahashi, H; Tamura, T; Tanaka, R; Tsuchiya, N; Yajima, N; Yamanaka, R | 1 |
Bacon, C; Egerer, G; Freier, K; Hofele, CM; Thiele, OC | 1 |
Barbui, T; Benedetti, F; Boccadoro, M; Ciceri, F; Corradini, P; Cortelazzo, S; Gallamini, A; Gianni, AM; Magni, M; Majolino, I; Mirto, S; Passera, R; Patti, C; Pileri, A; Pizzolo, G; Rambaldi, A; Tarella, C; Zanni, M | 1 |
Ayas, S; Cetiner, H; Gurbuz, A; Karateke, A | 1 |
Barrans, SL; Clawson, SM; Jack, AS; Mead, GM; Qian, W; Radford, JA; Stenning, SP; Walewski, J; Wolf, M; Yule, CL | 1 |
Cornelissen, JJ; Schnog, JB; Van Hest, RM; Van't Veer, MB | 1 |
Bang, YJ; Heo, DS; Im, SA; Kim, BK; Kim, BS; Kim, CW; Kim, DW; Kim, NK; Kim, TY; Park, S; Yoon, SS | 1 |
Abujamra, AL; Brunetto, AL; dos Santos, MP; Roesler, R; Schwartsmann, G | 1 |
Berkowitz, RS; Fülöp, V; Szepesi, J; Szigetvŕi, I; Török, M | 1 |
Ferreri, AJ; Foppoli, M; Mazzucchelli, L; Ponti, G; Ponzoni, M; Zucca, E | 1 |
Behnamfar, F; Behtash, N; Hamedi, B; Ramezanzadeh, F | 1 |
Bell, SD; Bourekas, EC; Macnealy, MW; McGregor, JM; Newton, HB; Ray Chaudhury, A; Slone, HW | 1 |
Behnamfar, F; Mousavi, SA | 1 |
Dzhulakian, UL; Egorova, EK; Giliazitdinova, EA; Gorgidze, LA; Kaplanskaia, IB; Krasil'nikova, BB; Kravchenko, SK; Kremenetskaia, AM; Lutsenko, IN; Magomedova, AU; Mar'in, DS; Margolin, OV; Ryzhikova, NA; Samoĭlova, RS; Valiev, TT; Vinogradova, IuE; Vorob'ev, AI; Vorob'ev, IA; Zvonkov, EE | 1 |
Cole, SP; Deeley, RG; DeGorter, MK; Gao, M; Grant, CE | 1 |
Arndt, CA; Hawkins, DS; Hoots, WK; Inwards, CY; Kleinerman, ES; Koshkina, NV; Morales-Arias, JA; Munsell, MF; Rodriguez, NI | 1 |
Abe, A; Hayasaka, K; Kawakami, K; Kawano, Y; Kumamoto, T; Nishikawa, T; Okamoto, Y; Tonooka, S | 1 |
Bischoff, J; Costa, SD; Ignatov, A; Smith, B; Taran, A | 1 |
Acerno, S; Biassoni, V; Casanova, M; Cefalo, G; Collini, P; Ferrari, A; Fossati-Bellani, F; Gandola, L; Luksch, R; Mariani, L; Massimino, M; Meazza, C; Modena, P; Pecori, E; Pignoli, E; Podda, M; Poggi, G; Polastri, D; Potepan, P; Ravagnani, F; Simonetti, F; Solero, CN; Spreafico, F; Terenziani, M | 1 |
Choi, KA; Huh, W; Kim, DJ; Kim, K; Kim, WS; Kim, YG; Ko, YH; Lee, JE; Oh, HY | 1 |
Aurer, I; Labar, B; Mitrović, Z; Mrsić, M; Nemet, D; Nola, M; Radman, I; Santek, F; Sertić, D; Serventi-Seiwerth, R; Stern-Padovan, R | 1 |
Berretta, S; Biassoni, V; Cefalo, G; Collini, P; Favre, C; Ferrari, A; Fossati-Bellani, F; Gandola, L; Giangaspero, F; Luksch, R; Massimino, M; Pecori, E; Pignoli, E; Poggi, G; Pollo, B; Riva, D; Sardi, I; Solero, C; Spreafico, F; Terenziani, M | 1 |
Belfort, P; Braga, A; Consonni, M; Delmanto, LR; Maestá, I; Michelin, OC; Rudge, MV | 1 |
Cao, Y; Feng, FZ; Wan, XR; Xiang, Y; Yang, XY | 1 |
Anderson, ML; Beasley, AD; Coleman, NM; Kolomeyevskaya, NV; Miller, HJ; Tanyi, JL | 1 |
Borowitz, MJ; Bowman, WP; Camitta, BM; Campana, D; Cao, X; Carroll, WL; Cheng, C; Davies, SM; Devidas, M; Downing, JR; Evans, WE; Fan, Y; French, D; Hunger, SP; Neale, G; Pei, D; Pounds, SB; Pui, CH; Relling, MV; Treviño, LR; Willman, CL; Yang, JJ; Yang, W | 1 |
Behm, FG; Campana, D; Hijiya, N; Hudson, MM; Onciu, M; Pui, CH; Razzouk, BI; Ribeiro, RC; Sandlund, JT; Zhou, Y | 1 |
Chiocca, E; Mekhjian, HS; Peruzzi, P; Porcu, P; Ray-Chaudhuri, A; Slone, WH | 1 |
Li, Y; Mi, Y; Qiu, L; Wang, J; Zhao, Y; Zou, D | 1 |
Choi, MK; Jun, HJ; Kim, K; Kim, KH; Kim, SJ; Kim, WS; Ko, YH; Lee, SY; Lim, DH | 1 |
Chen, GQ; Huang, Y; Wang, LS; Yu, Y; Yuan, TT; Zhou, CX; Zhuang, HY | 1 |
Cao, Y; Feng, F; Wan, X; Xiang, Y; Yang, X | 1 |
Agarwal, R; Fisher, RA; Hancock, B; Lindsay, I; Nagai, Y; Newlands, ES; Savage, PM; Schmid, P; Sebire, NJ; Seckl, MJ; Short, D; Wells, M; Wischnewsky, MB | 1 |
Bargetzi, M; Dudler, C; Gratwohl, A; Passweg, JR; Tichelli, A; Wernli, M | 1 |
Guan, ZZ; Lin, H; Ling, JY; Luo, WB; Peng, RJ; Sun, XF; Xia, Y; Xiang, XJ; Zhen, ZJ; Zheng, L | 1 |
Bhartia, S; Proctor, SJ; Sieniawski, M; Wilkinson, J | 1 |
Kawashima, A; Miyoshi, S; Nin, M; Nishimura, K; Ujike, T | 1 |
Conrad, AL; Go, RS | 1 |
Esparza, J; Hinojosa, J; Iglesias, S; Muñoz, MJ; Otero-Rodríguez, A; Ricoy, JR; Rodríguez-Gil, Y | 1 |
Chott, A; Drach, J; Fridrik, MA; Geissler, D; Greil, R; Hausmaninger, H; Krieger, O; Lang, A; Michlmayr, G; Oberaigner, W; Ulsperger, E | 1 |
Bleyer, A; Choi, M; Fuller, CD; Raney, RB; Wang, SJ | 1 |
Konno, R; Netsu, S; Nokubi, M; Ohmaru, T; Yamakawa, H | 1 |
Broccoli, A; Brusamolino, E; Cabras, MG; Chiappella, A; Finolezzi, E; Martelli, M; Rossi, A; Salvi, F; Stefoni, V; Zinzani, PL | 1 |
Biron, P; Blay, JY; Bosly, A; Casasnovas, O; Coiffier, B; Colin, P; Ferlay, C; Ghesquières, H; Haioun, C; Morel, P; Perol, D; Reman, O; Sebban, C; Tilly, H; Van den Neste, E | 1 |
Antonelli, A; Carpi, A; Cervetti, G; Fallahi, P; Franzoni, F; Galetta, F; Petrini, M; Regoli, F; Santoro, G; Tocchini, L | 1 |
Cao, Y; Feng, F; Xiang, Y | 1 |
Akutsu, M; Furukawa, Y; Izumi, T; Kano, Y; Mano, H; Miyawaki, S; Tanaka, M; Tsunoda, S; Yazawa, Y | 1 |
Byrne, GE; Coleman, F; Escalón, MP; Hosein, PJ; Lossos, IS; Morgensztern, D; Rosenblatt, JD; Walker, GR | 1 |
Baldini, L; Barbolini, E; Brugiatelli, M; Dell'Olio, M; Dondi, A; Federico, M; Giglio, G; Gobbi, PG; Luminari, S; Mannina, D; Merli, F; Polimeno, G; Stelitano, C | 1 |
Chott, A; Friedrich, C; Janka-Schaub, G; Kabisch, H; Schrum, J | 1 |
Grigg, AP; Hoyt, R; Ritchie, DS; Szer, J; Wirth, A | 1 |
Atkinson, HD; Macmull, S; O'Donnell, P; Saso, S; Skinner, JA; Tirabosco, R | 1 |
Cai, Y; Ling, JY; Sun, XF; Xia, Y; Yan, SL; Zhen, ZJ | 1 |
Angamuthu, N; Boyd, K; Chasty, R; Davies, J; Forsyth, P; Jack, F; Lennard, AL; Lyons, S; Mounter, P; Proctor, SJ; Revell, P; Sieniawski, M | 1 |
Baker, L; Cochrane, L; Delabie, J; Holte, H; Lauritzsen, GF; Mahendra, P; Roberts, C; Tauro, S | 1 |
Arima, H; Imai, Y; Inoue, D; Kimura, T; Maruoka, H; Matsushita, A; Mori, M; Nagai, K; Nagai, Y; Nagano, S; Shimoji, S; Suzuki, R; Tabata, S; Takahashi, T; Takiuchi, Y; Togami, K; Yanagita, S | 1 |
Aydin, A; Balat, O; Cebesoy, FB; Ozturk, E; Sever, T; Ugur, MG | 1 |
Hayashi, H; Kakimoto, T; Kurai, H; Mihara, A; Nakazato, T; Sanada, Y; Suzuki, K; Tachikawa, N; Yoshida, S; Yoshimura, Y | 1 |
Cho, YL; Choi, MH; Hong, DG; Lee, YS; Park, IS | 1 |
Buchbinder, D; Casillas, J; Linetsky, M; Steinberg, G | 1 |
Behm, FG; Graham, K; Hale, GA; Howard, SC; Hudson, MM; Kaste, S; Krasin, MJ; Kun, LE; Lowe, E; Mahmoud, H; Metzger, ML; Onciu, M; Pui, CH; Razzouk, BI; Rencher, R; Ribeiro, RC; Sandlund, JT; Zhou, Y | 1 |
Balter, R; Barra, S; Bertin, D; Biassoni, V; Cama, A; Casali, C; Collini, P; Di Rocco, C; Fidani, P; Gandola, L; Garrè, ML; Genitori, L; Giangaspero, F; Mascarin, M; Massimino, M; Milanaccio, C; Milano, GM; Modena, P; Nozza, P; Peretta, P; Potepan, P; Sardi, I; Scarzello, G; Tamburrini, G; Viscardi, E | 1 |
Gill, D; Ho, AD; Kuhnt, E; Loeffler, M; Österborg, A; Pettengell, R; Pfreundschuh, M; Rieger, M; Walewski, J; White, D | 1 |
Fujisawa, M; Miyake, H; Muramaki, M; Takenaka, A; Terakawa, T | 1 |
Bosly, A; Brière, J; Coiffier, B; Gisselbrecht, C; Molina, T; Morel, P; Mounier, N; Munck, JN; Quesnel, B; Ranta, D; Reyes, F; Thyss, A; Tilly, H | 1 |
Fukuhara, N; Harigae, H; Ichikawa, S; Ishizawa, K; Kameoka, J; Kohata, K; Nakajima, S; Okitsu, Y; Onishi, Y; Suzuki, M; Yamamoto, J | 1 |
Argnani, L; Baccarani, M; Broccoli, A; Derenzini, E; Fanti, S; Gandolfi, L; Pellegrini, C; Quirini, F; Stefoni, V; Zinzani, PL | 1 |
Aurer, I; Baars, JW; Borchmann, P; DeJong, D; Diehl, V; Döhner, H; Engert, A; Fischer, T; Glossmann, J; Hansmann, ML; Josting, A; Metzner, B; Müller, H; Niederwieser, D; Raemaekers, J; Schäfer-Eckart, K; Schmitz, N; Smardova, L; Sureda, A | 1 |
DeRyckere, D; Gore, L; Macy, ME | 1 |
Bredeson, C; Ewell, M; Goodman, SA; Horowitz, MM; Kahl, BS; Laport, GG; Negrin, RS; Tomblyn, MR; Vose, JM | 1 |
Ambroszkiewicz, J; Chełchowska, M; Gajewska, J; Klepacka, T; Laskowska-Klita, T; Woźniak, W | 1 |
Aldabbagh, K; Fabbro, M; Jacot, W; Pouderoux, S; Poujol, S; Roca, L; Romieu, G | 1 |
Ardeshna, KM; Goldstone, AH; Kayani, I; Linch, DC; Lowry, L; Marafioti, T; Mohamedbhai, SG; Sibson, K | 1 |
Suzuki, R | 1 |
Azuma, T; Kim, SW; Kobayashi, Y; Maeshima, AM; Maruyama, D; Matsuno, Y; Mori, M; Munakata, W; Nomoto, J; Taniguchi, H; Tobinai, K; Watanabe, T | 1 |
Ancliff, P; Darbyshire, P; Goulden, N; Green, N; Hancock, J; Leighton, C; Love, S; Masurekar, A; Moorman, AV; Morgan, M; Parker, C; Révész, T; Saha, V; Sutton, R; Waters, R | 1 |
Feng, FZ; Wan, XR; Xiang, Y; Zhou, Y | 1 |
Guan, XQ; Huang, LB; Ke, ZY; Luo, XQ; Xu, L; Zhang, XL; Zhang, YC | 1 |
Aoki, Y; Asato, K; Hirakawa, M; Inamine, M; Kudaka, W; Nagai, Y; Suzuki, S; Wakayama, A | 1 |
Harvey, R; Mitchell, H; Savage, P; Schmid, P; Seckl, M; White, S | 1 |
Khunamornpong, S; Settakorn, J; Siriaunkgul, S; Sukpan, K; Suprasert, P | 1 |
Andresen, S; Bolwell, BJ; Copelan, E; Dean, R; Hill, BT; Kalaycio, M; Pohlman, B; Rybicki, L; Smith, S; Sobecks, R; Sweetenham, J; Tench, S | 1 |
Hosokai, R; Imai, C; Imamura, M; Iwabuchi, H; Takachi, T; Uchiyama, M; Yoshida, S | 1 |
Abramson, JS; Barnes, JA; Feng, Y; Hochberg, EP; Lacasce, AS; Michaelson, JS; Neuberg, D; Toomey, CE | 1 |
Al-Futaisi, A; Al-Kharusi, N; Biswas, J; Ganesh, A; Khetan, V; Kumar, K; Raja, T | 1 |
Doggrell, SA | 1 |
Cho, J; Cho, WH; Jeon, DG; Kim, DH; Kim, MS; Koh, JS; Kong, CB; Lee, JA; Lee, SY; Lim, JS; Song, WS; Yoo, JY | 1 |
Csomor, J; Deák, B; Gaudi, I; Lengyel, Z; Lovey, J; Matolcsy, A; Molnár, Z; Petri, K; Rosta, A; Schneider, T; Tóth, E; Várady, E | 1 |
Dunning, D; Löckenhoff, CE; O'Donoghue, T | 1 |
Currimbhoy, Z; Desai, M; Joshi, R; Phatarpekar, A | 1 |
Benesch, M; Deinlein, F; Faldum, A; Fleischhack, G; Gerber, NU; Kortmann, RD; Krauss, J; Kuehl, J; Pietsch, T; Rutkowski, S; von Bueren, AO; von Hoff, K; Warmuth-Metz, M; Zwiener, I | 1 |
Bonnabry, P; Fleury-Souverain, S; Geiser, L; Hochstrasser, D; Nussbaumer, S; Sadeghipour, F; Veuthey, JL | 1 |
Chen, CH; Chiu, LH; Lee, WL; Liu, WM; Sun, HD; Wang, PH | 1 |
Bircher, C; Brown, D; McCarthy, A; Nirmal, DM; Rees, H; Seckl, MJ; Short, D; Smith, RP | 1 |
Dunn, S; Griffin, G; Hanson, D; Rittenhouse, DW; Walter, AW | 1 |
Cyriac, S; Rajendranath, R; Sagar, TG; Sridevi, V | 1 |
Acar, H; Aydemir, E; Bayrak, OF; Gulluoglu, S; Ozen, M; Sahin, F; Sevli, S; Yalvac, ME | 1 |
Bain, BJ; Innes, A; May, PC; Pavlů, J | 1 |
Maruyama, D | 2 |
Kamoto, A; Kawashima, A; Nakai, Y; Nakayama, M; Nishimura, K; Nonomura, N; Ono, Y; Takada, T; Takayama, H; Tanigawa, G; Tsujimura, A; Ujike, T; Yamaguchi, Y | 1 |
Cavallin-Stahl, E; Glass, B; Haenel, M; Kaiser, U; Loeffler, M; Pfreundschuh, M; Schmitz, N; Truemper, L; Wolf, M; Zeynalova, S | 1 |
Grubb, B; Henderson, DB; Pandya, AG | 1 |
Hamano, K; Harada, M; Inoue, T | 1 |
Chiba, S; Enami, T; Hasegawa, Y; Kondo, Y; Nakamura, N; Nishikii, H; Noguchi, M; Okoshi, Y; Sakata-Yanagimoto, M; Suzukawa, K; Yokoyama, Y | 1 |
Cole, LA | 1 |
Behler, CM; Cha, S; Damon, LE; Hwang, J; Issa, S; McDermott, M; O'Brien, J; Rubenstein, JL; Shuman, MA; Treseler, P; Valles, F; Wieduwilt, MJ | 1 |
Camilleri, MJ; Podjasek, JO | 1 |
Bouguern, H; Chaara, H; Melhouf, A; Rachad, M; Zahra Fdili, F | 1 |
Aydiner, A; Bengisu, E; Berkman, S; Ilhan, HR; Keskin, S; Tas, F; Topuz, E | 1 |
Cohen, S; Condous, G; Harnett, P; Pixton, S; Reid, S | 1 |
Ferreri, AJ; Govi, S; Pileri, SA; Savage, KJ | 1 |
Huang, TS; Lin, HW; Shih, SR; Yao, M | 1 |
Abedallaa, N; Baey, C; Besse, B; de Montpreville, VT; Fabre, D; Guigay, J; Pechoux, CL; Pignon, JP; Planchard, D; Soria, JC; Tremblay, L | 1 |
Amant, F; Devi, UK; Han, SN; Leunen, K; Neven, P; Vergote, I | 1 |
Fukushima, N; Hasegawa, Y; Hashimoto, C; Hyo, R; Ishida, F; Isobe, Y; Ito, Y; Izutsu, K; Kawa, K; Kimura, H; Kobayashi, H; Maeda, Y; Nakamura, S; Okamura, S; Oshimi, K; Suzuki, R; Suzumiya, J; Takizawa, J; Yamaguchi, M | 1 |
Amant, F; Berteloot, P; Devi, UK; Han, SN; Leunen, K; Neven, P; Vergote, I | 1 |
Lybol, C; Massuger, LFAG; Ottevanger, PB; Sweep, FCGJ; Thomas, CMG; Westerdijk, K | 1 |
Gafton, GI; Gudz', IuV; Ivanova, TV; Krzhivitskiĭ, PI; Kupatadze, DD; Lazareva, IuR; Levchenko, EV; Nabokov, VV; Novik, VI; Petrov, VG; Punanov, IuA; Safonova, SA | 1 |
D'Souza, R; Khan, F; McKimm, E; Vessal, S | 1 |
Abella, E; Amigo, ML; Barrios, M; Bravo, P; Brunet, S; García, O; González-Campos, J; Hernández-Rivas, JM; Montesinos, P; Ribera, JM | 1 |
Adde, M; Adeodou, O; Aken'Ova, Y; Brown, BJ; Durosinmi, M; Githang'a, J; Hurwitz, N; Kaijage, J; Leoncini, L; Magrath, I; Naresh, K; Ngoma, T; Rajab, J; Raphael, M; Rohatiner, A; Scanlan, P; Venzon, D | 1 |
Baptista, AM; Belfort, P | 1 |
Chim, CS; Kim, SJ; Kim, WS; Kwong, YL; Leung, AY; Lim, ST; Tang, T; Tse, E | 1 |
Centen, DW; Lybol, C; Massuger, LF; Ottevanger, PB; Sweep, FC; ten Kate-Booij, MJ; Thomas, CM; Verheijen, RH | 1 |
Blanken, EA; Boere, IA; Lybol, C; Massuger, LF; Ottevanger, PB; Reyners, AK; Sweep, FC; Thomas, CM; van Hoesel, RQ; Verheijen, RH; Westermann, AM | 1 |
Assanelli, A; Baldini, L; Caligaris-Cappio, F; Ferrari, A; Ferreri, AJ; Foppoli, M; Frezzato, M; Frungillo, N; Ilariucci, F; Licata, G; Mappa, S; Marturano, E; Proserpio, I; Reni, M; Sorarù, M; Stelitano, C; Vianello, F | 1 |
Ahn, HS; Kang, HJ; Kim, H; Lee, JW; Park, JD; Park, KD; Shin, HY; Yoon, JH | 1 |
Obuchi, W; Ohmine, K; Ohtsuki, S; Terasaki, T; Uchida, Y; Yamori, T | 1 |
Benesch, M; Deinlein, F; Faldum, A; Friedrich, C; Gerber, NU; Kortmann, RD; Kuehl, J; Kwiecien, R; Ottensmeier, H; Pietsch, T; Rutkowski, S; von Bueren, AO; von Hoff, K; Warmuth-Metz, M | 1 |
Fukayama, M; Kurokawa, M; Nakamura, F; Takazawa, Y; Uni, M; Yoshimi, A | 1 |
Agarwal, R; Alifrangis, C; Fisher, RA; Harvey, R; Savage, PM; Sebire, NJ; Seckl, MJ; Short, D | 1 |
Cheng, AL; Huang, HC; Kuo, SH; Lin, CW | 1 |
Goto, M; Hirokawa, W; Iwase, A; Kikkawa, F; Kondo, M; Nakahara, T; Nakamura, T; Sugita, A; Takikawa, S; Yamamoto, E | 1 |
Choi, YJ; Chun, KY; Kim, YW; Ro, DY | 1 |
Herbrecht, R; Jarfaut, A; Levêque, D; Santucci, R | 1 |
Brown, PN; D'Amore, F; Hagberg, H; Hagberg, O; Jerkeman, M; Pedersen, LM; Wästerlid, T | 1 |
Allen, J; Atlas, M; Dhall, G; Finlay, J; Gardner, S; Garvin, J; Haley, K; Ji, L; Judkins, A; Kennedy, G; Lasky, J; Moertel, C; Moore, T; Olshefski, R; Rassekh, SR; Shore, R; Sposto, R; Tekautz, T; Venkatramani, R; Zhou, S | 1 |
Ilson, DH | 1 |
Creutzig, U; Dworzak, MN; Reinhardt, D; Ritter, J; Schellong, G; Zimmermann, M | 1 |
Aggarwal, N; Agrawal, M; Chopra, S; Rana, SS; Raveendran, A; Sikka, P; Suri, V | 1 |
Chim, CS; Kwong, YL; Leung, AY; Pang, AW; Tse, E | 1 |
Antonelli, M; Biassoni, V; Gandola, L; Giangaspero, F; Massimino, M; Modena, P; Pecori, E; Poggi, G; Schiavello, E; Spreafico, F; Vajna De Pava, M | 1 |
Choi, MK; Hoon Lim, D; Kang, ES; Kim, DW; Kim, SJ; Kim, WS; Ko, YH; Park, JH; Pyo, DH; Seok, H | 1 |
Escherich, G; Hagel, C; Hartz, B; Löbel, U | 1 |
Hudson, MM; Kastan, MB; Kennedy, W; Onciu, M; Sandlund, JT | 1 |
Aleksandrova, LN; Bezborodova, OA; Iakubovskaia, RI; Kovalenko, AL; Nemtsova, ER; Venediktova, IuB | 1 |
Benigno, BB | 1 |
Auperin, A; Baruchel, A; Bergeron, C; Bertrand, Y; Coze, C; Lacombe, MJ; Lervat, C; Leverger, G; Méchinaud, F; Munzer, M; Nelken, B; Patte, C | 1 |
Collins, G; Eyre, T; Hildyard, C; Sheikh, S | 1 |
Bajpai, J; Deodhar, K; Gulia, S; Gupta, S; Kerkar, RA; Maheshwari, A; Menon, S; Rekhi, B; Seth, V | 1 |
Förster, A; Hartmann, K; Kashkar, H; Mrowietz, U; Preussner, LM; Rabenhorst, A; Seeger, JM | 1 |
Barr, PM; Caimi, PF; Carson, KR; Evens, AM; Gordon, LI; Gregory, SA; Helenowski, I; Islam, N; Jovanovic, B; Kolesar, J; Nabhan, C | 1 |
Kraus, TS; Tan, BT; Twist, CJ | 1 |
Bastide, C; Bruyère, F; Deville, JL; Flechon, A; Guy, L; Karsenty, G | 1 |
Hayashi, T; Ishii, T; Itami, Y; Kobayashi, Y; Minami, T; Nagai, Y; Nozawa, M; Shimizu, N; Uemura, H; Yamamoto, Y; Yoshimura, K | 1 |
Chan, JK; Chan, KH; Kwong, YL; Pang, AW; So, JC | 1 |
Chang, WJ; Kim, SJ; Kim, WS; Ko, YH | 1 |
Komagata, Y | 1 |
Bar-Sela, G; Miller, RC; Novotny, PJ; Sio, TT; Sohawon, S; Thariat, J; Van Houtte, P; Vu, CC | 1 |
Miyawaki, S | 1 |
Itani, K; Miyazaki, Y; Nagamatsu, K; Otsuka, E; Saburi, M; Saburi, Y; Urabe, S | 1 |
Brito-Ramirez, AS; Cantú-Rodríguez, OG; Gomez-Almaguer, D; Gutiérrez-Aguirre, H; Herrera-Garza, JL; Jaime-Pérez, JC; Pinzon-Uresti, MA | 1 |
Ajisawa, A; Hagiwara, S; Kitanaka, A; Kojima, Y; Nagai, H; Okada, S; Tanuma, J; Uehira, T | 1 |
Imamura, Y | 1 |
Hensel, M; Hentrich, M; Hoffmann, C; Mosthaf, F; Müller, M; Siehl, J; Wyen, C | 1 |
Chan, WK; Huang, B; Khong, PL; Kwong, YL; Lee, EY | 1 |
Bi, K; Chen, F; Fan, J; Hou, M; Liu, G; Ran, X; Wang, J; Wang, L; Wang, M; Wang, X; Wang, Z; Xu, R; Yang, E; Yang, S; Yu, W; Zhao, H | 1 |
Ascani, S; Capodanno, I; Ragazzi, M; Valli, R; Zanelli, M | 1 |
Maherus, EM; Rashidi, A | 1 |
Imai, K; Kato, T; Miyao, K; Niimi, K; Ono, Y; Sakai, T; Sakemura, R; Sawa, M; Tsushita, N | 1 |
Ellis, D; Necessary, CA; Roffwarg, D | 1 |
Amorosa, V; Frank, D; Harrison, N; Shah, NN; Stonecypher, M; Svoboda, J | 1 |
Anderson, JR; Barth, M; Cairo, MS; Frazer, JK; Galardy, P; Goldman, S; Gross, TG; Harrison, L; Perkins, SL; Sanger, W; Shiramizu, B; Smith, L; Weinstein, H | 1 |
Burbury, K; Carney, DA; Cheah, CY; Dickinson, M; Fedele, PL; George, A; Gilbertson, M; Harrison, SJ; Herbert, KE; Januszewicz, EH; Kennedy, GA; O'Rourke, K; Opat, SS; Prince, HM; Ritchie, DS; Seymour, JF; Tam, CS; Tan, SY; Westerman, DA; Wolf, M | 1 |
Choi, JY; Kang, ES; Kim, SJ; Kim, WS; Ko, YH; Lim, DH; Park, S | 1 |
Biasoni, D; Catanzaro, M; Farè, E; Giannatempo, P; Gianni, AM; Marongiu, M; Miceli, R; Necchi, A; Nicolai, N; Piva, L; Raggi, D; Salvioni, R; Stagni, S; Torelli, T | 1 |
Ancochea, Á; Fernández-Rodriguez, C; García-Pallarols, F; Gimeno, E; Salar, A; Sánchez-González, B | 1 |
Frenel, JS; Nowak, C; Philippe, HJ; Sagan, C; Tardif, C | 1 |
Jacobson, C; LaCasce, A | 1 |
Bae, SH; Chung, J; Heo, DS; Hyun, MS; Jeon, YK; Kang, YK; Kim, BS; Kim, CW; Kim, DW; Kim, H; Kim, HJ; Kim, TM; Lee, JS; Song, HS; Yang, SH; Yuh, YJ | 1 |
Fukushima, T | 1 |
Heo, DS; Jeon, YK; Keam, B; Kim, CW; Kim, DW; Kim, KH; Kim, M; Kim, TM; Lee, JS; Lee, SH | 1 |
Fu, WM; Hsieh, IS; Yang, RS | 1 |
Ashton, E; Hoffman, J; Shafer, A; Szutowska, M | 1 |
Han, B; Ren, T; Sha, G; Shen, X; Shen, Y; Xiang, Y; Yang, J | 1 |
Beck, J; Burmeister, T; Dengler, J; Döhner, H; Domanska-Czyz, K; Dührsen, U; Fietkau, R; Gökbuget, N; Hertenstein, B; Hiddemann, W; Hoelzer, D; Horst, HA; Hüttmann, A; Kneba, M; Reichle, A; Rieder, H; Schaich, M; Schmidt-Wolf, IG; Schwartz, S; Serve, H; Spiekermann, K; Thiel, E; Viardot, A; Walewski, J | 1 |
Wang, W; Wang, Z; Xiao, X | 1 |
Ahmad, S; Ahmed, M; Al-Badawi, IA; Al-Hashem, H; Al-Hayli, S; Al-Husaini, H; Darwish, A; Edesa, W; Elghamry, W; Elhassan, T; Eltigani, A; Madkhali, I; Omar, A; Soudy, H | 1 |
Anninga, J; Bernstein, M; Bielack, SS; Böhling, T; Butterfass-Bahloul, T; Calaminus, G; Capra, M; Deffenbaugh, C; Dhooge, C; Eriksson, M; Flanagan, AM; Gelderblom, H; Goorin, A; Gorlick, R; Gosheger, G; Grimer, RJ; Hall, KS; Helmke, K; Hogendoorn, PC; Hook, JM; Jovic, G; Jundt, G; Kager, L; Krailo, M; Kuehne, T; Lau, CC; Letson, GD; Marina, N; Meyer, J; Meyers, PA; Morris, C; Mottl, H; Nadel, H; Nagarajan, R; Randall, RL; Schomberg, P; Schwarz, R; Smeland, S; Sydes, MR; Teot, LA; Whelan, JS | 1 |
Calaminus, G; Göbel, U; Haas, R; Harms, D; Leuschner, I; Schneider, DT; Schönberger, S; Teske, C | 1 |
de Lima, PF; de Moraes, CN; Dias, MC; Junior, JB; Maia, L; Oba, E; Raposo-Ferreira, TM; Sudano, MJ | 1 |
Chai, AP; Mao, RR; Xu, L; Yang, YX; Yu, CL; Zhou, H | 1 |
Gilani, MM; Khorasanizadeh, F; Mousavi, AS; Zamani, A; Zendehdel, K | 1 |
Anurathapan, U; Choeyprasert, W; Chuansumrit, A; Hongeng, S; Nartthanarung, A; Pakakasama, S; Sirachainan, N; Songdej, D | 1 |
Camarata, M; Cooke, R; Dancy, G; Krell, J; Kwan, A; O'Nions, J; Savage, P; Seckl, MJ; Short, D; Swerdlow, A | 1 |
Al-Dandan, S; Alharbi, M; Alharbi, Q; Alharbi, T; Aljamaan, K; Alomari, A; Alsudairy, R; Alsultan, A; Bayoumi, Y; Jarrar, M; Musleh, O | 1 |
Ando, K; Kikuchi, T; Kikuti, YY; Kojima, M; Moriuchi, M; Murayama, H; Nakamura, N; Ogawa, Y; Tokunaka, M; Tsuboi, K; Yabe, M | 1 |
Kelpanides, I; Savage, P; Seckl, MJ; Short, D; Tuthill, M | 1 |
Chow, CL; Gubbels, SP; Guo, W; Trivedi, P; Zhao, X | 1 |
Advani, P; Foran, J; Garner, H; Goff, R; Jain, M; Jiang, L; Murray, P; Paulus, A; Pooley, R | 1 |
Abou Mourad, Y; Barnett, MJ; Broady, RC; Connors, JM; Forrest, DL; Gascoyne, RD; Gerrie, AS; Hogge, DE; Karsan, A; Nantel, SH; Narayanan, S; Nevill, TJ; Power, MM; Savage, KJ; Sehn, LH; Shepherd, JD; Slack, GW; Song, KW; Sun, H; Sutherland, HJ; Toze, CL; Villa, D | 1 |
Leite, AC; Maranhão, RC; Solano, TV; Tavares, ER | 1 |
Berkowitz, RS; Bernstein, MR; Goldstein, DP; Horowitz, NS; Maestá, I; Moulder, J; Ramírez, LA | 1 |
Johnson, DH; Reske, T; Ruiz, M | 1 |
Asada, H; Fujino, Y; Goto-Koshino, Y; Ohno, K; Tomiyasu, H; Tsujimoto, H | 1 |
Allen, PK; Arzu, I; Dabaja, B; Fayad, LE; Medeiros, LJ; Oki, Y; Pinnix, CC; Reed, VK; Rodriguez, A; Shihadeh, F; Tao, R; Westin, JR | 1 |
Esiashvili, N; Flowers, CR; Jegadeesh, N; Khan, MK; Liu, Y; Okwan-Duodu, D; Rajpara, R; Shi, Z | 1 |
Park, MJ | 2 |
Berkowitz, RS; Bernstein, MR; Goldstein, DP; Horowitz, NS; Maestá, I; Ramírez, LA | 1 |
Ambinder, R; Baiocchi, R; Cesarman, E; Kaplan, L; Lee, JY; Noy, A; Ratner, L; Reid, E; Wagner-Johnston, N | 1 |
Chang, J; Ding, H; Hao, SG; Hu, D; Li, ZC; Liu, LG; Ma, LY; Ma, YJ; Tao, R; Yan, Y; Zhang, WH | 1 |
Faaborg, L; Hansen, ES; Lindegaard, JC; Niemann, I; Ostenfeld, EB; Sunde, L | 1 |
Boonyapipat, S; Rattanaburi, A; Supasinth, Y | 1 |
Beshlawi, I; Bhuyan, D; El-Banna, N; Elmanzalawy, A; Rabah, F | 1 |
Bae, SH; Chi, HS; Eom, HS; Hyun, MS; Jang, DY; Joo, YD; Jung, CW; Kim, DY; Kim, H; Kim, HJ; Kim, I; Kim, MK; Lee, GW; Lee, JH; Lee, KH; Lee, SM; Lee, WS; Lim, SN; Moon, JH; Park, S; Ryoo, HM; Shin, HJ; Sohn, SK; Won, JH; Yang, DH; Yun, SC | 1 |
Kawaguchi, H; Kobayashi, M; Kurisu, K; Nosaka, R; Sugiyama, K; Takayasu, T; Yamasaki, F | 1 |
Abdi, S; Coleman, RE; Hancock, BW; Lo, C; Price, JM; Tidy, J; Winter, MC | 1 |
Ash, S; Cohen, IJ; Issakov, J; Kollender, Y; Shkalim-Zemer, V; Toledano, H; Yaniv, I | 1 |
Balcı, YI; Greenwood, T; Kenar, F; Koçyiğit, A; Özgürler Akpınar, F; Polat, A; Tesi, B; Yalçın, N | 1 |
Bakhshi, S; Batra, A; Khan, SA; Nataraj, V; Rastogi, S; Sharma, MC; Vishnubhatla, S | 1 |
Bernstein, ML; Devidas, M; Gebhardt, MC; Goorin, AM; Grier, HE; Healey, JH; Krailo, MD; Lipshultz, SE; Meyers, PA; Sato, JK; Schwartz, CL; Steinherz, LJ; Teot, LA; Wexler, LH | 1 |
Hashimoto, K; Kizaki, S; Matsui, H; Shozu, M; Usui, H | 1 |
Fukayama, M; Koda, K; Tajima, S; Takanashi, Y | 1 |
Ahn, YC; Kim, SJ; Kim, WS; Ko, YH; Oh, D | 1 |
Ferrari, S; Serra, M | 1 |
Beffermann C, N; Ocqueteau T, M; Pilcante S, J; Sarmiento M, M | 1 |
Abramson, JS; Cassaday, R; Chavez, JC; Fenske, TS; Gandhi, M; Jaso, J; Landsburg, DJ; Medeiros, LJ; Nabhan, C; Petrich, AM; Press, O; Shah, N; Sohani, AR; Song, K; Yang, DT; Zelenetz, AD | 1 |
Bendle, M; Boffito, M; Bower, M; Dalla Pria, A; Ramaswami, R | 1 |
Carpten, JD; Cortes, D; Craig, D; Kirov, I; McEachron, TA; Sassoon, A; Sender, LS; Wungwattana, M; Zabokrtsky, KB | 1 |
Gao, J; Guo, J; Guo, X; Jia, CS; Li, Q; Zhou, CY; Zhu, YP | 1 |
Bae, SN; Byun, SW; Park, TC | 1 |
Chang, Y; Cui, Y; Fu, X; Li, L; Li, W; Li, X; Ma, W; Nan, F; Su, L; Sun, Z; Wang, J; Wang, X; Wu, J; Xue, H; Zhang, L; Zhang, M; Zhang, X | 1 |
Cho, SH; Jung, KS; Kang, ES; Kim, SJ; Kim, WS; Ko, YH | 1 |
Burger, E; Ferreri, AJ; Finke, J; Fricker, H; Fritsch, K; Grishina, O; Ihorst, G; Illerhaus, G; Kasenda, B; Mikesch, K; Schorb, E; Valk, E; Zucca, E | 1 |
Rosen, D; Sinno, MG; Wittler, R | 1 |
Fukuda, T; Hashiguchi, Y; Ichimura, T; Kasai, M; Kuno, I; Matsumoto, Y; Sumi, T; Yasui, T | 1 |
McKinney, CM; Meier, CA; Merel, SE; Pottinger, PS | 1 |
Ding, X; Liu, B; Yang, J | 1 |
Mu, Q; Wan, Y; Xiao, S; Xue, M | 1 |
Cosio, S; Fanucchi, A; Gadducci, A; Manacorda, S; Pistolesi, S; Strigini, FL; Tana, R | 1 |
Chihara, D; Fanale, MA; Fayad, LE; Fowler, NH; Hagemeister, FB; Oki, Y; Westin, JR | 1 |
Bae, SH; Eom, HS; Hong, J; Jeong, SH; Kang, HJ; Kim, SJ; Kim, WS; Kwak, JY; Lee, H; Lee, JH; Lee, MH; Park, SK; Shin, DY; Suh, C; Yang, DH; Yhim, HY; Yoon, DH | 1 |
Cai, J; Chu, C; Hu, H; Liu, H; Peng, T; Tang, D; Wang, J; Yang, T; Zhang, J | 1 |
Berkowitz, RS; Braga, A; Burlá, M; Elias, KM; Lin, L; Madi, JM; Maestá, I; Sun, SY; Torres, B; Uberti, E; Viggiano, M | 1 |
Bai, QX; Chen, JP; Chen, XQ; Dong, BX; Gao, GX; Gu, HT; Hao, CX; Liang, R; Shu, MM; Wang, JH; Wang, JS; Wang, XM; Yang, L; Zeng, Y; Zhang, N; Zhang, T | 1 |
Balzarotti, M; Cabrera, ME; Ceriani, L; Chiappella, A; Cunningham, D; Ferreri, AJ; Giovanella, L; Gospodarowicz, MK; Guarini, A; Johnson, PW; Martelli, M; Ricardi, U; Stelitano, C; Zinzani, PL; Zucca, E | 1 |
Björkholm, M; Borrebaeck, CA; Eriksson, M; Fjordén, K; Fluge, Ø; Holte, H; Isinger-Ekstrand, A; Jerkeman, M; Leppä, S; Møller Pedersen, L; Pauly, F; Wingren, C | 1 |
Azuma, E; Hirayama, M; Imai, H; Iwamoto, S; Komada, Y; Matsumine, A; Miura, Y; Nakatani, K; Toyoda, H; Yodoya, N | 1 |
Al Sa'ey, H; Al Shawabkeh, MA; Al Sulaiti, M; Ganesan, S | 1 |
Chao, TK; Hou, WC; Kao, CC; Lai, YJ; Li, HM; Su, HY; Yu, MH | 1 |
Abdalla, B; Alfaar, AS; Awad, M; Rashed, WM; Taha, H; Zekri, W | 1 |
Celentano, A; Cirillo, N; De Rosa, G; Mascolo, M; Mignogna, MD | 1 |
Akamatsu, N; Fujioka, Y; Fukuyama, M; Hasegawa, K; Hayashi, A; Ibaraki, T; Kokudo, N; Koya, J; Kurokawa, M; Mizuno, H; Nakamura, F; Shinozaki-Ushiku, A | 1 |
Cortes, JE; Estrov, Z; Ferrajoli, A; Garcia-Manero, G; Jabbour, E; Kantarjian, HM; Khouri, M; Khoury, JD; Ko, H; O'Brien, SM; Pierce, S; Ravandi, F; Short, NJ; Thomas, DA; Thompson, PA; Verstovsek, S; Wierda, WG | 1 |
Eysbouts, YK; IntHout, J; Lok, CAR; Massuger, LFAG; Ottevanger, PB; Sweep, FCGJ | 1 |
Brown, J; Bruegl, A; Essel, KG; Gershenson, DM; Naumann, RW; Ramondetta, LM | 1 |
Amengual, JE; Barta, SK; Bast, MA; Behdad, A; Blum, KA; Calzada, O; Cassaday, RD; Chavez, JC; Cohen, JB; Costa, C; Falkiewicz, MK; Feldman, T; Fenske, TS; Gerson, JN; Hernandez-Ilizaliturri, F; Hill, BT; Howlett, C; Kaplan, JB; Landsburg, DJ; Lansigan, F; Li, S; Lue, JK; Maly, J; Mato, AR; Medeiros, LJ; Nathan, S; Olszewski, AJ; Peace, DJ; Persky, DO; Petrich, AM; Reddy, NM; Rivera, X; Singavi, A; Torka, P; Vose, JM | 1 |
Cho, YS; Heo, DS; Jung, SH; Keam, B; Kim, DW; Kim, HJ; Kim, IH; Kim, M; Kim, TM; Lee, JY; Lee, SH; Ock, CY | 1 |
Hashizume, A; Jikuya, R; Kawai, M; Kishida, T; Mizuno, N; Muraoka, K; Tatenuma, T; Umemoto, S; Washimi, K; Yasui, M | 1 |
Guo, N; Li, Q; Song, L; Wang, D; Yin, R | 1 |
Peng, L; Yang, M | 1 |
Hou, AJ; Jia, RF; Jiang, L; Yang, XY | 1 |
Fan, L; Li, JY; Liang, JH; Peter Gale, R; Wang, L; Wu, W; Xia, Y; Xu, W | 1 |
Cai, G; Chen, JY; Cheng, S; Huang, HY; Wang, CF; Xiong, J; Xu, PP; Zhao, WL; Zhao, X; Zhong, HJ | 1 |
Abid, S; Achour, A; Amara, I; Azzebi, A; Bacha, H; Bousabbeh, M; Guedri, Y; Rjiba-Touati, K; Salem, IB | 1 |
Bompas, E; Bouvier, C; Brisse, HJ; Brugieres, L; Castex, MP; Cheurfa, N; Corradini, N; Delaye, J; Entz-Werlé, N; Gaspar, N; Gentet, JC; Italiano, A; Le Deley, MC; Lervat, C; Marec-Berard, P; Mascard, E; Occean, BV; Pacquement, H; Piperno-Neumann, S; Redini, F; Saumet, L; Schmitt, C; Tabone, MD; Verite-Goulard, C | 1 |
Endo, M; Kakigano, A; Kimura, T; Matsuzaki, S; Takiuchi, T; Yoshino, K | 1 |
Baars, JW; Brouwer, R; Chamuleau, MED; de Jong, D; de Wreede, LC; Demandt, AMP; Doorduijn, JK; Hardi, L; Kersten, MJ; Kluin, PM; Nijland, M; Oosten, LEM; Siemes, C; Smeekes, OS; Stevens, WBC; Thielen, FW; Uyl-de Groot, CA; van Imhoff, GW; Veelken, H | 1 |
Bergamini, A; Candiani, M; Cioffi, R; Cormio, G; Gadducci, A; Giorgione, V; Mangili, G; Pella, F; Petrone, M; Rabaiotti, E | 1 |
Chen, J; Fan, Y; Hong, R; Ma, F; Ou, K; Sang, D; Wang, J; Xu, B; Yuan, P; Zhai, X; Zhao, C | 1 |
Abou Mourad, Y; Barnett, MJ; Broady, R; Connors, JM; Forrest, DL; Gerrie, AS; Hogge, DE; Leitch, H; Nantel, SH; Narayanan, S; Nevill, TJ; Power, MM; Ramadan, K; Sanford, DS; Sehn, LH; Slack, GW; Song, KW; Sutherland, HJ; Toze, CL; Tucker, T; Zhu, KY | 1 |
Fu, C; Huang, R; Liang, Y; Ren, Z; Xie, M; Yu, L; Zhang, Z; Zhu, F | 1 |
Cohen, JB; Flowers, CR; Hall, KH; Panjic, EH; Valla, K | 1 |
Jeng, A; Tulloch, LG; Younes, R | 1 |
Harada, N; Haruta, N; Higashiura, Y; Hisanaga, H; Nobuhara, I; Sado, T; Watanabe, H; Watanabe, S | 1 |
Akizawa, Y; Kanno, T; Matsui, H; Shozu, M; Usui, H | 1 |
Bettarello, G; Costa, LJM; da Matta Abreu, M; Dos Santos, KB; Hallack Neto, AE; Mayrink, GTC; Mota, MA; Pereira, J; Ribeiro, LC | 1 |
Huang, XF; Liu, W; Zhang, YQ; Zhao, W | 1 |
Coulter, J; Frijstein, MM; Golfier, F; Lok, CAR; Massuger, LFAG; Seckl, MJ; Ten Kate-Booij, MJ; van Trommel, NE | 1 |
Berkowitz, RS; Braga, A; Dos Santos Esteves, APV; Elias, KM; Filho, JR; Horowitz, NS; Mora, PAR; Sun, SY; Uberti, EH; Velarde, GC | 1 |
Ajona, D; Calvo, A; Cirauqui, C; de Aberasturi, AL; de Andrea, C; Exposito, F; Guruceaga, E; Montuenga, LM; Pio, R; Redin, E; Redrado, M; Vicent, S; Villalba, M | 1 |
Abboud, MR; Abou Ali, B; Akel, S; Boulos, F; El-Solh, H; Ghanem, KM; Haidar, R; Muwakkit, SA; Saab, R; Saghieh, S; Salman, M; Tamim, H | 1 |
Barroilhet, L; Buza, N; Hui, P; McGregor, SM; Zheng, X | 1 |
Jiang, B; Wu, Q; Yan, LJ | 1 |
Amaki, J; Ando, T; Asano, N; Kameoka, Y; Katayama, N; Kinoshita, S; Kobayashi, Y; Kubota, N; Maeda, T; Masaki, Y; Matsuoka, H; Miyazaki, K; Niitsu, N; Oguchi, M; Saito, B; Sakai, R; Sekiguchi, N; Suzuki, R; Takizawa, J; Tomita, N; Wada, H; Yamaguchi, M | 1 |
Anderson, J; Beavis, AL; Chau, DB; Gocke, CD; Jenson, E; Nickles Fader, A; Ronnett, BM; Stone, R | 1 |
Anract, P; Bertucci, F; Blay, JY; Bompas, E; Brugieres, L; Collard, O; Cupissol, D; de Pinieux, G; Delaye, J; Duffaud, F; Italiano, A; Laurence, V; Le Cesne, A; Le Deley, MC; Occean, BV; Penel, N; Perrin, C; Piperno-Neumann, S; Ray-Coquard, I; Rios, M | 1 |
Coyle, B; Grundy, RG; Jackson, HK; Kerr, ID; Kilday, JP; Liu, JF; Sabnis, DH; Storer, LCD | 1 |
Ino, K; Kajiyama, H; Kikkawa, F; Kotani, T; Niimi, K; Nishino, K; Sato, S; Suzuki, S; Yamamoto, E | 1 |
Hara, J; Okada, K; Sakamoto, H; Soejima, T; Yamasaki, K | 1 |
Chinen, Y; Horiike, S; Inaba, T; Kobayashi, T; Kuroda, J; Nagata, K; Shimura, Y; Sotozono, C; Takimoto-Shimomura, T; Tsukamoto, T | 1 |
Aftandilians, T; Dombrovsky, I; Stowe, RJ; Tilden, HR; Wong, S | 1 |
Hirano, Y; Ikemura, M; Kurokawa, M; Miyawaki, S; Nakatomi, H; Saito, N; Satou, M; Takayanagi, S; Tanaka, R; Tanaka, S; Taoka, K; Toyama, K | 1 |
Kobbe, R; Schmidtke, S; Schwärzler, P; Stang, A; Tolosa, E | 1 |
García-Hernández, MH; Godina-González, S; Medina-Rosales, MN | 1 |
Chen, H; Hagemeister, FB; He, Y; Li, Y; Manyam, GC; Montes-Moreno, S; Piris, MA; Strati, P; Xiao, L; Xu-Monette, ZY; Young, KH; Zhou, H | 1 |
Berkowitz, RS; Elias, KM; Goldstein, DP; Horowitz, NS; Jareemit, N | 1 |
Fukunaga, A; Inano, S; Kitano, T; Okamoto, Y; Shibata, S; Tabata, S; Takiuchi, Y; Yamamoto, K | 1 |
Kuhn, AK; Rubin, MF | 1 |
Asano, N; Igarashi, T; Izutsu, K; Katayama, N; Kato, K; Kinoshita, T; Miyawaki, K; Miyazaki, K; Nishikawa, M; Nishikori, M; Nishimura, Y; Ohata, K; Ohshima, K; Okamoto, M; Sakai, R; Sunami, K; Suzumiya, J; Takahashi, N; Tamaru, S; Yamada, T; Yamaguchi, M; Yamamoto, G; Yano, H; Yoshida, I | 1 |
Cook, LB; Phillips, AA | 1 |
Colton, BS; Glaspy, J; Hornstein, N; Larson, S; Timmerman, J | 1 |
Coleman, RE; Gillett, S; Hancock, BW; Hills, A; Ireson, J; Singh, K; Tidy, JA; Winter, MC | 1 |
Chen, Y; Wang, K | 1 |
Almeida, A; Bartosch, C; Cruz Pires, M; Peixinho, C | 1 |
Hojo, H; Ikeda, S; Koyama, D; Ohta, M; Sukegawa, M; Suzuki, M; Tsunoda, S | 1 |
Alderuccio, JP; Alencar, AJ; Iyer, SG; Lossos, IS; Reis, IM; Rosenblatt, JD; Saul, EE | 1 |
Braga, A; Mattar, R; Passos, JP; Signorini Filho, RC; Silva, ACBD; Sun, SY | 1 |
Allias Montmayeur, F; Bolze, PA; Descargues, P; Devouassoux-Shisheboran, M; Golfier, F; Hajri, T; Lotz, JP; Massardier, J; You, B | 1 |
Ai, L; Cao, Y; Li, K; Shen, C; Sun, D; Wu, H | 1 |
Grommes, C; Modelevsky, L; Reiss, SN; Yerram, P | 1 |
Amaki, J; Ando, T; Asano, N; Choi, I; Ejima, Y; Fukuhara, N; Hasegawa, M; Kagami, Y; Kameoka, Y; Katayama, N; Kubota, N; Maeda, T; Maruyama, D; Masaki, Y; Matsuoka, H; Miyazaki, K; Murayama, T; Oguchi, M; Sakai, R; Sekiguchi, N; Shimada, K; Suzuki, R; Taguchi, S; Takizawa, J; Terui, Y; Tsukamoto, H; Tsukamoto, N; Uoshima, N; Utsumi, T; Wada, H; Yamaguchi, M | 1 |
Banerjee, S; Datta, S; Jahnavi, J; Maity, TR; Samanta, A | 1 |
Das, SK; Panthi, RC; Shahi, A | 1 |
Chatterjee, T; Lindahl, L; Martial, A; Settypalli, S | 1 |
Bojalil-Álvarez, L; Cortés, JE; Fernández-Gutiérrez, JA; García-Villaseñor, E; Murrieta-Álvarez, I; Reyes-Cisneros, OA; Ruiz-Argüelles, GJ; Ruiz-Delgado, GJ; Sánchez-Bonilla, D | 1 |
Bonnabry, P; Fleury-Souverain, S; Guillarme, D; Maurin, J; Rudaz, S | 1 |
Berkowitz, RS; Braga, A; Elias, KM; Freitas, F; Fülöp, V; Horowitz, NS; Jareemit, N; Maestá, I; Paiva, G; Ramírez, LAC; Therasakvichya, S | 1 |
Gao, X; Huang, Y; Li, Y; Wu, M; Zhou, T; Zhu, Q | 1 |
Gillett, S; Hapuarachi, B; Ireson, J; Romanowski, C; Singh, K; Tidy, JA; Winter, MC | 1 |
Iino, H; Kanaya, S; Matsumura, I; Nakayama, K; Noguchi, H; Saito, A; Tahara, K; Terasaki, S; Toyama, K; Yoshida, T | 1 |
Baloch, SS; Khan, SR; Moosajee, M; Samon, Z; Shahid, A; Shahzadi, M; Tariq, M | 1 |
111 review(s) available for etoposide and methotrexate
Article | Year |
---|---|
Membrane transporters in drug development.
Topics: Animals; Computer Simulation; Decision Trees; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Drug Interactions; Humans; Membrane Transport Proteins; Mice; Mice, Knockout; Prescription Drugs | 2010 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Quinolone hybrids and their anti-cancer activities: An overview.
Topics: Animals; Antineoplastic Agents; Humans; Neoplasms; Quinolones; Structure-Activity Relationship | 2019 |
Coumarin-containing hybrids and their anticancer activities.
Topics: Animals; Antineoplastic Agents; Coumarins; Drug Design; Drug Discovery; Humans; Neoplasms; Structure-Activity Relationship | 2019 |
Recent National Cancer Institute lymphoma trials of etoposide-containing combination chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Lymphoma; Methotrexate; National Institutes of Health (U.S.); Prednisone; United States; Vincristine | 1992 |
Hypersensitivity reactions.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Asparaginase; Aziridines; Benzoquinones; Bleomycin; Chlorambucil; Cisplatin; Cyclophosphamide; Cytarabine; Dacarbazine; Drug Hypersensitivity; Etoposide; Fluorouracil; Humans; Ifosfamide; Melphalan; Methotrexate; Mitomycins; Neoplasms; Paclitaxel; Pentostatin; Procarbazine; Teniposide | 1992 |
Disposition of antineoplastic agents in the very young child.
Topics: Age Factors; Antineoplastic Agents; Blood Proteins; Child; Child, Preschool; Doxorubicin; Etoposide; Humans; Infant; Infant, Newborn; Liver; Mercaptopurine; Methotrexate; Neoplasms; Nervous System; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide | 1992 |
[Follicular lymphomas. Therapeutic indications].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Interferon-alpha; Leucovorin; Lymphoma, Follicular; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Vincristine | 1992 |
Cytotoxic treatment of metastatic breast cancer. Which drugs and drug combinations to use?
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Melphalan; Methotrexate; Mitomycin; Mitoxantrone; Neoplasm Metastasis; Vincristine | 1992 |
Studies of the Australasian Germ Cell Trial Group: the management of advanced testis cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Australia; Biomarkers, Tumor; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Humans; Male; Methotrexate; Multicenter Studies as Topic; Neoplasms, Germ Cell and Embryonal; Prognosis; Randomized Controlled Trials as Topic; Survival Rate; Testicular Neoplasms; Vinblastine; Vincristine | 1990 |
Long-term follow-up of ProMACE-CytaBOM in non-Hodgkin's lymphomas.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Evaluation; Etoposide; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Remission Induction; Survival Rate; Vincristine | 1991 |
[Treatment of relapses and failures in disseminated Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Cisplatin; Cyclophosphamide; Cytarabine; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Mechlorethamine; Melphalan; Methotrexate; Mitoguazone; Prednisone; Procarbazine; Remission Induction; Transplantation, Autologous; Transplantation, Homologous; Vinblastine; Vincristine | 1991 |
Single-agent chemotherapy for nonmetastatic gestational trophoblastic neoplasia. Perspectives for the 21st century after three decades of use.
Topics: Chorionic Gonadotropin; Dactinomycin; Etoposide; Female; Fluorouracil; Humans; Methotrexate; Pregnancy; Prognosis; Severity of Illness Index; Trophoblastic Neoplasms; Uterine Neoplasms | 1991 |
Modulation of cytotoxic drug activity by dipyridamole.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colonic Neoplasms; Cytarabine; Dipyridamole; Drug Interactions; Etoposide; Fluorouracil; Humans; Leucovorin; Methotrexate | 1990 |
[Non-Hodgkin's lymphomas: recent achievements and therapeutic perspectives].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Vincristine | 1985 |
Cell kinetics as related to treatment of patients with acute nonlymphoid leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bone Marrow; Bone Marrow Cells; Cell Cycle; Child; Cytarabine; Daunorubicin; Doxorubicin; Etoposide; Flow Cytometry; Hematopoietic Stem Cells; Humans; Hydrocortisone; Leukemia; Methotrexate; Mitotic Index; Neoplastic Stem Cells; Prednisone; Prognosis; Vincristine | 1985 |
European experience with ifosfamide in lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Etoposide; Europe; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone | 1989 |
Tracheoesophageal fistula in the patient with lymphoma: case report and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lymphomatoid Granulomatosis; Methotrexate; Prednisone; Prognosis; Reoperation; Skin Neoplasms; Tracheoesophageal Fistula; Vincristine | 1989 |
Experience with ifosfamide combinations in malignant lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Ifosfamide; Lymphoma; Methotrexate; Mitoguazone | 1989 |
Acute megakaryoblastic leukemia associated with mosaic Down's syndrome.
Topics: Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 17; Clone Cells; Cyclophosphamide; Cytarabine; Down Syndrome; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Infant; Leukemia, Megakaryoblastic, Acute; Methotrexate; Mosaicism; Prednisone; Thioguanine; Trisomy | 1987 |
Current chemotherapy of small cell lung cancer.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Complement Membrane Attack Complex; Complement System Proteins; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Lomustine; Lung Neoplasms; Methotrexate; Mitomycin; Mitomycins; Podophyllotoxin; Procarbazine; Prognosis; Time Factors; Vincristine | 1986 |
Indications for and benefits of intensive therapies in treatment of childhood cancers.
Topics: Acute Disease; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Etoposide; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Melphalan; Methotrexate; Neoplasms; Osteosarcoma; Risk; Sarcoma, Ewing | 1986 |
Pharmacologic aspects of lung cancer chemotherapy.
Topics: Antineoplastic Agents; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lung Neoplasms; Methotrexate; Sclerosing Solutions; Vinca Alkaloids | 1986 |
Pharmacokinetics of anticancer drugs in children.
Topics: Aminoacridines; Amsacrine; Antibiotics, Antineoplastic; Antineoplastic Agents; Bleomycin; Child; Cyclophosphamide; Etoposide; Humans; Kinetics; Mercaptopurine; Methotrexate; Naphthacenes; Podophyllotoxin; Teniposide; Vinca Alkaloids | 1983 |
Chemotherapy of esophageal cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Doxorubicin; Esophageal Neoplasms; Etoposide; Fluorouracil; Humans; Lomustine; Methotrexate; Mitoguazone; Mitomycin; Mitomycins; Neoplasm Metastasis; Postoperative Care; Preoperative Care; Vinblastine; Vindesine | 1984 |
High-risk metastatic gestational trophoblastic tumors. Current management.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Clinical Protocols; Clinical Trials as Topic; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hysterectomy; Lung Neoplasms; Methotrexate; Neoplasm Staging; Pregnancy; Prognosis; Remission Induction; Risk Factors; Survival Rate; Thoracotomy; Treatment Outcome; Trophoblastic Neoplasms; Uterine Neoplasms; Vaginal Neoplasms; Vincristine | 1994 |
Treatment of aggressive non-Hodgkin' lymphomas. Lessons from the past 10 years.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisolone; Prednisone; Randomized Controlled Trials as Topic; Remission Induction; Survival Rate; Vincristine | 1994 |
[Malignant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Lymphoma; Lymphoma, Non-Hodgkin; Methotrexate; Vincristine | 1994 |
[Improvement of survival of testicular cancer patients through chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Transplantation; Chlorambucil; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Male; Methotrexate; Survival Rate; Testicular Neoplasms; Vinblastine | 1995 |
Oral therapy for small cell lung cancer.
Topics: Administration, Oral; Altretamine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Etoposide; Humans; Ifosfamide; Infusions, Intravenous; Lomustine; Lung Neoplasms; Methotrexate; Procarbazine | 1995 |
Non small cell lung cancer and chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Fluorouracil; Humans; Indazoles; Lomustine; Lung Neoplasms; Methotrexate; Neoplasm Staging; Treatment Outcome | 1994 |
An update of Scandinavian studies of osteosarcoma.
Topics: Adolescent; Adult; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Clinical Protocols; Combined Modality Therapy; Doxorubicin; Etoposide; Humans; Ifosfamide; Methotrexate; Osteosarcoma; Scandinavian and Nordic Countries; Survival Rate; Treatment Outcome | 1993 |
Neoadjuvant chemotherapy for patients with osteosarcoma: University of Florida studies.
Topics: Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Florida; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Life Tables; Lung Neoplasms; Methotrexate; Osteosarcoma; Survival Analysis; Treatment Outcome | 1993 |
Clinical analysis of 670 cases in two trials of the European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group subtyped according to the Revised European-American Classification of Lymphoid Neoplasms: a comparison with the W
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Immunologic Factors; Immunophenotyping; Interferon alpha-2; Interferon-alpha; Life Tables; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Prognosis; Recombinant Proteins; Survival Analysis; Survival Rate; Vincristine | 1996 |
The treatment of advanced gastric cancer.
Topics: Antibiotics, Antineoplastic; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Etoposide; Fluorouracil; Gastrectomy; Humans; Leucovorin; Methotrexate; Mitomycins; Randomized Controlled Trials as Topic; Stomach Neoplasms | 1996 |
Chemotherapy of intermediate-grade non-Hodgkin's lymphoma: is "more" or "less" better?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, Phase II as Topic; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Vincristine | 1995 |
[Etoposide (VP-16) in gynecologic malignancy].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Humans; Methotrexate; Ovarian Neoplasms; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1996 |
[Primary cutaneous lymphoma--mycosis fungoides].
Topics: Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Electrons; Etoposide; Humans; Interferon-gamma; Leucovorin; Membrane Glycoproteins; Methotrexate; Mycosis Fungoides; Prednisone; PUVA Therapy; Skin Neoplasms; Vincristine | 1997 |
Primary adrenal lymphoma associated with adrenal insufficiency: a distinct clinical entity.
Topics: Addison Disease; Adrenal Cortex Neoplasms; Adrenal Gland Diseases; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cosyntropin; Cyclophosphamide; Dexamethasone; Diagnosis, Differential; Doxorubicin; Etoposide; Eye Neoplasms; Fatal Outcome; Humans; Hydrocortisone; Hyperkalemia; Ifosfamide; L-Lactate Dehydrogenase; Lymphoma, T-Cell; Male; Methotrexate; Neoplasm Proteins; Oculomotor Muscles; Prednisone; Tomography, X-Ray Computed; Tuberculosis, Endocrine; Vincristine | 1997 |
The growing teratoma syndrome in a nongerminomatous germ cell tumor of the pineal gland: a case report and review.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Diagnosis, Differential; Endodermal Sinus Tumor; Etoposide; Humans; Leucovorin; Male; Methotrexate; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Pineal Gland; Syndrome; Teratoma; Vincristine | 1997 |
Management of high-risk gestational trophoblastic disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cyclophosphamide; Dactinomycin; Etoposide; Female; Folic Acid; Humans; Liver Neoplasms; Methotrexate; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1998 |
[Treatment of recurrent gastric cancer].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Doxorubicin; Drug Administration Schedule; Epirubicin; Etoposide; Fluorouracil; Humans; Immunologic Factors; Irinotecan; Liver Neoplasms; Lymphatic Metastasis; Methotrexate; Mitomycin; Neoplastic Cells, Circulating; Peritoneal Neoplasms; Stomach Neoplasms | 1998 |
Burkitt's lymphoma involving the mandible: report of a case and review of Japanese cases.
Topics: Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Cyclophosphamide; Cytarabine; Epirubicin; Etoposide; Humans; Hydrocortisone; Japan; Male; Mandibular Neoplasms; Methotrexate; Prednisone; Soft Tissue Neoplasms | 1998 |
[Chemotherapy of gastric cancer].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Etoposide; Fluorouracil; Humans; Immunologic Factors; Irinotecan; Methotrexate; Stomach Neoplasms | 1998 |
Chemotherapy for advanced esthesioneuroblastoma: the Mayo Clinic experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Esthesioneuroblastoma, Olfactory; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Lymphatic Metastasis; Male; Mesna; Methotrexate; Middle Aged; Mitomycin; Nasal Cavity; Nose Neoplasms; Paranasal Sinus Neoplasms; Remission Induction; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine | 1998 |
[Chylothorax resulting from malignant non Hodgkin's lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chylothorax; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Remission Induction; Vincristine | 1998 |
[Familial hemophagocytic lymphohistiocytosis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Dexamethasone; Drug Administration Schedule; Etoposide; Genes, Recessive; Histiocytosis, Non-Langerhans-Cell; Humans; Methotrexate | 1998 |
[Chemotherapy for non-Hodgkin's lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Vincristine | 1998 |
Long-term third chronic phase of chronic myelogenous leukemia maintained by interferon-alpha and methotrexate.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Cytarabine; Etoposide; Humans; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocyte Count; Male; Methotrexate; Mitoxantrone; Remission Induction; Time; Treatment Outcome | 1999 |
Preoperative therapy for local-regional gastric cancer: rationale and review of trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Doxorubicin; Etoposide; Fluorouracil; Humans; Methotrexate; Mitomycin; Preoperative Care; Stomach Neoplasms; Tegafur; Uracil | 2000 |
Chemotherapy of metastatic gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Epirubicin; Etoposide; Fluorouracil; Humans; Leucovorin; Methotrexate; Randomized Controlled Trials as Topic; Stomach Neoplasms | 2000 |
Optimizing antimetabolite-based chemotherapy for the treatment of childhood acute lymphoblastic leukaemia.
Topics: Antimetabolites, Antineoplastic; Child; Cytarabine; Drug Administration Schedule; Etoposide; Humans; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide; Thioguanine | 2000 |
Induction therapy of adult acute lymphocytic leukemia without the use of vincristine or prednisone.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Controlled Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Dactinomycin; Doxorubicin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Male; Mercaptopurine; Methotrexate; Middle Aged; Mitoxantrone; Multicenter Studies as Topic; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prospective Studies; Randomized Controlled Trials as Topic; Recombinant Proteins; Remission Induction; Survival Analysis; Treatment Outcome; Vincristine | 2001 |
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infections; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Survival Analysis; Thrombocytopenia; Vincristine | 2001 |
Chemotherapy for trophoblastic disease: current standards.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Humans; Leucovorin; Methotrexate; Neoplasm Staging; Pregnancy; Prognosis; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 2002 |
Successful treatment of refractory Langerhans cell histiocytosis with unrelated cord blood transplantation.
Topics: Bone Marrow; Cladribine; Combined Modality Therapy; Cyclosporine; Cytarabine; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Fetal Blood; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histiocytosis, Langerhans-Cell; Humans; Infant, Newborn; Mercaptopurine; Methotrexate; Methylprednisolone; Prednisone; Remission Induction; Transplantation, Homologous; Vinblastine | 2001 |
Unrelated cord blood transplantation for an infant with chemotherapy-resistant progressive Langerhans cell histiocytosis.
Topics: Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease Progression; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Etoposide; Fetal Blood; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histiocytosis, Langerhans-Cell; Humans; Infant; Male; Mercaptopurine; Methotrexate; Methylprednisolone; Mitoxantrone; Prednisolone; Remission Induction; Transplantation Conditioning; Transplantation, Homologous; Vincristine | 2001 |
A clinical, molecular and cytogenetic study of 12 cases of human herpesvirus 8 associated primary effusion lymphoma in HIV-infected patients.
Topics: Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bleomycin; Chromosome Aberrations; Cidofovir; Cyclophosphamide; Cytosine; Doxorubicin; Drug Therapy, Combination; Etoposide; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Herpesviridae Infections; Herpesvirus 8, Human; Humans; Immunophenotyping; Interferon-alpha; Karyotyping; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Lymphoma, Large-Cell, Immunoblastic; Male; Methotrexate; Middle Aged; Organophosphonates; Organophosphorus Compounds; Polymerase Chain Reaction; Prednisone; Prognosis; Remission Induction; Survival Analysis; Vincristine; Vindesine; Viral Load | 2001 |
[Chemotherapy and radiotherapy for urological cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Kidney Neoplasms; Male; Methotrexate; Prostatic Neoplasms; Testicular Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine | 2002 |
Treatment of gestational trophoblastic tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Humans; Methotrexate; Neoplasm Staging; Practice Guidelines as Topic; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 2002 |
Anaplastic large cell lymphoma in childhood: analysis of 72 patients treated on The United Kingdom Children's Cancer Study Group chemotherapy regimens.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Infant; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Prednisolone; Recurrence; Risk; Thioguanine; United Kingdom; Vincristine | 2002 |
[Primary cardiac lymphoma: cytological diagnosis and treatment with response to polychemotherapy and hematopoietic precursor autotransplant. Presentation of a case a review of the literature].
Topics: Antineoplastic Combined Chemotherapy Protocols; Atrial Flutter; Carmustine; Cyclophosphamide; Cytarabine; Doxorubicin; Echocardiography, Transesophageal; Etoposide; Heart Failure; Heart Neoplasms; Heart Septum; Hematopoietic Stem Cell Transplantation; Humans; Hydrocortisone; Immunocompetence; Injections, Spinal; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Melphalan; Methotrexate; Middle Aged; Pleural Effusion; Prednisone; Remission Induction; Tomography, X-Ray Computed; Transplantation Conditioning; Transplantation, Autologous; Vincristine | 2002 |
[Gestational trophoblastic tumors and recent clinical information].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Contraceptives, Oral; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole; Methotrexate; Pregnancy; Prognosis; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 2002 |
Chemotherapy for breast cancer brain metastases.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Etoposide; Female; Fluorouracil; Humans; Methotrexate; Survival Rate; Treatment Outcome | 2002 |
Challenges in the management of Burkitt's lymphoma.
Topics: Adult; Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Bleomycin; Burkitt Lymphoma; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Enzyme Inhibitors; Etoposide; HIV Infections; Humans; Ifosfamide; Leucovorin; Methotrexate; Time Factors; Treatment Outcome; Urate Oxidase; Vincristine | 2002 |
Non-hodgkins lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Humans; Idarubicin; Ifosfamide; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Prednisolone; Prednisone; Vincristine | 2003 |
Post-transplant Burkitt's leukemia or lymphoma. Study of five cases treated with specific intensive therapy (PETHEMA ALL-3/97 trial).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dexamethasone; Epstein-Barr Virus Infections; Etoposide; Female; Heart Transplantation; Humans; Ifosfamide; Immunosuppression Therapy; Kidney Transplantation; Leucovorin; Liver Transplantation; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Prednisone; Remission Induction; Retrospective Studies; Transplantation; Treatment Outcome; Vincristine | 2003 |
Treatment-induced leukoencephalopathy in primary CNS lymphoma: a clinical and autopsy study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Cranial Irradiation; Cytarabine; Dementia; Dementia, Vascular; Demyelinating Diseases; Disease Progression; Doxorubicin; Epilepsy, Complex Partial; Etoposide; Eye Neoplasms; Fatal Outcome; Female; Gait Disorders, Neurologic; Humans; Immunocompetence; Intracranial Arteriosclerosis; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Procarbazine; Radiation Injuries; Retrospective Studies; Survival Analysis; Thiotepa; Vincristine | 2004 |
Depression: a case of neuronal life and death?
Topics: Animals; Antidepressive Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Death; Cell Division; Depression; Etoposide; Humans; Ifosfamide; Limbic System; Methotrexate; Models, Neurological; Models, Psychological; Mood Disorders; Neurons; Stress, Physiological | 2004 |
Testicular granulocytic sarcoma, a source of diagnostic confusion.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cell Nucleus; Cyclophosphamide; Cytarabine; Cytoplasmic Granules; Daunorubicin; Diagnosis, Differential; Diagnostic Errors; Doxorubicin; Etoposide; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisolone; Sarcoma, Myeloid; Testicular Neoplasms; Vincristine | 2004 |
[The second-line chemotherapy for urological cancers].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Gemcitabine; Humans; Ifosfamide; Male; Methotrexate; Paclitaxel; Survival Rate; Testicular Neoplasms; Treatment Outcome; Urologic Neoplasms; Vinblastine | 2005 |
Natural killer T-cell lymphoma of the tongue.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Killer Cells, Natural; Lymphoma, T-Cell; Male; Methotrexate; Prednisone; Radiotherapy, Adjuvant; Tongue Diseases; Tongue Neoplasms; Ulcer; Vincristine | 2005 |
Secondary chemotherapy for high-risk gestational trophoblastic neoplasia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Treatment Outcome; Vincristine | 2005 |
Anaplastic large cell lymphoma of bone--is it a bad tumor?
Topics: Activin Receptors, Type II; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Child; Child, Preschool; Cohort Studies; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Ki-1 Antigen; Lymphoma, Large-Cell, Anaplastic; Magnetic Resonance Imaging; Male; Methotrexate; Prognosis; Remission Induction; Scapula; Treatment Outcome; United Kingdom | 2007 |
Combination of gemcitabine and irinotecan for recurrent metastatic osteogenic sarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Cisplatin; Combined Modality Therapy; Deoxycytidine; Doxorubicin; Etoposide; Femoral Neoplasms; Gemcitabine; Head and Neck Neoplasms; Humans; Ifosfamide; Irinotecan; Leucovorin; Liver Neoplasms; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Osteosarcoma; Palliative Care; Salvage Therapy; Scalp; Skin Neoplasms; Thoracotomy | 2005 |
[Chemotherapy for brain tumor].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Drug Delivery Systems; Etoposide; Humans; Lymphoma; Medulloblastoma; Methotrexate; Neoplasms, Germ Cell and Embryonal; Nimustine; Oligodendroglioma; Platinum Compounds; Randomized Controlled Trials as Topic; Vincristine | 2005 |
Trilateral retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disease Progression; Etoposide; Eye Enucleation; Eye Neoplasms; Fatal Outcome; Female; Humans; Idarubicin; Ifosfamide; Male; Methotrexate; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Neoplastic Syndromes, Hereditary; Pinealoma; Prognosis; Retinoblastoma; Vincristine | 2007 |
Parotid acinar cell carcinoma in a long-term survivor of childhood acute lymphoblastic leukemia.
Topics: Adenoma, Sweat Gland; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carcinoma, Acinar Cell; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Epirubicin; Etoposide; Follow-Up Studies; Humans; Male; Mercaptopurine; Methotrexate; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Parotid Neoplasms; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence; Remission Induction; Survivors; Sweat Gland Neoplasms; Vincristine; Whole-Body Irradiation | 2008 |
Local treatment of ectopic pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Danazol; Etoposide; Fallopian Tubes; Female; Glucose; Humans; Laparoscopy; Methotrexate; Potassium Chloride; Pregnancy; Pregnancy, Ectopic; Prostaglandins; Salpingostomy; Ultrasonography, Prenatal | 2007 |
Treatment of metastatic gestational trophoblastic neoplasia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Vincristine | 2007 |
[Plasmacytoid urothelial carcinoma of the bladder: a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Diagnostic Imaging; Etoposide; Humans; Lymphatic Metastasis; Male; Methotrexate; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2009 |
Contralateral testicular relapse after prophylactic radiation in a patient with primary testicular diffuse large B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Blood-Testis Barrier; Bone Marrow; Carboplatin; Central Nervous System Neoplasms; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Injections, Spinal; Lymphatic Metastasis; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Orchiectomy; Prednisone; Radiotherapy, Adjuvant; Remission Induction; Rituximab; Salvage Therapy; Testicular Neoplasms; Transplantation Conditioning; Treatment Failure; Vincristine | 2009 |
Purely intramedullary spinal cord primitive neuroectodermal tumor: case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Etoposide; Humans; Infant; Magnetic Resonance Imaging; Male; Methotrexate; Neuroectodermal Tumors, Primitive; Paraparesis; Prognosis; Spinal Cord Neoplasms; Thoracic Vertebrae | 2009 |
Treatment of advanced extranodal NK/T cell lymphoma, nasal-type and aggressive NK-cell leukemia.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; Drug Therapy, Combination; Etoposide; Humans; Ifosfamide; Killer Cells, Natural; Leukemia, T-Cell; Lymphoma, Extranodal NK-T-Cell; Methotrexate; Treatment Outcome | 2010 |
[Treatment of Burkitt lymphoma and Burkitt-like lymphoma].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Rituximab; Vincristine | 2011 |
Anaplastic large cell lymphoma, ALK-positive.
Topics: Anaplastic Lymphoma Kinase; Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma, Large-Cell, Anaplastic; Methotrexate; Prednisolone; Prednisone; Receptor Protein-Tyrosine Kinases; Stem Cell Transplantation; T-Lymphocytes; Translocation, Genetic; Vincristine | 2012 |
Relapse of acute myeloid leukemia at the pituitary gland: a case report and review of literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cytarabine; Diabetes Insipidus; Etoposide; Female; Humans; Hypopituitarism; Idarubicin; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Methotrexate; Pituitary Neoplasms; Radiotherapy; Recurrence; Remission Induction; Vision Disorders | 2012 |
Spontaneous gastrosplenic fistula secondary to primary splenic lymphoma.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cooperative Behavior; Cyclophosphamide; Cytarabine; Diagnosis, Differential; Doxorubicin; Etoposide; Female; Fistula; Gastric Fistula; Humans; Ifosfamide; Image Interpretation, Computer-Assisted; Interdisciplinary Communication; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Multidetector Computed Tomography; Patient Care Team; Radiographic Image Enhancement; Rituximab; Spleen; Splenic Diseases; Splenic Neoplasms; Vincristine | 2010 |
Development of a curative treatment within the AML-BFM studies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Etoposide; Germany; Humans; Idarubicin; Leukemia, Erythroblastic, Acute; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Methotrexate; Multicenter Studies as Topic; Prednisone; Randomized Controlled Trials as Topic; Survival Rate; Thioguanine; Vincristine | 2013 |
[Chemotherapy in male external genital organs (testicular and penile cancer)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Cryopreservation; Etoposide; Fluorouracil; Humans; Ifosfamide; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Paclitaxel; Penile Neoplasms; Spermatozoa; Testicular Neoplasms; Vinblastine | 2013 |
[Serious organ damage and intractable clinical conditions in rheumatic and connective tissue disease--progress in pathophysiology and treatment. Topics: II. Clinical conditions special attention needed to be paid to; 4. Macrophage activating syndrome and
Topics: Antirheumatic Agents; Connective Tissue Diseases; Cyclosporine; Dexamethasone; Drug Therapy, Combination; Etoposide; gamma-Globins; Humans; Immunosuppressive Agents; Lymphohistiocytosis, Hemophagocytic; Macrophage Activation Syndrome; Methotrexate; Methylprednisolone; Pulse Therapy, Drug | 2013 |
[Current therapy for acute myeloid leukemia and acute promyelocytic leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Consolidation Chemotherapy; Cytarabine; Daunorubicin; Drug Discovery; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Induction Chemotherapy; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Maintenance Chemotherapy; Mercaptopurine; Methotrexate; Molecular Targeted Therapy; Mutation; Recurrence; Tretinoin; Vincristine | 2014 |
[Hemophagocytic lymphohistiocytosis].
Topics: Antibodies, Monoclonal, Murine-Derived; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Cyclosporine; Disease Progression; Doxorubicin; Drug Therapy, Combination; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphohistiocytosis, Hemophagocytic; Methotrexate; Multiple Organ Failure; Prednisolone; Prednisone; Rituximab; Severity of Illness Index; Transplantation Conditioning; Vidarabine; Vincristine | 2014 |
[Treatment strategy of gray zone lymphomas].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Prednisone; Rituximab; Vincristine | 2014 |
[Treatment of adult T-cell leukemia-lymphoma].
Topics: Allografts; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Human T-lymphotropic virus 1; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Methotrexate; Nitrosourea Compounds; Prednisolone; Prednisone; Prognosis; Salvage Therapy; Vincristine; Vindesine; Zidovudine | 2014 |
The role of chemotherapy for metastatic, relapsed and refractory osteosarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Deoxycytidine; Docetaxel; Etoposide; Gemcitabine; Humans; Ifosfamide; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Taxoids | 2014 |
Case report and review of immunodeficiency-associated Burkitt lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Doxorubicin; Etoposide; HIV Infections; Humans; Male; Methotrexate; Prednisone; Remission Induction; Rituximab; Vincristine | 2015 |
Prolonged response of meningeal carcinomatosis from non-small cell lung cancer to salvage intrathecal etoposide subsequent to failure of first-line methotrexate: a case report and literature review.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Drug; Etoposide; Humans; Immunosuppressive Agents; Injections, Spinal; Lung Neoplasms; Male; Meningeal Carcinomatosis; Methotrexate; Middle Aged; Neoplasms, Multiple Primary; Treatment Failure | 2015 |
Durable Response of Leptomeningeal Metastasis of Breast Cancer to Salvage Intrathecal Etoposide After Methotrexate: A Case Report and Literature Review.
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Etoposide; Female; Humans; Injections, Spinal; Meningeal Neoplasms; Methotrexate; Salvage Therapy | 2015 |
An update on chemotherapy for osteosarcoma.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Doxorubicin; Etoposide; Humans; Ifosfamide; Methotrexate; Neoadjuvant Therapy; Neoplasm Metastasis; Osteosarcoma; Prognosis; Randomized Controlled Trials as Topic | 2015 |
[Acquired hemophagocytic syndrome treated with HLH 94-04 chemotherapy protocol: Report of four cases].
Topics: Adult; Cyclosporine; Dexamethasone; Drug Therapy, Combination; Early Diagnosis; Etoposide; Female; Ferritins; Humans; Immunosuppressive Agents; Lymphohistiocytosis, Hemophagocytic; Male; Methotrexate; Young Adult | 2015 |
Effect of early goal directed therapy in the treatment of severe sepsis and/or septic shock.
Topics: Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Goals; Health Resources; Humans; Methotrexate; Prospective Studies; Sepsis; Shock, Septic | 2016 |
Postmenopausal choriocarcinoma: a rare case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Chorionic Gonadotropin, beta Subunit, Human; Cyclophosphamide; Dactinomycin; Etoposide; Female; Fluorouracil; Humans; Lung Neoplasms; Methotrexate; Middle Aged; Postmenopause; Vaginal Neoplasms; Vincristine | 2018 |
Conservative management of placenta percreta.
Topics: Cesarean Section; Conservative Treatment; Etoposide; Female; Hemorrhage; Humans; Hysterectomy; Methotrexate; Organ Sparing Treatments; Placenta Accreta; Postoperative Complications; Pregnancy; Urinary Bladder; Uterine Artery Embolization | 2018 |
How to Decide Which DLBCL Patients Should Receive CNS Prophylaxis.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Injections, Spinal; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Patient Selection; Prednisone; Risk Factors; Rituximab; Vincristine | 2018 |
Reactive hemophagocytic syndrome in the setting of acute human immunodeficiency virus 1 infection: case report and review of the literature.
Topics: Adrenal Cortex Hormones; Adult; Anti-Retroviral Agents; Etoposide; Exanthema; Histiocytosis; HIV Infections; HIV-1; Humans; Injections, Spinal; Lymphohistiocytosis, Hemophagocytic; Male; Methotrexate; Treatment Outcome | 2018 |
Multiple metastatic gestational trophoblastic disease after a twin pregnancy with complete hydatidiform mole and coexisting fetus, following assisted reproductive technology: Case report and literature review.
Topics: Abortion, Induced; Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Cyclophosphamide; Dactinomycin; Etoposide; Female; Fertilization in Vitro; Gestational Age; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Hysterectomy; Lung Neoplasms; Methotrexate; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy, Twin; Tomography, X-Ray Computed; Uterine Hemorrhage; Uterine Neoplasms; Vincristine | 2018 |
Successful Immunochemotherapy for Burkitt Lymphoma During Pregnancy as a Bridge to Postpartum High-Dose Methotrexate Therapy: A Case Report and Review of the Literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Immunotherapy; Methotrexate; Postpartum Period; Prednisolone; Pregnancy; Pregnancy Complications, Neoplastic; Rituximab; Vincristine | 2020 |
Primary cesarean scar choriocarcinoma: A case series and literature review.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cicatrix; Etoposide; Female; Humans; Methotrexate; Pregnancy; Retrospective Studies | 2023 |
Leptomeningeal disease as a presenting feature of gestational trophoblastic neoplasia: A review and recommendations for management.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Paclitaxel; Placenta; Pregnancy; Quality of Life; Retrospective Studies; Vincristine | 2023 |
Review of current literature on gestational trophoblastic neoplasia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Retrospective Studies; Vincristine | 2023 |
322 trial(s) available for etoposide and methotrexate
Article | Year |
---|---|
VP-16-213 versus polychemotherapy in patients with advanced small cell lung cancer.
Topics: Adult; Aged; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Podophyllotoxin; Prognosis; Vincristine | 1976 |
Thymosin fraction V and intensive combination chemotherapy. Prolonging the survival of patients with small-cell lung cancer.
Topics: Antineoplastic Agents; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Ifosfamide; Lomustine; Lung Neoplasms; Male; Methotrexate; Procarbazine; Thymosin; Thymus Hormones; Vincristine | 1979 |
Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Etoposide; Humans; Ifosfamide; Lomustine; Lung Neoplasms; Methotrexate; Procarbazine; Remission, Spontaneous; Vincristine | 1979 |
Calculation of received dose intensity for combinations of drugs using small-cell lung carcinoma treatment regimens as examples.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Numerical Analysis, Computer-Assisted; Vincristine | 1992 |
Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high-risk gestational trophoblastic disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Follow-Up Studies; Humans; Methotrexate; Pregnancy; Prospective Studies; Risk Factors; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1992 |
Etoposide versus methotrexate in small cell bronchial carcinoma. A randomized study of two types of four-drug chemotherapy regimens.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Prospective Studies; Vincristine | 1992 |
Cytosine arabinoside and etoposide (CARE) in relapsed and refractory non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged | 1992 |
Cyclic alternating chemotherapy of high-grade malignant non-Hodgkin lymphomas with VIM-Bleo and CHOP.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Leukopenia; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Prospective Studies; Time Factors; Vincristine | 1992 |
POMB/ACE chemotherapy in non-seminomatous germ cell tumours: outcome and importance of dose intensity.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Cytarabine; Dactinomycin; Dose-Response Relationship, Drug; Etoposide; Humans; Male; Mediastinal Neoplasms; Mesonephroma; Methotrexate; Middle Aged; Prognosis; Retroperitoneal Neoplasms; Teratoma; Testicular Neoplasms; Time Factors; Vincristine | 1992 |
Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM/IMVP-16 regimen. A multicenter study. Kiel Lymphoma Study Group.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Immunoblastic Lymphadenopathy; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Prospective Studies; Survival Analysis; Vincristine | 1992 |
Treatment of children with Hodgkin's disease--results of the German Pediatric Oncology Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Germany, West; Hodgkin Disease; Humans; Male; Methotrexate; Neoplasm Staging; Prednisone; Procarbazine; Radiotherapy Dosage; Sex Factors; Survival Rate; Vincristine | 1992 |
Effect of chemotherapy combined with caffeine for osteosarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Caffeine; Calcaneus; Chemotherapy, Adjuvant; Child; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Femoral Neoplasms; Humans; Ifosfamide; Infusions, Intra-Arterial; Male; Methotrexate; Osteosarcoma; Salvage Therapy; Tibia | 1992 |
FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Prospective Studies; Stomach Neoplasms; Survival Analysis | 1992 |
[Co-operative on salvage chemotherapy with VP-16 for malignant lymphoma. Hanshin Study Group on Treatment for Hematological Disorders].
Topics: Aclarubicin; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Hodgkin Disease; Humans; Immunoblastic Lymphadenopathy; Leukemia-Lymphoma, Adult T-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone | 1992 |
Cisplatin plus VP-16 combination chemotherapy in advanced refractory breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Evaluation; Drug Synergism; Etoposide; Female; Fluorouracil; Humans; Lung Neoplasms; Lymphatic Metastasis; Methotrexate; Middle Aged; Mitomycin; Skin Neoplasms; Time Factors | 1992 |
Sequential chemotherapy in good-prognosis patients with small-cell lung cancer.
Topics: Adult; Aged; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Methotrexate; Middle Aged; Prognosis; Vincristine; Vindesine | 1991 |
Comparison of cyclophosphamide, doxorubicin, and vincristine with an alternating regimen of methotrexate, etoposide, and cisplatin/cyclophosphamide, doxorubicin, and vincristine in the treatment of extensive-disease small-cell lung carcinoma: a Mid-Atlant
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Prognosis; Proportional Hazards Models; Survival Rate; Vincristine | 1991 |
A randomized trial of alternating chemotherapy versus best supportive care in advanced non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Prognosis; Radiotherapy; Survival Rate | 1991 |
Effective new low toxicity chemotherapy with carboplatin, vinblastine and methotrexate for small cell lung cancer: a randomised trial against doxorubicin, cyclophosphamide and etoposide.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Prognosis; Vinblastine | 1991 |
Small-cell carcinoma of the head and neck. A novel treatment regimen.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Laryngeal Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Radiotherapy Dosage; Remission Induction; Tongue Neoplasms; Vincristine | 1991 |
Studies of the Australasian Germ Cell Trial Group: the management of advanced testis cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Australia; Biomarkers, Tumor; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Humans; Male; Methotrexate; Multicenter Studies as Topic; Neoplasms, Germ Cell and Embryonal; Prognosis; Randomized Controlled Trials as Topic; Survival Rate; Testicular Neoplasms; Vinblastine; Vincristine | 1990 |
Unfavorable histologies of non-Hodgkin's lymphoma treated with ProMACE-CytaBOM: a groupwide Southwest Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cause of Death; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Remission Induction; Survival Rate; Vincristine | 1990 |
Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prospective Studies; Remission Induction; Survival Rate; Vincristine | 1991 |
[Non-Hodgkin's lymphomas. Results of alternating chemotherapy versus sequential chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Life Tables; Lymphoma, Non-Hodgkin; Methotrexate; Mexico; Prednisone; Remission Induction; Survival Rate; Vincristine | 1990 |
Evolution of neuropathy and myopathy during intensive vincristine/corticosteroid chemotherapy for non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; Electrophysiology; Etoposide; Gangliosides; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Motor Activity; Muscular Diseases; Neurologic Examination; Peripheral Nervous System Diseases; Prospective Studies; Random Allocation; Sensory Thresholds; Vincristine | 1991 |
Long-term follow-up of ProMACE-CytaBOM in non-Hodgkin's lymphomas.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Evaluation; Etoposide; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Remission Induction; Survival Rate; Vincristine | 1991 |
Prospective multicenter trial for the response-adapted treatment of high-grade malignant non-Hodgkin's lymphomas: updated results of the COP-BLAM/IMVP-16 protocol with randomized adjuvant radiotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prospective Studies; Remission Induction; Survival Rate; Vincristine | 1991 |
ProMACE-MOPP vs MACOP-B in high grade non-Hodgkin's lymphomas: a randomised study in a multicenter cooperative study group (NHLCSG).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisolone; Prednisone; Procarbazine; Vincristine | 1991 |
ProMACE-cytaBOM versus MACOP-B in intermediate and high grade NHL. Preliminary results of a prospective randomized trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Hematopoiesis; Humans; Inflammation; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mucous Membrane; Prednisolone; Prednisone; Prognosis; Prospective Studies; Survival Analysis; Vincristine | 1991 |
ProMACE-C-MOPP in aggressive non-Hodgkin's lymphoma. Long-term results in 45 patients treated in a single institution.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Vincristine | 1991 |
Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Daunorubicin; Etoposide; Follow-Up Studies; Graft vs Host Disease; Humans; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Time Factors; Transplantation, Homologous; Vincristine; Whole-Body Irradiation | 1991 |
High-risk metastatic gestational trophoblastic disease. A new dose-intensive, multiagent chemotherapeutic regimen.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Methotrexate; Neoplasm Metastasis; Pilot Projects; Pregnancy; Prognosis; Risk Factors; Severity of Illness Index; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1991 |
Combination chemotherapy of limited-stage small-cell lung cancer. A controlled trial on 221 patients comparing two alternating regimens.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hematologic Diseases; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prospective Studies; Recurrence; Remission Induction; Survival Rate; Vincristine | 1991 |
[Chemotherapy in metastasizing prostate carcinoma].
Topics: Aged; Antineoplastic Agents; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Male; Methotrexate; Prostatic Neoplasms; Survival Analysis | 1991 |
MIME combination chemotherapy in recurrent or refractory lymphoproliferative malignancies. A phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Mitoguazone; Prognosis | 1991 |
[Intensification of chemotherapy of acute myeloid leukemia in children: report on the studies of the AML-BFM 78 and AML-BFM 83 protocols].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Etoposide; Germany, West; Humans; Leukemia, Myeloid, Acute; Methotrexate; Prednisone; Prognosis; Remission Induction; Thioguanine; Time Factors; Vincristine | 1991 |
Cisplatin and etoposide as first-line chemotherapy for metastatic breast carcinoma: a prospective randomized trial of the Italian Oncology Group for Clinical Research.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Etoposide; Female; Fluorouracil; Humans; Methotrexate; Middle Aged | 1991 |
Intensive chemoradiotherapy and autologous bone marrow transplantation for poor prognosis neuroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Infant; Methotrexate; Neuroblastoma; Procarbazine; Prognosis; Transplantation, Autologous; Vincristine; Whole-Body Irradiation | 1991 |
Treatment of hemophagocytic lymphohistiocytosis with chemotherapy and bone marrow transplantation: a single-center study of 22 cases.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Bone Marrow Transplantation; Child, Preschool; Etoposide; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Male; Methotrexate; Time Factors | 1991 |
A randomized comparison of standard chemotherapy versus alternating chemotherapy and maintenance versus no maintenance therapy for extensive-stage small-cell lung cancer: a phase III study of the Eastern Cooperative Oncology Group.
Topics: Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Multicenter Studies as Topic; Prospective Studies; Random Allocation; Remission Induction; Survival Rate; Vincristine | 1990 |
[Progress and obstacles in chemotherapy and combined modality treatment of small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Procarbazine; Survival Rate; Vincristine | 1990 |
Induction chemo-radiotherapy and maintenance alternating chemotherapy for small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Procarbazine; Vincristine | 1990 |
Alternating radiotherapy and chemotherapy in 173 consecutive patients with limited small cell lung carcinoma. GROP and the French Cancer Center's Lung Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; France; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Survival Rate | 1990 |
Treatment of relapsed acute lymphocytic leukemia in adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Brain Neoplasms; Combined Modality Therapy; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Female; Germany, West; Humans; Ifosfamide; Leucovorin; Life Tables; Male; Methotrexate; Middle Aged; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Spinal Cord Neoplasms; Teniposide; Testicular Neoplasms; Vindesine | 1990 |
[Experiences with a new second-line protocol in the treatment of pretreated and advanced Hodgkin disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Methotrexate; Middle Aged; Prednisolone; Remission Induction | 1990 |
What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants?
Topics: Acute Disease; Anemia, Aplastic; Bone Marrow Transplantation; Chronic Disease; Clinical Trials as Topic; Cyclophosphamide; Cyclosporins; Etoposide; Female; Follow-Up Studies; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppression Therapy; Leukemia; Male; Methotrexate; Myelodysplastic Syndromes; Prednisone; Random Allocation; Risk Factors; Whole-Body Irradiation | 1990 |
Phase II study of MOPLACE chemotherapy for patients with previously treated Hodgkin's disease: a CALGB study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Drug Evaluation; Drug Tolerance; Etoposide; Female; Hodgkin Disease; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Prednisone; Remission Induction; Survival Rate; Vincristine | 1990 |
Cooperative study of pirarubicin against urological cancers and future direction of its combination use. The Clinical Study Group of THP for Urological Malignant Tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Male; Methotrexate; Pilot Projects; Urologic Neoplasms | 1990 |
Intracavitary chemotherapy.
Topics: Anthraquinones; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Catheters, Indwelling; Cisplatin; Clinical Trials as Topic; Cytarabine; Doxorubicin; Etoposide; Fluorouracil; Humans; Immunotherapy; Infusions, Parenteral; Melphalan; Methotrexate; Mitomycins; Mitoxantrone; Neoplasms; Organoplatinum Compounds | 1986 |
Treatment of patients with poor prognosis anaplastic germ cell tumours (AGCT) of the testis and other sites.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Dactinomycin; Drug Administration Schedule; Dysgerminoma; Etoposide; Humans; Male; Methotrexate; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Teratoma; Testicular Neoplasms; Vincristine | 1987 |
Southwest oncology group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Time Factors; Vincristine | 1987 |
The prognostic value of response to the first cycle of chemotherapy in small cell lung cancer. Results of a multicenter German trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Small Cell; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lomustine; Lung Neoplasms; Male; Methotrexate; Nimustine; Nitrosourea Compounds; Peplomycin; Prognosis; Random Allocation; Vincristine; Vindesine | 1987 |
German-Austrian multicenter trial for aggressive non-Hodgkin lymphomas: COP-BLAM/IMVP-16 chemotherapy with randomized adjuvant radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Vincristine | 1988 |
[Multicenter prospective risk-adapted study on the therapy of non-Hodgkin's lymphomas of high malignancy. Use of COP-BLAM/IMVP-16 and randomized adjuvant radiotherapy--study concept and preliminary results].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Mesna; Methotrexate; Prednisone; Procarbazine; Vincristine | 1988 |
The treatment of indolent lymphomas: watchful waiting v aggressive combined modality treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Evaluation Studies as Topic; Humans; Leucovorin; Leukemia; Leukemia, Radiation-Induced; Lymph Nodes; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Neoplasms, Multiple Primary; Neoplasms, Radiation-Induced; Palliative Care; Prednisone; Procarbazine; Random Allocation; Vincristine | 1988 |
[Sequential alternating chemotherapy of highly malignant non-Hodgkin's lymphomas with VIM-Bleo and CHOP. Initial results].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Vincristine | 1989 |
[Risk-adapted therapy of highly malignant non-Hodgkin's lymphomas with COP-BLAM/IMVP-16: a prospective multicenter study].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Mesna; Methotrexate; Middle Aged; Prednisone; Procarbazine; Prospective Studies; Risk Factors; Vincristine | 1989 |
Weekly alternating etoposide, methotrexate, and actinomycin/vincristine and cyclophosphamide chemotherapy for the treatment of CNS metastases of choriocarcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Chorionic Gonadotropin; Clinical Trials as Topic; Craniotomy; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Methotrexate; Middle Aged; Prognosis; Vincristine | 1989 |
Duration of chemotherapy in small cell lung cancer: a Cancer Research Campaign trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Multicenter Studies as Topic; Random Allocation; Vincristine | 1989 |
Controlled trial of twelve versus six courses of chemotherapy in the treatment of small-cell lung cancer. Report to the Medical Research Council by its Lung Cancer Working Party.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clinical Trials as Topic; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Multicenter Studies as Topic; Prognosis; Quality of Life; Random Allocation; Vincristine | 1989 |
[Small cell lung cancer: a retrospective analysis of results of chemotherapy and combined modality treatment].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Nimustine; Procarbazine; Random Allocation; Remission Induction; Retrospective Studies; Vincristine | 1989 |
A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Prognosis; Random Allocation; Remission Induction; Warfarin | 1989 |
Alternating chemotherapy with or without VP-16 in extensive-stage small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lomustine; Lung Neoplasms; Methotrexate; Neoplasm Staging; Random Allocation; Remission Induction; Time Factors; Vincristine | 1989 |
Chemotherapy plus adjuvant surgery for local small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Staging; Pneumonectomy; Preoperative Care; Remission Induction; Vincristine | 1989 |
Phase II trial with alternating two drug schedules, CAP/MEC', for advanced (stage III Mo/M1) non-small-cell lung cancer.
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Staging | 1989 |
Treatment of small cell lung cancer with induction chemotherapy followed by late intensification.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Methotrexate; Middle Aged; Multicenter Studies as Topic; Neoplasm Staging; Remission Induction; Survival Rate; Vincristine | 1989 |
Cyclic alternating polychemotherapy with or without upper and lower half-body irradiation in small cell anaplastic lung cancer. A randomized study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Random Allocation; Time Factors; Vincristine | 1987 |
Chemotherapy of advanced non-small-cell lung cancer with cyclophosphamide, adriamycin, methotrexate, and procarbazine versus cisplatin and etoposide. A randomized study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Procarbazine; Prognosis; Random Allocation | 1988 |
Non small cell lung cancer (NSCLC). A prospective randomized trial with alternating chemotherapy CEP/MEC' versus no treatment.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Prospective Studies; Random Allocation | 1988 |
Alternating versus sequential chemotherapy in small cell lung cancer. A randomized German multicenter trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lomustine; Lung Neoplasms; Male; Methotrexate; Prognosis; Vincristine; Vindesine | 1987 |
The superiority of combination chemotherapy including etoposide based on in vivo cell cycle analysis in the treatment of extensive small-cell lung cancer: a randomized trial of 288 consecutive patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Autopsy; Carcinoma, Small Cell; Clinical Trials as Topic; Drug Administration Schedule; Etoposide; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Random Allocation | 1987 |
Multimodal therapy for limited small-cell lung cancer: a randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders; and with wide-field versus reduced-field radiation in partial responders: a Southwes
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Radiotherapy; Random Allocation; Vincristine | 1987 |
The childhood AML studies BFM-78 and -83: treatment results and risk factor analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Etoposide; Germany, West; Humans; Leukemia, Myeloid, Acute; Methotrexate; Prednisone; Prognosis; Remission Induction; Risk; Thioguanine; Vincristine | 1987 |
A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Neoplasm Metastasis; Procarbazine; Progesterone; Random Allocation; Vinblastine; Vindesine | 1986 |
Etoposide (VP-16-213) and cis-dichlorodiammineplatinum (DDP) in advanced breast carcinoma resistant to previous chemotherapy.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Podophyllotoxin; Vincristine | 1986 |
Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations.
Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Etoposide; Female; Humans; Leukopenia; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Procarbazine; Vincristine | 1982 |
Parenteral intravenous nutrition (PIVN) as an adjunct to chemotherapy in small cell anaplastic lung carcinoma.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Bone Marrow; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Gastrointestinal Diseases; Humans; Ifosfamide; Lung Neoplasms; Male; Methotrexate; Middle Aged; Parenteral Nutrition; Procarbazine; Random Allocation; Vincristine | 1981 |
Early crossover of induction chemotherapy in small cell lung carcinoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Procarbazine; Prospective Studies; Vincristine | 1983 |
Combined modality treatment of extensive small cell lung cancer: a Southwest Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Brain Neoplasms; Carcinoma, Small Cell; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Humans; Leukopenia; Lung Neoplasms; Methotrexate; Random Allocation; Stomatitis; Vincristine | 1984 |
Mitomycin-C, etoposide, cisplatin, and hexamethylmelamine (MEPH) as a second-line regimen in lung cancer.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leukopenia; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Neoplasm Metastasis; Thrombocytopenia; Vomiting | 1984 |
A prospective randomized study of adjuvant parenteral nutrition in the treatment of diffuse lymphoma: effect on drug tolerance.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Drug Tolerance; Etoposide; Humans; Leucovorin; Leukocyte Count; Lymphoma; Mechlorethamine; Methotrexate; Nutrition Disorders; Parenteral Nutrition; Platelet Count; Prednisone; Procarbazine; Prospective Studies; Random Allocation; Serum Albumin; Vincristine | 1981 |
Role of intravenous hyperalimentation as an adjunct to intensive chemotherapy for small cell bronchogenic carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Bone Marrow; Carcinoma, Bronchogenic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Gastrointestinal Diseases; Humans; Ifosfamide; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neutropenia; Parenteral Nutrition; Procarbazine; Vincristine | 1981 |
Chemotherapy for malignant mesothelioma; CAMEO.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Male; Mesothelioma; Methotrexate; Middle Aged; Pleural Neoplasms; Prognosis; Radiotherapy Dosage; Vincristine | 1982 |
[Induction chemotherapy followed by adjuvant surgery (IC-AS) in patients with stage I-II small cell lung cancer (SCLC)].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Nimustine; Salvage Therapy; Vincristine | 1995 |
A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). II: Quality of life. Medical Research Council Lung Cancer Working Party.
Topics: Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Carcinoma, Small Cell; Cyclophosphamide; Depression; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Lung Neoplasms; Male; Medical Records; Methotrexate; Middle Aged; Nausea; Palliative Care; Patient Compliance; Quality of Life; Self-Assessment; Vincristine; Vomiting | 1993 |
[CAMBO-VIP for advanced diffuse large cell lymphoma (LSG classification)--a long-term follow-up study].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Liver; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Prognosis; Remission Induction; Vincristine | 1994 |
EORTC study of non-Hodgkin's lymphoma: phase III study comparing CHVmP-VB and ProMACE-MOPP in patients with stage II, III, and IV intermediate- and high-grade lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Life Tables; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Remission Induction; Survival Analysis; Teniposide; Thrombocytopenia; Treatment Outcome; Vincristine | 1994 |
A phase III comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermediate- or high-grade non-Hodgkin's lymphoma: results of SWOG-8516 (Intergroup 0067), the National High-Priority Lymphoma Study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisone; Remission Induction; Survival Analysis; Treatment Failure; Vincristine | 1994 |
MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Multivariate Analysis; Prednisone; Procarbazine; Prognosis; Prospective Studies; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine | 1994 |
Autologous bone marrow transplantation in poor-risk high-grade non-Hodgkin's lymphoma in first complete remission. Newcastle and Northern Lymphoma Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Platelets; Bone Marrow Transplantation; Chlorambucil; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Neutropenia; Neutrophils; Platelet Count; Prednisolone; Retrospective Studies; Risk Factors; Vincristine; Vindesine | 1994 |
Diffuse small noncleaved-cell, non-Burkitt's lymphoma in adults: a high-grade lymphoma responsive to ProMACE-based combination chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Prognosis; Remission Induction; Survival Rate; Vincristine | 1994 |
Peripheral T-cell non-Hodgkin's lymphomas of low malignancy: prospective study of 25 patients with pleomorphic small cell lymphoma, lymphoepitheloid cell (Lennert's) lymphoma and T-zone lymphoma. The Kiel Lymphoma Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Peripheral; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Prognosis; Prospective Studies; Survival Analysis; Vincristine | 1994 |
Effect of granulocyte colony-stimulating factor in patients with diffuse large cell lymphoma treated with intensive chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Immunologic Factors; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Mitoxantrone; Prednisone; Procarbazine; Prospective Studies; Treatment Outcome; Vincristine | 1994 |
Combined chemotherapy and granulocyte colony-stimulating factor (G-CSF) mobilise large numbers of peripheral blood progenitor cells in pretreated patients.
Topics: Adult; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Cells; Colony-Forming Units Assay; Cyclophosphamide; Cytarabine; Dexamethasone; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Leukapheresis; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neutropenia; Salvage Therapy; Treatment Outcome | 1994 |
Reduction of the systemic toxicity of cisplatin by intra-arterial hepatic route administration for liver malignancies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Kidney Diseases; Leucovorin; Liver; Liver Neoplasms; Methotrexate; Neoplasms; Nervous System Diseases; Ovarian Neoplasms; Remission Induction; Spectrophotometry, Atomic; Tumor Cells, Cultured; Vinblastine | 1995 |
Quality versus quantity of life in the treatment of patients with advanced small-cell lung cancer? A randomized phase III comparison of weekly carboplatin and teniposide versus cisplatin, adriamycin, etoposide alternating with cyclophosphamide, methotrexa
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Palliative Care; Prospective Studies; Quality of Life; Surveys and Questionnaires; Survival Rate; Teniposide; Vincristine | 1995 |
High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy.
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Bone Marrow Transplantation; Carmustine; Cisplatin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Leucovorin; Male; Mechlorethamine; Methotrexate; Prednisolone; Prednisone; Procarbazine; Remission Induction; Salvage Therapy; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 1995 |
Combined chemotherapy and radiotherapy in diffuse large cell immunoblastic lymphoma: a phase II study of CHOP/bleomycin/methotrexate alternating with ifosfamide/methotrexate/etoposide.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Large-Cell, Immunoblastic; Male; Methotrexate; Neoplasm Staging; Prednisone; Survival Analysis; Treatment Outcome; Vincristine | 1995 |
Short-term weekly chemotherapy followed by high-dose therapy with autologous bone marrow transplantation for lymphoblastic and Burkitt's lymphomas in adult patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Burkitt Lymphoma; Carmustine; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Survival Rate; Transplantation, Autologous; Vincristine | 1995 |
L-asparaginase may potentiate the leukemogenic effect of the epipodophyllotoxins.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Synergism; Etoposide; Humans; Infant; Karyotyping; Leukemia, Myeloid; Mercaptopurine; Methotrexate; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone | 1995 |
Efficacy of four different regimens in 64 mantle-cell lymphoma cases: clinicopathologic comparison with 498 other non-Hodgkin's lymphoma subtypes. European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Europe; Female; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Recombinant Proteins; Remission Induction; Survival Rate; Teniposide; Vincristine | 1995 |
Prospective multimodality treatment of SCLC--experience during the past 18 years.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Pneumonectomy; Postoperative Care; Prednisone; Procarbazine; Radiotherapy Dosage; Vincristine | 1995 |
Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisone; Prospective Studies; Survival Analysis; Treatment Outcome; Vincristine | 1993 |
Effective therapy for poor-prognosis non-Hodgkin's lymphoma with 8 weeks of high-dose-intensity combination chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Multivariate Analysis; Prednisone; Prognosis; Vincristine | 1993 |
[NEO-MACOP-B chemotherapy for the treatment of advanced-stage aggressive non-Hodgkin's lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Mitoxantrone; Prednisolone; Remission Induction; Vincristine | 1993 |
Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: application to LNH-87 protocol. The GELA. (Groupe d'Etude des Lymphomes de l'Adulte).
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; France; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Methylprednisolone; Middle Aged; Mitoxantrone; Prednisolone; Prognosis; Remission Induction; Survival Rate; Transplantation, Autologous; Vindesine | 1993 |
Combined-modality treatment of small-cell lung cancer: randomized comparison of three induction chemotherapies followed by maintenance chemotherapy with or without radiotherapy to the chest. Swiss Group for Clinical Cancer Research (SAKK).
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Contraindications; Cranial Irradiation; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Prospective Studies; Radiotherapy; Radiotherapy, Adjuvant; Regression Analysis; Remission Induction; Switzerland; Thorax; Vincristine | 1994 |
Four-step high-dose sequential chemotherapy with double hematopoietic progenitor-cell rescue for metastatic breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Feasibility Studies; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Melphalan; Methotrexate; Middle Aged; Mitoxantrone; Neoplasm Metastasis; Neutropenia; Remission Induction; Thrombocytopenia; Vincristine | 1995 |
Improved treatment results of non-Hodgkin's lymphoma in children: a report from the Children's Cancer and Leukemia Study Group of Japan.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Infant; Japan; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Prednisolone; Remission Induction; Vincristine | 1995 |
Preliminary results of methotrexate, etoposide and cisplatin in the treatment of urothelial cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cisplatin; Etoposide; Female; Humans; Male; Methotrexate; Middle Aged; Remission Induction; Survival Rate; Urologic Neoplasms | 1995 |
The subrenal capsule assay in selecting chemotherapy for ovarian cancer: a prospective randomized trial.
Topics: Aged; Altretamine; Animals; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Carboplatin; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Methotrexate; Mice; Mice, Inbred Strains; Middle Aged; Ovarian Neoplasms; Prospective Studies; Subrenal Capsule Assay; Tegafur | 1995 |
CMF vs alternating CMF/EV in the adjuvant treatment of operable breast cancer. A single centre randomised clinical trial (Naples GUN-3 study).
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Staging; Survival Rate; Vindesine | 1995 |
Early versus late alternating chemotherapy in small-cell lung cancer. Swiss Group for Clinical Cancer Research (SAKK).
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Patient Acceptance of Health Care; Quality of Life; Remission Induction; Survivors; Treatment Outcome; Vincristine | 1995 |
Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Clinical Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Infant; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Time Factors | 1995 |
High-dose Ara-C for remission induction and consolidation of previously untreated adults with ALL or lymphoblastic lymphoma.
Topics: Adolescent; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cytarabine; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Male; Methotrexate; Middle Aged; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Survival Rate; Time Factors; Vincristine | 1995 |
High-dose sequential (HDS) chemotherapy with blood and marrow cell autograft as salvage treatment in very poor prognosis, relapsed non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Bone Marrow Transplantation; Cyclophosphamide; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Methotrexate; Middle Aged; Prognosis; Recurrence; Transplantation, Autologous | 1993 |
A six-drug regimen (MAPECO) for intermediate or high-grade non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Vincristine | 1994 |
Combined immunochemotherapy (CEP, M-VEP + BCG) in the treatment of invasive bladder tumors.
Topics: Administration, Intravesical; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Cisplatin; Combined Modality Therapy; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Immunotherapy, Active; Lomustine; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Prednimustine; Urinary Bladder Neoplasms; Vinblastine | 1994 |
A randomized clinical trial in bronchogenic small-cell carcinoma evaluating alternating maintenance therapy of vincristine, adriamycin, procarbazine, and etoposide (VAPE) with cyclophosphamide, CCNU, and methotrexate (CCM) versus CCM maintenance alone in
Topics: Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Mitomycin; Procarbazine; Remission Induction; Vinblastine; Vincristine | 1994 |
Phase-II trial with M-CAVe-CEC as a salvage chemotherapeutic regimen for early relapsed or primary refractory Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Methotrexate; Middle Aged; Salvage Therapy; Vinblastine | 1994 |
Results of adjuvant chemotherapy for invasive urothelial cancer with lymph-node metastasis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Kidney Neoplasms; Kidney Pelvis; Longitudinal Studies; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Survival Rate; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine | 1994 |
[Small cell bronchial cancer. Comparison of results of weekly polychemotherapy using multiple drugs with standard chemotherapy. European Lung Cancer Working Party].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Prognosis; Survival Rate; Vincristine; Vindesine | 1994 |
Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cause of Death; Child; Chromosome Aberrations; Chromosome Disorders; Cyclosporine; Cytogenetics; Drug Therapy, Combination; Etoposide; Female; Graft vs Host Disease; Humans; Immunosuppression Therapy; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Methylprednisolone; Middle Aged; Recurrence; Survival Rate; Whole-Body Irradiation | 1994 |
Alternating radiotherapy and chemotherapy in limited small cell lung cancer: the IGR protocols. French FNCLCC Lung Cancer Study Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiotherapy Dosage; Remission Induction; Survival Rate; Treatment Failure | 1994 |
An update of Scandinavian studies of osteosarcoma.
Topics: Adolescent; Adult; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Clinical Protocols; Combined Modality Therapy; Doxorubicin; Etoposide; Humans; Ifosfamide; Methotrexate; Osteosarcoma; Scandinavian and Nordic Countries; Survival Rate; Treatment Outcome | 1993 |
Neoadjuvant chemotherapy for patients with osteosarcoma: University of Florida studies.
Topics: Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Florida; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Life Tables; Lung Neoplasms; Methotrexate; Osteosarcoma; Survival Analysis; Treatment Outcome | 1993 |
Neoadjuvant chemotherapy for invasive bladder carcinoma: disease outcome and bladder preservation and relationship to local tumor response.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Survival Rate; Time Factors; Urinary Bladder Neoplasms; Vinblastine | 1994 |
Treatment strategy for disseminated Langerhans cell histiocytosis. DAL HX-83 Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Diabetes Insipidus; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Infant; Infant, Newborn; Male; Mercaptopurine; Methotrexate; Prednisone; Prognosis; Prospective Studies; Recurrence; Remission Induction; Severity of Illness Index; Survival Analysis; Treatment Outcome; Vinblastine | 1994 |
CVM versus ACE in the treatment of small cell lung cancer.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Infant, Newborn; Infections; Leukopenia; Lung Neoplasms; Male; Methotrexate; Middle Aged; Thrombocytopenia; Treatment Outcome; Vinblastine | 1993 |
A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). I: Survival and prognostic factors. Medical Research Council Lung Cancer Wor
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cause of Death; Chi-Square Distribution; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Lung Neoplasms; Male; Methotrexate; Middle Aged; Prognosis; Proportional Hazards Models; Regression Analysis; Survival Analysis; Survival Rate; Treatment Outcome; Vincristine | 1993 |
A phase II trial of alternating chemotherapy in patients with inoperable non-small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Survival Analysis; Treatment Outcome | 1994 |
A phase II study of etoposide, cisplatin plus methotrexate in patients with advanced refractory breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Etoposide; Female; Humans; Methotrexate; Middle Aged; Salvage Therapy | 1993 |
A randomized study comparing cyclophosphamide, doxorubicin, vincristine (CAV) with cyclophosphamide, etoposide, vincristine, methotrexate (CEVM) in patients with small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Vincristine | 1993 |
Etoposide in combination as first-line chemotherapy for advanced Hodgkin disease. A Cancer and Leukemia Group B study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Female; Hodgkin Disease; Humans; Leucovorin; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisolone; Prednisone; Procarbazine; Vinblastine; Vincristine | 1993 |
[Clinical trial of the systemic chemotherapy for advanced prostatic cancer patients].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Humans; Male; Methotrexate; Middle Aged; Prognosis; Prostatic Neoplasms | 1993 |
CEOP-IMVP-Dexa in the treatment of aggressive lymphomas: an Austrian multicenter trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Epirubicin; Etoposide; Feasibility Studies; Female; Folic Acid; Hematologic Diseases; Humans; Ifosfamide; Karnofsky Performance Status; Lymphoma, Non-Hodgkin; Male; Mesna; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prednisolone; Remission Induction; Risk Factors; Survival Rate; Vincristine | 1996 |
Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor prognosis. Medical Research Council Lung Cancer Working Party.
Topics: Activities of Daily Living; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Etoposide; Female; Humans; Male; Methotrexate; Middle Aged; Palliative Care; Patient Compliance; Quality of Life; Stress, Psychological; Survival Analysis; Vincristine | 1996 |
ProMECE-CytaBOM vs MACOP-B in advanced aggressive non-Hodgkin's lymphoma: long term results of a multicenter study of the Italian Lymphoma Study Group (GISL).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Epirubicin; Etoposide; Feasibility Studies; Female; Hemoglobins; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Prednisone; Vincristine | 1995 |
Intermediate and high-grade gastric non-Hodgkin's lymphoma: a prospective study of non-surgical treatment with primary chemotherapy, with or without radiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Gastrointestinal Hemorrhage; Humans; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prospective Studies; Radiotherapy, Adjuvant; Stomach Neoplasms; Vincristine | 1995 |
Administration of rhG-CSF increases complete remission rates after CHOP and ProMACE/CytaBOM for non-Hodgkin's lymphoma: a pilot study. Hokkaido Study Group of Malignant Lymphoma and rhG-CSF.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Immunologic Factors; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Pilot Projects; Prednisone; Recombinant Proteins; Remission Induction; Vincristine | 1995 |
A weekly alternating chemotherapy regimen with low toxicity for the treatment of aggressive lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Remission Induction; Treatment Outcome; Vincristine | 1996 |
A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-Münster Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Etoposide; Female; Fever; Filgrastim; Gastrointestinal Diseases; Germany; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Ifosfamide; Infant; Infection Control; Life Tables; Male; Mercaptopurine; Methotrexate; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prospective Studies; Recombinant Proteins; Risk; Survival Analysis; Thioguanine; Vincristine; Vindesine | 1996 |
Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neutropenia; Prednisone; Survival Analysis; Thrombocytopenia; Vincristine | 1996 |
Severe atypical neuropathy associated with administration of hematopoietic colony-stimulating factors and vincristine.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Foot Diseases; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Infant; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Multivariate Analysis; Pain; Peripheral Nervous System Diseases; Vincristine | 1996 |
Ifosfamide, etoposide, cytarabine, and methotrexate as salvage chemotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Disease Progression; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Life Tables; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Recombinant Proteins; Remission Induction; Salvage Therapy; Survival Analysis; Treatment Outcome; Whole-Body Irradiation | 1996 |
High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: a prospective randomized italian multicenter s
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prospective Studies; Salvage Therapy; Vincristine | 1996 |
Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Busulfan; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisolone; Prognosis; Survival Rate; Transplantation, Autologous; Vincristine | 1996 |
Clinical analysis of 670 cases in two trials of the European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group subtyped according to the Revised European-American Classification of Lymphoid Neoplasms: a comparison with the W
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Immunologic Factors; Immunophenotyping; Interferon alpha-2; Interferon-alpha; Life Tables; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Prognosis; Recombinant Proteins; Survival Analysis; Survival Rate; Vincristine | 1996 |
Phase I trial of dose escalation with growth factor support in patients with previously untreated diffuse aggressive lymphomas: determination of the maximum-tolerated dose of ProMACE-CytaBOM.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Etoposide; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisone; Survival Analysis; Treatment Outcome; Vincristine | 1996 |
Relationship between minimal residual disease and outcome in adult acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Bone Marrow Transplantation; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Resistance, Neoplasm; Etoposide; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Humans; Mercaptopurine; Methotrexate; Middle Aged; Neoplasm, Residual; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Survival Analysis; Treatment Outcome; Vincristine | 1996 |
A randomised comparison of a third-generation regimen (PACEBOM) with a standard regimen (CHOP) in patients with histologically aggressive non-Hodgkin's lymphoma: a British National Lymphoma Investigation report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisolone; Prednisone; Survival Analysis; Vincristine | 1996 |
PROMACE-MOPP and intrathecal chemotherapy for CNS lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Injections, Spinal; Lymphoma, Large B-Cell, Diffuse; Male; Mechlorethamine; Methotrexate; Middle Aged; Neurologic Examination; Prednisone; Procarbazine; Steroids; Survival Analysis; Vincristine | 1996 |
Correlation of in vitro drug sensitivity testing results with response to chemotherapy and survival: comparison of non-small cell lung cancer and small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Evaluation Studies as Topic; Humans; Lomustine; Lung Neoplasms; Mechlorethamine; Methotrexate; Palliative Care; Predictive Value of Tests; Prospective Studies; Specimen Handling; Survival Analysis; Treatment Outcome; Tumor Cells, Cultured; Vincristine | 1996 |
Prognostic implications of ploidy and proliferative activity in the diffuse, aggressive non-Hodgkin's lymphomas.
Topics: Adult; Aged; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Cell Division; Cyclophosphamide; Cytarabine; Dexamethasone; DNA, Neoplasm; Doxorubicin; Etoposide; Female; Flow Cytometry; Humans; Leucovorin; Life Tables; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Severity of Illness Index; Survival Analysis; Treatment Outcome; Vincristine | 1996 |
[In vivo effect of etoposide on the pharmacokinetics of methotrexate].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Clinical Protocols; Dose-Response Relationship, Drug; Drug Interactions; Etoposide; Humans; Medulloblastoma; Methotrexate | 1996 |
CHOP vs. ProMACE-CytaBOM in the treatment of aggressive non-Hodgkin's lymphomas: long-term results of a multicenter randomized trial.(PETHEMA: Spanish Cooperative Group for the Study of Hematological Malignancies Treatment, Spanish Society of Hematology).
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Treatment Outcome; Vincristine | 1996 |
A single-center study of 11 patients with intraocular lymphoma treated with conventional chemotherapy followed by high-dose chemotherapy and autologous bone marrow transplantation in 5 cases.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cisplatin; Combined Modality Therapy; Cytarabine; Dose-Response Relationship, Drug; Etoposide; Eye Neoplasms; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Prospective Studies | 1996 |
Subclassification of diffuse large B-cell lymphomas according to the Kiel classification: distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factor.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Life Tables; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Large-Cell, Immunoblastic; Male; Methotrexate; Middle Aged; Multivariate Analysis; Prednisone; Procarbazine; Prognosis; Prospective Studies; Radiotherapy, Adjuvant; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine | 1997 |
Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (MRC AML10). Adult and Childhood Leukaemia Working Parties of the Medica
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Female; Humans; Hydrocortisone; Infant; Leukemia, Myeloid; Life Tables; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Patient Compliance; Remission Induction; Survival Analysis; Thioguanine; Treatment Outcome | 1997 |
Activity of standard-dose carboplatin, cyclophosphamide, and etoposide in patients with metastatic breast cancer with previous exposure to anthracyclines.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Cyclophosphamide; Etoposide; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Retreatment; Survival Rate | 1997 |
PACE BOM chemotherapy: a 12-week regimen for advanced Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Fertility; Follow-Up Studies; Hematologic Diseases; Hodgkin Disease; Humans; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisolone; Retreatment; Treatment Outcome; Vincristine | 1997 |
Multiple cycles of aggressive chemotherapy prior to autologous peripheral stem cell transplantation for lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Drug Synergism; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Survival Analysis; Treatment Outcome | 1997 |
A double-blind, randomized study of two different dosage regimens of intravenous dolasetron in patients receiving high-dose cisplatin chemotherapy.
Topics: Aged; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Double-Blind Method; Doxorubicin; Etoposide; Female; Fluorouracil; Humans; Indoles; Injections, Intravenous; Leucovorin; Male; Methotrexate; Quinolizines; Vinblastine | 1997 |
CHOP-based chemotherapy is as effective as alternating PEEC/CHOP chemotherapy in a randomised trial in high-grade non-Hodgkin's lymphoma. Scotland and Newcastle Lymphoma Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Methylprednisolone; Middle Aged; Prednisolone; Survival Rate; Vincristine; Vindesine | 1997 |
A phase II multicenter trial of high-dose sequential chemotherapy and peripheral blood stem cell transplantation as initial therapy for patients with high-risk non-Hodgkin's lymphoma.
Topics: Adult; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Filgrastim; Follow-Up Studies; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Leucovorin; Lymphoma, Non-Hodgkin; Male; Melphalan; Methotrexate; Middle Aged; Prednisone; Recombinant Proteins; Treatment Outcome; Vincristine | 1997 |
Thiopurine drugs in the treatment of childhood leukaemia: the influence of inherited thiopurine methyltransferase activity on drug metabolism and cytotoxicity.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Cytarabine; Dexamethasone; Erythrocytes; Etoposide; Female; Humans; Male; Mercaptopurine; Methotrexate; Methyltransferases; Phenotype; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Thioguanine; Vincristine | 1997 |
Randomized open label phase III trial of CEOP/IMVP-Dexa alternating chemotherapy and filgrastim versus CEOP/IMVP-Dexa alternating chemotherapy for aggressive non-Hodgkin's lymphoma (NHL). A multicenter trial by the Austrian Working Group for Medical Tumor
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Epirubicin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lymphocyte Count; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neutropenia; Prednisolone; Recombinant Proteins; Vincristine | 1997 |
The assessment of value of transvaginal ultrasound for monitoring of gestational trophoblastic disease treatment.
Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Monitoring, Physiologic; Ovary; Pregnancy; Trophoblastic Neoplasms; Ultrasonography; Uterine Neoplasms; Uterus | 1997 |
CHOP therapy: has shorter-course therapy had an impact on lymphomas?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisone; Randomized Controlled Trials as Topic; Time Factors; Vincristine | 1998 |
A phase I trial of high dose ProMACE-CytaBOM with granulocyte colony stimulating factor for patients with non-Hodgkin's lymphoma.
Topics: Adult; Age Factors; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Vincristine | 1998 |
Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicin.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Combined Modality Therapy; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Treatment Outcome; Vincristine | 1998 |
[Long-term follow up of aggressive lymphoma patients treated with CAMBO-VIP--clinical significance of a residual mass after otherwise successful chemotherapy].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm, Residual; Time Factors; Vincristine | 1998 |
Additional chemotherapy agents improve treatment outcome for children and adults with advanced B-cell lymphomas.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Neoplasm Staging; Survival Rate; Vincristine | 1998 |
Effects of recombinant granulocyte colony-stimulating factor (G-CSF) in patients treated with ProMACE-CytaBOM for HIV-related non-Hodgkin's lymphoma (NHL).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; HIV; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Recombinant Proteins; Retrospective Studies; Treatment Outcome; Vincristine | 1998 |
[Treatment of children with non-Hodgkin's lymphoma with CCLSG NHL 855/890 protocols long-term outcome and incidence of secondary malignancies].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Hydrocortisone; Infant; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Neoplasms, Second Primary; Prednisolone; Remission Induction; Treatment Outcome; Vincristine | 1998 |
Early stem cell transplantation for chronic lymphocytic leukaemia: a chance for cure?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Chlorambucil; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Hydrocortisone; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Melphalan; Methotrexate; Methylprednisolone; Middle Aged; Mitomycins; Prednisone; Prospective Studies; Treatment Outcome; Vincristine | 1998 |
Alternating triple therapy for the treatment of intermediate grade and immunoblastic lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Male; Mesna; Methotrexate; Methylprednisolone Hemisuccinate; Middle Aged; Mitoxantrone; Prednisone; Prognosis; Vincristine | 1998 |
Improved survival with early intensification: combined results from the Medical Research Council childhood ALL randomised trials, UKALL X and UKALL XI. Medical Research Council Working Party on Childhood Leukaemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Daunorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Infant; Infant, Newborn; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Thioguanine; Vincristine | 1998 |
Five-year follow-up of a prospective randomised multi-centre trial of weekly chemotherapy (CAPOMEt) versus cyclical chemotherapy (CHOP-Mtx) in the treatment of aggressive non-Hodgkin's lymphoma. Central Lymphoma Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisolone; Prospective Studies; Survival Rate; United Kingdom; Vincristine | 1998 |
Synchronous radiochemotherapy in unfavorable brain tumors of children and young adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemical and Drug Induced Liver Injury; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Deafness; Disease Progression; Disease-Free Survival; Etoposide; Follow-Up Studies; Glioma; Hearing Loss; Hematologic Diseases; Humans; Ifosfamide; Infections; Life Tables; Lomustine; Medulloblastoma; Methotrexate; Prognosis; Radiotherapy, Adjuvant; Remission Induction; Vincristine | 1998 |
The MACOP-B and VACOP-B combination chemotherapy for young patients with intermediate-grade non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Vincristine | 1998 |
CD30(+) anaplastic large-cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Child; Chromosomes, Human, Pair 2; Chromosomes, Human, Pair 5; Cyclophosphamide; Doxorubicin; Etoposide; Follow-Up Studies; France; Humans; Immunophenotyping; Lymphoma, Large-Cell, Anaplastic; Methotrexate; Prednisone; Prognosis; Protein-Tyrosine Kinases; Remission Induction; Retrospective Studies; Risk Factors; Survival Analysis; Survival Rate; Translocation, Genetic; Treatment Outcome; Vinblastine; Vincristine | 1998 |
[Chemotherapy of resistant and recurrent lymphoma based on a combination of ifosfamide and etoposide. Antitumor effects, toxicity and stimulation of peripheral stem cells].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Neoplasm; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Leukapheresis; Lymphoma, Non-Hodgkin; Male; Mesna; Methotrexate; Middle Aged; Mitoxantrone; Recurrence; Salvage Therapy; Transplantation Conditioning | 1998 |
Efficacy of two different ProMACE-CytaBOM derived regimens in advanced aggressive non-Hodgkin's lymphoma. Final report of a multicenter trial conducted by GISL.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Female; Heart Diseases; Hematologic Diseases; Humans; Idarubicin; Italy; Karnofsky Performance Status; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Proportional Hazards Models; Remission Induction; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine | 1998 |
Local host response in osteosarcoma after chemotherapy referred to radiographs, CT, tumour necrosis and patient survival.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Mesna; Methotrexate; Middle Aged; Necrosis; Neoadjuvant Therapy; Osteosarcoma; Predictive Value of Tests; Prognosis; Tomography, X-Ray Computed | 1998 |
Effect of etoposide on the pharmacokinetics of methotrexate in vivo.
Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Etoposide; Humans; Leucovorin; Medulloblastoma; Methotrexate; Mitolactol; Procarbazine | 1998 |
Phase I-II study of 5-fluorouracil, leucovorin, doxorubicin, methotrexate, and long-term oral etoposide (FLAME) in unresectable or metastatic gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Stomach Neoplasms; Survival Analysis | 1998 |
[Studies of childhood non-Hodgkin's lymphoma--treatment results with the CCLSG NHL 960 protocol. Children's Cancer and Leukemia Study Group (CCLSG)].
Topics: Adolescent; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Infant; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Vincristine | 1998 |
High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Etoposide; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Male; Methotrexate; Methylprednisolone; Middle Aged; Remission Induction; Time Factors; Transplantation, Homologous | 1997 |
BOMP/EPI intensive alternating chemotherapy for IGCCC poor-prognosis germ-cell tumors: the Spanish Germ-Cell Cancer Group experience (GG)
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Confidence Intervals; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Germinoma; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prognosis; Survival Rate; Testicular Neoplasms; Treatment Outcome; Vincristine | 1999 |
Mobilization of peripheral blood progenitor cells in patients with breast cancer: a prospective randomized trial comparing rhG-CSF with the combination of rhG-CSF plus rhEpo after VIP-E chemotherapy.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Epirubicin; Erythropoietin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Prospective Studies; Recombinant Proteins; Transplantation Conditioning; Transplantation, Autologous | 1999 |
Cervical adenocarcinoma, a novel combination chemotherapy with mitomycin C, etoposide, and cisplatin for advanced or recurrent disease.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Etoposide; Female; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Uterine Cervical Neoplasms | 1999 |
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Burkitt Lymphoma; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Prednisolone; Treatment Outcome; Vincristine | 1999 |
A phase II trial of 200% ProMACE-CytaBOM in patients with previously untreated aggressive lymphomas: analysis of response, toxicity, and dose intensity.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Treatment Failure; Treatment Outcome; Vincristine | 1999 |
Three new active cisplatin-containing combinations in the neoadjuvant treatment of locally advanced and locally recurrent breast carcinoma: a randomized phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Epirubicin; Etoposide; Female; Humans; Leucovorin; Methotrexate; Middle Aged; Mitomycin; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Vincristine | 1999 |
Comparison of CMF (cyclophosphamide, methotrexate, and 5-fluorouracil) with a rotational crossing and a sequential intensification regimen in advanced breast cancer: a prospective randomized study.
Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Prospective Studies; Remission Induction; Survival Rate; Treatment Outcome | 1999 |
CEOP-B/VIMB vs. promace-CytaBOM in the treatment of intermediate or high grade non-Hodgkin's lymphoma: A randomised multicenter study of Southern Italy Cooperative Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Survival Analysis; Treatment Outcome; Vincristine | 2000 |
Effects of G-CSF and high-dose methylprednisolone on peripheral stem cells, serum IL-3 levels and hematological parameters in acute lymphoblastic leukemia patients with neutropenia: a pilot study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Etoposide; Glucocorticoids; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Humans; Interleukin-3; Methotrexate; Methylprednisolone; Neutropenia; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Vincristine | 2000 |
Feasibility of high-dose chemotherapy without stem cell support as a first-line treatment for non-Hodgkin's aggressive lymphoma: a pilot study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Component Removal; Cyclophosphamide; Doxorubicin; Etoposide; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Pilot Projects; Prednisone; Survival Rate; Vincristine | 2000 |
A randomized British National Lymphoma Investigation trial of CHOP vs. a weekly multi-agent regimen (PACEBOM) in patients with histologically aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chi-Square Distribution; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Prednisolone; Severity of Illness Index; Survival Analysis; United Kingdom; Vincristine | 2000 |
Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials. UK Medical Research Council's Working Party on Childhood Leukaemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Infant; Infections; Male; Methotrexate; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Proportional Hazards Models; Remission Induction; Risk; Survival Analysis; Thioguanine; Treatment Outcome; Vincristine | 2000 |
Use of recombinant human granulocyte colony-stimulating factor to increase chemotherapy dose-intensity: a randomized trial in very high-risk childhood acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Infant; Infant, Newborn; Male; Methotrexate; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recombinant Proteins; Thrombocytopenia; Treatment Outcome; Vincristine | 2000 |
Interferon alpha consolidation after intensive chemotherapy does not prolong the progression-free survival of patients with low-grade non-Hodgkin's lymphoma: results of the Southwest Oncology Group randomized phase III study 8809.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Recombinant Proteins; Remission Induction; Vincristine | 2000 |
Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high-risk gestational trophoblastic tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Disease-Free Survival; Etoposide; Female; Humans; Methotrexate; Middle Aged; Pregnancy; Risk Factors; Salvage Therapy; Treatment Outcome; Trophoblastic Neoplasms; Uterine Neoplasms | 2000 |
Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the Europe
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Levoleucovorin; Male; Methotrexate; Middle Aged; Proportional Hazards Models; Stomach Neoplasms; Survival Analysis | 2000 |
[Different chemotherapy protocols for intermediate and high grade malignant non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prospective Studies; Remission Induction; Vincristine | 1997 |
Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study.
Topics: Adult; Age Factors; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Prognosis; Prospective Studies; Remission Induction; Risk Factors; Statistics, Nonparametric; Vindesine | 2000 |
Sample sizes for cancer trials where Health Related Quality of Life is the primary outcome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Etoposide; Humans; Lung Neoplasms; Methotrexate; Normal Distribution; Quality of Life; Randomized Controlled Trials as Topic; Sample Size; Statistics as Topic; Surveys and Questionnaires; Vincristine | 2000 |
Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cyclosporine; Cytarabine; Etoposide; Female; Graft vs Tumor Effect; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Male; Melphalan; Methotrexate; Middle Aged; Pilot Projects; Risk Factors; Survival Rate; Transplantation Chimera; Vidarabine | 2000 |
Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: an updated report.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Disease-Free Survival; Doxorubicin; Etoposide; Extremities; Female; Fertility; Follow-Up Studies; Humans; Ifosfamide; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Osteosarcoma; Patient Compliance; Plastic Surgery Procedures; Postoperative Complications; Radiography; Reoperation; Survival Rate | 2000 |
Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Eye Neoplasms; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Nervous System Diseases; Salvage Therapy; Thiotepa | 2001 |
Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol.
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Chromosome Aberrations; Chromosome Disorders; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Female; Humans; Infant; Leukocyte Count; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Remission Induction; Risk Factors; Sex Factors; Thioguanine; United Kingdom; Vincristine | 2001 |
The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Infant; Leucovorin; Lymphoma, B-Cell; Male; Methotrexate; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Recurrence; Remission Induction; Survival Rate; Vincristine | 2001 |
Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: a randomized study.
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Female; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Infusions, Intravenous; Injections, Intravenous; Life Tables; Male; Methotrexate; Middle Aged; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vincristine | 2001 |
Outcome of acute lymphoblastic leukemia in children with AL90 regimen: impact of response to treatment and sex difference on prognostic factors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Immunophenotyping; Infant; Male; Mercaptopurine; Methotrexate; Multivariate Analysis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Radiotherapy, Adjuvant; Remission Induction; Risk; Risk Factors; Severity of Illness Index; Sex Factors; Survival Analysis; Treatment Outcome; Vincristine | 2001 |
Combination chemotherapy containing mitoguazone, ifosfamide, methotrexate, etoposide (MIME) and G-CSF efficiently mobilize peripheral blood progenitor cells in heavily pre-treated relapsed lymphoma patients.
Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Component Removal; Etoposide; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma; Methotrexate; Middle Aged; Mitoguazone; Premedication; Recurrence; Transplantation, Autologous | 2001 |
Ifosfamide- and etoposide-based chemotherapy as salvage and mobilizing regimens for poor prognosis lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Graft Survival; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Kinetics; Lymphoma; Male; Mesna; Methotrexate; Middle Aged; Mitoxantrone; Prognosis; Salvage Therapy; Treatment Outcome | 2001 |
Autologous peripheral blood stem cell transplantation in patients with relapsed lymphoma results in accelerated haematopoietic reconstitution, improved quality of life and cost reduction compared with bone marrow transplantation: the Hovon 22 study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chi-Square Distribution; Cisplatin; Cost-Benefit Analysis; Cytarabine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prospective Studies; Quality of Life; Recurrence; Statistics, Nonparametric; Survival Rate; Transplantation, Autologous | 2001 |
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infections; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Survival Analysis; Thrombocytopenia; Vincristine | 2001 |
Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine | 2002 |
Efficacy of carboplatin with an MEP (mitoxantrone, etoposide and prednisone) regimen for relapsed and CHOP-resistant diffuse large B-cell lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Resistance, Multiple; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Mitoxantrone; Neoplasm Staging; Prednisone; Recurrence; Survival Rate; Time Factors; Vincristine | 2002 |
Role of radiotherapy in the treatment of supratentorial primitive neuroectodermal tumors in childhood: results of the prospective German brain tumor trials HIT 88/89 and 91.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lomustine; Male; Methotrexate; Neoplasm Recurrence, Local; Neuroectodermal Tumors; Radiotherapy Dosage; Supratentorial Neoplasms; Survival Rate; Treatment Outcome; Vincristine | 2002 |
Outcome is not improved by the use of alternating chemotherapy in elderly patients with aggressive lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoxantrone; Prednisone; Prospective Studies; Remission Induction; Survival Analysis; Treatment Outcome; Vindesine | 2001 |
Less intense conditioning with fludarabine, cyclophosphamide, idarubicin and etoposide (FCIE) followed by allogeneic unselected peripheral blood stem cell transplantation in elderly patients with leukemia.
Topics: Adult; Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Etoposide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2002 |
Intensive, very short-term chemotherapy for advanced Burkitt's lymphoma in children.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Central Nervous System Neoplasms; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Injections, Spinal; Male; Methotrexate; Palliative Care; Prognosis; Risk Factors; Treatment Outcome; Vincristine | 2002 |
Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.
Topics: Adolescent; Adult; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Gastrointestinal Diseases; Germinoma; Hematologic Diseases; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Peripheral Nervous System Diseases; Prognosis; Prospective Studies; Remission Induction; Seminoma; Survival Analysis; Survival Rate; Testicular Neoplasms; Treatment Outcome; Vincristine | 2002 |
An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; L-Lactate Dehydrogenase; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prognosis; Prospective Studies; Risk Factors; Survival Rate; Treatment Outcome; United Kingdom; Vincristine | 2002 |
Activity of postoperative carboplatin, etoposide, and high-dose methotrexate in pediatric CNS embryonal tumors: results of a phase II study in newly diagnosed children.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Disease-Free Survival; Etoposide; Female; Humans; Infant; Male; Medulloblastoma; Methotrexate; Neoplasms, Germ Cell and Embryonal; Prognosis; Treatment Outcome | 2002 |
Outcome of B-cell non-Hodgkin lymphoma protocol CCCG-B NHL97: a report from Chinese multi-center cooperative group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; China; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Lymphoma, B-Cell; Male; Mesna; Methotrexate; Prednisone; Treatment Outcome; Vincristine | 2002 |
A prospective study of P-IMVP-16/CBDCA: a novel salvage chemotherapy for patients with aggressive non-Hodgkin's lymphoma who had previously received CHOP therapy as first-line chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Neoplasm Staging; Prednisone; Prospective Studies; Salvage Therapy; Survival Rate; Time Factors; Treatment Failure; Vincristine | 2002 |
Etoposide, doxorubicin and cisplatin alternating with 5-fluorouracil, doxorubicin and high-dose methotrexate in patients with advanced adenocarcinoma of the stomach or the gastroesophageal junction.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Stomach Neoplasms; Treatment Outcome | 2002 |
Nasal NK/T-cell lymphoma with disseminated disease treated with aggressive combined therapy.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Killer Cells, Natural; Leucovorin; Lung Neoplasms; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Nose Neoplasms; Radiotherapy, Adjuvant; Remission Induction; Skin Neoplasms; Treatment Outcome | 2003 |
The dose related effect of steroids on blast reduction rate and event free survival in children with acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Male; Methotrexate; Methylprednisolone; Neoplastic Stem Cells; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Remission Induction; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine | 2003 |
Unstratified chemotherapy for non-metastatic osteosarcoma of the extremities in children.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Extremities; Female; Humans; Male; Methotrexate; Osteosarcoma; Statistics, Nonparametric; Survival Analysis; Taiwan; Treatment Outcome | 2003 |
Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Prospective Studies; Risk Factors; Vincristine | 2003 |
A pilot study of CODOX-M/IVAC in primary refractory or relapsed high-grade non-Hodgkin's lymphoma. A Scotland and Newcastle Lymphoma Group Study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease Progression; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Injections, Spinal; Lenograstim; Leucovorin; Lymphoma, Non-Hodgkin; Male; Mesna; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pilot Projects; Prognosis; Recombinant Proteins; Salvage Therapy; Sepsis; Treatment Outcome; Vincristine | 2003 |
Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Methotrexate; Middle Aged; Prednisone; Prognosis; Retrospective Studies; Risk Factors; Treatment Outcome; Vincristine | 2004 |
Modified magrath regimens for adults with Burkitt and Burkitt-like lymphomas: preserved efficacy with decreased toxicity.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Leucovorin; Mesna; Methotrexate; Middle Aged; Survival Analysis; Treatment Outcome; Vincristine | 2004 |
Salvage chemotherapy for high-risk gestational trophoblastic tumor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Leucovorin; Methotrexate; Middle Aged; Risk Factors; Salvage Therapy; Treatment Outcome | 2004 |
EMA/EP chemotherapy for chemorefractory gestational trophoblastic tumor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cisplatin; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Treatment Outcome | 2004 |
Toxicity and efficacy of intensive chemotherapy for children with acute lymphoblastic leukemia (ALL) after first bone marrow or extramedullary relapse.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacteremia; Bone Marrow Neoplasms; Child; Child, Preschool; Cytarabine; Dexamethasone; Etoposide; Female; Flow Cytometry; Humans; Idarubicin; Ifosfamide; Infant; Infusions, Intravenous; Leucovorin; Male; Mesna; Methotrexate; Mouth Mucosa; Polyethylene Glycols; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Stomatitis; Thioguanine; Treatment Outcome; Vincristine | 2004 |
Outcome of children with B cell lymphoma in Venezuela with the LMB-89 protocol.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Cytarabine; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hepatitis B; Hepatitis B Vaccines; Humans; Hydrocortisone; Leucovorin; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Recurrence; Treatment Outcome; Venezuela; Vincristine | 2004 |
Glomerular dysfunction, independent of tubular dysfunction, induced by antineoplastic chemotherapy in children.
Topics: Acute Disease; Adolescent; Albuminuria; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Creatinine; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Glomerular Filtration Rate; Humans; Kidney Tubules; Leukemia; Lymphoma; Methotrexate; Neoplasms; Neuroblastoma; Osteosarcoma; Proteinuria; Rhabdomyosarcoma; Vincristine | 2004 |
Long-term results of dose density therapy in patients with aggressive lymphoma.
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Cyclophosphamide; Dexamethasone; Epirubicin; Etoposide; Humans; Ifosfamide; Longitudinal Studies; Lymphoma; Mesna; Methotrexate; Middle Aged; Prednisone; Survival Analysis; Treatment Failure; Treatment Outcome; Vincristine | 2005 |
Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG).
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Infusions, Intravenous; Injections, Subcutaneous; Male; Melphalan; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Recurrence; Treatment Outcome; Vincristine | 2005 |
Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Leucovorin; Male; Medulloblastoma; Mesna; Methotrexate; Risk Factors; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome; Vincristine | 2004 |
Relapse rate of patients with low-risk gestational trophoblastic tumor initially treated with single-agent chemotherapy.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Infusions, Intravenous; Injections, Intramuscular; Leucovorin; Methotrexate; Recurrence; Remission Induction; Risk Factors; Treatment Outcome | 2005 |
Treatment of early childhood medulloblastoma by postoperative chemotherapy alone.
Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child, Preschool; Cyclophosphamide; Etoposide; Follow-Up Studies; Humans; Infant; Intelligence; Medulloblastoma; Methotrexate; Neoplasm Recurrence, Local; Neuropsychological Tests; Postoperative Care; Proportional Hazards Models; Remission Induction; Survival Analysis; Vincristine | 2005 |
[Clinical randomized comparative trial of ProMACE-CytaBOM regimen and CHOP regimen in treating non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Leukopenia; Lymphoma, B-Cell; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Nausea; Prednisone; Remission Induction; Survival Rate; Thrombocytopenia; Vincristine | 2005 |
Late magnetic resonance imaging features of leukoencephalopathy in children with central nervous system tumours following high-dose methotrexate and neuraxis radiation therapy.
Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Dementia, Vascular; Etoposide; Humans; Infant; Magnetic Resonance Imaging; Medulloblastoma; Methotrexate | 2005 |
Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Leucovorin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Prospective Studies; Survival Rate; Vincristine | 2005 |
Combination chemotherapy with adriamycin, cyclophosphamide, vincristine, methotrexate, etoposide and dexamethasone (ACOMED) followed by involved field radiotherapy induces high remission rates and durable long-term survival in patients with aggressive mal
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Radiotherapy; Survival Analysis; Survivors; Vincristine | 2005 |
[Trial of front-line intensive chemotherapy followed by peripheral blood stem cell transplantation in high-intermediate and high risk non-Hodgkin's lymphoma patients].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prednisolone; Pulse Therapy, Drug; Remission Induction; Risk; Survival Rate; Treatment Outcome; Vincristine | 2005 |
The role of dose size in a chemotherapy regimen (ProMECE-CytaBOM) for the first-line treatment of large B-cell lymphomas: a randomized trial by the Gruppo Italiano Studio Linfomi (GISL).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Epirubicin; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Prednisone; Vincristine | 2006 |
[Bladder preservation for locally advanced bladder cancer by transurethral resection, systemic chemotherapy and radiation].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cystectomy; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Radiotherapy Dosage; Urinary Bladder Neoplasms; Vinblastine | 2006 |
Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.
Topics: Acute Disease; Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Down Syndrome; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Hydrocortisone; Infant; Infections; Japan; Kaplan-Meier Estimate; Leukemia, Myeloid; Male; Methotrexate; Mitoxantrone; Remission Induction; Survival Analysis; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome; Tretinoin; Vincristine | 2007 |
Influence of low-energy laser in the prevention of oral mucositis in children with cancer receiving chemotherapy.
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Child; Child, Preschool; Cohort Studies; Etoposide; Female; Humans; Ifosfamide; Irinotecan; Low-Level Light Therapy; Male; Methotrexate; Mouth Mucosa; Neoplasms; Nutritional Status; Oral Hygiene; Severity of Illness Index; Stomatitis; Treatment Outcome | 2007 |
High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma; Male; Methotrexate; Methylprednisolone; Middle Aged; Remission Induction; Stem Cell Transplantation; Transplantation, Autologous | 2006 |
Brainstem primitive neuroectodermal tumors (bstPNET): results of treatment with intensive induction chemotherapy followed by consolidative chemotherapy with autologous hematopoietic cell rescue.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Brain Damage, Chronic; Brain Stem; Carboplatin; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Etoposide; Humans; Infant; Infratentorial Neoplasms; Leucovorin; Mesna; Methotrexate; Neuroectodermal Tumors, Primitive; Peripheral Blood Stem Cell Transplantation; Remission Induction; Thiotepa; Transplantation, Autologous; Vincristine | 2008 |
Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Celiac Disease; Combined Modality Therapy; Cytarabine; Enteral Nutrition; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Immunosuppressive Agents; Lymphoma, T-Cell, Peripheral; Male; Melphalan; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Podophyllotoxin; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2007 |
Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in the treatment of cerebral metastasis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Breast Neoplasms; Carboplatin; Cyclophosphamide; Etoposide; Female; Humans; Infusions, Intra-Arterial; Lung Neoplasms; Lymphoma; Male; Methotrexate; Middle Aged; Osmosis; Ovarian Neoplasms; Prospective Studies; Survival Rate | 2007 |
SFOP OS94: a randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Methotrexate; Osteosarcoma; Preoperative Care | 2007 |
Donor lymphocyte infusion for the treatment of leukemia relapse after HLA-mismatched/haploidentical T-cell-replete hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Antineoplastic Agents; Benzamides; Child; Combined Modality Therapy; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Female; Graft vs Host Disease; Graft vs Leukemia Effect; Haplotypes; Histocompatibility; HLA Antigens; Humans; Imatinib Mesylate; Immunosuppressive Agents; Kaplan-Meier Estimate; Leukemia; Lymphocyte Transfusion; Male; Methotrexate; Mitoxantrone; Pancytopenia; Peripheral Blood Stem Cell Transplantation; Piperazines; Pyrimidines; Recurrence; Remission Induction; Salvage Therapy; Tissue Donors; Treatment Outcome | 2007 |
Relapsed or refractory gestational trophoblastic neoplasia treated with the etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EP-EMA) regimen.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Chemical and Drug Induced Liver Injury; Cisplatin; Cyclophosphamide; Dactinomycin; Dose-Response Relationship, Drug; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Outcome; Remission Induction; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vincristine | 2007 |
[Results of the SHOP LNHB98 (LMB89) trial in pediatric patients with B-cell non-Hodgkin's lymphoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Infant; Leucovorin; Lymphoma, B-Cell; Male; Methotrexate; Prednisone; Prospective Studies; Vincristine | 2007 |
CMED in the treatment of nasal natural killer cell lymphoma with distant metastases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Etoposide; Female; Humans; Killer Cells, Natural; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Nose Neoplasms; Radiotherapy, Adjuvant; Salvage Therapy; Survival Analysis; Treatment Outcome | 2007 |
Salvage therapy and late neurotoxicity in patients with recurrent primary CNS lymphoma treated with a modified ProMACE-MOPP hybrid regimen.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma; Male; Mechlorethamine; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neurotoxicity Syndromes; Prednisone; Procarbazine; Retrospective Studies; Salvage Therapy; Survival Analysis; Vincristine | 2007 |
Intensive chemotherapy regimen (LMB86) for St Jude stage IV AIDS-related Burkitt lymphoma/leukemia: a prospective study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Burkitt Lymphoma; CD4 Lymphocyte Count; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lymphoma, AIDS-Related; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Prospective Studies; Treatment Outcome; Vincristine | 2007 |
GAMEC--a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Dose-Response Relationship, Drug; Etoposide; Humans; Methotrexate; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prognosis; Recurrence; Treatment Outcome | 2007 |
Phase II study of chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia or lymphoblastic lymphoma: Japan Clinical Oncology Group Study 9004.
Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Combined Modality Therapy; Cytarabine; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Mercaptopurine; Methotrexate; Middle Aged; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Stem Cell Transplantation; Transplantation, Autologous | 2007 |
Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the Head Start I and I
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Male; Mesna; Methotrexate; Neuroectodermal Tumors, Primitive; Supratentorial Neoplasms; Survival Rate; Vincristine | 2008 |
Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trial.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Prospective Studies; Recurrence; Remission Induction; Rituximab; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous | 2008 |
Intraarterial chemotherapy and osmotic blood-brain barrier disruption for patients with embryonal and germ cell tumors of the central nervous system.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Carboplatin; Central Nervous System Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Etoposide; Female; Humans; Infant; Infusions, Intra-Arterial; Male; Methotrexate; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Survival Analysis; Treatment Outcome | 2008 |
Results of a phase III clinical trial: CHOP versus CMED in peripheral T-cell lymphoma unspecified.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Lymphoma, T-Cell, Peripheral; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Vincristine; Young Adult | 2008 |
Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; Etoposide; Humans; Ifosfamide; Leukemia, Lymphoid; Lymphoma, Extranodal NK-T-Cell; Methotrexate; Middle Aged; Recurrence | 2008 |
A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Cytogenetic Analysis; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Ifosfamide; Immunophenotyping; Methotrexate; Middle Aged; Treatment Outcome; Vincristine | 2008 |
Effective second-line chemotherapy for extranodal NK/T-cell lymphoma consisting of etoposide, ifosfamide, methotrexate, and prednisolone.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Disease-Free Survival; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Prednisolone; Recurrence; Survival Analysis; Treatment Outcome; Young Adult | 2009 |
Treatment of relapsed or refractory aggressive non-hodgkin lymphoma with two ifosfamide-based regimens, IMVP and ICE.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy; Treatment Outcome | 2008 |
DV-ICE, intensive induction and early transplantation for adult patients with acute lymphoblastic leukemia: a phase II study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Dexamethasone; Disease-Free Survival; Early Termination of Clinical Trials; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Hydrocortisone; Idarubicin; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Treatment Failure; Vincristine; Young Adult | 2009 |
[Efficacy of modified B-NHL-BFM-90 protocol on anaplastic T-cell lymphoma in children and adolescents].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; L-Lactate Dehydrogenase; Leukopenia; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Neoplasm Staging; Remission Induction; Stem Cell Transplantation; Thrombocytopenia; Vincristine; Vindesine | 2009 |
Dose-dense therapy improves survival in aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Doxorubicin; Epirubicin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Infections; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Prognosis; Recombinant Proteins; Survival Rate; Vincristine; Young Adult | 2010 |
Long-term follow-up of an age-adapted C5R protocol followed by radiotherapy in 99 newly diagnosed primary CNS lymphomas: a prospective multicentric phase II study of the Groupe d'Etude des Lymphomes de l'Adulte (GELA).
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Societies, Medical; Time Factors; Vincristine; Young Adult | 2010 |
In vitro and in vivo study on the antioxidant activity of dexrazoxane.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Bleomycin; Chromans; Cyclophosphamide; Cytarabine; Epirubicin; Etoposide; Female; Free Radical Scavengers; Glutathione; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Razoxane; Time Factors; Uric Acid; Vincristine | 2010 |
High rate and prolonged duration of complete remissions induced by rituximab, methotrexate, doxorubicin, cyclophosphamide, vincristine, ifosfamide, etoposide, cytarabine, and thalidomide (R-MACLO-IVAM-T), a modification of the National Cancer Institute 89
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Mantle-Cell; Male; Methotrexate; Middle Aged; Remission Induction; Rituximab; Thalidomide; Treatment Outcome; Vincristine | 2010 |
Dose-intensified treatment of Burkitt lymphoma and B-cell lymphoma unclassifiable, (with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma) in young adults (<50 years): a comparison of two adapted BFM protocols.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cohort Studies; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisolone; Survival Analysis; Vincristine; Vindesine; Young Adult | 2010 |
Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group study.
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Kaplan-Meier Estimate; Leucovorin; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Methotrexate; Middle Aged; Mitoxantrone; Multivariate Analysis; Prednisolone; Prednisone; Proportional Hazards Models; Prospective Studies; Rituximab; Treatment Outcome; Vincristine; Young Adult | 2011 |
Comparison of two high-dose cyclophosphamide, doxorubicin, vincristine, and prednisone derived regimens in patients aged under 60 years with low-intermediate risk aggressive lymphoma: a final analysis of the multicenter LNH93-2 protocol.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Prospective Studies; Survival Rate; Vindesine; Young Adult | 2010 |
Dose intensity of chemotherapy in patients with relapsed Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Etoposide; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Methotrexate; Neoplasm Recurrence, Local; Peripheral Blood Stem Cell Transplantation; Prognosis | 2010 |
Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Histocompatibility; HLA Antigens; Humans; Living Donors; Lymphoma, Follicular; Male; Methotrexate; Middle Aged; Remission Induction; Rituximab; Salvage Therapy; Siblings; Tacrolimus; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2011 |
Clinical utility of biochemical bone turnover markers in children and adolescents with osteosarcoma.
Topics: Adolescent; Adult; Alkaline Phosphatase; Antineoplastic Agents; Biomarkers; Child; Child, Preschool; Cisplatin; Collagen Type I; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Methotrexate; Osteocalcin; Osteosarcoma; Young Adult | 2010 |
Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial.
Topics: Adolescent; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Humans; Idarubicin; Infant; Kaplan-Meier Estimate; Leukocyte Count; Male; Mercaptopurine; Methotrexate; Mitoxantrone; Polyethylene Glycols; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Risk Assessment; Treatment Outcome; United Kingdom; Vidarabine; Vincristine | 2010 |
Immunochemotherapy with intensive consolidation for primary CNS lymphoma: a pilot study and prognostic assessment by diffusion-weighted MRI.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Brain; Central Nervous System Neoplasms; Consolidation Chemotherapy; Cytarabine; Dacarbazine; Diffusion Magnetic Resonance Imaging; Etoposide; Female; Humans; Immunotherapy; Lymphoma; Male; Methotrexate; Middle Aged; Prognosis; Remission Induction; Rituximab; Survival Analysis; Temozolomide; Treatment Outcome | 2012 |
Bullous acral erythema: an additional consideration in the differential diagnosis of pauci-inflammatory subepidermal bullae*.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blister; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hand-Foot Syndrome; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Middle Aged; Prednisolone; Vincristine | 2012 |
Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK/T-cell lymphoma, nasal type.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; DNA, Viral; Epstein-Barr Virus Infections; Etoposide; Female; Herpesvirus 4, Human; Humans; Ifosfamide; Kaplan-Meier Estimate; Leukopenia; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Nasal Mucosa; Neutropenia; Prognosis; Prospective Studies; Steroids; Treatment Outcome; Young Adult | 2012 |
Treatment of young patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia using increased dose of imatinib and deintensified chemotherapy before allogeneic stem cell transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Combined Modality Therapy; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Etoposide; Female; Humans; Imatinib Mesylate; Male; Mercaptopurine; Methotrexate; Middle Aged; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Pyrimidines; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome; Vincristine; Young Adult | 2012 |
Treatment of Burkitt lymphoma in equatorial Africa using a simple three-drug combination followed by a salvage regimen for patients with persistent or recurrent disease.
Topics: Adolescent; Adult; Africa South of the Sahara; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cause of Death; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Mesna; Methotrexate; Middle Aged; Neoplasm Staging; Recurrence; Remission Induction; Risk; Salvage Therapy; Survival Rate; Treatment Outcome; Vincristine; Young Adult | 2012 |
Evolving of therapeutic strategies for CNS-PNET.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Humans; Infant; Kaplan-Meier Estimate; Male; Methotrexate; Neuroectodermal Tumors, Primitive; Thiotepa; Vincristine | 2013 |
A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Polyethylene Glycols; Rituximab; Thrombocytopenia; Treatment Outcome; Vincristine; Young Adult | 2013 |
Midtreatment ¹⁸F-FDG PET/CT Scan for Early Response Assessment of SMILE Therapy in Natural Killer/T-Cell Lymphoma: A Prospective Study from a Single Center.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prednisolone; Prospective Studies; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2014 |
[Prospective multicentre study of chemotherapeutic regimen containing pirarubicin on the treatment of relapsed or refractory acute myeloid leukemia in adults].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Doxorubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Methotrexate; Prospective Studies; Recurrence; Remission Induction | 2014 |
Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: a Children's Oncology Group Report.
Topics: Adolescent; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Burkitt Lymphoma; Central Nervous System Neoplasms; Child; Consolidation Chemotherapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Genes, myc; Humans; Immunotherapy; Infusions, Intravenous; Kaplan-Meier Estimate; Lymphoma, B-Cell; Maintenance Chemotherapy; Male; Methotrexate; Prednisone; Remission Induction; Rituximab; Typhlitis; Vincristine | 2014 |
A phase II study of ifosfamide, methotrexate, etoposide, and prednisolone for previously untreated stage I/II extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial of the Korean Cancer Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Killer Cells, Natural; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Nose Neoplasms; Prednisolone; Republic of Korea; Treatment Outcome; Young Adult | 2014 |
Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Immunotherapy; Injections, Spinal; Leukemia; Male; Methotrexate; Middle Aged; Prognosis; Prospective Studies; Remission Induction; Rituximab; Young Adult | 2014 |
EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Interferon-alpha; Male; Methotrexate; Neoadjuvant Therapy; Osteosarcoma; Polyethylene Glycols; Quality of Life; Research Design; Young Adult | 2015 |
Comparative outcome of Thai pediatric osteosarcoma treated with two protocols: the role of high-dose methotrexate (HDMTX) in a single institute experience.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Extremities; Feasibility Studies; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Maximum Tolerated Dose; Methotrexate; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Staging; Osteosarcoma; Prognosis; Retrospective Studies; Survival Rate | 2014 |
AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; HIV Infections; HIV-1; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Rituximab; Treatment Outcome; Vincristine; Young Adult | 2015 |
Long-term follow-up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Induction Chemotherapy; Male; Methotrexate; Middle Aged; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence; Remission Induction; Survival Analysis; Transplantation, Homologous; Vincristine | 2015 |
Developing a prognostic model for patients with localized osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate: A single-center experience of 237 patients.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Staging; Osteosarcoma; Prognosis; Retrospective Studies; Survival Rate | 2015 |
DDGP versus SMILE in Newly Diagnosed Advanced Natural Killer/T-Cell Lymphoma: A Randomized Controlled, Multicenter, Open-label Study in China.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; China; Cisplatin; Deoxycytidine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Gemcitabine; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Natural Killer T-Cells; Neoplasm Recurrence, Local; Polyethylene Glycols; Remission Induction; Young Adult | 2016 |
High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma--a randomized phase III trial (MATRix).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Stem Cell Transplantation; Thiotepa; Transplantation, Autologous | 2016 |
Phase II trial of concurrent chemoradiotherapy with L-asparaginase and MIDLE chemotherapy for newly diagnosed stage I/II extranodal NK/T-cell lymphoma, nasal type (CISL-1008).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chemoradiotherapy; Cisplatin; Dexamethasone; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Neoplasm Staging; Radiotherapy Dosage; Radiotherapy, Conformal; Republic of Korea; Time Factors; Treatment Outcome | 2016 |
A phase 2 study of methotrexate, etoposide, dexamethasone, and pegaspargase chemotherapy for newly diagnosed, relapsed, or refractory extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial in Northwest China.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers; China; Dexamethasone; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Immunophenotyping; Kaplan-Meier Estimate; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Neoplasm Staging; Polyethylene Glycols; Prognosis; Recurrence; Retreatment; Treatment Outcome; Young Adult | 2017 |
Plasma immunoprofiling of patients with high-risk diffuse large B-cell lymphoma: a Nordic Lymphoma Group study.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Blood Proteins; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Immunophenotyping; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Monitoring, Physiologic; Prednisolone; Prednisone; Prognosis; Protein Array Analysis; Proteomics; Risk Factors; Rituximab; Survival Analysis; Vincristine; Young Adult | 2016 |
Efficacy of pegaspargase, etoposide, methotrexate and dexamethasone in newly diagnosed advanced-stage extra-nodal natural killer/T-cell lymphoma with the analysis of the prognosis of whole blood EBV-DNA.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; Disease-Free Survival; DNA, Viral; Etoposide; Female; Herpesvirus 4, Human; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Polyethylene Glycols; Survival Rate | 2017 |
A Phase II Study of Methotrexate, Etoposide, Dexamethasone and Pegaspargase Sandwiched with Radiotherapy in the Treatment of Newly Diagnosed, Stage IE to IIE Extranodal Natural-Killer/T-Cell Lymphoma, Nasal-Type.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Combined Modality Therapy; Dexamethasone; Disease-Free Survival; Etoposide; Female; Herpesvirus 4, Human; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Neoplasm Staging; Polyethylene Glycols; Prognosis | 2017 |
Results of methotrexate-etoposide-ifosfamide based regimen (M-EI) in osteosarcoma patients included in the French OS2006/sarcome-09 study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Diphosphonates; Doxorubicin; Etoposide; Female; France; Humans; Ifosfamide; Imidazoles; Kaplan-Meier Estimate; Male; Methotrexate; Neutropenia; Osteosarcoma; Young Adult; Zoledronic Acid | 2018 |
LEAM versus CBV for conditioning in autologous hematopoietic stem cell transplantation for lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lomustine; Lymphoma; Male; Methotrexate; Prednisolone; Prospective Studies; Transplantation Conditioning; Transplantation, Autologous | 2019 |
Improved prognosis of extranodal NK/T cell lymphoma, nasal type of nasal origin but not extranasal origin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Etoposide; Female; Humans; Ifosfamide; Japan; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Skin Neoplasms; Steroids | 2019 |
Results of API-AI based regimen in osteosarcoma adult patients included in the French OS2006/Sarcome-09 study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Follow-Up Studies; France; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Osteosarcoma; Prognosis; Survival Rate; Young Adult; Zoledronic Acid | 2020 |
The efficacy and toxicity of 4-day chemotherapy with methotrexate, etoposide and actinomycin D in patients with choriocarcinoma and high-risk gestational trophoblastic neoplasia.
Topics: Adolescent; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Leukopenia; Menstrual Cycle; Methotrexate; Middle Aged; Nausea; Pregnancy; Retrospective Studies; Treatment Outcome; Uterine Neoplasms; Young Adult | 2020 |
DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase II study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Rituximab; Vincristine | 2020 |
R-MACLO-IVAM regimen followed by maintenance therapy induces durable remissions in untreated mantle cell lymphoma - Long term follow up results.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Mantle-Cell; Maintenance Chemotherapy; Male; Methotrexate; Middle Aged; Progression-Free Survival; Prospective Studies; Remission Induction; Rituximab; Thalidomide; Vincristine; Young Adult | 2021 |
883 other study(ies) available for etoposide and methotrexate
Article | Year |
---|---|
Structure-activity relationships of antineoplastic agents in multidrug resistance.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Cricetinae; Dactinomycin; Drug Resistance; Leukemia L1210; Mice; Regression Analysis; Structure-Activity Relationship; Tumor Cells, Cultured | 1990 |
Bis(bioreductive) alkylating agents: synthesis and biological activity in a nude mouse human carcinoma model.
Topics: Animals; Antineoplastic Agents; Benzoquinones; Burkitt Lymphoma; Cell Line; Cisplatin; Drug Resistance; Humans; Methotrexate; Mice; Mice, Nude; Nasopharyngeal Neoplasms; Quinones; Tumor Stem Cell Assay; Vinblastine | 1983 |
Anthracyclines modulate multidrug resistance protein (MRP) mediated organic anion transport.
Topics: Adenosine Triphosphate; Anthracyclines; ATP-Binding Cassette Transporters; Binding Sites; Biological Transport; Cell Membrane; Daunorubicin; Glutathione; Humans; Multidrug Resistance-Associated Proteins; Tumor Cells, Cultured | 1997 |
Cytotoxic cholestane glycosides from the bulbs of Ornithogalum saundersiae.
Topics: Antineoplastic Agents, Phytogenic; Cholestanes; Drug Screening Assays, Antitumor; Glycosides; HL-60 Cells; Humans; Hydrolysis; Liliaceae; Plant Roots; Plants, Medicinal; Spectrometry, Mass, Fast Atom Bombardment; Tumor Cells, Cultured | 2001 |
Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: effect of polyglutamylation on MTX transport.
Topics: 3T3 Cells; Animals; ATP-Binding Cassette Transporters; Biological Transport; Drug Resistance, Multiple; Folic Acid; Humans; Leucovorin; Methotrexate; Mice; Multidrug Resistance-Associated Proteins; Osmolar Concentration; Polyglutamic Acid; Tritium | 2001 |
Rational use of in vitro P-glycoprotein assays in drug discovery.
Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Chromatography, Liquid; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Humans; Mass Spectrometry; Pharmacology; Spodoptera | 2001 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Characterization of the transport properties of human multidrug resistance protein 7 (MRP7, ABCC10).
Topics: Biological Transport; Cells, Cultured; Cyclosporine; Estradiol; Glycocholic Acid; Humans; Kinetics; Leukotriene Antagonists; Leukotriene C4; Multidrug Resistance-Associated Proteins; Osmotic Pressure; Propionates; Quinolines; Recombinant Proteins; Transfection | 2003 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations.
Topics: Antineoplastic Agents; Models, Chemical; Octanols; Quantitative Structure-Activity Relationship; Water | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
Topics: Candida albicans; Membrane Transport Proteins; Saccharomyces cerevisiae; Structure-Activity Relationship; Substrate Specificity | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
Synthesis and antiproliferative activity of novel symmetrical alkylthio- and alkylseleno-imidocarbamates.
Topics: Antineoplastic Agents; Apoptosis; Carbamates; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Humans; Inhibitory Concentration 50 | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Identification of a glutathione peroxidase inhibitor that reverses resistance to anticancer drugs in human B-cell lymphoma cell lines.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Catalytic Domain; Cattle; Cell Line, Tumor; Crystallography, X-Ray; Drug Resistance, Neoplasm; Enzyme Inhibitors; Glutathione Peroxidase; Humans; Hydrazones; Inhibitory Concentration 50; Lymphoma, B-Cell; Molecular Structure | 2012 |
Structural variations on antitumour agents derived from bisacylimidoselenocarbamate. A proposal for structure-activity relationships based on the analysis of conformational behaviour.
Topics: Antineoplastic Agents; Carbamates; HT29 Cells; Humans; MCF-7 Cells; Models, Molecular; Molecular Conformation; Organoselenium Compounds; Structure-Activity Relationship | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Interaction of human organic anion transporter polypeptides 1B1 and 1B3 with antineoplastic compounds.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line; Humans; Liver-Specific Organic Anion Transporter 1; Molecular Structure; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Peptides; Solute Carrier Organic Anion Transporter Family Member 1B3 | 2015 |
Synthesis and antitumor activity of a novel series of 6-substituted pyrrolo[2,3-d]pyrimidines as potential nonclassical antifolates targeting both thymidylate and purine nucleotide biosynthesis.
Topics: Antineoplastic Agents; Cell Culture Techniques; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Folic Acid Antagonists; Humans; Molecular Docking Simulation; Molecular Structure; Purine Nucleotides; Pyrimidines; Pyrroles; Structure-Activity Relationship; Thymidylate Synthase | 2015 |
Novel 6-substituted benzoyl and non-benzoyl straight chain pyrrolo[2,3-d]pyrimidines as potential antitumor agents with multitargeted inhibition of TS, GARFTase and AICARFTase.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Models, Molecular; Molecular Structure; Phosphoribosylaminoimidazolecarboxamide Formyltransferase; Phosphoribosylglycinamide Formyltransferase; Pyrimidines; Pyrroles; Structure-Activity Relationship; Thymidylate Synthase | 2017 |
Comparative study of early effects of epipodophyllotoxin derivatives and other cytostatic agents on mastocytoma cultures.
Topics: Antineoplastic Agents; Bleomycin; Cell Division; Cell Line; Colchicine; Cytarabine; DNA, Neoplasm; Etoposide; Mast-Cell Sarcoma; Mechlorethamine; Mercaptopurine; Methotrexate; Mitosis; Neoplasm Proteins; Neoplasms, Experimental; Podophyllotoxin; Razoxane; RNA, Neoplasm; Teniposide; Vincristine; X-Rays | 1977 |
Intensive induction therapy for small cell carcinoma of the lung.
Topics: Aged; Antineoplastic Agents; Bone Marrow; Carcinoma, Small Cell; Carmustine; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Procarbazine; Remission, Spontaneous; Vincristine | 1979 |
[VP 16-213 in combination with endoxan, methotrexate and oncovin as polychemotherapy for bronchogenic carcinoma].
Topics: Adenocarcinoma; Anaplasia; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Etoposide; Humans; Lung Neoplasms; Methotrexate; Neoplasm Metastasis; Podophyllotoxin; Remission, Spontaneous; Vincristine | 1977 |
Combination chemotherapy with 4'Demethylepipodophyllotoxin 9-(4,6-0-ethylidene-beta-D-glucopyranoside), VP 16-213 (NSC 141540) in L1210 leukemia.
Topics: Animals; Antineoplastic Agents; Carmustine; Cyclophosphamide; Cytarabine; Dactinomycin; Daunorubicin; Drug Therapy, Combination; Etoposide; Female; Fluorouracil; Leukemia L1210; Male; Mercaptopurine; Methotrexate; Mice; Mice, Inbred DBA; Podophyllotoxin; Vincristine | 1976 |
Chemotherapy with MACOP-B and VACOP-B for intermediate- and high-grade non-Hodgkin's lymphoma: clinical results and analysis of prognostic factors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prednisolone; Prednisone; Prognosis; Retrospective Studies; Vincristine | 1992 |
[Primary non-Hodgkin's lymphoma of paranasal sinuses. Review of the literature and a case report].
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Ethmoid Sinus; Etoposide; Female; Frontal Sinus; Humans; Lymphoma, Non-Hodgkin; Maxillary Sinus Neoplasms; Methotrexate; Paranasal Sinus Neoplasms; Prednisone; Vincristine | 1992 |
Tryptophan and serotonin metabolism in familial erythrophagocytic lymphohistiocytosis.
Topics: Aging; Amino Acids; Biopterins; Child, Preschool; Etoposide; Histiocytosis, Non-Langerhans-Cell; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Infant; Male; Methotrexate; Neopterin; Prednisolone; Serotonin; Tryptophan | 1992 |
A pilot study of intensive weekly chemotherapy for extensive disease small-cell lung carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Leucovorin; Lung Neoplasms; Methotrexate; Neoplasm Metastasis; Pilot Projects; Recurrence; Treatment Outcome; Vincristine | 1992 |
Potentiation of etoposide cytotoxicity against a human ovarian cancer cell line by pretreatment with non-toxic concentrations of methotrexate or aphidicolin.
Topics: Aphidicolin; Cell Survival; DNA Topoisomerases, Type I; DNA, Neoplasm; Drug Synergism; Etoposide; Female; Humans; Methotrexate; Mitosis; Ovarian Neoplasms; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1992 |
[High dose chemotherapy with autologous bone marrow rescue for small cell lung cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow Transplantation; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Transplantation, Autologous; Vincristine | 1992 |
Metastatic choriocarcinoma with coexistent term pregnancy following four recurrent consecutive moles.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole; Lung Neoplasms; Methotrexate; Platinum; Pregnancy; Pregnancy Complications, Neoplastic; Uterine Neoplasms | 1992 |
[Magnetic resonance tomography in follow-up of hydatidiform mole].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Magnetic Resonance Imaging; Methotrexate; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms; Uterus | 1992 |
[The treatment of small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cyclophosphamide; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Prospective Studies; Survival Rate; Vincristine | 1992 |
Alternating non-cross-resistant chemotherapy for non-Hodgkin's lymphoma of intermediate-grade and high-grade malignancy. A pilot study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Resistance; Etoposide; Female; Humans; Ifosfamide; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Pilot Projects; Prednisolone | 1992 |
[Experimental study of CF chemotherapy, combined with another one chemotherapeutic drug against head and neck cancer cell lines].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Fluorouracil; Head and Neck Neoplasms; Humans; Methotrexate; Peplomycin; Tumor Cells, Cultured; Vincristine | 1992 |
Effect of combination chemotherapy with cefoperazone on non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cefoperazone; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Prednisone; Remission Induction; Vincristine | 1992 |
Malignant ovarian germ cell tumors: the experience at the Hospital de la Santa Creu i Sant Pau.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Dysgerminoma; Etoposide; Female; Follow-Up Studies; Humans; Menstruation; Methotrexate; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Ovary; Reproduction; Retrospective Studies; Uterus; Vinblastine; Vincristine | 1992 |
Obstructing endobronchial bands complicating radiation therapy for lung carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bronchi; Bronchoscopy; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Fibrosis; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Prednisone; Radiotherapy; Radiotherapy Dosage; Vincristine | 1992 |
[Recent progress in the chemotherapy program and its theoretical background--malignant lymphoma].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Lymphoma; Methotrexate; Prednisolone; Survival Rate; Vincristine | 1992 |
[Treatment of elderly patients with hematological malignancies].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Hodgkin Disease; Humans; Leucovorin; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Methotrexate; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Vincristine | 1992 |
Successful treatment of a primary endodermal sinus tumor of the liver.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Hepatectomy; Humans; Liver Neoplasms; Mesonephroma; Methotrexate; Vincristine | 1992 |
Etoposide, ifosfamide, and methotrexate combination chemotherapy for aggressive non-Hodgkin's lymphomas after failure of the LNH 84 regimen.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Salvage Therapy; Vindesine | 1992 |
Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML Study 8498.
Topics: Acute Disease; Adolescent; Adult; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Azacitidine; Child; Chromosome Aberrations; Chromosome Disorders; Cytarabine; Daunorubicin; Down Syndrome; Etoposide; Female; Follow-Up Studies; Humans; Leukemia, Myeloid; Male; Mercaptopurine; Methotrexate; Prednisone; Remission Induction; Thioguanine; Vincristine | 1992 |
[Salvage therapy for recurrent or refractory non-Hodgkin's lymphoma with etoposide, methotrexate, vindesine and prednisolone (EMVP)].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Recurrence; Salvage Therapy; Survival Rate; Vindesine | 1992 |
Etoposide, doxorubicin, and cisplatin chemotherapy for advanced gastric cancer: an old lesson revisited.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Fluorouracil; Humans; Methotrexate; Stomach Neoplasms; Survival Analysis | 1992 |
[MEC treatment (methotrexate, etoposide, cisplatin) for urothelial cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Kidney Neoplasms; Male; Methotrexate; Middle Aged; Urinary Bladder Neoplasms | 1992 |
[Treatment of primary therapy refractory choriocarcinoma using the EMA-CO protocol].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Follow-Up Studies; Humans; Hysterectomy, Vaginal; Kidney Neoplasms; Methotrexate; Nephrectomy; Pregnancy; Uterine Neoplasms; Vincristine | 1992 |
[Characterization of two novel cell lines established from a single human uterine cervical adenocarcinoma, and their chemosensitivities and hormonal effects on their proliferation].
Topics: Adenocarcinoma; Animals; Carbazilquinone; Cell Division; Drug Screening Assays, Antitumor; Estradiol; Etoposide; Female; Humans; Methotrexate; Mice; Mitomycin; Neoplasm Transplantation; Progesterone; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 1992 |
Treatment for B-cell-type lymphoma in a girl associated with Bloom's syndrome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bloom Syndrome; Child; Chromosome Aberrations; Cyclophosphamide; Doxorubicin; Etoposide; Female; Genetic Predisposition to Disease; Humans; Hydrocortisone; Lymphoma, B-Cell; Methotrexate; Pharyngeal Neoplasms; Prednisolone; Prognosis; Remission Induction | 1992 |
[Combined treatment of invasive bladder cancer by intra-arterial infusion chemotherapy of cisplatin with or without other anticancer agents and concurrent radiotherapy--initial response and side effects].
Topics: Aged; Aged, 80 and over; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Humans; Iliac Artery; Infusions, Intravenous; Japan; Male; Methotrexate; Middle Aged; Retrospective Studies; Urinary Bladder Neoplasms | 1992 |
Effect of etoposide, carmustine, vincristine, 5-fluorouracil, or methotrexate on radiobiologically oxic and hypoxic cells in a C3H mouse mammary carcinoma in situ.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma in Situ; Carmustine; Cell Division; Cell Hypoxia; Combined Modality Therapy; Etoposide; Female; Fluorouracil; Male; Mammary Neoplasms, Experimental; Methotrexate; Mice; Mice, Inbred C3H; Vincristine | 1992 |
Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Combined Modality Therapy; Craniotomy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hysterectomy; Methotrexate; Pregnancy; Survival Rate; Thoracotomy; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1991 |
Lack of cross-resistance to fostriecin in a human small-cell lung carcinoma cell line showing topoisomerase II-related drug resistance.
Topics: Alkenes; Antibiotics, Antineoplastic; Carcinoma, Small Cell; Cell Line; Cell Nucleus; DNA Topoisomerases, Type II; Drug Resistance; Drug Screening Assays, Antitumor; Etoposide; Humans; Lung Neoplasms; Methotrexate; Polyenes; Pyrones; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1991 |
[Clinical application of enzyme inhibitors--hematologic malignancies].
Topics: Cytarabine; Deoxycytidine; DNA Topoisomerases, Type I; Etoposide; Gemcitabine; Humans; Leukemia; Mercaptopurine; Methotrexate; Purines; Pyrimidines; Thioguanine; Topoisomerase I Inhibitors | 1991 |
[Alternating chemotherapeutic treatment in patients with localized undifferentiated small-cell carcinoma of the lung].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lomustine; Lung Neoplasms; Methotrexate; Procarbazine; Remission Induction; Time Factors; Vincristine | 1991 |
Salvage chemotherapy with CCNU and methotrexate for small cell lung cancer resistant to CAV/PE alternating chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Resistance; Etoposide; Female; Humans; Leukopenia; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Remission Induction; Salvage Therapy; Vincristine | 1991 |
A human leukemia cell line made resistant to two folate analogues, trimetrexate and N10-propargyl-5,8-dideazafolic acid (CB3717).
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Division; Cell Line; Cisplatin; Cross Reactions; Dactinomycin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Etoposide; Fluorouracil; Folic Acid; Humans; Leucovorin; Membrane Glycoproteins; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Quinazolines; RNA, Messenger; Thymidylate Synthase; Trimetrexate; Vincristine | 1991 |
Treatment of bladder carcinoma using a germ cell chemotherapy protocol.
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Carcinoembryonic Antigen; Carcinoma, Transitional Cell; Chorionic Gonadotropin; Cisplatin; Etoposide; Humans; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Urinary Bladder Neoplasms; Vincristine | 1990 |
Postoperative chemotherapy for primary intracranial germ cell tumor.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Child; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Leucovorin; Male; Methotrexate; Neoplasms, Germ Cell and Embryonal; Postoperative Period; Vincristine | 1990 |
Respiratory failure due to choriocarcinoma: a study of 103 dyspneic patients.
Topics: Adult; Anemia; Blood Gas Analysis; Choriocarcinoma; Cyanosis; Dactinomycin; Drug Therapy, Combination; Dyspnea; Etoposide; Extracorporeal Membrane Oxygenation; Female; Humans; Hypertension, Pulmonary; Lung; Lung Neoplasms; Methotrexate; Pregnancy; Radiography; Respiratory Insufficiency; Risk Factors; Tachycardia; Uterine Neoplasms | 1990 |
Angiotropic (intravascular) large cell lymphoma. A clinicopathologic study of seven cases with unique clinical presentations.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Immunohistochemistry; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Vincristine | 1990 |
Pneumothorax following cytotoxic chemotherapy in malignant lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dacarbazine; Doxorubicin; Etoposide; Humans; Lung; Lung Neoplasms; Lymphoma; Male; Methotrexate; Middle Aged; Pneumothorax; Prednisone; Procarbazine; Radiography; Vinblastine; Vincristine | 1990 |
A brief-duration combination chemotherapy for elderly patients with poor-prognosis non-Hodgkin's lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Staging; Prednisone; Prognosis; Remission Induction; Survival Rate | 1991 |
Cytoreductive surgery in disseminated non-seminomatous germ cell tumours of testis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Teratoma; Testicular Neoplasms; Vincristine | 1991 |
A clinical phase II study of ProMACE-CytaBOM.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Evaluation; Etoposide; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Vincristine | 1991 |
Placental site trophoblastic tumor in a postmenopausal woman.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Menopause; Methotrexate; Middle Aged; Neoplasms; Placenta Diseases; Pregnancy; Trophoblastic Neoplasms | 1991 |
Effective treatment of small-noncleaved-cell lymphoma with high-intensity, brief-duration chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hematologic Diseases; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Survival Rate; Vincristine | 1991 |
MACOP-B and VACOP-B in diffuse large cell lymphomas and MOPP/ABV in Hodgkin's disease.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Female; Hodgkin Disease; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Male; Mechlorethamine; Methotrexate; Middle Aged; Mouth Mucosa; Prednisone; Procarbazine; Prognosis; Remission Induction; Stomatitis; Survival Rate; Vinblastine; Vincristine | 1991 |
Etoposide, ifosfamide, and methotrexate with or without bleomycin in refractory or recurrent lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Drug Evaluation; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Ifosfamide; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Remission Induction; Survival Rate | 1991 |
Results of treatment with high intensity, brief duration chemotherapy in poor prognosis non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; L-Lactate Dehydrogenase; Leucovorin; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; Vincristine | 1991 |
Intensive weekly combination chemotherapy for patients with intermediate-grade and high-grade non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Central Nervous System Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Survival Analysis; Vincristine | 1991 |
Prolonged disease-free survival after high-dose sequential chemo-radiotherapy and haemopoietic autologous transplantation in poor prognosis Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Male; Melphalan; Methotrexate; Prognosis; Recombinant Proteins; Remission Induction; Survival Rate; Transplantation, Autologous; Vincristine; Whole-Body Irradiation | 1991 |
Applications of gallium-67 scintigraphy in the management of patients with malignant lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Citrates; Citric Acid; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Gallium Radioisotopes; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Prednisone; Radionuclide Imaging; Vincristine | 1991 |
Enhancement of etoposide and methotrexate sensitivity by indomethacin in vitro.
Topics: Animals; Bleomycin; Drug Synergism; Etoposide; Humans; Indomethacin; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lipoxygenase Inhibitors; Lung Neoplasms; Lymphoma; Methotrexate; Neoplasms, Experimental; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prostaglandins; Protein Kinase Inhibitors; Tumor Cells, Cultured | 1991 |
Childhood Ki-1 lymphoma: presentation as a buttock mass.
Topics: Aneuploidy; Antigens, CD; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Buttocks; Child; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Gene Rearrangement, T-Lymphocyte; Humans; Ki-1 Antigen; Lymphatic Metastasis; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Prednisone; Remission Induction; Soft Tissue Neoplasms; T-Lymphocytes, Helper-Inducer; Vincristine | 1991 |
Improvement in survival from choriocarcinoma in Harare.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cause of Death; Choriocarcinoma; Dactinomycin; Etoposide; Female; Hospitals, Urban; Humans; Leucovorin; Methotrexate; Pregnancy; Prospective Studies; Retrospective Studies; Survival Analysis; Uterine Neoplasms; Zimbabwe | 1991 |
[Malignant lymphomas. Preliminary report of the National Protocol of Antineoplastic Drugs].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoguazone; Neoplasm Staging; Prednisone; Procarbazine; Vincristine | 1991 |
Unexpected acute neurologic toxicity in the treatment of children with acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cytarabine; Etoposide; Female; Humans; Infant; Leucovorin; Male; Methotrexate; Nervous System Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1992 |
[European School of Oncology (ESO)--gastric cancer treatment strategy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Fluorouracil; Humans; Methotrexate; Prognosis; Stomach Neoplasms | 1992 |
Normal pregnancy after curative multiagent chemotherapy for choriocarcinoma with brain metastases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Cisplatin; Dactinomycin; Etoposide; Female; Humans; Lung Neoplasms; Methotrexate; Pregnancy; Pregnancy Complications, Neoplastic; Primary Ovarian Insufficiency; Uterine Neoplasms | 1991 |
[The activity of etoposide (VP16) in combination chemotherapy against human bladder cancer cells in vitro].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Etoposide; Humans; Methotrexate; Tumor Cells, Cultured; Tumor Stem Cell Assay; Urinary Bladder Neoplasms; Vinblastine | 1991 |
Recurrent disseminated retinoblastoma treated by high-dose chemotherapy, total body irradiation, and autologous bone marrow rescue.
Topics: Antibodies, Monoclonal; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Bone Marrow Purging; Bone Marrow Transplantation; Bone Neoplasms; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Eye Enucleation; Eye Neoplasms; Female; Gangliosides; Humans; Mandibular Neoplasms; Methotrexate; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Remission Induction; Retinoblastoma; Transplantation, Autologous; Vincristine; Whole-Body Irradiation | 1991 |
Small-cell lung cancer in elderly patients: the case for chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Prednisone; Retrospective Studies; Survival Rate; Vincristine | 1991 |
[Intensification chemotherapy followed by allogenieic and autologous bone marrow transplantation in acute non-lymphoblastic leukemia in children].
Topics: Adolescent; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Daunorubicin; Etoposide; Evaluation Studies as Topic; Female; Humans; Infant; Leukemia, Myeloid, Acute; Life Tables; Male; Methotrexate; Mitoxantrone; Remission Induction; Survival Rate; Thioguanine; Transplantation, Autologous; Transplantation, Homologous | 1991 |
Neoadjuvant chemotherapy for nonmetastatic osteosarcoma of the extremities.
Topics: Adolescent; Adult; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Lengthening; Bone Neoplasms; Bone Transplantation; Child; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Italy; Male; Methotrexate; Osteosarcoma; Osteotomy; Postoperative Care; Preoperative Care; Prognosis; Prostheses and Implants; Survival Rate | 1991 |
Lactobacillus septicemia, an unusual complication during the treatment of metastatic choriocarcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Lactobacillus acidophilus; Methotrexate; Ovarian Neoplasms; Pregnancy; Sepsis; Uterine Neoplasms; Uterus; Vagina; Vincristine | 1991 |
Experience with salvage regimens at M.D. Anderson Hospital.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Drug Evaluation; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lymphoma; Lymphoma, Non-Hodgkin; Mesna; Methotrexate; Methylprednisolone; Methylprednisolone Hemisuccinate; Mitoguazone; Mitoxantrone; Remission Induction; Survival Rate | 1991 |
Massively bleeding gastrosplenic fistula following cytostatic chemotherapy of a malignant lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Fistula; Gastric Fistula; Gastrointestinal Hemorrhage; Humans; Ifosfamide; Lymphoma; Male; Methotrexate; Splenic Diseases; Stomach Neoplasms | 1991 |
[Combination chemotherapy of methotrexate, etoposide, adriamycin and cisplatin (M-EAP) for advanced urothelial cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Male; Methotrexate; Middle Aged; Prognosis; Ureteral Neoplasms; Urinary Bladder Neoplasms | 1991 |
Weekly etoposide, methotrexate and actinomycin D, alternating with cyclophosphamide plus vincristine (EMA/CO): a phase II study in advanced gastric carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Drug Evaluation; Etoposide; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Staging; Remission Induction; Stomach Neoplasms; Vincristine | 1991 |
Granulocytic sarcoma or large cell lymphoma?
Topics: Biopsy; Child, Preschool; Cyclophosphamide; Daunorubicin; Diagnosis, Differential; Etoposide; Female; Humans; Leukemia, Myeloid; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Methotrexate; Thiotepa; Vincristine | 1991 |
Radiation induction of drug resistance in RIF-1: correlation of tumor and cell culture results.
Topics: Animals; Dose-Response Relationship, Radiation; Doxorubicin; Drug Resistance; Etoposide; Fluorouracil; Methotrexate; Mice; Tumor Cells, Cultured | 1991 |
Salvage therapy with PROMACE in relapsed non-Hodgkin malignant lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone | 1991 |
Familial hemophagocytic lymphohistiocytosis. Clinical review based on the findings in seven children.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Child, Preschool; Combined Modality Therapy; Etoposide; Exchange Transfusion, Whole Blood; Female; Glucocorticoids; Histiocytosis, Non-Langerhans-Cell; Humans; Immunization, Passive; Infant; Male; Methotrexate; Plasmapheresis; Spleen; Teniposide | 1991 |
Cisplatin combination chemotherapy for elderly patients with urothelial tumours.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lomustine; Male; Methotrexate; Urologic Neoplasms; Vinblastine | 1991 |
[In vitro combined effects of pirarubicin (THP) and various antitumor drugs on human tumor cell lines].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Female; Humans; Leukemia, Myeloid; Methotrexate; Mitomycin; Mitomycins; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 1990 |
Effective salvage chemotherapy with etoposide, dactinomycin, and methotrexate in refractory germ cell cancer. Australasian Germ Cell Trial Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dactinomycin; Drug Evaluation; Etoposide; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Remission Induction; Stomatitis; Testicular Neoplasms; Time Factors | 1990 |
Increase in topoisomerase-II-mediated DNA breaks and cytotoxicity of VP16 in human U937 lymphoma cells pretreated with low doses of methotrexate.
Topics: Blotting, Western; Cell Line; DNA; DNA Damage; DNA, Neoplasm; DNA, Single-Stranded; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Electrophoresis, Polyacrylamide Gel; Etoposide; Flow Cytometry; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Time Factors; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1990 |
Large cell carcinoma of the lung secreting human chorionic gonadotropin which responded to combination chemotherapy: case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chorionic Gonadotropin; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Humans; Lung Neoplasms; Male; Methotrexate | 1990 |
[Acute coronary thrombosis and myocardial ischemia following chemotherapy of Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Coronary Disease; Coronary Thrombosis; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Male; Methotrexate; Myocardial Infarction; Neoplasm Recurrence, Local | 1990 |
Flowcytometric analysis of DNA pattern of cells derived from xeroderma pigmentosum A--hypersensitivity to vincristine, etoposide and methotrexate.
Topics: Cell Line; DNA Repair; Etoposide; Flow Cytometry; Humans; Methotrexate; Vincristine; Xeroderma Pigmentosum | 1990 |
[Plasma methotrexate concentrations in urothelial cancer chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Kidney Neoplasms; Kidney Pelvis; Male; Methotrexate; Middle Aged; Urinary Bladder Neoplasms | 1990 |
Successful treatment of acute leukemia with t(4;11) in an infant with congenital hypothyroidism.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Differentiation; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 4; Congenital Hypothyroidism; Cranial Irradiation; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Hypothyroidism; Infant; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Translocation, Genetic; Vincristine | 1990 |
[Effect of 2 different forms of chemotherapy on remission in patients with advanced ovarian cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lomustine; Methotrexate; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Peptichemio; Survival Rate | 1990 |
[CEM chemotherapy (cisplatin, etoposide, methotrexate) for advanced urothelial cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Male; Methotrexate; Middle Aged; Urogenital Neoplasms | 1990 |
Erythema nodosum and non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Erythema Nodosum; Etoposide; Female; Humans; Intestinal Obstruction; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Periarthritis; Prednisone | 1990 |
Subrenal capsule assay as a test to predict the effectiveness of chemotherapy in choriocarcinoma.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cisplatin; Cyclophosphamide; Dactinomycin; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Lung Neoplasms; Methotrexate; Mice; Mice, Nude; Subrenal Capsule Assay; Vincristine | 1990 |
Methyl-GAG, ifosfamide, methotrexate and etoposide (MIME) as salvage therapy for Hodgkin's disease and non-Hodgkin's lymphoma. The Swedish Lymphoma Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoguazone; Recurrence; Remission Induction; Retrospective Studies | 1990 |
Central nervous system involvement in the erythrophagocytic disorders of infancy: the role of cerebrospinal fluid neopterins in their differential diagnosis and clinical management.
Topics: Biopterins; Central Nervous System Diseases; Diagnosis, Differential; Drug Therapy, Combination; Etoposide; Histiocytosis, Non-Langerhans-Cell; Humans; Infant; Infant, Newborn; Macrophage Activation; Methotrexate; Neopterin; Prednisolone; Virus Diseases | 1990 |
Antibacterial activities of antineoplastic agents.
Topics: Antineoplastic Agents; Bacteria; Bleomycin; Doxorubicin; Etoposide; Fluorouracil; Methotrexate; Microbial Sensitivity Tests; Mitomycin; Mitomycins | 1985 |
Successful management of metastatic and primary germ cell tumors in the brain.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Child; Cisplatin; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Tomography, X-Ray Computed; Vincristine | 1986 |
Etoposide, methotrexate, and bleomycin in drug-resistant gestational trophoblastic disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Etoposide; Female; Humans; Methotrexate; Middle Aged; Ovarian Neoplasms; Pregnancy; Trophoblastic Neoplasms | 1986 |
Current optimum management of anaplastic germ cell tumours of the testis and other sites.
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Humans; Male; Methotrexate; Neoplasms, Germ Cell and Embryonal; Prognosis; Testicular Neoplasms; Vincristine | 1986 |
Hematologic malignancies: non-Hodgkin's lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Leucovorin; Lymphoma; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Vinblastine; Vincristine | 1986 |
Fertility after chemotherapy for ovarian germ cell tumours.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Female; Fertility; Humans; Menstruation; Methotrexate; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Ovary; Vincristine | 1987 |
Fertility after chemotherapy for male and female germ cell tumours.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Female; Fertility; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Menstruation; Methotrexate; Middle Aged; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Spermatogenesis; Testicular Neoplasms; Vincristine | 1987 |
Is ectopic production of human chorionic gonadotrophin (hCG) or alpha fetoprotein (AFP) by tumours a marker of chemosensitivity?
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin; Cisplatin; Dactinomycin; Doxorubicin; Etoposide; Hormones, Ectopic; Humans; Leucovorin; Methotrexate; Neoplasms; Vincristine | 1986 |
The role of chemotherapy for epidemic Kaposi's sarcoma.
Topics: Acquired Immunodeficiency Syndrome; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Etoposide; Humans; Methotrexate; Sarcoma, Kaposi; Vinblastine; Vincristine | 1987 |
Retrospective analysis of stage I and II indolent lymphomas at the National Cancer Institute.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Prognosis; Radiotherapy, High-Energy; Retrospective Studies; Vincristine | 1988 |
Chemotherapy-resistant gestational trophoblastic neoplasia treated successfully with cisplatin, etoposide, and bleomycin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cisplatin; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Middle Aged; Pneumonia; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms | 1988 |
Response-oriented therapy with CHOP and VIM-Bleo in high-grade malignant non-Hodgkin's lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Remission Induction; Vincristine | 1988 |
Southwest Oncology Group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Evaluation; Etoposide; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Vincristine | 1988 |
Chemotherapy for poor risk germ cell tumours. An independent evaluation of the POMB/ACE regime.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Cytarabine; Dactinomycin; Dysgerminoma; Etoposide; Humans; Male; Methotrexate; Neoplasms, Germ Cell and Embryonal; Teratoma; Testicular Neoplasms; Vincristine | 1988 |
Long-term outcome in patients with germ cell tumours treated with POMB/ACE chemotherapy: comparison of commonly used classification systems of good and poor prognosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Humans; Male; Methotrexate; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Vincristine | 1989 |
The effect of intensity of administered treatment on the outcome of germ cell tumours treated with POMB/ACE chemotherapy.
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Chorionic Gonadotropin; Cyclophosphamide; Cytarabine; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Humans; Methotrexate; Neoplasms, Germ Cell and Embryonal; Vincristine | 1989 |
[Chemotherapy of carcinoma of the prostate and testis: experimental study in vivo and in vitro].
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Line; Cisplatin; Cytarabine; Etoposide; Fluorouracil; Male; Methotrexate; Mice; Mice, Nude; Neoplasm Transplantation; Peplomycin; Prostatic Neoplasms; Testicular Neoplasms; Tumor Cells, Cultured; Tumor Stem Cell Assay; Vinblastine; Vincristine | 1988 |
Gall bladder perforation in response to chemotherapy in a patient with a histiocytic lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Ascites; Bile; Bleomycin; Chylous Ascites; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Gallbladder Diseases; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Prednisone; Vincristine | 1988 |
[Clinical evaluation of chemotherapy in urologic cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Staging; Penile Neoplasms; Prognosis; Remission Induction; Testicular Neoplasms; Urinary Bladder Neoplasms; Urogenital Neoplasms; Vinblastine | 1989 |
Treatment of disseminated germ cell tumours of the testis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Humans; Leukocyte Count; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis; Testicular Neoplasms; Testis; Vinblastine; Vincristine | 1989 |
VP-16, ifosfamide, and methotrexate combination chemotherapy for aggressive non-Hodgkin's lymphomas after failure of the LNH 84 regimen.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Prednisolone; Remission Induction; Vindesine | 1989 |
In vitro chemosensitivity of four new carcinoma of the cervix cell lines: relationship to radiosensitivity.
Topics: Antineoplastic Agents; Bleomycin; Cell Line; Cisplatin; Drug Tolerance; Etoposide; Female; Humans; Methotrexate; Radiation Tolerance; Tumor Cells, Cultured; Tumor Stem Cell Assay; Uterine Cervical Neoplasms | 1989 |
[Salvage chemotherapy with a combination of VP-16, ifosfamide, procarbazine, prednisolone, bleomycin and methotrexate (VIPP-BM) for refractory malignant lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Etoposide; Female; Humans; Ifosfamide; Lymphoma; Male; Methotrexate; Middle Aged; Prednisolone; Procarbazine | 1989 |
Sequential combination chemotherapy (CABOPP/VIM) for the treatment of high-grade malignant non-Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Vincristine | 1989 |
Advanced mycosis fungoides: chemotherapy with etoposide, methotrexate, bleomycin, and prednimustine.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Etoposide; Female; Humans; Male; Methotrexate; Middle Aged; Mycosis Fungoides; Prednimustine; Skin Neoplasms | 1989 |
Novel approaches to intraperitoneal drug delivery.
Topics: Antineoplastic Agents; Dipyridamole; Dose-Response Relationship, Drug; Drug Evaluation; Drug Synergism; Etoposide; Female; Humans; Infusion Pumps; Infusions, Parenteral; Long-Term Care; Methotrexate; Ovarian Neoplasms; Peritoneal Neoplasms; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1989 |
Overexpression of DNA replication and repair enzymes in cisplatin-resistant human colon carcinoma HCT8 cells and circumvention by azidothymidine.
Topics: Cell Line; Cisplatin; Colonic Neoplasms; DNA Polymerase I; DNA Polymerase II; DNA Repair; DNA Replication; Drug Resistance; Etoposide; Floxuridine; Fluorouracil; Humans; Methotrexate; Tetrahydrofolate Dehydrogenase; Thymidine Kinase; Thymidylate Synthase; Tumor Cells, Cultured; Zidovudine | 1989 |
Evaluation of management of gestational trophoblastic tumor in National Taiwan University Hospital.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Leucovorin; Leukopenia; Liver; Mercaptopurine; Methotrexate; Middle Aged; Pregnancy; Pregnancy Complications, Neoplastic; Prognosis; Remission Induction; Risk Factors; Taiwan; Trophoblastic Neoplasms; Uterine Neoplasms | 1989 |
Successful salvage therapy of resistant gestational trophoblastic disease with etoposide, methotrexate, dactinomycin, vincristine, and cyclophosphamide.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1989 |
Systemic therapy for small-cell lung cancer: old themes replayed, new ones awaited.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lomustine; Lung Neoplasms; Methotrexate; Mitomycin; Mitomycins | 1989 |
Treatment of small cell lung cancer by eight weeks chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Leucovorin; Lung Neoplasms; Methotrexate; Middle Aged; Time Factors; Vincristine | 1989 |
ProMACE-MOPP combination chemotherapy for diffuse lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Vincristine | 1985 |
VP-16 in combinations for first-line treatment of malignant germ-cell tumors and gestational choriocarcinoma.
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Choriocarcinoma; Chorionic Gonadotropin; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Female; Humans; Male; Methotrexate; Neoplasms, Germ Cell and Embryonal; Podophyllotoxin; Pregnancy; Uterine Neoplasms; Vincristine | 1985 |
Chemotherapy for non-seminomatous germ-cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Cisplatin; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Humans; Male; Methotrexate; Teratoma; Testicular Neoplasms; Vinblastine; Vincristine | 1985 |
Familial hemophagocytic lymphohistiocytosis: therapy in the German experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Infant; Infant, Newborn; Male; Mercaptopurine; Methotrexate; Prednisone; Recurrence | 1989 |
Treatment of familial lymphohistiocytosis: chemotherapy or bone marrow transplant?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Etoposide; Histiocytosis, Non-Langerhans-Cell; Humans; Infant; Methotrexate | 1989 |
[Transplantation of bone marrow from unrelated donors in chronic myeloid leukemia].
Topics: Bone Marrow Transplantation; Chronic Disease; Cyclophosphamide; Cyclosporins; Drug Therapy, Combination; Etoposide; Graft vs Host Reaction; HLA Antigens; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methotrexate; Tissue Donors; Whole-Body Irradiation | 1989 |
[Successful conservative treatment of cervical pregnancy].
Topics: Adult; Cervix Uteri; Drug Therapy, Combination; Etoposide; Female; Humans; Methotrexate; Pregnancy; Pregnancy, Ectopic; Ultrasonography | 1989 |
Treatment of choroidal metastasis from choriocarcinoma. Case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Choroid Neoplasms; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Pregnancy; Remission Induction; Retinal Hemorrhage; Uterine Neoplasms; Vincristine | 1989 |
Advanced gastric cancer: a new combined surgical and oncological approach.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Gastrectomy; Humans; Male; Methotrexate; Middle Aged; Reoperation; Stomach Neoplasms | 1989 |
EMOP/CA chemotherapy for the treatment of aggressive non-Hodgkin's lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisolone; Vincristine | 1989 |
Alternating six-drug combination chemotherapy induction for intermediate and high-grade non-Hodgkin's lymphoma.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisolone; Time Factors; Vincristine | 1989 |
Childhood non-Hodgkin's lymphoma in Egypt: preliminary results of treatment with a new ifosfamide-containing regimen.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Drug Evaluation; Egypt; Etoposide; Female; Humans; Ifosfamide; Infant; Lymphoma, Non-Hodgkin; Male; Methotrexate; Remission Induction; Time Factors; Vincristine | 1989 |
Treatment of localized aggressive lymphomas with combination chemotherapy followed by involved-field radiation therapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Leucovorin; Lymphoma; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Remission Induction; Vincristine | 1989 |
[Chemotherapy of high-risk trophoblastic neoplasia].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Pregnancy; Prognosis; Risk; Trophoblastic Neoplasms; Vincristine | 1987 |
Management of high-risk gestational trophoblastic disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Pregnancy; Risk Factors; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1987 |
[COMVp regimen in the treatment of small cell lung cancer--report of 106 patients].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Vincristine | 1987 |
Results of a combined chemo-radiotherapeutic program in 61 patients affected by small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Procarbazine; Radiography; Vincristine; Vomiting | 1988 |
Increase in etoposide-induced topoisomerase II-mediated DNA breaks after cell synchronization induced by low doses of methotrexate.
Topics: Cell Cycle; Cell Line; Cell Survival; DNA Damage; DNA Topoisomerases, Type II; Etoposide; Humans; In Vitro Techniques; Methotrexate | 1988 |
EMA/CO regimen in high-risk gestational trophoblastic tumor (GTT).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Hydroxyurea; Methotrexate; Middle Aged; Pregnancy; Pregnancy Complications, Neoplastic; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1988 |
Treatment of refractory and relapsed non-Hodgkin's lymphoma with ifosfamide, methotrexate and etoposide.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Time Factors | 1989 |
Intensive alternating chemotherapy regimen in small cell carcinoma of the lung.
Topics: Actuarial Analysis; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Brain Neoplasms; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Gastrointestinal Hemorrhage; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Thrombocytopenia; Vincristine | 1985 |
Relationship between myelosuppression and chemotherapeutic response in small cell bronchogenic carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Humans; Leucovorin; Lung Neoplasms; Methotrexate; Vincristine | 1985 |
Three months' treatment with cyclophosphamide, VP-16-213 followed by methotrexate and thoracic radiotherapy for small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Humans; Leukopenia; Lung Neoplasms; Male; Methotrexate; Middle Aged | 1985 |
Intensive induction treatment of small cell bronchogenic carcinoma with cyclophosphamide, methotrexate, and etoposide.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyclophosphamide; Etoposide; Female; Humans; Leukocyte Count; Lung Neoplasms; Male; Methotrexate; Middle Aged; Platelet Count | 1985 |
Three months treatment with chemotherapy and radiotherapy for small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged | 1985 |
Acute nonlymphocytic leukemia, preleukemia, and solid tumors following intensive chemotherapy of small cell carcinoma of the lung.
Topics: Acute Disease; Carcinoma, Small Cell; Chromosome Aberrations; Chromosome Disorders; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Leukemia; Lomustine; Lung Neoplasms; Male; Methotrexate; Preleukemia; Risk; Vincristine | 1985 |
Hepatic metastases in gestational trophoblastic disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Follow-Up Studies; Humans; Leukopenia; Liver Neoplasms; Methotrexate; Middle Aged; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms | 1986 |
Developments in chemotherapy for medium- and high-risk patients with gestational trophoblastic tumours (1979-1984).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Pregnancy; Prognosis; Risk; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1986 |
Cyclic alternating chemotherapy for small cell carcinoma of the lung.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Mitomycins; Nausea; Prospective Studies; Vincristine; Vomiting | 1985 |
Invasive mole.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole, Invasive; Hysterectomy; Leucovorin; Methotrexate; Pregnancy; Uterine Neoplasms; Vincristine | 1986 |
Short duration combination chemotherapy in the treatment of small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Vincristine | 1986 |
Long-term effects of intravenous hyperalimentation administered during intensive chemotherapy for small cell bronchogenic carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Hypersensitivity, Delayed; Ifosfamide; Lung Neoplasms; Male; Methotrexate; Middle Aged; Parenteral Nutrition, Total; Procarbazine; Prognosis; Vincristine | 1987 |
Chemotherapy for gestational trophoblastic tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Choriocarcinoma; Chorionic Gonadotropin; Cisplatin; Dactinomycin; Drug Administration Schedule; Drug Resistance; Etoposide; Female; Humans; Hydatidiform Mole; Luteinizing Hormone; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Complications, Neoplastic; Prognosis; Trophoblastic Neoplasms; Uterine Neoplasms | 1987 |
Targeting of neoglycoprotein-drug conjugates to cultured human embryonal carcinoma cells.
Topics: Antineoplastic Agents; Cell Line; Cell Survival; Cisplatin; Etoposide; Glycoproteins; Humans; Lectins; Leupeptins; Methotrexate; Pharmaceutical Vehicles; Receptors, Cell Surface; Teratoma | 1987 |
Improved local control of thoracic disease in small cell lung cancer with higher dose thoracic irradiation and cyclic chemotherapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Radiotherapy Dosage | 1987 |
Results of recent salvage chemotherapy regimens for lymphoma and Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Drug Evaluation; Etoposide; Humans; Ifosfamide; Lymphoma; Methotrexate; Methylprednisolone; Mitoguazone; Transplantation, Autologous | 1988 |
[Modification of hCG secretion by biological modulators of cell response and cytostatics in the normal placenta and choriocarcinoma cells].
Topics: Biological Factors; Choriocarcinoma; Chorionic Gonadotropin; Chorionic Villi; Cytokines; Etoposide; Female; Humans; Methotrexate; Pregnancy; Tumor Cells, Cultured; Uterine Neoplasms | 1988 |
Intraocular involvement of Burkitt's lymphoma in a Bedouin child.
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Burkitt Lymphoma; Carmustine; Child, Preschool; Cyclophosphamide; Cytarabine; Etoposide; Eye Neoplasms; Female; Humans; Hydrocortisone; Methotrexate; Vincristine; Vitreous Body | 1987 |
[Large doses of cytarabine, etoposide and methotrexate (CEM protocol) in the treatment of lymphoblastic leukemia in adults, resistant to conventional treatment, and of recurrences].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Humans; Leukemia, Lymphoid; Methotrexate; Middle Aged | 1988 |
Sequential multiagent chemotherapy incorporating cisplatin, doxorubicin, and cyclophosphamide in the treatment of metastatic breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Menopause; Methotrexate; Middle Aged; Neoplasm Metastasis; Receptors, Estrogen | 1988 |
Death from chemotherapy in gestational trophoblastic disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Cyclophosphamide; Etoposide; Female; Humans; Lung Neoplasms; Methotrexate; Necrosis; Pregnancy; Pulmonary Embolism; Uterine Neoplasms | 1988 |
[THP-COP, BHAC-VMP alternating chemotherapy in patients with non-Hodgkin's lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Prednisone; Remission Induction; Vincristine | 1988 |
[Results of combination chemotherapy in advanced urothelial cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Urologic Neoplasms | 1988 |
Ifosfamide and VP-16213 combination chemotherapy combined with ablative chemotherapy and autologous marrow transplantation as salvage treatment for malignant lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cytarabine; Etoposide; Humans; Ifosfamide; Lymphoma; Melphalan; Methotrexate; Middle Aged; Mitoguazone; Podophyllotoxin | 1988 |
Term pregnancy after three trophoblastic disease events.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole; Methotrexate; Neoplasms, Multiple Primary; Pregnancy; Uterine Neoplasms; Vincristine | 1988 |
Natural cytotoxicity impairment in familial haemophagocytic lymphohistiocytosis.
Topics: Antibody-Dependent Cell Cytotoxicity; Child, Preschool; Combined Modality Therapy; Cytotoxicity, Immunologic; Etoposide; Female; Humans; Infant; Killer Cells, Natural; Lymphatic Diseases; Lymphokines; Male; Methotrexate; Remission Induction; Steroids | 1988 |
[Basic and clinical study of anticancer effect of etoposide on choriocarcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Dactinomycin; Drug Evaluation; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Methotrexate; Pregnancy; Remission Induction; Tumor Cells, Cultured; Uterine Neoplasms | 1988 |
Treatment of resistant non-Hodgkin's lymphomas with cisplatin, etoposide, vindesine, methotrexate with leucovorin rescue. Greek Lymphoma Research Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Resistance; Etoposide; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Vindesine | 1987 |
Salvage treatment for Hodgkin's disease in relapse.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Methotrexate; Mitoguazone; Prognosis | 1987 |
MIME chemotherapy (methyl-GAG, ifosfamide, methotrexate, etoposide) as treatment for recurrent Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Hematologic Diseases; Hematuria; Hodgkin Disease; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Mitoguazone | 1987 |
Third-line chemotherapy for resistant Hodgkin's disease with lomustine, etoposide, and methotrexate.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Hodgkin Disease; Humans; Leukopenia; Lomustine; Male; Methotrexate; Middle Aged | 1987 |
[New combination chemotherapy against drug-resistant choriocarcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cells, Cultured; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Drug Evaluation, Preclinical; Etoposide; Female; Humans; Methotrexate; Pregnancy; Remission Induction; Risk; Uterine Neoplasms | 1987 |
Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study.
Topics: Adenocarcinoma; Aged; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Neoplasm Metastasis; Procarbazine; Progesterone; Prognosis; Serum Albumin; Vinblastine | 1986 |
Transient protection of cultured human cells against antitumor agents by 12-O-tetradecanoylphorbol-13-acetate.
Topics: Antineoplastic Agents; Cell Division; Cell Survival; Cells, Cultured; Diglycerides; Dose-Response Relationship, Drug; Etoposide; Humans; Methotrexate; Mitoxantrone; Nasopharyngeal Neoplasms; Tetradecanoylphorbol Acetate; Time Factors; Type C Phospholipases; Verapamil; Vincristine | 1987 |
Results of MIME salvage regimen for recurrent or refractory lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Resistance; Etoposide; Humans; Ifosfamide; Lymphoma; Methotrexate; Mitoguazone; Prognosis; Remission Induction | 1987 |
[Chemotherapy for advanced diffuse non-Hodgkin's lymphoma with non-cross-resistant alternating AVCP/EMLP regimens].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Remission Induction; Vincristine | 1986 |
Treatment of four patients with erythrophagocytic lymphohistiocytosis by a combination of epipodophyllotoxin, steroids, intrathecal methotrexate, and cranial irradiation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Erythrocytes; Etoposide; Female; Humans; Infant; Injections, Spinal; Lymphatic Diseases; Male; Methotrexate; Methylprednisolone; Phagocytosis; Prednisone | 1985 |
Chemotherapy of invasive carcinoma of the bladder.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Etoposide; Humans; Lymphatic Metastasis; Methotrexate; Neoplasm Invasiveness; Urinary Bladder Neoplasms | 1985 |
Malignant histiocytosis resistant to anthracycline. Response to intensive treatment with etoposide and amsacrine.
Topics: Adult; Aminoacridines; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Doxorubicin; Drug Resistance; Etoposide; Female; Hepatomegaly; Humans; Leucovorin; Leukocyte Count; Lymphatic Diseases; Methotrexate; Prednisone; Splenomegaly; Vincristine | 1985 |
[VP 16-213].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Humans; Leucovorin; Lymphoma; Methotrexate; Podophyllotoxin; Prednisolone | 1985 |
Castability of crown and bridge alloys.
Topics: Antineoplastic Combined Chemotherapy Protocols; Crowns; Cyclophosphamide; Dental Alloys; Dental Casting Investment; Dental Casting Technique; Denture, Partial, Fixed; Doxorubicin; Etoposide; Gold Alloys; Methotrexate; Surface Properties; Vincristine | 1985 |
[Allogeneic bone marrow transplantation after fractionated whole body irradiation. Results at the Kiel transplantation center].
Topics: Acyclovir; Adolescent; Adult; Amphotericin B; Anemia, Aplastic; Bone Marrow Transplantation; Child; Cyclophosphamide; Etoposide; Female; Graft Survival; Graft vs Host Disease; Herpes Genitalis; HLA Antigens; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Nystatin; Prednisolone; Tissue Donors; Whole-Body Irradiation | 1985 |
Response of ovarian cancer to combined cytotoxic agents in the subrenal capsule assay: Part I.
Topics: Aclarubicin; Adolescent; Adult; Aged; Altretamine; Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cisplatin; Cyclophosphamide; Cystadenocarcinoma; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Methotrexate; Mice; Middle Aged; Mitomycins; Naphthacenes; Neoplasm Transplantation; Ovarian Neoplasms; Tegafur; Tumor Stem Cell Assay; Vincristine | 1985 |
Ifosfamide and etoposide as salvage therapy for non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Ifosfamide; Lymphoma; Methotrexate; Podophyllotoxin; Recurrence | 1986 |
MACC (methotrexate, doxorubicin, cyclophosphamide and lomustine) versus cis-platinum and etoposide in the treatment of advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Podophyllotoxin; Time Factors | 1986 |
Timing- and sequence-dependent synergism between etoposide and methotrexate or etoposide, methotrexate and 5-fluorouracil in advanced leukemia L1210.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Synergism; Etoposide; Female; Fluorouracil; Leukemia L1210; Methotrexate; Mice; Mice, Inbred Strains; Podophyllotoxin; Time Factors | 1985 |
Predictive testing of vulvar and cervical cancers to chemotherapy by the subrenal capsule assay.
Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Resistance; Etoposide; Female; Humans; Kidney; Methotrexate; Mice; Middle Aged; Neoplasm Transplantation; Tumor Stem Cell Assay; Uterine Cervical Neoplasms; Vulvar Neoplasms | 1985 |
[3 multicenter phase II studies of the treatment of small cell bronchogenic carcinoma (incl. AIO studies BI + BII)].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Vinblastine; Vincristine; Vindesine | 1984 |
Clinical trials in cancer medicine.
Topics: Adult; Antineoplastic Agents; Bleomycin; Breast Neoplasms; Clinical Trials as Topic; Doxorubicin; Etoposide; Female; Humans; Male; Methotrexate; Platinum; Tamoxifen; Teniposide; Testicular Neoplasms | 1980 |
Anti-tumour activity of the epipodophyllin derivative VP16-213 (etoposide: NSC-141540) in gestational choriocarcinoma.
Topics: Adult; Bleomycin; Choriocarcinoma; Chorionic Gonadotropin; Drug Therapy, Combination; Etoposide; Female; Humans; Methotrexate; Middle Aged; Podophyllotoxin; Pregnancy; Uterine Neoplasms; Vincristine | 1980 |
Teniposide (VM-26)- and etoposide (VP-16-213)-induced augmentation of methotrexate transport and polyglutamylation in Ehrlich ascites tumor cells in vitro.
Topics: Animals; Biological Transport; Carcinoma, Ehrlich Tumor; Cells, Cultured; Chlorides; Etoposide; Glucose; Kinetics; Methotrexate; Mice; Peptides; Podophyllotoxin; Polyglutamic Acid; Teniposide; Vincristine; Water | 1982 |
Sequential chemotherapy and late intensification for malignant lymphomas of aggressive histologic type.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Therapy, Combination; Etoposide; Humans; Ifosfamide; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Radiography, Abdominal; Remission, Spontaneous; Time Factors; Vincristine | 1983 |
Further advances in the management of malignant teratomas of the testis and other sites.
Topics: alpha-Fetoproteins; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin; Cyclophosphamide; Cytarabine; Dactinomycin; Drug Therapy, Combination; Etoposide; Humans; Lung Neoplasms; Male; Mediastinal Neoplasms; Methotrexate; Neoplasm Staging; Prognosis; Retroperitoneal Neoplasms; Teratoma; Testicular Neoplasms; Vincristine | 1983 |
The syndrome of partial mole.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Etoposide; Female; Humans; Hydatidiform Mole; Methotrexate; Middle Aged; Peptide Fragments; Pregnancy; Risk; Syndrome; Uterine Neoplasms | 1984 |
Poor-prognosis gestational trophoblastic disease: an update.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Humans; Methotrexate; Pregnancy; Prognosis; Trophoblastic Neoplasms; Uterine Neoplasms | 1984 |
Drug testing using a soft agar stem cell assay on patient and xenograft tumor material.
Topics: Animals; Antineoplastic Agents; Bleomycin; Cisplatin; Colony-Forming Units Assay; Drug Synergism; Etoposide; Female; Granulosa Cell Tumor; Humans; Melphalan; Methotrexate; Mice; Misonidazole; Neoplasm Transplantation; Neoplasms; Ovarian Neoplasms; Transplantation, Heterologous; Tumor Stem Cell Assay; Vinblastine | 1984 |
Tumor size, response rate, and prognosis in small cell carcinoma of the bronchus treated by combination chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Small Cell; Cyclophosphamide; Drug Therapy, Combination; Etoposide; Female; Humans; Inappropriate ADH Syndrome; Leucovorin; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged | 1982 |
Alternating non-cross-resistant combination chemotherapy for small cell anaplastic carcinoma of the lung.
Topics: Antineoplastic Agents; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Etoposide; Humans; Lung Neoplasms; Methotrexate; Vincristine | 1982 |
Non-cross-resistant chemotherapy and consolidation radiotherapy for small cell carcinoma of the lung.
Topics: Adult; Aged; Altretamine; Antineoplastic Agents; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Prognosis; Vincristine | 1982 |
[Prevention of recurrence of small-cell lung cancer by adjuvant polychemotherapy (author's transl)].
Topics: Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Lomustine; Lung Neoplasms; Methotrexate; Neoplasm Recurrence, Local; Vincristine | 1982 |
VP16-213 in combined modality treatment of small cell carcinoma of the lung.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Humans; Lung Neoplasms; Methotrexate; Nausea; Neoplasm Staging; Podophyllotoxin | 1982 |
Small-cell bronchogenic carcinoma--primary and relapse therapy with etoposide (VP-16), methotrexate and CCNU.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Drug Therapy, Combination; Etoposide; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin | 1982 |
Small cell lung cancer. Serial bronchofiberscopy and photographic documentation--the bridge sign.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bronchoscopy; Carcinoma, Small Cell; Cicatrix; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Fiber Optic Technology; Humans; Ifosfamide; Lomustine; Lung Neoplasms; Methotrexate; Prospective Studies; Vincristine | 1983 |
Effects of intensive induction chemotherapy for extensive-disease small cell bronchogenic carcinoma in protected environment-prophylactic antibiotic units.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Environment, Controlled; Etoposide; Female; Humans; Ifosfamide; Leukocyte Count; Lung Neoplasms; Male; Mediastinal Neoplasms; Methotrexate; Middle Aged; Procarbazine; Vincristine | 1984 |
Cyclic alternating combination chemotherapy for small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Time Factors; Vincristine | 1984 |
Current problems in the management of non-Hodgkin's lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma; Methotrexate; Prednisone; Vincristine | 1984 |
Prolonged initial remission in patients with nodular mixed lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Lymphoma, Follicular; Male; Mechlorethamine; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Time Factors; Vincristine | 1984 |
Systemic chemotherapy of murine bladder cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cell Line; Cisplatin; Disease Models, Animal; Dose-Response Relationship, Drug; Etoposide; FANFT; Female; Methotrexate; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Urinary Bladder Neoplasms | 1984 |
Murine L5178Y cells resulting in altered drug sensitivities from fractionated radiation exposure in vitro.
Topics: Animals; Antineoplastic Agents; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Etoposide; Fluorouracil; Hydroxyurea; Leukemia L5178; Leukemia, Experimental; Methotrexate; Mice; Vincristine | 1984 |
Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Etoposide; Female; Humans; Leucovorin; Leukopenia; Lymphoma; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Vincristine | 1983 |
Erythema and desquamation after high-dose methotrexate.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Erythema; Etoposide; Female; Humans; Leucovorin; Lymphoma; Methotrexate; Prednisone | 1983 |
[Tumors of the vitelline sac located in the vagina in children. Apropos of 11 cases].
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Infant; Mesonephroma; Methotrexate; Vaginal Neoplasms | 1983 |
Chemotherapy-induced interstitial pneumonitis during treatment of small cell anaplastic lung cancer.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Autopsy; Biopsy; Cyclophosphamide; Etoposide; Female; Humans; Hypoxia; Lung Neoplasms; Male; Methotrexate; Middle Aged; Pulmonary Fibrosis; Serologic Tests | 1984 |
Adriamycin and VP16-213 combination treatment for breast cancer previously treated by the CMF regimen.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Etoposide; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Podophyllotoxin | 1982 |
VP-16 and adriamycin in patients with advanced breast cancer.
Topics: Adenocarcinoma; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Fluorouracil; Humans; Leukopenia; Male; Methotrexate; Middle Aged; Podophyllotoxin; Prednisone; Thrombocytopenia; Vincristine; Vomiting | 1982 |
IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Cyclophosphamide; Drug Therapy, Combination; Etoposide; Humans; Ifosfamide; Inflammation; Lymphoma; Methotrexate; Mucous Membrane; Neutropenia; Podophyllotoxin; Recurrence | 1982 |
Oral VP-16-213 in advanced bronchogenic carcinoma and toxic effects when combined with methotrexate.
Topics: Bone Marrow Diseases; Doxorubicin; Drug Therapy, Combination; Etoposide; Humans; Lung Neoplasms; Methotrexate; Podophyllotoxin; Vincristine | 1981 |
[Treatment of patients with trophoblastic tumors in the Academic Medical Center: 31 patients in 10 years, 1983-1992].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole; Methotrexate; Pregnancy; Prognosis; Retrospective Studies; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1995 |
Lack of functional retinoblastoma protein mediates increased resistance to antimetabolites in human sarcoma cell lines.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Base Sequence; Bone Neoplasms; Cell Division; Cell Line; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fibrosarcoma; Floxuridine; Humans; Liposarcoma; Methotrexate; Molecular Sequence Data; Oligonucleotide Probes; Osteosarcoma; Recombinant Proteins; Retinoblastoma Protein; Tetrahydrofolate Dehydrogenase; Thymidylate Synthase; Transfection; Tumor Cells, Cultured | 1995 |
[A case of gastric cancer responding well to MTX/5-FU (methotrexate/5-fluorouracil) and PMUE (CDDP, MMC, UFT, etoposide) therapies upon lymphnode recurrence].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Mitomycin; Stomach Neoplasms; Tegafur; Uracil | 1995 |
Ultraviolet recall associated with etoposide and cyclophosphamide therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Eruptions; Etoposide; Humans; Leucovorin; Male; Methotrexate; Prednisolone; Recurrence; Sunburn; Vincristine | 1993 |
Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colony-Forming Units Assay; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Length of Stay; Leukapheresis; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Vincristine | 1993 |
[A case of stage IIIB2 infantile yolk sac tumor of testis achieved complete remission by "COMPE" chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Endodermal Sinus Tumor; Etoposide; Humans; Infant; Lung Neoplasms; Male; Methotrexate; Peplomycin; Remission Induction; Testicular Neoplasms; Vincristine | 1993 |
[Lung residuals following chemotherapy in patients with stage III nonseminomatous testicular cancer. Report of 4 cases].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Etoposide; Germinoma; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Peplomycin; Testicular Neoplasms; Thoracotomy; Vincristine | 1994 |
[Increased blood cell destruction during vigorous regeneration of bone marrow after CAMBO-VIP chemotherapy for non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Cell Count; Bone Marrow Cells; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Vincristine | 1994 |
Intermediate-grade lymphomas treated with cyclophosphamide-doxorubicin- vincristine-prednisone-bleomycin alternated with cyclophosphamide-methotrexate-etoposide-dexamethasone. Application of prognostic models to data analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Radiotherapy Dosage; Remission Induction; Survival Rate; Vincristine | 1994 |
[Low dose COMPE. Cisplatin, vincristine, methotrexate, peplomycin, etoposide chemotherapy for advanced testicular cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Drug Administration Schedule; Etoposide; Humans; Male; Methotrexate; Neoplasm Staging; Peplomycin; Seminoma; Testicular Neoplasms; Vincristine | 1994 |
Comparable prognostic factors and survival in elderly patients with aggressive non-Hodgkin's lymphoma treated with standard-dose adriamycin-based regimens.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Retrospective Studies; Survival Analysis; Vincristine | 1994 |
Secondary myelodysplastic syndrome following bone marrow transplantation: report of two cases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma; Male; Methotrexate; Myelodysplastic Syndromes; Prednisone; Procarbazine; Rectal Neoplasms; Risk Factors; Seminoma; Testicular Neoplasms; Transplantation, Autologous; Vincristine | 1994 |
Clostridium septicum abscess in hepatic metastases: successful medical management.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Carmustine; Ceftazidime; Cisplatin; Clindamycin; Clostridium Infections; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Fluorouracil; Gases; Granulocyte Colony-Stimulating Factor; Humans; Imipenem; Immunocompromised Host; Liver Abscess; Liver Neoplasms; Methotrexate; Neutropenia; Sepsis | 1994 |
A cooperative study on ProMACE-CytaBOM in aggressive non-Hodgkin's lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Feasibility Studies; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Vincristine | 1994 |
The response of diffuse large cell and other intermediate grade non-Hodgkin's lymphomas to adriamycin containing combination chemotherapy.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Leucovorin; Lomustine; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Melphalan; Methotrexate; Middle Aged; Phosphoramide Mustards; Prednisolone; Prednisone; Prognosis; Retrospective Studies; Survival Analysis; Time Factors; Treatment Outcome; Vincristine | 1994 |
Malignant germ cell tumors in childhood.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Etoposide; Female; Germinoma; Humans; India; Infant; Male; Methotrexate; Ovarian Neoplasms; Prognosis; Testicular Neoplasms; Treatment Outcome; Vinblastine | 1994 |
Brain metastases of gestational trophoblastic tumor.
Topics: Adult; Antineoplastic Agents; Biomarkers, Tumor; Brain Neoplasms; Chlorambucil; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Dactinomycin; Etoposide; Female; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Neoplasm Staging; Palliative Care; Peptide Fragments; Pregnancy; Remission Induction; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Trophoblastic Neoplasms; Uterine Neoplasms | 1994 |
Successful resolution of persistent trophoblastic disease after partial mole with the EMA-CO regimen.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole; Methotrexate; Peptide Fragments; Pregnancy; Trophoblastic Neoplasms; Ultrasonography; Uterine Neoplasms; Vacuum Curettage; Vincristine | 1994 |
The long-term outcome of patients who relapse after chemotherapy for non-seminomatous germ cell tumours.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Genital Neoplasms, Male; Germinoma; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Risk Factors; Survival Analysis; Time Factors; Vinblastine; Vincristine | 1994 |
A novel strategy using G-CSF to support EMA/CO for high-risk gestational trophoblastic disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Methotrexate; Pregnancy; Trophoblastic Neoplasms; Trophoblastic Tumor, Placental Site; Uterine Neoplasms; Vincristine | 1995 |
Recurrent gestational trophoblastic disease following in-vitro fertilization.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Cyclophosphamide; Dactinomycin; Embryo Transfer; Etoposide; Female; Fertilization in Vitro; Humans; Infertility, Female; Methotrexate; Peptide Fragments; Pregnancy; Recurrence; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1994 |
Osteosarcoma following radiation treatment for meningioma: report of a case and effective treatment with chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Cisplatin; Dactinomycin; Etoposide; Female; Gonadotropin-Releasing Hormone; Humans; Ifosfamide; Lung Neoplasms; Meningeal Neoplasms; Meningioma; Methotrexate; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Osteosarcoma; Tamoxifen; Tomography, X-Ray Computed; Vincristine | 1994 |
Influence of molecular characteristics on clinical outcome in human immunodeficiency virus-associated non-Hodgkin's lymphoma: identification of a subgroup with favorable clinical outcome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blotting, Southern; CD4 Lymphocyte Count; Clone Cells; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; DNA, Neoplasm; DNA, Viral; Doxorubicin; Etoposide; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Genes, Immunoglobulin; Genes, myc; Granulocyte-Macrophage Colony-Stimulating Factor; Herpesvirus 4, Human; Humans; Immunoglobulin Variable Region; Immunologic Factors; Leucovorin; Life Tables; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Methotrexate; Polymerase Chain Reaction; Prednisone; Proportional Hazards Models; Radiotherapy, Adjuvant; Recombinant Proteins; RNA, Messenger; RNA, Neoplasm; Survival Analysis; Treatment Outcome; Vincristine | 1995 |
Secondary tumours following etoposide containing therapy for germ cell cancer.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Cyclophosphamide; Cytarabine; Dactinomycin; Dose-Response Relationship, Drug; Etoposide; Germinoma; Humans; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Neoplasms, Second Primary; Testicular Neoplasms; Vincristine | 1995 |
Serum levels of interleukin-10 in patients with diffuse large cell lymphoma: lack of correlation with prognosis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Enzyme-Linked Immunosorbent Assay; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Interleukin-10; Life Tables; Lymphoma, Large B-Cell, Diffuse; Male; Mesna; Methotrexate; Methylprednisolone Hemisuccinate; Middle Aged; Mitoxantrone; Neoplasm Proteins; Prognosis; Risk Factors; Sensitivity and Specificity; Severity of Illness Index; Survival Analysis; Treatment Outcome; Vincristine | 1995 |
Failure of normalization of alphafetoprotein levels following the successful treatment of teratoma: a diagnostic trap for the unwary.
Topics: Adult; Alcohol Drinking; alpha-Fetoproteins; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Humans; Male; Methotrexate; Orchiectomy; Teratoma; Thoracotomy; Vincristine | 1995 |
Visual hallucinations following treatment with vincristine.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cyclophosphamide; Doxorubicin; Etoposide; Hallucinations; Humans; Lymphoma, T-Cell; Male; Melphalan; Methotrexate; Middle Aged; Multiple Myeloma; Prednisolone; Prednisone; Procarbazine; Salvage Therapy; Serotonin; Structure-Activity Relationship; Vincristine | 1994 |
Tubulin alterations in taxol-induced apoptosis parallel those observed with other drugs.
Topics: Apoptosis; Cell Line; Centrosome; Etoposide; Methotrexate; Paclitaxel; RNA; Tubulin | 1995 |
Effects of rhG-CSF on infection complications and impaired function of neutrophils secondary to chemotherapy for non-Hodgkin's lymphoma. Hokkaido Study Group of Malignant Lymphoma, and rhG-CSF, Japan.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Adhesion Molecules; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Infection Control; Luminescent Measurements; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Neoplasm Proteins; Neutropenia; Neutrophils; Prednisone; Recombinant Proteins; Respiratory Burst; Vincristine | 1995 |
[Spontaneous pneumothorax in response to chemotherapy of metastatic germinal tumor].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Choriocarcinoma; Cisplatin; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Male; Mediastinal Neoplasms; Methotrexate; Pneumothorax; Testicular Neoplasms; Vincristine | 1995 |
[Combination chemotherapy with POMB/ACE (cisplatin, vincristine, methotrexate, bleomycin, actinomycin D, cyclophosphamide, etoposide) in advanced non-seminomatous testicular tumor].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Embryonal; Choriocarcinoma; Cisplatin; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Endodermal Sinus Tumor; Etoposide; Humans; Lymphatic Metastasis; Male; Methotrexate; Remission Induction; Teratoma; Testicular Neoplasms; Vincristine | 1995 |
Aggressive treatment for postcardiac transplant lymphoproliferation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppression Therapy; Life Tables; Lymphoproliferative Disorders; Male; Mechlorethamine; Methotrexate; Middle Aged; Multiple Organ Failure; Postoperative Complications; Prednisone; Procarbazine; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine | 1995 |
Ifosfamide, mitoxantrone and etoposide (VIM) as salvage therapy of low toxicity in non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prognosis; Recurrence; Retrospective Studies; Salvage Therapy; Survival Rate; Time Factors; Transplantation, Autologous | 1995 |
Therapy-related acute myelomonocytic leukemia following successful treatment for acute promyelocytic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 10; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Cytarabine; Etoposide; Female; Humans; Idarubicin; Karyotyping; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Mercaptopurine; Methotrexate; Mitoxantrone; Neoplasms, Second Primary; Remission Induction; Thioguanine; Translocation, Genetic | 1995 |
Gestational choriocarcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Chorionic Gonadotropin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Lung Neoplasms; Methotrexate; Postpartum Period; Pregnancy; Prognosis; Spinal Neoplasms; Uterine Neoplasms; Vincristine | 1995 |
[Comparative study on urinary parameters reflecting renal damage during chemotherapy for urological cancer].
Topics: Acetylglucosaminidase; Adolescent; Adult; Aged; Aminopeptidases; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD13 Antigens; Cisplatin; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Etoposide; Humans; Ifosfamide; Kidney Diseases; Male; Methotrexate; Middle Aged; Prostatic Neoplasms; Proteinuria; Urinary Bladder Neoplasms; Vincristine | 1993 |
[A case of testicular choriocarcinoma achieving pathological complete response by "COMPE" chemotherapy, consisting of cisplatin, vincristine, methotrexate, peplomycin, and etoposide].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Choriocarcinoma; Cisplatin; Drug Administration Schedule; Etoposide; Humans; Hydronephrosis; Male; Methotrexate; Peplomycin; Remission Induction; Testicular Neoplasms; Vinblastine; Vincristine | 1993 |
Results of treatment of small non-cleaved cell lymphoma in patients without positive HIV serology.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; HIV Seropositivity; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Recurrence; Survival Rate; Vincristine | 1993 |
[Optimal way of administration of granulocyte colony stimulating factor in the treatment of urological cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Male; Methotrexate; Middle Aged; Testicular Neoplasms; Ureteral Neoplasms; Urinary Bladder Neoplasms; Vinblastine | 1993 |
[New salvage chemotherapy (cisplatin, adriamycin, bleomycin, methotrexate, etoposide) for advanced nonseminomatous testicular cancer: experience in three cases].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Lymphatic Metastasis; Male; Methotrexate; Neoplasms, Germ Cell and Embryonal; Neoplasms, Multiple Primary; Salvage Therapy; Testicular Neoplasms | 1993 |
CHOP versus intensive regimens in non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Vincristine | 1993 |
Gonadal function after MACOP-B or VACOP-B with or without dose intensification and ABMT in young patients with aggressive non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Ovarian Diseases; Prednisone; Retrospective Studies; Testicular Diseases; Vincristine | 1993 |
Treatment of poor prognosis non-Hodgkin's lymphoma with intensive, inpatient combination chemotherapy of brief duration: long-term followup.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Prognosis; Survival Analysis; Vincristine | 1993 |
Bilateral hard palate masses.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Diagnosis, Differential; Doxorubicin; Etoposide; Fatal Outcome; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neurofibroma; Palatal Neoplasms; Prednisone; Vincristine | 1993 |
Gestational trophoblastic disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Humans; Hydatidiform Mole; Leucovorin; Methotrexate; Neoplasm Metastasis; Neoplasm Staging; Pregnancy; Prognosis; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1994 |
Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: the case for aggressive management.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Karnofsky Performance Status; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Platelet Transfusion; Recurrence; Remission Induction; Survival Analysis; Thiotepa; Transplantation, Homologous; Whole-Body Irradiation | 1995 |
Prolonged impairment of hematopoiesis after high-dose therapy followed by autologous bone marrow transplantation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Busulfan; Carmustine; Cell Count; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Etoposide; Female; Follow-Up Studies; Hematopoiesis; Hematopoietic Cell Growth Factors; Humans; Male; Melphalan; Methotrexate; Middle Aged; Mitoxantrone; Multivariate Analysis; Neoplasms; Prognosis; Radiation Injuries; Treatment Outcome; Vincristine; Whole-Body Irradiation | 1995 |
Antifolates can potentiate topoisomerase II inhibitors in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Division; Cell Line; Cell Survival; DNA Damage; DNA, Neoplasm; Drug Synergism; Etoposide; Folic Acid Antagonists; Head and Neck Neoplasms; Humans; Male; Methotrexate; Mice; Mice, Inbred C3H; Novobiocin; Ornithine; Pterins; Topoisomerase II Inhibitors; Trimetrexate; Tumor Cells, Cultured | 1995 |
Haemophagocytic lymphohistiocytosis: experience at two U.K. centres.
Topics: Bone Marrow; Bone Marrow Transplantation; Child; Child, Preschool; Drug Therapy, Combination; Etoposide; Female; Fibrinogen; Follow-Up Studies; Histiocytosis, Non-Langerhans-Cell; Humans; Infant; Infant, Newborn; Male; Methotrexate; Methylprednisolone; Retrospective Studies; Survival Analysis; Thrombocytopenia; Treatment Outcome; United Kingdom | 1994 |
[Sequential chemotherapy with or without GM-CSF in acute myeloid leukemia (AML) in the advanced phase: current status of protocols EMA 86 and EMA 91].
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Dactinomycin; Drug Administration Schedule; Etoposide; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukemia, Myeloid; Methotrexate; Middle Aged | 1994 |
Intermediate and high grade malignant non-Hodgkin's lymphomas: preliminary results using a new combination regimen (EVE-COPEM).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Epirubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Prednisone; Vincristine; Vindesine | 1993 |
Excretion of Ascaris lumbricoides during total body irradiation.
Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Ascariasis; Ascaris lumbricoides; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Gastrointestinal Contents; Humans; Intestinal Diseases, Parasitic; Leucovorin; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Vincristine; Vomiting; Whole-Body Irradiation | 1994 |
[Immunohistochemical study and treatment result of small cell lung carcinoma using combination chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chromogranin A; Chromogranins; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Phosphopyruvate Hydratase; Prednisone; Prognosis; Remission Induction; Vincristine | 1994 |
Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Colonic Neoplasms; Cyclophosphamide; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Ifosfamide; Leukemia P388; Mammary Neoplasms, Animal; Melanoma, Experimental; Methotrexate; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Mitomycin; Sarcoma, Experimental; Vinblastine | 1994 |
EMACO in high risk gestational trophoblast disease--the Australian experience. Gestational Trophoblast Subcommittee, Clinical Oncological Society of Australia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Australia; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Middle Aged; Pregnancy; Risk; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1994 |
Successful bone marrow transplant for a patient with T-lymphoblastic lymphoma in second remission preconditioned by total-body irradiation plus melphalan and etoposide.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclosporine; Etoposide; Graft vs Host Disease; Humans; Male; Melphalan; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Whole-Body Irradiation | 1994 |
Relapsing chickenpox in a young man with non-Hodgkin's lymphoma.
Topics: Acyclovir; Adult; Antineoplastic Combined Chemotherapy Protocols; Chickenpox; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Herpesvirus 3, Human; Humans; Immunocompromised Host; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Recurrence; Vincristine; Virus Activation | 1994 |
Consolidative thoracic radiotherapy and prophylactic cranial irradiation in limited disease small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Lomustine; Lung Neoplasms; Methotrexate; Remission Induction; Survival Analysis; Thorax; Treatment Outcome; Vincristine | 1993 |
The prognostic significance of bone marrow metastases in small cell lung cancer patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Prognosis; Proportional Hazards Models; Survival Analysis | 1993 |
Langerhans cell histiocytosis in an adult.
Topics: Administration, Topical; Adult; Axilla; Diabetes Insipidus; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Mechlorethamine; Methotrexate; Scalp | 1994 |
[Cytological features and prognosis of megakaryoblastic leukemia].
Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Histocytochemistry; Humans; Infant; Male; Methotrexate; Microscopy, Electron; Middle Aged; Nitrosourea Compounds; Peroxidase; Prednisolone; Prognosis; Thrombocythemia, Essential; Vincristine | 1994 |
A Bayesian analysis of institutional effects in a multicenter cancer clinical trial.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Biometry; Carcinoma, Small Cell; Cyclophosphamide; Data Interpretation, Statistical; Doxorubicin; Etoposide; Humans; Lung Neoplasms; Methotrexate; Multicenter Studies as Topic; Probability; Proportional Hazards Models; Randomized Controlled Trials as Topic; Vincristine | 1994 |
[Leiomyosarcoma of the prostate: response to treatment with cisplatin, etoposide and methotrexate chemotherapy: a case report].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Humans; Leiomyosarcoma; Lung Neoplasms; Male; Methotrexate; Prostatic Neoplasms | 1994 |
High-dose, brief duration, multiagent chemotherapy for metastatic breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Hemorrhage; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Methotrexate; Middle Aged; Neutropenia; Remission Induction; Survival Rate; Thrombocytopenia | 1994 |
ProMACE day 1/MOPP day 8 chemotherapy for prolymphocytic leukemia: a case report of prolonged survival.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Leukemia, B-Cell; Leukemia, Prolymphocytic; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Time Factors; Vincristine | 1994 |
Chemotherapy combined with surgery in the treatment of gestational trophoblastic disease (GTD).
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Choriocarcinoma; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Resistance; Etoposide; Female; Humans; Hydatidiform Mole; Hydroxyurea; Hysterectomy; Lung Neoplasms; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Pregnancy; Salvage Therapy; Thoracotomy; Treatment Outcome; Trophoblastic Neoplasms; Uterine Hemorrhage; Uterine Neoplasms; Vincristine | 1993 |
Acute leukemia in association with Langerhans cell histiocytosis.
Topics: Adolescent; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Infant; Leukemia, Myeloid, Acute; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Registries; Retrospective Studies; Surveys and Questionnaires; Vinblastine; Vincristine | 1994 |
[A study of first and second line chemotherapies in gestational choriocarcinoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Pregnancy; Prognosis; Uterine Neoplasms; Vincristine | 1993 |
A simulated sequential analysis based on data from two MRC trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Data Interpretation, Statistical; Etoposide; Humans; Lung Neoplasms; Methotrexate; Proportional Hazards Models; Radiotherapy, High-Energy; Randomized Controlled Trials as Topic; Regression Analysis; Research Design; Survival Analysis; Survival Rate; Vincristine | 1993 |
Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Methotrexate; Pregnancy; Prognosis; Remission Induction; Risk Factors; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1994 |
[MEP (methotrexate, etoposide and cisplatin) and M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced uroepithelial cancer--a preliminary report of MEP as second line chemotherapy for recurrence after M-VAC].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Ureteral Neoplasms; Urinary Bladder Neoplasms; Vinblastine | 1994 |
[Successful oral administration of etoposide therapy for refractory malignant lymphoma treated with frequent combination chemotherapy].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Leucovorin; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Recurrence; Salvage Therapy; Vincristine | 1993 |
Changes in the oral microflora during cytotoxic chemotherapy in children being treated for acute leukemia.
Topics: Adolescent; Analysis of Variance; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacterial Infections; Candida albicans; Candidiasis, Oral; Chi-Square Distribution; Child; Child, Preschool; Chlorhexidine; Colony Count, Microbial; Cytarabine; Daunorubicin; Etoposide; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant; Leukemia, Myeloid, Acute; Male; Mercaptopurine; Methotrexate; Mouth; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Streptococcus mutans; Thioguanine; Trimethoprim, Sulfamethoxazole Drug Combination; Vincristine | 1993 |
[Intraarterial infusion chemotherapy for recurrent or unresectable gastric cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Mitomycin; Peritonitis; Prognosis; Stomach Neoplasms; Survival Rate | 1993 |
Orbito-ocular granulocytic sarcoma (OOGS) and acute myeloblastic leukemia (AML) with duplication of Philadelphia chromosome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Eye Neoplasms; Humans; Karyotyping; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Multigene Family; Neoplasms, Multiple Primary; Orbital Neoplasms; Philadelphia Chromosome; Thioguanine | 1993 |
Liver metastases of gestational trophoblastic tumor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cisplatin; Dactinomycin; Etoposide; Female; Humans; Liver Neoplasms; Methotrexate; Middle Aged; Pregnancy; Retrospective Studies; Treatment Outcome; Trophoblastic Neoplasms; Uterine Neoplasms | 1993 |
Pulmonary hypertension--a rare presentation of choriocarcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hypertension, Pulmonary; Leucovorin; Methotrexate; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1993 |
Plasma methotrexate levels in patients receiving etoposide, methotrexate, actinomycin, cyclophosphamide, and vincristine (EMA-CO) chemotherapy for trophoblastic neoplasia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1993 |
Lomustine, etoposide, methotrexate and prednisone (LEMP) therapy for relapsed and refractory non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Lomustine; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Remission Induction | 1993 |
High frequency of etoposide (VP-16)-related secondary leukemia in children with non-Hodgkin's lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparagine; Child; Child, Preschool; Chromosome Aberrations; Chromosomes, Human, Pair 11; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Life Tables; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Neoplasms, Second Primary; Risk; Vincristine | 1993 |
Myocardial ischemia after treatment with methotrexate, etoposide and cisplatin.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Humans; Male; Methotrexate; Middle Aged; Myocardial Ischemia; Urinary Bladder Neoplasms | 1993 |
Induction chemotherapy and intensification with autologous bone marrow reinfusion in patients with locally advanced and disseminated breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Prednisone; Prognosis; Remission Induction; Time Factors; Transplantation, Autologous; Vincristine | 1993 |
IEVM chemotherapy with rhGM-CSF support for aggressive non-Hodgkin's lymphomas: a pilot study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Etoposide; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Pilot Projects; Recombinant Proteins | 1993 |
Role of total body irradiation as based on the comparison of preparation regimens for allogeneic bone marrow transplantation for acute leukemia in first complete remission.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Etoposide; Female; Humans; Infant; Japan; Leukemia; Male; Methotrexate; Nimustine; Proportional Hazards Models; Radiotherapy Dosage; Remission Induction; Transplantation, Homologous; Whole-Body Irradiation | 1993 |
Serum methotrexate (MTX) concentrations and prognosis in patients with osteosarcoma of the extremities treated with a multidrug neoadjuvant regimen.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Child; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Extremities; Female; Humans; Ifosfamide; Male; Methotrexate; Osteosarcoma; Prognosis | 1993 |
Surgical treatment of small cell carcinoma of the lung: advantage of preoperative chemotherapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prednisone; Preoperative Care; Prognosis; Retrospective Studies; Vincristine | 1995 |
[A case of adult pure yolk sac tumor of the testis achieving pathological complete response by chemotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Endodermal Sinus Tumor; Etoposide; Humans; Male; Methotrexate; Peplomycin; Remission Induction; Testicular Neoplasms; Vincristine | 1995 |
Chemotherapy for AIDS-related and endemic African Kaposi's sarcoma in southern Africa.
Topics: Adult; AIDS-Related Opportunistic Infections; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dactinomycin; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Remission Induction; Retrospective Studies; Sarcoma, Kaposi; Skin Neoplasms; South Africa; Survival Rate; Treatment Failure; Treatment Outcome; Vinblastine; Vincristine | 1995 |
Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis.
Topics: Adult; Aged; Bone Marrow Transplantation; Cyclophosphamide; Etoposide; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Histocompatibility; Humans; Leukemia; Male; Methotrexate; Middle Aged; Recombinant Proteins; Recurrence; Survival Rate; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 1995 |
Steroid-free chemotherapy decreases the risk of hepatitis flare-up in hepatitis B virus carriers with non-Hodgkin's lymphoma.
Topics: Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Contraindications; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Glucocorticoids; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Prospective Studies; Vincristine; Virus Activation | 1996 |
Pneumocystis carinii pneumonia in adults with acute leukaemia: is there a need for primary chemoprophylaxis?
Topics: Aclarubicin; Acute Disease; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cohort Studies; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Female; Finland; Humans; Immunocompromised Host; Incidence; Leukemia; Male; Mercaptopurine; Methotrexate; Middle Aged; Mitoxantrone; Pneumonia, Pneumocystis; Prednisone; Premedication; Retrospective Studies; Thioguanine; Trimethoprim, Sulfamethoxazole Drug Combination; Vincristine | 1996 |
Effects of Taxol on choriocarcinoma cells.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Choriocarcinoma; Chorionic Gonadotropin; Cycloheximide; Etoposide; Female; Humans; Methotrexate; Paclitaxel; Pregnancy; Tumor Cells, Cultured; Uterine Neoplasms | 1995 |
Treatment of resistant gestational choriocarcinoma with taxol: a report of two cases.
Topics: Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Frontal Lobe; Humans; Liver Neoplasms; Lung Neoplasms; Methotrexate; Middle Aged; Paclitaxel; Platinum; Pregnancy; Pregnancy Complications, Neoplastic; Uterine Neoplasms; Vincristine | 1996 |
Metastatic cerebral choriocarcinoma coexistent with a viable pregnancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Diagnosis, Differential; Etoposide; Female; Humans; Methotrexate; Pregnancy; Pregnancy Complications, Neoplastic; Vincristine | 1996 |
Management of low-risk gestational trophoblastic tumors with etoposide (VP16) in patients resistant to methotrexate.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Drug Resistance; Etoposide; Female; Humans; Methotrexate; Middle Aged; Pregnancy; Prognosis; Treatment Outcome; Trophoblastic Neoplasms | 1996 |
A single institution experience with weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Humans; Hydatidiform Mole; Injections, Intramuscular; Methotrexate; Pregnancy; Remission Induction; Uterine Neoplasms; Vincristine | 1996 |
Methyl-GAG, ifosfamide, methotrexate and etoposide (MIME) as salvage therapy for non-Hodgkin's lymphomas: a Swedish national prospective study. Swedish Lymphoma Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoguazone; Prospective Studies; Salvage Therapy; Sweden; Transplantation, Autologous; Treatment Outcome | 1996 |
Enhanced magnetic resonance imaging in monitoring of conservative treatment of cervical pregnancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cervix Uteri; Curettage; Etoposide; Female; Humans; Magnetic Resonance Imaging; Methotrexate; Monitoring, Physiologic; Pregnancy; Pregnancy, Ectopic | 1995 |
True histiocytic lymphoma following therapy for lymphoblastic neoplasms.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Fatal Outcome; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Mercaptopurine; Methotrexate; Methylprednisolone; Neoplasms, Second Primary; Neoplastic Stem Cells; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Remission Induction; Scapula; Spinal Neoplasms; Vincristine | 1996 |
Cytokine network in peripheral blood mononuclear cells after allogeneic bone marrow transplantation.
Topics: Bone Marrow Transplantation; Cyclophosphamide; Cyclosporine; Cytokines; Etoposide; Gene Expression; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Interleukins; Lymphocytes; Methotrexate; Polymerase Chain Reaction; RNA, Messenger; Transplantation, Homologous; Whole-Body Irradiation | 1996 |
Comparison of costs for infusion versus bolus chemotherapy administration: analysis of five standard chemotherapy regimens in three common tumors--Part one. Model projections for cost based on charges.
Topics: Antibiotics, Antineoplastic; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Colonic Neoplasms; Costs and Cost Analysis; Cyclophosphamide; Disposable Equipment; Doxorubicin; Drug Costs; Etoposide; Fees, Medical; Fees, Pharmaceutical; Female; Fluorouracil; Humans; Infusions, Intravenous; Injections, Intravenous; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Models, Economic; Prednisone; Survival Rate; Vincristine | 1996 |
[In vitro chemosensitivity test for seven undifferentiated thyroid carcinoma cell lines using MTT assay].
Topics: Antineoplastic Agents; Bleomycin; Carcinoma; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Humans; Methotrexate; Tetrazolium Salts; Thiazoles; Thyroid Neoplasms; Tumor Cells, Cultured; Vincristine | 1996 |
Full chemotherapy in elderly patients with small cell bronchial carcinoma.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Carcinoma, Small Cell; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Lomustine; Male; Methotrexate; Middle Aged; Multivariate Analysis; Radiotherapy, Adjuvant; Sepsis; Survival Rate; Vincristine | 1996 |
Chemotherapy for ovarian germ cell tumours.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Germinoma; Humans; Leucovorin; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Remission Induction; Salvage Therapy; Survival Rate; Vincristine | 1996 |
Platinum-based chemotherapy for advanced transitional cell carcinoma of the upper urinary tract.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Etoposide; Humans; Kidney Neoplasms; Methotrexate; Middle Aged; Neoplasm Staging; Survival Rate; Treatment Outcome; Ureteral Neoplasms; Vinblastine | 1996 |
Metastatic choroidal choriocarcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Choroid Neoplasms; Cyclophosphamide; Dactinomycin; Etoposide; Fatal Outcome; Female; Humans; Methotrexate; Pregnancy; Uterine Neoplasms | 1996 |
Persistent partial molar pregnancy. A report of uterus-preserving treatment and follow-up with magnetic resonance imaging.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole; Magnetic Resonance Imaging; Methotrexate; Pregnancy; Uterine Neoplasms; Vincristine | 1996 |
Epstein-Barr virus associated Burkitt lymphoma in a heart transplant recipient.
Topics: Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Burkitt Lymphoma; Cyclophosphamide; Cyclosporine; Cytarabine; Doxorubicin; Etoposide; Heart Transplantation; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Postoperative Complications; Prednisolone; Remission Induction; T-Lymphocytes, Cytotoxic; Tumor Virus Infections; Vincristine | 1996 |
Successful mobilisation of blood stem cells following previous autologous bone marrow transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Cells; Bone Marrow; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Epirubicin; Etoposide; Hematopoietic Stem Cells; Humans; Ifosfamide; Leukapheresis; Lymphoma, Follicular; Male; Melphalan; Methotrexate; Podophyllotoxin; Prednisolone; Prednisone; Transplantation Conditioning; Transplantation, Autologous; Vincristine | 1996 |
[Spinal cord compression as the presenting form of non-Hodgkin's lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Epidural Space; Etoposide; Female; Humans; Laminectomy; Leucovorin; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Mechlorethamine; Methotrexate; Middle Aged; Paresis; Paresthesia; Prednisone; Procarbazine; Soft Tissue Neoplasms; Spinal Cord Compression; Spinal Neoplasms; Thoracic Neoplasms; Thoracic Vertebrae; Urinary Retention; Vincristine | 1995 |
Unusual presentation of a metastatic choriocarcinoma following a full term pregnancy: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Dactinomycin; Etoposide; Fatal Outcome; Female; Humans; Liver Neoplasms; Methotrexate; Pregnancy; Uterine Neoplasms; Vincristine | 1996 |
Gestational choriocarcinoma metastatic to the brain treated successfully by stereotactic radiosurgery and chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Pregnancy; Pregnancy Complications, Neoplastic; Radiosurgery; Tomography, X-Ray Computed; Treatment Outcome; Uterine Neoplasms; Vincristine | 1996 |
Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Etoposide; Female; Follow-Up Studies; Humans; Incidence; Methotrexate; Middle Aged; Neoplasms, Second Primary; Pregnancy; Time Factors; Trophoblastic Neoplasms; Uterine Neoplasms | 1996 |
Intensive oral methotrexate protects against lymphoid marrow relapse in childhood B-precursor acute lymphoblastic leukemia.
Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Infant; Male; Mercaptopurine; Methotrexate; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence | 1996 |
Exacerbation of hepatitis in hepatitis B carriers following chemotherapy for haematological malignancies.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carrier State; Chronic Disease; Cyclophosphamide; Cytarabine; Daunorubicin; Disease Progression; Doxorubicin; Etoposide; Female; Hepatic Encephalopathy; Hepatitis B; Humans; Leucovorin; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Vincristine | 1996 |
Successful treatment of lymphomatoid granulomatosis using cyclosporin-A after failure of intensive chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; CD4-Positive T-Lymphocytes; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Doxorubicin; Etoposide; Humans; Immunosuppressive Agents; Lung Diseases; Lymphomatoid Granulomatosis; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Recurrence; Remission Induction; Salvage Therapy; Vincristine | 1996 |
Gestational trophoblastic disease presenting as a large metastasis to the finger.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dactinomycin; Diagnosis, Differential; Doxorubicin; Etoposide; Female; Fingers; Humans; Leucovorin; Methotrexate; Pregnancy; Pregnancy Complications, Neoplastic; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1996 |
Increased deoxycytidine kinase activity by etoposide in L1210 murine leukemic cells.
Topics: Animals; Cytarabine; Deoxycytidine Kinase; Etoposide; Leukemia L1210; Methotrexate; Mice; Phosphorylation | 1996 |
The management of gestational trophoblastic tumors with etoposide, methotrexate, and actinomycin D.
Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Pregnancy; Retrospective Studies; Trophoblastic Neoplasms; Uterine Neoplasms | 1997 |
Testicular morphological changes in children with acute lymphoblastic leukemia following chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Hydrocortisone; Leydig Cells; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Sertoli Cells; Spermatogonia; Testis | 1996 |
Treatment of relapsed non-Hodgkin's lymphoma after BEAM chemotherapy and autologous transplantation by BU/CY chemotherapy and salvage transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Epirubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Injections, Spinal; Lymphoma, B-Cell, Marginal Zone; Male; Melphalan; Methotrexate; Prednisone; Recurrence; Remission Induction; Retreatment; Salvage Therapy; Stomach Neoplasms; Transplantation Conditioning; Tumor Lysis Syndrome; Vincristine | 1997 |
Intensified and high-dose chemotherapy with granulocyte colony-stimulating factor and autologous stem-cell transplantation support as first-line therapy in high-risk diffuse large-cell lymphoma.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leucovorin; Leukapheresis; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Methotrexate; Middle Aged; Mitoxantrone; Pilot Projects; Prednisone; Risk; Survival Analysis; Transplantation, Autologous; Treatment Outcome; Vincristine | 1997 |
A pilot study on the use of the ProMACE-CytaBOM regimen as a first-line treatment of advanced follicular non-Hodgkin's lymphoma. Gruppo Italiano per lo Studio dei Linfomi.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neutropenia; Pilot Projects; Prednisone; Remission Induction; Survival Analysis; Treatment Failure; Vincristine | 1997 |
Multidrug resistance in androgen-independent growing rat prostate carcinoma cells is mediated by P-glycoprotein.
Topics: Androgens; Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Fluorescent Dyes; Genes, MDR; Male; Methotrexate; Neoplasms, Hormone-Dependent; Paclitaxel; Prostatic Neoplasms; Rats; Rhodamine 123; Rhodamines; Tumor Cells, Cultured; Verapamil; Vinblastine | 1997 |
In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia.
Topics: Aclarubicin; Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bleomycin; Bone Marrow; Cell Survival; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Follow-Up Studies; Humans; Infant; Infant, Newborn; Life Tables; Melphalan; Methotrexate; Mitomycin; Mitoxantrone; Neoplastic Stem Cells; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Recurrence; Remission Induction; Tumor Cells, Cultured; Vincristine | 1997 |
Chemotherapeutic induction of long-term remission in metastatic medulloblastoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cerebellar Neoplasms; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Medulloblastoma; Methotrexate; Remission Induction; Vincristine | 1997 |
Long-term toxicity and neuropathology associated with the sequencing of cranial irradiation and enhanced chemotherapy delivery.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Cranial Irradiation; Dose-Response Relationship, Radiation; Drug Administration Schedule; Etoposide; Mannitol; Methotrexate; Radiation Injuries, Experimental; Radiotherapy, Adjuvant; Rats; Treatment Outcome | 1997 |
Sequential intensive treatment with the F-MACHOP regimen (+/- radiotherapy) and autologous stem cell transplantation for primary systemic CD30 (Ki-1)--positive anaplastic large cell lymphoma in adults.
Topics: Adolescent; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fluorouracil; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Prospective Studies; Remission Induction; Transplantation Conditioning; Transplantation, Autologous; Vincristine | 1997 |
Bilateral primary renal non-Hodgkin's lymphoma presenting with acute renal failure: successful treatment with systemic chemotherapy.
Topics: Acute Kidney Injury; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Kidney Neoplasms; Lymphoma, Follicular; Male; Methotrexate; Neoplasms, Multiple Primary; Prednisone; Remission Induction; Vincristine | 1997 |
Successful correction of hemophagocytic lymphohistiocytosis with related or unrelated bone marrow transplantation.
Topics: Adrenal Cortex Hormones; Bone Marrow Transplantation; Child, Preschool; Combined Modality Therapy; Cyclosporine; Etoposide; Female; Graft vs Host Disease; Histiocytosis, Non-Langerhans-Cell; Humans; Immunosuppressive Agents; Infant; Injections, Spinal; Killer Cells, Natural; Male; Methotrexate; Remission Induction; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome | 1997 |
Cisplatin, vincristine, methotrexate, peplomycin, etoposide (COMPE) therapy for disseminated germ cell testicular tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cisplatin; Etoposide; Germinoma; Humans; Male; Methotrexate; Middle Aged; Peplomycin; Survival Analysis; Testicular Neoplasms; Treatment Outcome; Vincristine | 1997 |
Blast crisis of chronic myelogenous leukemia in long-lasting systemic lupus erythematosus: regression of both diseases after autologous bone marrow transplantation.
Topics: Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Blast Crisis; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cytarabine; Etoposide; Female; Humans; Idarubicin; Immunologic Factors; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lupus Erythematosus, Systemic; Methotrexate; Prednisone; Remission Induction; Transplantation, Autologous; Vincristine | 1997 |
EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Humans; Methotrexate; Middle Aged; Pregnancy; Risk; Risk Factors; Survival Analysis; Treatment Outcome; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1997 |
Treatment of men with metastatic non-seminomatous germ cell tumours with cyclical POMB/ACE chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Germinoma; Humans; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Survival Rate; Testicular Neoplasms; Vincristine | 1997 |
Comparison of apoptosis in wild-type and Fas-resistant cells: chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions.
Topics: Affinity Labels; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Biotin; Camptothecin; Caspase 3; Caspase 7; Caspases; Cisplatin; Cysteine Endopeptidases; Doxorubicin; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Fas Ligand Protein; fas Receptor; Flow Cytometry; Humans; Lamin Type B; Lamins; Leukemia-Lymphoma, Adult T-Cell; Membrane Glycoproteins; Methotrexate; Neoplasm Proteins; Nuclear Proteins; Oligopeptides; Poly(ADP-ribose) Polymerases; Staurosporine; Topoisomerase II Inhibitors; Topotecan; Tumor Cells, Cultured | 1997 |
Bcl-2 and Bcl-XL can differentially block chemotherapy-induced cell death.
Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-X Protein; Clone Cells; Drug Resistance, Neoplasm; Etoposide; Fluorouracil; Gamma Rays; Genes, bcl-2; Humans; Hydroxyurea; Methotrexate; Mice; Proto-Oncogene Proteins c-bcl-2; Recombinant Fusion Proteins; S Phase; Teniposide; Transfection; Vincristine | 1997 |
Pharmacokinetic monitoring of anticancer drugs at King Faisal Specialist Hospital, Riyadh, Saudi Arabia.
Topics: Antineoplastic Agents; Chromatography, High Pressure Liquid; Doxorubicin; Etoposide; Fluorouracil; Humans; Methotrexate; Mitoxantrone; Reference Values; Saudi Arabia | 1997 |
High incidence of secondary myelodysplastic syndromes following PROMACE-MOPP and involved field radiotherapy for localized gastric non-Hodgkin's lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Incidence; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Prednisone; Procarbazine; Prospective Studies; Radiotherapy, Adjuvant; Stomach Neoplasms; Vincristine | 1996 |
POMB/ACE chemotherapy for mediastinal germ-cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Germinoma; Humans; Male; Mediastinal Neoplasms; Methotrexate; Treatment Outcome; Vincristine | 1997 |
POMB/ACE chemotherapy for mediastinal germ cell tumours.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Follow-Up Studies; Germinoma; Humans; Male; Mediastinal Neoplasms; Methotrexate; Middle Aged; Seminoma; Survival Rate; Treatment Outcome; Vincristine | 1997 |
The role of radiation therapy and chemotherapy in the treatment of Merkel cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Merkel Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasms, Multiple Primary; Prognosis; Radiotherapy, High-Energy; Retrospective Studies; Skin Neoplasms; Survival Analysis; Treatment Outcome; Vincristine | 1997 |
High dose chemotherapy and stem cell rescue for aggressive non-Hodgkin's lymphoma: pattern of failure and implications for involved-field radiotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Mitoguazone; Radiotherapy, Adjuvant; Recurrence; Remission Induction; Treatment Failure | 1997 |
A bicistronic retroviral vector for protecting hematopoietic cells against antifolates and P-glycoprotein effluxed drugs.
Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Cloning, Molecular; Drug Resistance, Multiple; Etoposide; Folic Acid Antagonists; Gene Expression; Genetic Vectors; Hematopoietic Stem Cells; Humans; Methotrexate; Paclitaxel; Proviruses; Retroviridae; Tetrahydrofolate Dehydrogenase; Transformation, Genetic; Trimetrexate; Tumor Cells, Cultured; Vinblastine | 1997 |
BEAM chemotherapy and autologous haemopoietic progenitor cell transplantation as front-line therapy for high-risk patients with diffuse large cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Methotrexate; Middle Aged; Prednisone; Survival Rate; Treatment Outcome; Vincristine | 1997 |
Salvage therapy for relapsed or refractory childhood acute lymphocytic leukemia by alternative administration a lymphoid- and myeloid-directed chemotherapeutic regimen consisting of dual modulation of ara-C, hydroxyurea, and etoposide.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Fever; Gastrointestinal Diseases; Humans; Hydrocortisone; Hydroxyurea; Leucovorin; Male; Methotrexate; Mitoxantrone; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Salvage Therapy; Treatment Outcome | 1997 |
[A case of primary mediastinal choriocarcinoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Choriocarcinoma; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Male; Mediastinal Neoplasms; Methotrexate | 1997 |
Advanced diffuse large-cell lymphoma treated with 12-week combination chemotherapy: natural history of relapse after initial complete response and prognostic variables defining outcome after relapse.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Multivariate Analysis; Prednisone; Prognosis; Recurrence; Retrospective Studies; Vincristine | 1997 |
Metastatic placental site trophoblastic tumor: long-term remission in a patient treated with EMA/CO chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Lung Neoplasms; Methotrexate; Pregnancy; Radiography; Remission Induction; Trophoblastic Tumor, Placental Site; Uterine Neoplasms; Vaginal Neoplasms; Vincristine | 1998 |
[A case of primary endobronchial mucosa-associated lymphoid tissue lymphoma with middle lobe atelectasis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, B-Cell, Marginal Zone; Methotrexate; Middle Aged; Pulmonary Atelectasis; Remission Induction; Vincristine | 1997 |
Management of resistant gestational trophoblastic tumors.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Leucovorin; Methotrexate; Pregnancy; Risk Factors; Treatment Outcome; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1998 |
Multidrug resistance modulation in rhabdomyosarcoma and neuroblastoma cell lines.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Cell Survival; Cisplatin; Cyclophosphamide; Cyclosporine; Doxorubicin; Drug Resistance, Multiple; Etoposide; Humans; Kinetics; Lung Neoplasms; Methotrexate; Neuroblastoma; Rhabdomyosarcoma; Time Factors; Tumor Cells, Cultured; Verapamil; Vincristine | 1998 |
Methyl-GAG, ifosfamide, methotrexate and etoposide (MIME) as salvage therapy for Hodgkin's disease: a prospective study.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Mitoguazone; Neoplasms, Second Primary; Prospective Studies; Salvage Therapy; Survival Analysis | 1998 |
Systemic chemotherapy alone for patients with non-acquired immunodeficiency syndrome-related central nervous system lymphoma: a pilot study of the BOMES protocol.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Disease Progression; Etoposide; Female; Humans; Lymphoma, AIDS-Related; Male; Methotrexate; Methylprednisolone Hemisuccinate; Middle Aged; Pilot Projects; Prospective Studies; Survival Rate; Treatment Outcome; Vincristine | 1998 |
Treatment of multifocal lymphoma of bone with intensified ProMACE-CytaBOM chemotherapy and involved field radiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Prednisone; Survival Analysis; Tomography, X-Ray Computed; Vincristine | 1998 |
Levels of proteins C and S do not decline subsequent to first line chemotherapy in lymphoma patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; alpha-2-Antiplasmin; Antineoplastic Combined Chemotherapy Protocols; Antithrombin III; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fibrin Fibrinogen Degradation Products; Hodgkin Disease; Humans; Leucovorin; Lymphoma; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Mitoxantrone; Partial Thromboplastin Time; Plasminogen; Prednisone; Procarbazine; Protein C; Protein S; Thrombophilia; Time Factors; Vinblastine; Vincristine | 1997 |
Combination chemotherapy with mitoguazon, ifosfamide, MTX, etoposide (MIME) and G-CSF can efficiently mobilize PBPC in patients with Hodgkin's and non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Dexamethasone; Etoposide; Female; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Melphalan; Methotrexate; Middle Aged; Mitoguazone; Salvage Therapy; Time Factors | 1998 |
Fewer chromosome aberrations and earlier apoptosis induced by DNA synthesis inhibitors, a topoisomerase II inhibitor or alkylating agents in human cells with normal compared with mutant p53.
Topics: Alkylating Agents; Antineoplastic Agents; Aphidicolin; Apoptosis; B-Lymphocytes; Cell Division; Cell Line; Chromosome Aberrations; Cytarabine; DNA Replication; Etoposide; Humans; Hydroxyurea; Methotrexate; Mutagenesis; Nucleic Acid Synthesis Inhibitors; Radiation, Ionizing; Topoisomerase II Inhibitors; Tumor Suppressor Protein p53 | 1998 |
Chemotherapeutic agents used in the treatment of childhood malignancies have direct effects on growth plate chondrocyte proliferation.
Topics: Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carboplatin; Cell Cycle; Cell Division; Cells, Cultured; Chondrocytes; Cisplatin; Dactinomycin; Dexamethasone; Etoposide; Growth Plate; Male; Mercaptopurine; Methotrexate; Prednisolone; Rats; Rats, Sprague-Dawley; Thioguanine | 1998 |
Two cases of fatal bleomycin pneumonitis complicating the treatment of non-Hodgkin's lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Pneumonia; Prednisolone; Pulmonary Fibrosis; Vascular Neoplasms; Vincristine | 1998 |
Comparison of chemotherapies with methotrexate, VP-16 and actinomycin-D in low-risk gestational trophoblastic disease. Remission rates and drug toxicities.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury; Chorionic Gonadotropin; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Hematologic Diseases; Humans; Methotrexate; Pregnancy; Remission Induction; Risk Factors; Trophoblastic Neoplasms; Uterine Neoplasms | 1998 |
Necrosis of myometrial choriocarcinoma with fulminating sepsis complicating chemotherapy for trophoblastic tumor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Myometrium; Necrosis; Neoplasms, Multiple Primary; Pregnancy; Remission Induction; Sepsis; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1998 |
[Usefulness of magnetic resonance imaging for evaluation of therapeutic efficacy of bone metastases from bladder cancer: a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Urinary Bladder Neoplasms; Vinblastine | 1998 |
Induction of drug-resistant bladder carcinoma cells in vitro: impact on polychemotherapy with cisplatin, methotrexate and vinblastine (CMV).
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cell Cycle; Cell Division; Cisplatin; DNA, Neoplasm; Drug Resistance, Neoplasm; Etoposide; Flow Cytometry; Humans; Methotrexate; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Vinblastine | 1998 |
[Meningoradiculitis revealing an occult medulloblastoma-PNET in an adult].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Cisplatin; Etoposide; Humans; Magnetic Resonance Imaging; Male; Medulloblastoma; Meningitis; Methotrexate; Middle Aged; Neuroectodermal Tumors, Primitive; Oculomotor Nerve; Polyradiculopathy | 1998 |
[The growing teratoma syndrome: report of a case].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Male; Methotrexate; Orchiectomy; Peplomycin; Syndrome; Teratoma; Testicular Neoplasms; Vincristine | 1998 |
[A case of primary malignant lymphoma of the bladder].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisolone; Remission Induction; Urinary Bladder Neoplasms; Vincristine | 1998 |
Secondary acute myeloid leukemia following treatment with VP16-containing regimens for non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Enzyme Inhibitors; Etoposide; Fatal Outcome; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Leukemia, Monocytic, Acute; Leukemia, Myelomonocytic, Acute; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell; Male; Methotrexate; Mitoxantrone; Neoplasm Proteins; Neoplasms, Second Primary; Prednisone; Topoisomerase II Inhibitors; Vincristine | 1998 |
Decreased delivery and acute toxicity of cranial irradiation and chemotherapy given with osmotic blood-brain barrier disruption in a rodent model: the issue of sequence.
Topics: Analysis of Variance; Animals; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain; Carboplatin; Combined Modality Therapy; Etoposide; Female; Infusions, Intra-Arterial; Methotrexate; Radiotherapy; Random Allocation; Rats; Rats, Long-Evans; Tritium | 1995 |
Long-term follow-up of non-Hodgkin's lymphoma patients treated with ProMACE-CytaBOM: an effective regimen for the intermediate grade subtype.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neutropenia; Prednisone; Survival Rate; Treatment Outcome; Vincristine | 1998 |
The effects of etoposide on testicular function in boys treated for Hodgkin's disease.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Follicle Stimulating Hormone; Hodgkin Disease; Humans; Luteinizing Hormone; Male; Methotrexate; Prednisone; Procarbazine; Puberty; Remission Induction; Testis; Testosterone; Vincristine | 1998 |
The management of high-risk gestational trophoblastic tumours (GTT).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Middle Aged; Pregnancy; Prognosis; Retrospective Studies; Survival Analysis; Treatment Outcome; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1998 |
Effects of multiagent chemotherapy and independent risk factors in the treatment of high-risk GTT--25 years experiences of KRI-TRD.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole; Korea; Methotrexate; Pregnancy; Proportional Hazards Models; Retrospective Studies; Risk Factors; Survival Analysis; Treatment Outcome; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1998 |
Chemotherapy for gestational trophoblastic tumours hastens menopause by 3 years.
Topics: Adult; Antineoplastic Agents; Choriocarcinoma; Dactinomycin; Etoposide; Female; Follow-Up Studies; Humans; Hydroxyurea; Leucovorin; Menopause, Premature; Mercaptopurine; Methotrexate; Middle Aged; Pregnancy; Retrospective Studies; Risk Factors; Trophoblastic Neoplasms | 1998 |
Separation of etoposide phosphate and methotrexate by capillary zone electrophoresis using UV detection with a high sensitivity cell.
Topics: Antineoplastic Agents; Electrophoresis, Capillary; Etoposide; Female; Humans; Methotrexate; Organophosphorus Compounds | 1998 |
High-dose sequential chemotherapy with autologous blood stem cell rescue for relapsed or resistant lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Resistance, Neoplasm; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Methotrexate; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Stem Cells | 1998 |
Schedule-dependent and -independent antitumor activity of paclitaxel-based combination chemotherapy against M-109 murine lung carcinoma in vivo.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Female; Injections, Intravenous; Lung Neoplasms; Male; Methotrexate; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Nitrosourea Compounds; Paclitaxel; Vinblastine | 1998 |
Downbeat nystagmus caused by thiamine deficiency: an unusual presentation of CNS localization of large cell anaplastic CD 30-positive non-Hodgkin's lymphoma.
Topics: Adult; Anisocoria; Antineoplastic Combined Chemotherapy Protocols; Aphasia; Bleomycin; Brain Neoplasms; Cyclophosphamide; Cytarabine; Dizziness; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hemiplegia; Humans; Lymphoma, Large-Cell, Anaplastic; Methotrexate; Mitoxantrone; Neoplastic Stem Cells; Nystagmus, Pathologic; Prednisone; Remission Induction; Thiamine; Vincristine; Vomiting; Wernicke Encephalopathy | 1999 |
Ifosfamide/etoposide alternating with high-dose methotrexate: evaluation of a chemotherapy regimen for poor-risk osteosarcoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Humans; Ifosfamide; Male; Methotrexate; Osteosarcoma; Recurrence; Retrospective Studies | 1999 |
Gestational trophoblastic disease: does central nervous system chemoprophylaxis have a role?
Topics: Adolescent; Adult; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dactinomycin; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Lung Neoplasms; Methotrexate; Middle Aged; Patient Compliance; Pregnancy; Prognosis; Retrospective Studies; Risk Assessment; Trophoblastic Neoplasms; Uterine Neoplasms | 1999 |
The presentation and management of post-partum choriocarcinoma.
Topics: Adult; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Leucovorin; Methotrexate; Postpartum Hemorrhage; Postpartum Period; Pregnancy; Retrospective Studies; Uterine Neoplasms; Vincristine | 1999 |
[Effects of various mutant p53 on the sensitivity of cells to cytostatics].
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Clone Cells; Colony-Forming Units Assay; Etoposide; Humans; Methotrexate; Mice; Mutation, Missense; Rats; Tumor Suppressor Protein p53; Vinblastine | 1999 |
[Reye syndrome in a child having received chemotherapy].
Topics: Abdominal Neoplasms; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Male; Methotrexate; Prednisone; Reye Syndrome; Vincristine | 1998 |
Evaluation of apoptosis and necrosis induction in cultured cells of lung carcinomas under effect of cytostatic drugs in vitro.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Bleomycin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Epirubicin; Etoposide; Humans; Lung Neoplasms; Methotrexate; Necrosis; Tumor Cells, Cultured; Vinblastine; Vincristine | 1999 |
Evaluation of individual sensitivity to cytostatic drugs of in vitro cultured lung tumor cells.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Bleomycin; Carcinoma, Non-Small-Cell Lung; Cell Division; Cisplatin; Epirubicin; Etoposide; Fluorouracil; Lung Neoplasms; Methotrexate; Tumor Cells, Cultured; Vinblastine; Vincristine | 1999 |
MRP3, an organic anion transporter able to transport anti-cancer drugs.
Topics: Animals; Antineoplastic Agents; ATP-Binding Cassette Transporters; Cell Line; DNA, Complementary; Dogs; Drug Carriers; Drug Resistance, Multiple; Etoposide; Gene Expression; Humans; Methotrexate; Molecular Sequence Data; Multidrug Resistance-Associated Proteins; Teniposide | 1999 |
Hypophyseal non-Hodgkin's lymphoma presenting with diabetes insipidus: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Diabetes Insipidus; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Magnetic Resonance Spectroscopy; Male; Methotrexate; Middle Aged; Pituitary Neoplasms; Prednisone; Procarbazine; Tomography, X-Ray Computed; Vincristine | 1999 |
Cutaneous granulocytic sarcoma mimicking immunoblastic large cell lymphoma.
Topics: Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Diagnosis, Differential; Doxorubicin; Etoposide; Flow Cytometry; Humans; Immunohistochemistry; Immunophenotyping; Leukemia, Myeloid; Lymph Nodes; Lymphoma, Large-Cell, Immunoblastic; Male; Methotrexate; Microscopy, Electron; Prednisone; Skin Neoplasms; Treatment Outcome; Vincristine | 1999 |
The influence of radiation and chemotherapy-related DNA strand breaks on carcinogenesis: an evaluation.
Topics: Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cisplatin; Dactinomycin; DNA Damage; DNA, Neoplasm; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Doxorubicin; Etoposide; Leukemia, Experimental; Methotrexate; Mice; Tumor Cells, Cultured; Vincristine | 1999 |
Clinical assessment of EMA/CO induced DNA damage in peripheral blood lymphocytes of high-risk gestational trophoblastic tumor patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; DNA Damage; Etoposide; Female; Humans; Lymphocytes; Methotrexate; Pregnancy; Trophoblastic Neoplasms; Vincristine | 1999 |
[Primary lymphoma of the thyroid with contralateral recurrence--case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Citrates; Cyclophosphamide; Dexamethasone; Epirubicin; Etoposide; Female; Gallium; Gallium Radioisotopes; Humans; Ifosfamide; Lymphoma; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Radiopharmaceuticals; Remission Induction; Technetium; Thallium; Thyroid Neoplasms; Thyroidectomy; Vincristine | 1999 |
[Lymphoma of the mandible: presentation of 2 cases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Male; Mandibular Neoplasms; Methotrexate; Middle Aged; Prednisone; Remission Induction; Transplantation, Autologous | 1999 |
[Burkitt's lymphoma--a case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Diagnosis, Differential; Epirubicin; Etoposide; Female; Humans; Methotrexate; Prednisone; Vincristine | 1999 |
Diffuse large-cell lymphoma of the testis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Prospective Studies; Recurrence; Retrospective Studies; Salvage Therapy; Testicular Neoplasms; Treatment Outcome; Vincristine | 1999 |
Effect of fluconazole on the growth and adhesion of Candida albicans in the presence of antineoplastic agents.
Topics: Antifungal Agents; Antineoplastic Agents; Candida albicans; Candidiasis, Oral; Cell Adhesion; Drug Interactions; Epithelial Cells; Etoposide; Fluconazole; Humans; Methotrexate; Microbial Sensitivity Tests; Mouth Mucosa | 1999 |
Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic plac
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Cisplatin; Cohort Studies; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Placenta; Pregnancy; Remission Induction; Risk Factors; Survival Rate; Trophoblastic Neoplasms; Uterine Neoplasms | 2000 |
A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL).
Topics: Adolescent; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Italy; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Pilot Projects; Prednisone; Recurrence; Survival Rate; Vincristine | 2000 |
In vitro cytotoxic effects of fludarabine (2-F-ara-A) in combination with commonly used antileukemic agents by isobologram analysis.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Cell Survival; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Humans; Hydroxyurea; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Methotrexate; Neoplastic Stem Cells; Tumor Cells, Cultured; Vidarabine; Vidarabine Phosphate; Vincristine | 2000 |
[Long-term results of small cell lung cancer treated by surgery combined with postoperative chemotherapy: a report of 65 patients].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Postoperative Period; Survival Rate; Vincristine | 1997 |
A brief intensive chemotherapy in T-prolymphocytic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Leukemia, Prolymphocytic; Leukemia, T-Cell; Male; Methotrexate; Middle Aged; Pentostatin; Prognosis; T-Lymphocyte Subsets; Transplantation, Autologous; Vincristine | 2000 |
Long-term follow-up of advanced-stage low-grade lymphoma patients treated upfront with high-dose sequential chemotherapy and autograft.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease Progression; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Melphalan; Methotrexate; Middle Aged; Mitoxantrone; Remission Induction; Survival Analysis; Treatment Outcome; Vincristine | 2000 |
Complications of systemic chemotherapy as treatment of retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclosporine; Cytarabine; Etoposide; Female; Fever; Humans; Infant; Male; Methotrexate; Neutropenia; Organophosphorus Compounds; Retinal Neoplasms; Retinoblastoma; Thrombocytopenia; Vincristine | 2000 |
Anthracyclines trigger apoptosis of both G0-G1 and cycling peripheral blood lymphocytes and induce massive deletion of mature T and B cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; B-Lymphocytes; Camptothecin; Cell Cycle; Cells, Cultured; Daunorubicin; Doxorubicin; Etoposide; Fluorouracil; G1 Phase; Humans; Lymph Nodes; Lymphocyte Depletion; Lymphocytes; Methotrexate; Mice; Mice, Inbred BALB C; Resting Phase, Cell Cycle; Spleen; T-Lymphocytes; Thymus Gland | 2000 |
Treatment of persistent trophoblastic disease later than 6 months after diagnosis of molar pregnancy.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Databases as Topic; England; Etoposide; Female; Follow-Up Studies; Humans; Hydatidiform Mole; Leucovorin; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pregnancy; Prognosis; Registries; Salvage Therapy; Time Factors; Treatment Outcome; Trophoblastic Neoplasms; Uterine Neoplasms | 2000 |
Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Pregnancy; Retrospective Studies; Trophoblastic Neoplasms; Uterine Neoplasms | 2000 |
Proteasome inhibition circumvents solid tumor resistance to topoisomerase II-directed drugs.
Topics: Acetylcysteine; Animals; Antigens, Neoplasm; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Blotting, Northern; Cell Cycle; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; DNA Topoisomerases, Type II; DNA-Binding Proteins; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Glucose; Humans; Hypoxia; Immunoblotting; Isoenzymes; Methotrexate; Mice; Mice, Nude; Multienzyme Complexes; Neoplasm Transplantation; Nucleic Acid Synthesis Inhibitors; Proteasome Endopeptidase Complex; Time Factors; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Vincristine | 2000 |
Chemotherapy of gestational trophoblastic disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Pregnancy; Trophoblastic Tumor, Placental Site; Uterine Neoplasms; Vincristine | 2000 |
Treatment of malignant ovarian germ cell tumors with preservation of fertility: reproductive performance after persistent remission.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Dysgerminoma; Endodermal Sinus Tumor; Etoposide; Female; Fertility; Follow-Up Studies; Germinoma; Humans; Leucovorin; Menstruation; Methotrexate; Ovarian Neoplasms; Remission Induction; Reproduction; Vincristine | 2000 |
Kinetics of early therapeutic response as measured by quantitative PCR predicts survival in a murine xenograft model of human T cell acute lymphoblastic leukemia.
Topics: Animals; Antineoplastic Agents; Calibration; Cell Cycle; Cyclophosphamide; Cytarabine; DNA, Neoplasm; Doxorubicin; Drug Evaluation; Etoposide; Female; Flow Cytometry; Humans; Leukemia-Lymphoma, Adult T-Cell; Methotrexate; Mice; Mice, SCID; Neoplasm Transplantation; Neoplasm, Residual; Polymerase Chain Reaction; Prognosis; Reference Standards; Risk Assessment; Specific Pathogen-Free Organisms; Survival Analysis; Transplantation, Heterologous; Tumor Cells, Cultured; Vincristine | 2000 |
The role of p53 in death of IL-3-dependent cells in response to cytotoxic drugs.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bleomycin; Bone Marrow Cells; Cells, Cultured; Cisplatin; Colony-Forming Units Assay; DNA Damage; DNA Replication; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Floxuridine; Genes, p53; Hematopoietic Stem Cells; Hydroxyurea; Interleukin-3; Methotrexate; Mice; Mice, Inbred C57BL; Mice, Knockout; Radiation Tolerance; Tumor Suppressor Protein p53 | 2000 |
Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma by combined methotrexate and prednisone.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cyclosporine; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Immunoblastic Lymphadenopathy; Immunosuppressive Agents; Lymphoma, T-Cell, Peripheral; Male; Methotrexate; Prednisone; Remission Induction; Vincristine | 2000 |
Improving the outcome of salvage treatment for non-seminomatous germ cell tumours (NSGCT).
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dactinomycin; Disease-Free Survival; Etoposide; Humans; Ifosfamide; Male; Methotrexate; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Teratoma; Testicular Neoplasms; Treatment Outcome; Vinblastine; Vincristine | 2000 |
Intensive chemotherapy (LNHIV-91 regimen) and G-CSF for HIV associated non-Hodgkin's lymphoma.
Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD4 Lymphocyte Count; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Evaluation; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hospitalization; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Recurrence; Survival Rate; Treatment Outcome; Vindesine | 2000 |
Interferon does not prolong progression-free survival after ProMACE-MOPP.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Interferon-alpha; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Vincristine | 2000 |
Clinical relevance of the lung resistance protein in diffuse large B-cell lymphomas.
Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; ATP-Binding Cassette Transporters; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Resistance, Multiple; Etoposide; Female; Humans; Immunohistochemistry; Lomustine; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Prednimustine; Prednisone; Regression Analysis; Survival Analysis; Treatment Outcome; Vault Ribonucleoprotein Particles; Vincristine | 2000 |
Postpartum choriocarcinoma complicated by brain and lung metastases treated successfully with EMA/CO regimen.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cerebral Hemorrhage; Choriocarcinoma; Cyclophosphamide; Etoposide; Female; Humans; Infant; Lung Neoplasms; Magnetic Resonance Imaging; Methotrexate; Pregnancy; Tomography, X-Ray Computed; Uterine Neoplasms; Vincristine | 2000 |
Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Daunorubicin; Etoposide; Female; Flow Cytometry; Humans; Hydrocortisone; Immunophenotyping; Infant; Male; Mercaptopurine; Methotrexate; Neoplasm, Residual; Neoplastic Cells, Circulating; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Prospective Studies; Remission Induction; Treatment Outcome; Vincristine | 2000 |
Involvement of the appendix in a relapsed case of primary nasal NK/T-cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Appendectomy; Appendiceal Neoplasms; Appendicitis; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Humans; Intestinal Perforation; Killer Cells, Natural; Leucovorin; Lymphoma, T-Cell; Male; Methotrexate; Methylprednisolone; Nitrosourea Compounds; Nose Neoplasms; Prednisone; Skin Neoplasms; Splenic Neoplasms; Tumor Virus Infections; Vincristine | 2000 |
[Sézary syndrome showing a stable clinical course for more than four years after oral administration of etoposide and methotrexate].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Methotrexate; Middle Aged; Sezary Syndrome; Skin Neoplasms; Time Factors | 2000 |
Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic cell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphoma.
Topics: Acute Kidney Injury; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Marrow Purging; Cardiomyopathies; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Cyclophosphamide; Cystitis; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hemorrhage; Humans; Infections; Leucovorin; Life Tables; Lymphoma, Non-Hodgkin; Male; Melphalan; Methotrexate; Middle Aged; Mitoxantrone; Pilot Projects; Salvage Therapy; Survival Analysis; Survival Rate; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vincristine | 2000 |
Methotrexate infusion in low-risk gestational trophoblastic disease.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Etoposide; Female; Humans; Hydatidiform Mole; Infusions, Intravenous; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Prospective Studies; Remission Induction; Risk Factors | 2000 |
Chemotherapy and marrow transplantation for congenital leukaemia.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Etoposide; Female; Humans; Infant, Newborn; Leukemia; Methotrexate; Mitoxantrone; Prednisolone; Treatment Outcome; Vincristine | 2001 |
Should we always choose a nonparametric test when comparing two apparently nonnormal distributions?
Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Data Interpretation, Statistical; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Leukocyte Count; Lymphoma, Non-Hodgkin; Methotrexate; Mitoguazone; Models, Statistical; Neutrophils; Numerical Analysis, Computer-Assisted; Sample Size; Software; Statistical Distributions; Statistics, Nonparametric; Stochastic Processes; Time Factors | 2001 |
Bone marrow involvement by nasal NK cell lymphoma at diagnosis is uncommon.
Topics: Adult; Aged; Aged, 80 and over; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Chemotherapy, Adjuvant; Cyclophosphamide; Cytarabine; Epirubicin; Etoposide; Female; Humans; Immunoenzyme Techniques; In Situ Hybridization; Killer Cells, Natural; Lymphoma; Male; Methotrexate; Middle Aged; Nose Neoplasms; Prednisone; Radiotherapy; RNA, Viral; Treatment Outcome; Vincristine | 2001 |
Adjuvant hysterectomy in low-risk gestational trophoblastic disease.
Topics: Adolescent; Adult; Antineoplastic Agents; Chemotherapy, Adjuvant; Dactinomycin; Etoposide; Female; Humans; Hysterectomy; Methotrexate; Middle Aged; Pregnancy; Treatment Outcome; Trophoblastic Neoplasms; Uterine Neoplasms | 2001 |
Primary high-grade mucosa-associated lymphoid tissue-type lymphoma of the cervix presenting as a common endocervical polyp.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cyclophosphamide; Cytarabine; Diagnosis, Differential; Epirubicin; Etoposide; Female; Humans; Hysterectomy; Immunohistochemistry; In Situ Hybridization; Lymphoma, B-Cell, Marginal Zone; Methotrexate; Middle Aged; Neoplasm Proteins; Polyps; Prednisone; Uterine Cervical Neoplasms; Vincristine | 2001 |
[Methotrexate combined chemotherapy for chemorefractory gestational trophoblastic tumour].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Hydatidiform Mole, Invasive; Methotrexate; Middle Aged; Pregnancy; Uterine Neoplasms; Vincristine | 1999 |
Topoisomerase II inhibitor induced leukemia in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Homosexuality, Male; Humans; Idarubicin; Leukemia, Myeloid, Acute; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Neoplasm Metastasis; Neoplasms, Second Primary; Topoisomerase II Inhibitors | 2001 |
Lenograstim and filgrastim effects on neutrophil motility in patients undergoing chemotherapy: evaluation by computer-assisted image analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD18 Antigens; Cell Movement; Chemotaxis, Leukocyte; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Filgrastim; Glycosylation; Granulocyte Colony-Stimulating Factor; Humans; Image Processing, Computer-Assisted; Lenograstim; Lymphoma, Non-Hodgkin; Methotrexate; Neutrophils; Prednisone; Protein Processing, Post-Translational; Recombinant Proteins; Vincristine | 2001 |
Metastatic placental site trophoblastic tumor. Report of a case with complete response to chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Lung Neoplasms; Methotrexate; Pregnancy; Remission Induction; Trophoblastic Tumor, Placental Site; Uterine Neoplasms; Vincristine | 2001 |
Early onset Pneumocystis carinii pneumonia after allogeneic peripheral blood stem cell transplantation.
Topics: Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Combined Modality Therapy; Cytarabine; Daunorubicin; Etoposide; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Immune System; Immunocompromised Host; Male; Methotrexate; Middle Aged; Opportunistic Infections; Pneumonia, Pneumocystis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Respiratory Insufficiency; Transplantation Conditioning; Transplantation, Autologous; Trimethoprim, Sulfamethoxazole Drug Combination; Vincristine; Whole-Body Irradiation | 2001 |
Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphoma.
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Arthralgia; Arthroplasty, Replacement, Hip; Asparaginase; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Female; Femur Head Necrosis; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Mercaptopurine; Methotrexate; Mitoxantrone; Osteonecrosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Risk Factors; Treatment Outcome; Vincristine | 2001 |
Metastatic placental site trophoblastic tumors: clinical aspects of two unique cases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Cyclophosphamide; Dactinomycin; Etoposide; Fatal Outcome; Female; Humans; Lung Neoplasms; Methotrexate; Pregnancy; Trophoblastic Tumor, Placental Site; Uterine Neoplasms; Vincristine | 2001 |
Central nervous system involvement in gestational trophoblastic neoplasia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chorionic Gonadotropin, beta Subunit, Human; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Pregnancy; Prospective Studies; Survival Analysis; Tomography, X-Ray Computed; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 2001 |
Intensification of salvage treatment with high-dose sequential chemotherapy improves the outcome of patients with refractory or relapsed aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Recurrence; Regression Analysis; Retrospective Studies; Salvage Therapy; Survival Rate; Transplantation, Autologous | 2001 |
[Typical forms of choriocarcinoma in clinical practice--diagnosis and therapeutic course in four patients].
Topics: Abortion, Induced; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Choriocarcinoma; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Methotrexate; Neoplasm Metastasis; Pregnancy; Radiography; Uterine Neoplasms | 2001 |
Separation of selected anticancer drugs using superheated water as the mobile phase.
Topics: Antineoplastic Agents; Etoposide; Fluorouracil; Hot Temperature; Methotrexate; Water | 2001 |
Sensitivity of soft tissue sarcoma cell lines to chemotherapeutic agents: identification of ecteinascidin-743 as a potent cytotoxic agent.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Cell Cycle; Cell Survival; Dioxoles; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Humans; Inhibitory Concentration 50; Isoquinolines; Methotrexate; Proto-Oncogene Proteins c-bcl-2; Retinoblastoma Protein; Sarcoma; Sensitivity and Specificity; Tetrahydroisoquinolines; Trabectedin; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2001 |
Correlation between decreased apoptosis and multidrug resistance (MDR) in murine leukemic T cell lines.
Topics: Animals; Antineoplastic Agents; Apoptosis; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Etoposide; Leukemia, T-Cell; Methotrexate; Mice; Tumor Cells, Cultured; Vincristine | 2001 |
Rituximab in combination with interferon-alpha in relapsed and refractory diffuse large B-cell non-Hodgkin's lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Humans; Ifosfamide; Immunologic Factors; Immunotherapy; Interferon-alpha; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Radiotherapy, Adjuvant; Remission Induction; Rituximab; Vincristine | 2001 |
Management of a 16-year-old boy with adenocarcinoma at the esophageal gastric junction.
Topics: Adenocarcinoma; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Diagnosis, Differential; Doxorubicin; Esophagogastric Junction; Etoposide; Fluorouracil; Humans; Male; Methotrexate; Paclitaxel; Stomach Neoplasms | 2001 |
Adult lymphoblastic lymphoma in Taiwan: an analysis of treatment results of 26 patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Mechlorethamine; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Procarbazine; Prognosis; Recurrence; Retrospective Studies; Survival Analysis; Taiwan; Treatment Outcome; Vincristine | 2001 |
[Effective treatment with Lamivudine of patients with reactivation of hepatitis B following chemotherapy administration].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Leukemia-Lymphoma, Adult T-Cell; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Reverse Transcriptase Inhibitors; Vincristine; Virus Activation | 2001 |
Intracellular glutathione deficiency is associated with enhanced nuclear factor-kappaB activation in older non-insulin dependent diabetic patients.
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diabetes Mellitus, Type 2; DNA; Doxorubicin; Electrophoretic Mobility Shift Assay; Etoposide; Female; Glutathione; Humans; Interleukin-6; Male; Methotrexate; NF-kappa B; Sulfhydryl Compounds | 2001 |
Point mutations of the BCL-6 gene: clinical and prognostic correlation in B-diffuse large cell lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Chromosomes, Human, Pair 3; Cyclophosphamide; Cytarabine; Disease-Free Survival; DNA Mutational Analysis; DNA-Binding Proteins; DNA, Neoplasm; Doxorubicin; Etoposide; Female; Genes, bcl-2; Humans; Life Tables; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Methotrexate; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Point Mutation; Prednisolone; Prednisone; Prognosis; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-6; Proto-Oncogenes; Transcription Factors; Treatment Outcome; Vincristine | 2002 |
[Chemotherapy-associated myelosuppression in gynecological oncology].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Cobalt Radioisotopes; Combined Modality Therapy; Cyclophosphamide; Data Interpretation, Statistical; Etoposide; Female; Fluorouracil; Hematopoiesis; Humans; Leukopoiesis; Lymph Node Excision; Lymphatic Metastasis; Mastectomy, Segmental; Methotrexate; Middle Aged; Ovarian Neoplasms; Platelet Count; Radioisotope Teletherapy; Radiotherapy Dosage | 2001 |
Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Clinical Protocols; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Methotrexate; Pregnancy; Risk; Survival Analysis; Treatment Outcome; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 2002 |
Choriocarcinoma and epithelial trophoblastic tumor: successful treatment of relapse with hysterectomy and high-dose chemotherapy with peripheral stem cell support: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Dose-Response Relationship, Drug; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Hysterectomy; Lung Neoplasms; Methotrexate; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 2002 |
[An autopsy case of pulmonary and central nervous system metastatic osteosarcoma treated with thirty-six courses of chemotherapy over four years].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carboplatin; Cisplatin; Dacarbazine; Deoxycytidine; Docetaxel; Drug Administration Schedule; Etoposide; Gemcitabine; Humans; Ifosfamide; Lung Neoplasms; Male; Methotrexate; Osteosarcoma; Paclitaxel; Spinal Cord Neoplasms; Survivors; Taxoids; Vincristine; Vindesine | 2002 |
Expression of P53 and bcl-2 proteins in T-cell lymphoblastic lymphoma: prognostic implications.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Immunohistochemistry; Logistic Models; Longitudinal Studies; Male; Methotrexate; Neoplasm Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Proto-Oncogene Proteins c-bcl-2; Recurrence; Retrospective Studies; Survival Analysis; Tumor Suppressor Protein p53; Vincristine | 2002 |
Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Immunophenotyping; Male; Mercaptopurine; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Risk Factors; Treatment Outcome; Vincristine | 2002 |
Cure in a case of primary hepatic lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Liver Neoplasms; Lymphoma; Male; Methotrexate; Prednisolone; Tomography, X-Ray Computed; Vincristine | 2000 |
[Abdominal presentation of B-cell non-Hodgkin's lymphoma (B-NHL) - surgical treatment and its results. Report of the Polish Paediatric Leukaemia/Lymphoma Study Group].
Topics: Abdominal Neoplasms; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Infant; Laparotomy; Leucovorin; Lymphoma, B-Cell; Male; Methotrexate; Prednisone; Risk Factors; Time Factors; Treatment Outcome; Vincristine | 2000 |
In vitro effects of chemotherapeutic agents on human osteoblast-like cells.
Topics: Alkaline Phosphatase; Asparaginase; Bone Diseases, Metabolic; Cell Count; Cell Culture Techniques; Cell Differentiation; Dexamethasone; Etoposide; Humans; Methotrexate; Osteoblasts; Vincristine | 2002 |
Successful conservative treatment for advanced interstitial pregnancy. A case report.
Topics: Abortifacient Agents, Nonsteroidal; Adult; Antineoplastic Agents, Phytogenic; Diagnosis, Differential; Etoposide; Female; Humans; Infusions, Intravenous; Injections, Intralesional; Methotrexate; Pregnancy; Pregnancy, Tubal; Ultrasonography, Interventional; Ultrasonography, Prenatal | 2002 |
Alpha(4)beta(7)/alpha(4)beta(1) dual integrin antagonists block alpha(4)beta(7)-dependent adhesion under shear flow.
Topics: Animals; Antibodies, Blocking; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cell Adhesion; Cell Adhesion Molecules; Cyclophosphamide; Doxorubicin; Endothelium, Vascular; Etoposide; Female; Flow Cytometry; Humans; Immunoglobulin G; Immunoglobulins; Integrin alpha4beta1; Integrins; Ligands; Lymphocytes; Methotrexate; Mice; Mice, Inbred BALB C; Mucoproteins; Peyer's Patches; Phenylalanine; Receptors, Lymphocyte Homing; Recombinant Fusion Proteins; Rheology | 2002 |
Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Société Française d'Oncologie Pédiatrique LMB89 protocol.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; France; Humans; Hydrocortisone; Leucovorin; Lymphoma, B-Cell; Male; Methotrexate; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Survival Rate; Treatment Outcome; Tumor Lysis Syndrome; Urate Oxidase; Vincristine | 2002 |
Management of brain metastases in patients with high-risk gestational trophoblastic tumors.
Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cause of Death; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Pregnancy Outcome; Pregnancy, High-Risk; Prognosis; Remission Induction; Retrospective Studies; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine | 2002 |
Natural killer cells contribute to the lethality of a murine model of Escherichia coli infection.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; CD3 Complex; Cells, Cultured; Cyclophosphamide; DNA-Binding Proteins; Doxorubicin; Endothelium, Vascular; Escherichia coli Infections; Etoposide; Female; Humans; Injections, Intraperitoneal; Intercellular Adhesion Molecule-1; Interferon-gamma; Interleukin-1; Killer Cells, Natural; Methotrexate; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; NF-kappa B; Phosphorylation; Receptors, Antigen, T-Cell; Sepsis; Spleen; STAT1 Transcription Factor; Survival Rate; Trans-Activators; Tumor Necrosis Factor-alpha; Umbilical Veins | 2002 |
Clinical characteristics of gestational trophoblastic disease at a single institute.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Leucovorin; Methotrexate; Middle Aged; Pregnancy; Pregnancy Complications, Neoplastic; Prognosis; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 2002 |
Combination of ifosfamide, methotrexate, and etoposide (IMVP) as a salvage therapy for relapsed and refractory aggressive non-Hodgkin lymphoma: retrospective study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Neoplasm Staging; Retrospective Studies; Salvage Therapy; Survival Analysis | 2002 |
A dexamethasone, vinblastine, cyclophosphamide, etoposide, methotrexate and bleomycin (D-VICEMB) protocol as first-line treatment of patients aged 70 years or older affected by intermediate/high grade non-Hodgkin's lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Survival Rate; Vinblastine | 2002 |
Tailored chemotherapy for malignant lymphoma arising in the setting of posttransplant lymphoproliferative disorder after solid organ transplantation.
Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Burkitt Lymphoma; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Fatal Outcome; Female; Heart Transplantation; Humans; Immunosuppression Therapy; Kidney Transplantation; Lung Neoplasms; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Male; Methotrexate; Postoperative Complications; Prednisone; Remission Induction; Stomach Neoplasms; Survival Analysis; Treatment Outcome; Vincristine | 2002 |
Coexisting true hermaphroditism and partial hydatidiform mole developing metastatic gestational trophoblastic tumors. A case report.
Topics: Abortion, Therapeutic; Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Disorders of Sex Development; Etoposide; Female; Fetus; Humans; Hydatidiform Mole; Lung Neoplasms; Magnetic Resonance Imaging; Male; Methotrexate; Mosaicism; Neoplasms, Multiple Primary; Pregnancy; Pregnancy Complications, Neoplastic; Radiography; Trophoblastic Neoplasms; Uterine Neoplasms | 2002 |
Case of PSTT treated with chemotherapy followed by open uterine tumor resection to preserve fertility.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Fertility; Humans; Methotrexate; Pregnancy; Trophoblastic Tumor, Placental Site; Uterine Neoplasms; Vincristine | 2002 |
Dental abnormalities in children after chemotherapy treatment for acute lymphoid leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dental Enamel Hypoplasia; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Infant; Male; Mercaptopurine; Methotrexate; Odontogenesis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Teniposide; Tooth Abnormalities; Tooth Diseases; Tooth Eruption; Tooth Root; Vincristine | 2003 |
[A patient with mantle cell lymphoma who successfully underwent auto-PBSCT in combination with in vivo purging of tumor cells using rituximab].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Purging; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunotherapy; Lymphoma, Mantle-Cell; Methotrexate; Middle Aged; Prednisone; Remission Induction; Rituximab; Transplantation, Autologous; Vincristine | 2002 |
HHV8-related non-Hodgkin's lymphoma of the spermatic cord in a patient with HIV-associated multicentric Castleman disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Castleman Disease; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Genital Neoplasms, Male; Herpesviridae Infections; Herpesvirus 8, Human; Humans; Lymphoma, AIDS-Related; Male; Methotrexate; Middle Aged; Orchiectomy; Prednisone; Remission Induction; Sarcoma, Kaposi; Skin Neoplasms; Spermatic Cord; Splenectomy; Tumor Virus Infections; Vincristine | 2003 |
Coeliac disease following high-dose chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Celiac Disease; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Diarrhea; Diet; Doxorubicin; Etoposide; Glutens; Humans; Lomustine; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Morbidity; Prednisolone; Vincristine | 2002 |
The effects of chemotherapeutic agents on the regulation of thrombin on cell surfaces.
Topics: alpha-Macroglobulins; Antineoplastic Agents; Antithrombins; Cell Membrane; Doxorubicin; Etoposide; Humans; Methotrexate; Prothrombin; Thrombin; Thromboplastin; Thrombosis; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Vincristine | 2003 |
Long-term sequelae in children treated for brain tumors: impairments, disability, and handicap.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Atrophy; Brain; Brain Damage, Chronic; Brain Neoplasms; Calcinosis; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disabled Children; Epilepsy; Etoposide; Female; Humans; Hydrocephalus; Infant; Intellectual Disability; Learning Disabilities; Lomustine; Magnetic Resonance Imaging; Male; Methotrexate; Movement Disorders; Neoplasm Recurrence, Local; Prevalence; Procarbazine; Radiation Injuries; Slovenia; Survivors; Tomography, X-Ray Computed; Unemployment; Vincristine; Vision Disorders | 2003 |
High survival rate in childhood non-Hodgkin lymphoma without CNS involvement: results of BFM 95 study in Kuwait.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Kuwait; Leucovorin; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Mercaptopurine; Mesna; Methotrexate; Neoplasm Staging; Prednisolone; Prednisone; Survival Rate; Thioguanine; Treatment Outcome; Vincristine | 2003 |
Risk of abnormal pregnancy completing chemotherapy for gestational trophoblastic tumor.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Pregnancy Outcome; Remission Induction; Time Factors | 2003 |
Salvage treatment with etoposide (VP-16), ifosfamide and cytarabine (Ara-C) for patients with recurrent primary central nervous system lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Child, Preschool; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Life Tables; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Analysis; Thrombocytopenia; Vincristine | 2003 |
Fertility in male patients treated with neoadjuvant chemotherapy for osteosarcoma.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Incidence; Infant, Newborn; Italy; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Oligospermia; Osteosarcoma; Puberty; Semen Preservation; Sperm Count; Surveys and Questionnaires | 2003 |
Induction of long-term remission of a relapsed childhood B-acute lymphoblastic leukemia with rituximab chimeric anti-CD20 monoclonal antibody and autologous stem cell transplantation.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Burkitt Lymphoma; Child; Combined Modality Therapy; Cytarabine; Dexamethasone; Etoposide; Humans; Immunotherapy; Leukemic Infiltration; Male; Meninges; Methotrexate; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Rituximab; Salvage Therapy; Testis; Topotecan; Transplantation, Autologous; Vindesine | 2003 |
Primary mediastinal large B-cell lymphoma with sclerosis in pediatric and adolescent patients: treatment and results from three therapeutic studies of the Berlin-Frankfurt-Münster Group.
Topics: Adolescent; Adrenal Cortex Hormones; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Child; Child, Preschool; Cytarabine; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Infant; L-Lactate Dehydrogenase; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Prognosis; Sclerosis; Treatment Outcome | 2003 |
[Cerebral metastasis in choriocarcinoma a case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blindness; Brain Neoplasms; Cerebral Angiography; Choriocarcinoma; Chorionic Gonadotropin; Combined Modality Therapy; Dactinomycin; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Intracranial Aneurysm; Leucovorin; Methotrexate; Pregnancy; Prognosis; Radiotherapy Dosage; Time Factors; Tomography, X-Ray Computed; Uterine Neoplasms; Vincristine | 2003 |
Primary colorectal T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Barium Sulfate; Bleomycin; Colonoscopy; Colorectal Neoplasms; Cyclophosphamide; Cytarabine; Diagnosis, Differential; Doxorubicin; Enema; Etoposide; Humans; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Prednisone; Vincristine | 2003 |
Epithelioid trophoblastic tumour: report of a case in the fallopian tube.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chorionic Gonadotropin, beta Subunit, Human; Dactinomycin; Disease-Free Survival; Doxorubicin; Epidermal Growth Factor; Epithelioid Cells; Etoposide; Fallopian Tube Neoplasms; Female; Humans; Hysterectomy; Immunohistochemistry; Inhibins; Leucovorin; Methotrexate; Pregnancy; Treatment Outcome; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 2003 |
Fatal toxicity following radio- and chemotherapy of medulloblastoma in a child with unrecognized Nijmegen breakage syndrome.
Topics: Abnormalities, Multiple; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Cell Cycle Proteins; Child; Chromosome Breakage; Cisplatin; Cytarabine; Death, Sudden, Cardiac; Etoposide; Fatal Outcome; Humans; Ifosfamide; Infratentorial Neoplasms; Male; Medulloblastoma; Methotrexate; Nuclear Proteins; Polymerase Chain Reaction; Syndrome | 2003 |
High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma: a multicenter study of the intergruppo Italiano Linfomi showing prolonged disease free survival in patients
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Melphalan; Methotrexate; Middle Aged; Mitoxantrone; Prognosis; Transplantation, Autologous; Treatment Outcome | 2003 |
Current status and future of relapsed primary central nervous system lymphoma (PCNSL).
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Organophosphorus Compounds; Radioimmunotherapy; Recurrence; Rituximab; Time Factors | 2003 |
Pregnancy after EMA/CO for gestational trophoblastic disease: a report from The Netherlands.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Attitude to Health; Cohort Studies; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole; Methotrexate; Middle Aged; Motivation; Netherlands; Pregnancy; Pregnancy Outcome; Prognosis; Uterine Neoplasms; Vincristine | 2003 |
Presentation serum selenium predicts for overall survival, dose delivery, and first treatment response in aggressive non-Hodgkin's lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Biomarkers, Tumor; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Linear Models; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Predictive Value of Tests; Prednisone; Proportional Hazards Models; Retrospective Studies; Selenium; Survival Analysis; Vincristine | 2003 |
Chemotherapy and antiangiogenesis--drug-specific, dose-related effects.
Topics: Animals; Antineoplastic Agents; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Endothelial Growth Factors; Etoposide; Fluorouracil; Humans; Injections, Intravenous; Intercellular Signaling Peptides and Proteins; Lymphokines; Male; Mesentery; Methotrexate; Neovascularization, Physiologic; Paclitaxel; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Weight Gain | 2003 |
Characterization of the role of polar amino acid residues within predicted transmembrane helix 17 in determining the substrate specificity of multidrug resistance protein 3.
Topics: Amino Acid Sequence; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Transporters; Biological Transport; Cell Division; Cell Line; Cell Membrane; DNA Primers; Drug Resistance, Multiple; Enzyme Inhibitors; Estradiol; Etoposide; Humans; Hydrogen Bonding; Kinetics; Leukotriene C4; Methotrexate; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation; Polymerase Chain Reaction; Sequence Homology, Amino Acid; Structure-Activity Relationship; Substrate Specificity; Taurocholic Acid; Transfection | 2003 |
Patients with high-risk aggressive lymphoma treated with frontline intensive chemotherapy and autografting: evidence of marked differences in outcome between patients with age-adjusted International Prognostic Index scores 2 and 3.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Peripheral Blood Stem Cell Transplantation; Prognosis; Treatment Outcome | 2003 |
Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, AIDS-Related; Male; Methotrexate; Middle Aged; Retrospective Studies | 2003 |
[Evaluation of surgical resection of pulmonary metastasis of trophoblastic tumour].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole, Invasive; Lung Neoplasms; Male; Methotrexate; Middle Aged; Pneumonectomy; Pregnancy; Prognosis; Retrospective Studies; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 2003 |
[A lemp for bedside otiatric examinations].
Topics: Ear; Etoposide; Humans; Methotrexate; Physical Examination | 1953 |
Rituximab in heavily pretreated cutaneous B-cell lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Mitoxantrone; Orchiectomy; Prednisone; Recurrence; Remission Induction; Rituximab; Skin Neoplasms; Testis; Vincristine | 2003 |
Infertility rates following POMB/ACE chemotherapy for male and female germ cell tumours - a retrospective long-term follow-up study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Dactinomycin; Dose-Response Relationship, Drug; Etoposide; Female; Follow-Up Studies; Germinoma; Humans; Infertility, Female; Infertility, Male; Male; Methotrexate; Middle Aged; Retrospective Studies; Risk Factors; Vincristine | 2003 |
Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Remission Induction; Safety; Salvage Therapy; Survival Rate; Transplantation, Autologous; Treatment Outcome | 2003 |
Encouraging result of tamoxifen in a retinoblastoma patient with central nervous system metastasis.
Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Eye Enucleation; Eye Neoplasms; Female; Glucocorticoids; Humans; Meningeal Neoplasms; Methotrexate; Retinoblastoma; Skull Neoplasms; Tamoxifen; Vincristine | 2003 |
Graft-versus-lymphoma effect of donor lymphocyte infusion in indolent lymphomas relapsed after allogeneic stem cell transplantation.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Graft vs Host Disease; Graft vs Tumor Effect; Humans; Immunophenotyping; Lymphocyte Depletion; Lymphocyte Transfusion; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Polymerase Chain Reaction; Prednisolone; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Recurrence; Remission Induction; Rituximab; Salvage Therapy; Tissue Donors; Transplantation, Homologous; Treatment Outcome; Vincristine | 2003 |
Successful salvage therapy of resistant gestational trophoblastic disease with etoposide, methotrexate, actinomycin-D, etoposide, cisplatin (EMA/EP).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Dactinomycin; Diagnosis, Differential; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Hysterectomy; Methotrexate; Pregnancy; Salvage Therapy; Trophoblastic Neoplasms; Uterine Neoplasms | 2004 |
Cardiac lymphoma successfully treated with high dose chemotherapy followed by autologous haematopoietic stem cell transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Chest Pain; Combined Modality Therapy; Cough; Cyclophosphamide; Doxorubicin; Etoposide; Female; Heart Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Nitrosourea Compounds; Prednisolone; Procarbazine; Remission Induction; Transplantation, Autologous; Vincristine | 2003 |
Association of intestinal malignant lymphoma and ulcerative colitis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colitis, Ulcerative; Colonoscopy; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Lymphoma; Methotrexate; Peripheral Blood Stem Cell Transplantation; Sigmoid Neoplasms; Vincristine | 2003 |
Feasibility of central co-ordinated EMA/CO for gestational trophoblastic disease in the Netherlands.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Pregnancy; Retrospective Studies; Risk Factors; Treatment Outcome; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 2004 |
The management and survival of patients with advanced germ-cell tumours: improving outcome in intermediate and poor prognosis patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Databases, Factual; Disease-Free Survival; Doxorubicin; Etoposide; Germinoma; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Registries; Retrospective Studies; Risk Factors; Survival Analysis; Testicular Neoplasms | 2004 |
Cell cycle activation linked to neuronal cell death initiated by DNA damage.
Topics: Animals; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Cell Cycle; Cell Cycle Proteins; Cells, Cultured; Colchicine; DNA Damage; DNA-Binding Proteins; Etoposide; Female; Homocysteine; Male; Methotrexate; Mice; Nerve Degeneration; Neurons; Protein Serine-Threonine Kinases; Rats; Staurosporine; Tumor Suppressor Proteins | 2004 |
Intracellular IL-4/IFN-gamma producing peripheral T lymphocyte subsets in B cell non-Hodgkin's lymphoma patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD4-Positive T-Lymphocytes; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Interferon-gamma; Interleukin-4; Intracellular Fluid; Lymphocyte Count; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Prednisone; Remission Induction; T-Lymphocyte Subsets; Th1 Cells; Th2 Cells; Vincristine | 2004 |
Safety of rituximab therapy during the first trimester of pregnancy: a case history.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cladribine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease Progression; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant, Newborn; Lymphoma, Follicular; Male; Methotrexate; Mitoguazone; Peripheral Blood Stem Cell Transplantation; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pregnancy Trimester, First; Remission Induction; Rituximab; Safety; Transplantation, Autologous; Vincristine | 2004 |
Management of patients with metastatic gestational trophoblastic tumor.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Pregnancy; Retrospective Studies; Risk Factors | 2004 |
[Comparing CHOP, CHOP+HD-MTX,and BFM-90 regimens in the survival rate of children and adolescents with B cell non-Hodgkin's lymphoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Infant; Leucovorin; Lymphoma, B-Cell; Male; Methotrexate; Neoplasm Staging; Prednisone; Survival Rate; Vincristine; Vindesine | 2004 |
Atypical teratoid/rhabdoid tumour with leptomeningeal dissemination in an adult.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Cisplatin; Combined Modality Therapy; Disease Progression; Etoposide; Humans; Ifosfamide; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Methotrexate; Neoplasm Invasiveness; Rhabdoid Tumor; Teratoma | 2004 |
Placental site trophoblastic tumor: an overview.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Fertility; Humans; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Placenta Diseases; Pregnancy; Retrospective Studies; Treatment Outcome; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 2004 |
Nasal-type NK/T-cell lymphoma successfully treated with ProMACE-CytaBOM therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Facial Neoplasms; Humans; Killer Cells, Natural; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Prednisone; Skin Neoplasms; Vincristine | 2004 |
Tumor excision and reconstruction of the upper cervical spine: a multidisciplinary approach.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Axis, Cervical Vertebra; Bone Transplantation; Cervical Atlas; Chemotherapy, Adjuvant; Chondrosarcoma; Chordoma; Combined Modality Therapy; Cranial Fossa, Posterior; Etoposide; Fatal Outcome; Female; Femoral Neoplasms; Humans; Ifosfamide; Interdisciplinary Communication; Internal Fixators; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Osteosarcoma; Palliative Care; Patient Care Team; Proton Therapy; Remission Induction; Skull Base Neoplasms; Spinal Fusion; Spinal Neoplasms; Surgical Flaps | 2004 |
Coexistence of treatment-related MLL cleavage and rearrangement in a child with haemophagocytic lymphohistiocytosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blotting, Southern; Dexamethasone; DNA-Binding Proteins; Epstein-Barr Virus Infections; Etoposide; Gene Rearrangement; Histiocytosis, Non-Langerhans-Cell; Histone-Lysine N-Methyltransferase; Humans; Infant; Leukemia, Myelomonocytic, Acute; Male; Methotrexate; Myeloid-Lymphoid Leukemia Protein; Neoplasms, Second Primary; Nucleic Acid Synthesis Inhibitors; Polymerase Chain Reaction; Proto-Oncogenes; Time Factors; Topoisomerase II Inhibitors; Transcription Factors | 2004 |
Long-term survival in high-grade axial osteosarcoma with bone and lung metastases treated with chemotherapy only.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Child, Preschool; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Lumbar Vertebrae; Lung Neoplasms; Male; Methotrexate; Osteosarcoma; Thoracic Vertebrae; Time Factors; Tomography, X-Ray Computed | 2005 |
Chemoresistant placental site trophoblastic tumor with hilar lymph node metastasis: an unusual site of involvement.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Lymphatic Metastasis; Methotrexate; Pregnancy; Trophoblastic Tumor, Placental Site; Vincristine | 2005 |
[Treatment of primary mediastinal large B-cell lymphomas].
Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Chemotherapy, Adjuvant; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prednisolone; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Vincristine | 2004 |
Combined chemotherapy with carmustine, doxorubicin, etoposide, vincristine, and cyclophosphamide plus mitoxantrone, cytarabine and methotrexate with citrovorum factor for the treatment of aggressive non-Hodgkin lymphoma: a long-term follow-up study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoxantrone; Survival Rate; Vincristine | 2005 |
Small cell carcinoma of bladder: a single-center prospective study of 25 cases treated in analogy to small cell lung cancer.
Topics: Age Factors; Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Comorbidity; Cyclophosphamide; Cystectomy; Doxorubicin; Etoposide; Feasibility Studies; Female; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Palliative Care; Prognosis; Prospective Studies; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2005 |
Modified ProMACE-MOPP hybrid regimen with moderate-dose methotrexate for patients with primary CNS lymphoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cranial Irradiation; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Leukopenia; Lymphoma; Male; Mechlorethamine; Methotrexate; Middle Aged; Pneumonia; Prednisone; Procarbazine; Retrospective Studies; Sepsis; Vincristine | 2005 |
[Treatment of childhood Burkitt lymphoma according to LMB89 protocol in Casablanca].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Infant; Leucovorin; Male; Methotrexate; Prednisone; Recurrence; Remission Induction; Survival Analysis; Vincristine | 2005 |
Nephrotic syndrome in patients with peripheral blood stem cell transplant.
Topics: Acute Kidney Injury; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Busulfan; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytomegalovirus Infections; Etoposide; Glomerulonephritis, Membranous; Graft vs Host Disease; Humans; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Multiple Myeloma; Nephrotic Syndrome; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Prednisone; Rituximab; Sepsis; Staphylococcal Infections; Tacrolimus; Transplantation Conditioning | 2005 |
[Etopside, methotrexate, kengshengmycin/etopside, cisplatin chemotherapy for chemorefractory gestational trophoblastic tumour].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Dactinomycin; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Leukopenia; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Treatment Outcome; Trophoblastic Tumor, Placental Site; Uterine Neoplasms | 2005 |
[Study on the indication of surgical resection of pulmonary metastasis of malignant trophoblastic tumor].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Chorionic Gonadotropin, beta Subunit, Human; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Humans; Hydatidiform Mole, Invasive; Lung; Lung Neoplasms; Methotrexate; Pneumonectomy; Pregnancy; Radiography; Trophoblastic Neoplasms; Uterine Neoplasms | 2005 |
Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cyclosporine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histiocytosis, Non-Langerhans-Cell; Humans; Immunophenotyping; Infant; Male; Methotrexate; Odds Ratio; Regression Analysis; Reoperation; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2005 |
Highly active antiretroviral therapy and outcome of AIDS-related Burkitt's lymphoma or leukemia. Results of the PETHEMA-LAL3/97 study.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Leucovorin; Leukemia; Lymphoma, AIDS-Related; Male; Methotrexate; Middle Aged; Prednisone; Treatment Outcome; Vincristine | 2005 |
Liposome-mediated transfection of mature taste cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cells, Cultured; Etoposide; Gene Expression Regulation; Genetic Vectors; Green Fluorescent Proteins; Immunohistochemistry; Isoenzymes; Liposomes; Lomustine; Luminescent Proteins; Male; Methotrexate; Mice; Mice, Inbred C57BL; Neural Cell Adhesion Molecules; Neurons; Peptide Elongation Factor 1; Phospholipase C beta; Rats; Rats, Sprague-Dawley; Taste Buds; Transfection; Type C Phospholipases; Ubiquitin Thiolesterase | 2005 |
Localization and differential activity of P-glycoprotein in the bovine olfactory and nasal respiratory mucosae.
Topics: 2,4-Dinitrophenol; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cattle; Etoposide; Immunohistochemistry; In Vitro Techniques; Methotrexate; Nasal Mucosa; Olfactory Mucosa; Permeability; Propionates; Quinidine; Quinolines | 2005 |
Primary lacrimal sac non-Hodgkin's lymphoma in a child.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Eye Neoplasms; Female; Humans; Hydrocortisone; Hyperplasia; Lacrimal Apparatus; Leucovorin; Lymph Nodes; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Prednisone; Vincristine | 2005 |
[Cardiac effects of cytokines produced after rituximab infusion].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathy, Dilated; Drug Monitoring; Etoposide; Fatal Outcome; Humans; Ifosfamide; Immunoglobulin M; Male; Methotrexate; Middle Aged; Mitoguazone; Rituximab; Waldenstrom Macroglobulinemia | 2005 |
T-cell acute lymphoblastic leukemia relapsing as acute myelogenous leukemia.
Topics: Acute Disease; Adolescent; Antigens, CD7; Antigens, Differentiation, T-Lymphocyte; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Cell Differentiation; Cell Lineage; Core Binding Factor Alpha 2 Subunit; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Diagnosis, Differential; Doxorubicin; Etoposide; Fatal Outcome; Female; Gene Dosage; Histone-Lysine N-Methyltransferase; Humans; Immunophenotyping; Karyotyping; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myeloid; Mercaptopurine; Methotrexate; Myeloid-Lymphoid Leukemia Protein; Neoplasms, Second Primary; Neoplastic Stem Cells; Proto-Oncogenes; Recurrence; T-Lymphocyte Subsets; Vincristine | 2007 |
New treatment options have changed the survival of patients with follicular lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Lymphoma, Follicular; Male; Mechlorethamine; Methotrexate; Middle Aged; Multivariate Analysis; Prednisone; Procarbazine; Proportional Hazards Models; Prospective Studies; Survival Rate; United States; Vincristine | 2005 |
Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; British Columbia; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Methotrexate; Middle Aged; Prednisone; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome; Vincristine | 2006 |
IMVP-16/Pd followed by high-dose chemotherapy and autologous stem cell transplantation as a salvage therapy for refractory or relapsed peripheral T-cell lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Recurrence; Retrospective Studies; Salvage Therapy; Stem Cell Transplantation; Survival Analysis; Treatment Outcome; Vincristine | 2005 |
Term delivery choriocarcinoma patient with brain and lung metastases successfully treated by etoposide, methotrexate, actomycin D, cyclophosphamide and vincristine (EMA-CO) chemotherapy.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Lung Neoplasms; Methotrexate; Pregnancy; Uterine Neoplasms; Vincristine | 2005 |
Osmotic blood-brain barrier disruption chemotherapy for diffuse pontine gliomas.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Stem Neoplasms; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Drug Delivery Systems; Etoposide; Female; Glioma; Humans; Male; Methotrexate; Osmosis; Retrospective Studies; Treatment Outcome | 2006 |
Adjuvant chemotherapy for Merkel cell carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Merkel Cell; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Disease-Free Survival; Etoposide; Extremities; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Radiotherapy, Adjuvant; Reoperation; Skin Neoplasms; Treatment Outcome | 2005 |
Successful treatment with voriconazole of Aspergillus brain abscess in a boy with medulloblastoma.
Topics: Administration, Oral; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillus fumigatus; Brain Abscess; Carboplatin; Cerebral Ventricle Neoplasms; Child; Combined Modality Therapy; Cranial Irradiation; Craniotomy; Cyclophosphamide; Diagnostic Errors; Etoposide; Humans; Immunocompromised Host; Infusions, Intravenous; Lomustine; Male; Medulloblastoma; Methotrexate; Neoplasm Recurrence, Local; Neuroaspergillosis; Pyrimidines; Surgical Wound Infection; Triazoles; Vincristine; Voriconazole | 2007 |
[Treatment results of Langerhans cell histiocytosis with LSH II protocol].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Drug Therapy, Combination; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Infant; Male; Mercaptopurine; Methotrexate; Prednisone; Remission Induction; Vinblastine | 2005 |
Supratentorial primitive neuroectodermal tumors (S-PNET) in children: A prospective experience with adjuvant intensive chemotherapy and hyperfractionated accelerated radiotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Chi-Square Distribution; Child; Child, Preschool; Cyclophosphamide; Dose Fractionation, Radiation; Etoposide; Female; Humans; Lomustine; Male; Methotrexate; Neuroectodermal Tumors, Primitive; Prospective Studies; Stem Cell Transplantation; Supratentorial Neoplasms; Survival Analysis; Thiotepa; Treatment Outcome; Vincristine | 2006 |
Choriocarcinoma with markedly elevated serum hCG levels and negative urine hCG levels.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Chorionic Gonadotropin, beta Subunit, Human; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Lung Neoplasms; Methotrexate; Pregnancy; Treatment Outcome; Uterine Neoplasms; Vincristine | 2006 |
Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials.
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Etoposide; Female; Humans; Male; Mercaptopurine; Methotrexate; Patient Selection; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Randomized Controlled Trials as Topic; Remission Induction; Research Design; Survival Analysis; Thioguanine; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome; Vincristine | 2007 |
Extramedullary infiltration at diagnosis and prognosis in children with acute myelogenous leukemia.
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Central Nervous System; Child; Child, Preschool; Cytarabine; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Gingiva; Humans; Hydrocortisone; Idarubicin; Infant; Infant, Newborn; Japan; Kaplan-Meier Estimate; Leukemia, Myeloid; Leukemic Infiltration; Male; Methotrexate; Orbit; Prognosis; Remission Induction; Sarcoma, Myeloid; Skin; Testis | 2007 |
Metastatic choriocarcinoma successfully treated with paclitaxel and carboplatin after interstitial lung disease induced by EMA-CO.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Liver Neoplasms; Lung Diseases, Interstitial; Lung Neoplasms; Methotrexate; Paclitaxel; Uterine Neoplasms; Vincristine | 2006 |
Improved outcome in childhood acute myeloid leukemia in Singapore with the MRC AML 10 protocol.
Topics: Acute Disease; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Cytarabine; Daunorubicin; Developing Countries; Disease-Free Survival; Drug Evaluation; Etoposide; Female; Gastrointestinal Diseases; Heart Diseases; Hematologic Diseases; Humans; Infant; Infections; Kaplan-Meier Estimate; Leukemia, Myeloid; Male; Mercaptopurine; Methotrexate; Mitoxantrone; Prednisone; Remission Induction; Retrospective Studies; Singapore; Survival Analysis; Thioguanine; Treatment Outcome; Vincristine | 2007 |
Retroperitoneal fibrosis after chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Retroperitoneal Fibrosis; Retroperitoneal Neoplasms; Vincristine | 2007 |
[IEMAD (modified MIME) therapy for refractory or relapsed non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dexamethasone; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoguazone; Recurrence | 2006 |
Methotrexate, bleomycin, and Etoposide in the treatment of gestational trophoblastic neoplasia.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Retrospective Studies; Survival Rate; Treatment Outcome; Uterine Neoplasms | 2006 |
Uterine choriocarcinoma in a postmenopausal woman.
Topics: Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Choriocarcinoma; Chorionic Gonadotropin, beta Subunit, Human; Combined Modality Therapy; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Methotrexate; Middle Aged; Postmenopause; Uterine Neoplasms; Vincristine | 2006 |
Recurrent gestational trophoblastic tumor: management and risk factors for recurrence.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Dactinomycin; Etoposide; Female; Fluorouracil; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pregnancy; Retrospective Studies; Risk Factors; Vincristine | 2006 |
Treatment and prognosis of post term choriocarcinoma in The Netherlands.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cohort Studies; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole; Liver Neoplasms; Lung Neoplasms; Methotrexate; Netherlands; Pregnancy; Prognosis; Retrospective Studies; Uterine Neoplasms; Vincristine | 2006 |
Sequential multidrug chemotherapy (CHOP-VA-MB) in patients with high-grade non-Hodgkin's lymphoma--a 20-year follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Retrospective Studies; Time Factors; Vincristine | 2006 |
Successful father-to-son stem cell transplantation in a child with hemophagocytic lymphohistiocytosis using a reduced-intensity conditioning regimen.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Etoposide; Family; Graft vs Host Disease; Humans; Infant; Lymphohistiocytosis, Hemophagocytic; Magnetic Resonance Imaging; Male; Melphalan; Methotrexate; Stem Cell Transplantation; Transplantation Conditioning; Vidarabine | 2006 |
Combination chemotherapy with 5-fluorouracil, methotrexate and etoposide for patients with high-risk gestational trophoblastic tumors: a report based on our 11-year clinical experiences.
Topics: Antineoplastic Combined Chemotherapy Protocols; China; Drug Resistance, Neoplasm; Etoposide; Female; Fluorouracil; Humans; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Survival Analysis; Treatment Outcome; Trophoblastic Neoplasms; Uterine Neoplasms | 2006 |
Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Ependymoma; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Methotrexate; Neoplasm Recurrence, Local; Thiotepa; Transplantation, Autologous; Treatment Outcome; Vincristine | 2007 |
Results of CHOP chemotherapy for diffuse large B-cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Neoplasm Staging; Prednisone; Remission Induction; Survival Analysis; Treatment Outcome; Vincristine | 2006 |
First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy +/- radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Prednisolone; Remission Induction; Time Factors; Treatment Outcome | 2006 |
[Twenty years of treating childhood acute lymphoblastic leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Infant; Male; Mercaptopurine; Methotrexate; Multivariate Analysis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Prognosis; Recurrence; Risk Factors; Survival Rate; Time Factors; Vincristine | 2006 |
Treatment of Burkitt's lymphoma during pregnancy.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant, Newborn; Male; Methotrexate; Pregnancy; Pregnancy Complications, Neoplastic; Registries; Vincristine | 2006 |
Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Illinois; Medical Records; Methotrexate; Middle Aged; Neoplasm Metastasis; Pregnancy; Retrospective Studies; Survival Analysis; Treatment Outcome; Uterine Neoplasms; Vincristine | 2006 |
Role of surgery in the management of high-risk gestational trophoblastic neoplasia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Hysterectomy; Illinois; Medical Records; Methotrexate; Middle Aged; Pregnancy; Retrospective Studies; Survival Analysis; Uterine Neoplasms; Vincristine | 2006 |
Management of gestational trophoblastic neoplasia with metastasis to the central nervous system: A 12-year review at the Philippine General Hospital.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Injections, Spinal; Medical Records; Methotrexate; Middle Aged; Neoplasm Metastasis; Philippines; Pregnancy; Retrospective Studies; Survival Analysis; Uterine Neoplasms; Vincristine | 2006 |
Mediastinal follicular dendritic cell sarcoma involving bone marrow: a case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Dendritic Cells, Follicular; Deoxycytidine; Docetaxel; Etoposide; Female; Gemcitabine; Humans; Ifosfamide; Immunoenzyme Techniques; Mediastinal Neoplasms; Methotrexate; Middle Aged; Sarcoma; Taxoids; Treatment Outcome | 2006 |
High-risk gestational trophoblastic neoplasia with brain metastases: individualized multidisciplinary therapy in the management of four patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Cisplatin; Craniotomy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Folic Acid; Gestational Trophoblastic Disease; Humans; Methotrexate; Neoplasm Staging; Pregnancy; Radiosurgery; Risk Factors; Vincristine | 2007 |
Ultraviolet recall reaction after total body irradiation, etoposide, and methotrexate therapy.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Etoposide; Humans; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Skin; Sunburn; Ultraviolet Rays; Whole-Body Irradiation | 2007 |
Long-term follow-up of autologous peripheral blood stem cell transplantation in the treatment of a patient with acute panmyelosis with myelofibrosis.
Topics: Acute Disease; Anemia, Refractory; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Erythropoietin; Etoposide; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Mitoxantrone; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Primary Myelofibrosis; Recombinant Proteins; Transplantation Conditioning; Transplantation, Autologous; Whole-Body Irradiation | 2006 |
Successful neoadjuvant synchronous chemo- and radiotherapy for disseminated primary intracranial choriocarcinoma: case report.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Choriocarcinoma; Chorionic Gonadotropin, beta Subunit, Human; Combined Modality Therapy; Etoposide; Humans; Male; Methotrexate; Neoadjuvant Therapy; Peripheral Blood Stem Cell Transplantation; Treatment Outcome | 2007 |
Evidence of a novel antiapoptotic factor: role of inhibitor of differentiation or DNA binding (Id-1) in anticancer drug-induced apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma, Hepatocellular; Catechin; Cell Line, Tumor; Cell Survival; Cisplatin; Down-Regulation; Doxorubicin; Etoposide; Female; HeLa Cells; Humans; Inhibitor of Differentiation Protein 1; Liver Neoplasms; Male; Mechlorethamine; Methotrexate; Mitomycin; Nasopharyngeal Neoplasms; Paclitaxel; Prostatic Neoplasms; Vincristine | 2007 |
Divergent cytotoxic effects of PKC412 in combination with conventional antileukemic agents in FLT3 mutation-positive versus -negative leukemia cell lines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Line, Tumor; Cytarabine; Doxorubicin; Etoposide; fms-Like Tyrosine Kinase 3; Humans; Idarubicin; Leukemia; Methotrexate; Mitoxantrone; Mutation; Protein Kinase C; Staurosporine | 2007 |
Early-onset sarcoidosis mimicking refractory cutaneous histiocytosis.
Topics: Child; Diagnosis, Differential; Diagnostic Errors; Early Diagnosis; Etoposide; Facial Dermatoses; Female; Histiocytosis; Humans; Hypercalcemia; Interferon-gamma; Interleukins; Macrophage Activation; Methotrexate; Prednisolone; Sarcoidosis; Skin Diseases; Vinblastine | 2008 |
CODOX-M/IVAC (NCI 89-C-41) in children and adolescents with Burkitt's leukemia/lymphoma and large B-cell lymphomas: a 15-year monocentric experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Leukemia; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Risk Factors; Survival Rate; Treatment Outcome; Vincristine | 2007 |
[Early relapse of Burkitt's lymphoma with t(8;14) and t(14;18) after rituximab-combined CODOX-M and IVAC therapy].
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 8; Cyclophosphamide; Cytarabine; Disease Progression; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Methotrexate; Recurrence; Remission Induction; Rituximab; Translocation, Genetic; Vincristine | 2007 |
[MTX-HOPE (methotrexate, hydrocortisone, vincristine, sobuzoxane, and etoposide) as a low-dose salvage chemotherapy for recurrent or refractory non-Hodgkin's lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Hydrocortisone; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neutropenia; Piperazines; Salvage Therapy; Survival Rate; Thrombocytopenia; Vincristine | 2007 |
A 'pre-induction course' with non-cross-reacting cytostatic drugs for rapid tumour load reduction improves outcome in adult acute lymphoblastic leukaemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Cytarabine; Drug Therapy, Combination; Etoposide; Female; Humans; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome; Tumor Burden | 2007 |
Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Carotid Artery, Internal; Catheterization, Peripheral; Cyclophosphamide; Cytarabine; Etoposide; Female; Fluorescein Angiography; Humans; Injections, Spinal; Lymphoma; Male; Mannitol; Methotrexate; Middle Aged; Pigment Epithelium of Eye; Retinal Diseases; Retrospective Studies; Tomography, Optical Coherence; Vertebral Artery | 2007 |
Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cryptogenic Organizing Pneumonia; Cyclophosphamide; Cyclosporine; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunosuppressive Agents; Lymphoma, T-Cell, Peripheral; Methotrexate; Neoplasm Recurrence, Local; Palatal Neoplasms; Remission Induction; Salvage Therapy; Transplantation, Homologous; Vincristine | 2007 |
Ad-PUMA sensitizes drug-resistant choriocarcinoma cells to chemotherapeutic agents.
Topics: Adenoviridae; Animals; Apoptosis; Apoptosis Regulatory Proteins; Cell Growth Processes; Cell Line, Tumor; Choriocarcinoma; Combined Modality Therapy; Drug Resistance, Neoplasm; Etoposide; Female; Fluorouracil; Genetic Therapy; Humans; Methotrexate; Mice; Mice, Nude; Proto-Oncogene Proteins; RNA, Messenger; Tumor Suppressor Protein p53; Uterine Neoplasms; Xenograft Model Antitumor Assays | 2007 |
Lipomembranous panniculitis in a patient with acute leukemia induced by chemotherapy.
Topics: Adipose Tissue; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Fat Necrosis; Female; Humans; Methotrexate; Panniculitis; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2008 |
Management of high-risk hydatidiform mole and persistent gestational trophoblastic neoplasia: the Korean experience.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Cisplatin; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole; Korea; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Pregnancy; Prospective Studies; Registries; Retrospective Studies; Risk Factors; Salvage Therapy; Severity of Illness Index; Uterine Neoplasms | 2007 |
Re: Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Cyclophosphamide; Cytarabine; Etoposide; Fluorescein Angiography; Humans; Injections, Spinal; Lymphoma; Mannitol; Methotrexate; Pigment Epithelium of Eye; Retinal Diseases | 2007 |
Hepatitis A-associated macrophage activation syndrome in children with systemic juvenile idiopathic arthritis: report of 2 cases.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Arthritis, Juvenile; Child, Preschool; Dexamethasone; Etoposide; Fatal Outcome; Female; Hepatitis A; Humans; Lymphohistiocytosis, Hemophagocytic; Macrophage Activation; Methotrexate | 2008 |
Multiple cutaneous relapses in an adolescent in anaplastic large cell lymphoma diagnosed by FNAC.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy, Fine-Needle; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Mitoguazone; Neoplasm Recurrence, Local; Prednisone; Skin Neoplasms; Vincristine | 2008 |
Frequency and spectrum of central nervous system involvement in 193 children with haemophagocytic lymphohistiocytosis.
Topics: Antineoplastic Agents; Central Nervous System; Central Nervous System Diseases; Child; Child, Preschool; Clinical Protocols; Cohort Studies; Dexamethasone; Etoposide; Female; Humans; Infant; Lymphohistiocytosis, Hemophagocytic; Magnetic Resonance Imaging; Male; Methotrexate; Proportional Hazards Models; Seizures; Stem Cell Transplantation; Survival Rate; Tomography, X-Ray Computed | 2008 |
Gestational choriocarcinoma: morphological features in a liquid-based endometrial cytological sample.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Dactinomycin; Doxorubicin; Endometrium; Etoposide; Female; Humans; Leucovorin; Lung Neoplasms; Methotrexate; Pregnancy; Uterine Neoplasms; Vincristine | 2008 |
Multimodality treatment of osteosarcoma: radiation in a high-risk cohort.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Cohort Studies; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Medical Records; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Radiotherapy Dosage; Retrospective Studies; Risk Factors; Survival Rate | 2008 |
Assessment of the response to chemotherapy in gestational trophoblastic neoplasia with vaginal metastases.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Retrospective Studies; Survival Analysis; Vaginal Neoplasms; Vincristine; Young Adult | 2008 |
[Case of malignant lymphoma associated with rheumatoid arthritis].
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Arthritis, Rheumatoid; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Etoposide; Female; Humans; Lymph Nodes; Lymphoma, B-Cell; Mediastinum; Methotrexate; Prednisolone; Remission Induction; Rituximab; Tomography, X-Ray Computed; Vincristine | 2008 |
Sub-acute demyelinating neuropathy associated with an NK/T cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Cytarabine; Demyelinating Diseases; Doxorubicin; Etoposide; Facial Paralysis; Female; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Magnetic Resonance Imaging; Methotrexate; Neurologic Examination; Omentum; Paraneoplastic Polyneuropathy; Spinal Nerve Roots; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2008 |
Uterine choriocarcinoma accompanied by an extremely high human chorionic gonadotropin level and thyrotoxicosis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Chorionic Gonadotropin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Thyrotoxicosis; Triiodothyronine; Uterine Neoplasms; Vincristine | 2008 |
Results of treatment of 112 cases of primary CNS lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemotherapy, Adjuvant; Cognition; Cranial Irradiation; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Kaplan-Meier Estimate; Karnofsky Performance Status; Leucovorin; Lymphoma; Male; Mechlorethamine; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vincristine | 2008 |
Interdisciplinary combined treatment of craniofacial osteosarcoma with neoadjuvant and adjuvant chemotherapy and excision of the tumour: a retrospective study.
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Mandibular Neoplasms; Maxillary Neoplasms; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Osteosarcoma; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Young Adult | 2008 |
Rituximab improves the efficacy of high-dose chemotherapy with autograft for high-risk follicular and diffuse large B-cell lymphoma: a multicenter Gruppo Italiano Terapie Innnovative nei linfomi survey.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Disease Progression; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Italy; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Methotrexate; Middle Aged; Prognosis; Proportional Hazards Models; Retrospective Studies; Risk Factors; Rituximab; Survival Rate; Thiotepa; Transplantation, Autologous; Treatment Outcome | 2008 |
Placental site trophoblastic tumor with multiple metastases and complete response to salvage BEP regimen: a case report and review of the literature.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Chorionic Gonadotropin; Cisplatin; Cyclophosphamide; Dactinomycin; Digestive System Neoplasms; Endocrine Gland Neoplasms; Etoposide; Female; Humans; Hysterectomy; Kidney Neoplasms; Lung Neoplasms; Lymph Node Excision; Methotrexate; Pelvis; Pregnancy; Trophoblastic Tumor, Placental Site; Uterine Hemorrhage; Uterine Neoplasms; Vincristine; Young Adult | 2009 |
Extremely slow methotrexate elimination in a patient with t(9;22) positive acute lymphoblastic leukemia treated with imatinib.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Chromosomes, Human, Pair 22; Chromosomes, Human, Pair 9; Cytarabine; Drug Interactions; Edema; Etoposide; Female; Humans; Imatinib Mesylate; Leucovorin; Methotrexate; Middle Aged; Piperazines; Pleural Effusion, Malignant; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Sodium Potassium Chloride Symporter Inhibitors; Translocation, Genetic | 2008 |
Sodium butyrate enhances the cytotoxic effect of antineoplastic drugs in human lymphoblastic T-cells.
Topics: Antineoplastic Agents; Bleomycin; Butyrates; Cell Proliferation; Cytarabine; Doxorubicin; Drug Synergism; Etoposide; Humans; Jurkat Cells; Leukemia, T-Cell; Methotrexate; T-Lymphocytes; Vincristine | 2009 |
Diagnosis and treatment of high-risk metastatic gestational trophoblastic neoplasia in Hungary.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Hungary; Hysterectomy; Methotrexate; Middle Aged; Pregnancy; Risk Factors; Vincristine; Young Adult | 2008 |
The impact of histopathologic diagnosis on the proper management of testis neoplasms.
Topics: Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain; Cisplatin; Cytarabine; Diagnosis, Differential; Etoposide; Fatal Outcome; Humans; Immunohistochemistry; Interferon Regulatory Factors; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Orchiectomy; Radiography; Recurrence; Remission Induction; Seminoma; Testicular Neoplasms | 2008 |
Term delivery following successful treatment of choriocarcinoma with brain metastases, a case report and review of literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Cisplatin; Craniotomy; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Pregnancy; Pregnancy Outcome; Term Birth; Uterine Neoplasms | 2009 |
Primary meningeal CNS lymphoma treated with intra-arterial chemotherapy and blood-brain barrier disruption.
Topics: Antineoplastic Agents; Blood-Brain Barrier; Central Nervous System Neoplasms; Enzyme Inhibitors; Etoposide; Female; Humans; Injections, Intra-Arterial; Injections, Intravenous; Lymphoma, Large-Cell, Immunoblastic; Magnetic Resonance Imaging; Methotrexate; Middle Aged; Organophosphorus Compounds | 2008 |
Gestational trophoblastic tumor with liver metastasis after misoprostol abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Liver Neoplasms; Methotrexate; Misoprostol; Pregnancy; Uterine Neoplasms; Vincristine | 2009 |
[Efficacy of therapy of different variants of anaplastic large T-cell lymphomas].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bleomycin; Cyclophosphamide; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Remission Induction; Treatment Outcome; Vincristine | 2008 |
Structural determinants of substrate specificity differences between human multidrug resistance protein (MRP) 1 (ABCC1) and MRP3 (ABCC3).
Topics: Amino Acid Sequence; Amino Acid Substitution; Cell Line; Cell Membrane; Cell Survival; Doxorubicin; Drug Resistance, Neoplasm; Estradiol; Estrone; Etoposide; Glutathione; Humans; Kinetics; Leukotriene C4; Methotrexate; Models, Molecular; Molecular Sequence Data; Multidrug Resistance-Associated Proteins; Mutagenesis, Site-Directed; Protein Binding; Recombinant Fusion Proteins; Substrate Specificity; Transfection; Vincristine | 2008 |
COX-2 expression correlates with survival in patients with osteosarcoma lung metastases.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Biomarkers, Tumor; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclooxygenase 2; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Proteins; Neoplasm Recurrence, Local; Osteosarcoma; Pneumonectomy; Prognosis; Retrospective Studies; Salvage Therapy; Survival Analysis | 2008 |
Severe neurotoxicities in a case of Charcot-Marie-Tooth disease type 2 caused by vincristine for acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Charcot-Marie-Tooth Disease; Contraindications; Cytarabine; Daunorubicin; Etoposide; Gait Disorders, Neurologic; Humans; Male; Mercaptopurine; Methotrexate; Muscle Weakness; Neural Conduction; Peripheral Nervous System Diseases; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Vincristine | 2008 |
Methotrexate monotherapy for high-risk gestational trophoblastic neoplasia after therapy with etoposide, methotrexate, and dactinomycin: a case report.
Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Pregnancy; Treatment Outcome; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 2008 |
No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Medulloblastoma; Methotrexate; Neoplasm Recurrence, Local; Radiotherapy Dosage; Remission Induction; Salvage Therapy; Thiotepa; Vincristine; Young Adult | 2009 |
Efficacy of continuous venovenous hemofiltration with chemotherapy in patients with Burkitt lymphoma and leukemia at high risk of tumor lysis syndrome.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hemofiltration; Humans; Hydrocortisone; Hyperuricemia; Kidney Function Tests; Leucovorin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Retrospective Studies; Risk; Survival Analysis; Tumor Lysis Syndrome; Vincristine | 2009 |
Hyperfractionated accelerated radiotherapy in the Milan strategy for metastatic medulloblastoma.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dose Fractionation, Radiation; Etoposide; Female; Humans; Male; Medulloblastoma; Methotrexate; Neoplasm Metastasis; Radiotherapy Dosage; Survival Rate; Treatment Outcome | 2009 |
Maternal and perinatal outcomes of first pregnancy after chemotherapy for gestational trophoblastic neoplasia in Brazilian women.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brazil; Cisplatin; Cohort Studies; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Hydroxyurea; Methotrexate; Pregnancy; Pregnancy Outcome; Retrospective Studies; Risk Factors; Vincristine | 2009 |
[Pulmonary resection in the management of gestational trophoblastic neoplasia: a clinical study].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Lung Neoplasms; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Pneumonectomy; Pregnancy; Prognosis; Retrospective Studies | 2008 |
Balloon tamponade of hemorrhage after uterine curettage for gestational trophoblastic disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Balloon Occlusion; Catheterization; Dactinomycin; Dilatation and Curettage; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Leucovorin; Lung Neoplasms; Methotrexate; Pregnancy; Uterine Hemorrhage | 2009 |
Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Etoposide; Female; Flow Cytometry; Follow-Up Studies; Genotype; Germ-Line Mutation; Humans; Infant; Linear Models; Linkage Disequilibrium; Male; Methotrexate; Neoplasm, Residual; Odds Ratio; Phenotype; Polymorphism, Single Nucleotide; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Retrospective Studies; Risk Assessment; Risk Factors | 2009 |
Effective treatment of advanced-stage childhood lymphoblastic lymphoma without prophylactic cranial irradiation: results of St Jude NHL13 study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; B-Lymphocytes; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Injections, Spinal; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; T-Lymphocytes; Treatment Outcome; Vincristine | 2009 |
Reversal of neurological deficit after chemotherapy in BCL-6-positive neurolymphomatosis. Case report.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachial Plexus Neuropathies; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, B-Cell; Magnetic Resonance Imaging; Male; Methotrexate; Peripheral Nervous System Neoplasms; Prednisone; Proto-Oncogene Proteins c-bcl-6; Rituximab; Vincristine | 2009 |
Additional chromosomal abnormalities and their prognostic significance in adult Philadelphia-positive acute lymphoblastic leukemia: with or without imatinib in chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Chromosome Aberrations; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Female; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Kaplan-Meier Estimate; Male; Mercaptopurine; Methotrexate; Middle Aged; Mitoxantrone; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Pyrimidines; Salvage Therapy; Vincristine; Vindesine; Young Adult | 2009 |
Treatment outcome of adult patients with Burkitt lymphoma: results using the LMB protocol in Korea.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Drug Evaluation; Etoposide; Female; Hematologic Diseases; Humans; Kaplan-Meier Estimate; Korea; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Proportional Hazards Models; Retrospective Studies; Risk Factors; Sepsis; Treatment Outcome; Vincristine; Young Adult | 2009 |
Nuclear translocation of dihydrofolate reductase is not a pre-requisite for DNA damage induced apoptosis.
Topics: Amino Acid Sequence; Apoptosis; Camptothecin; Caspase 3; Cell Line, Tumor; Cell Nucleus; DNA Damage; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Enzyme Activation; Etoposide; Humans; Leukemia; Methotrexate; Microtubules; Molecular Sequence Data; Neoplasm Proteins; Protein Transport; Tetrahydrofolate Dehydrogenase | 2009 |
Surgical resection in the management of pulmonary metastatic disease of gestational trophoblastic neoplasia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Fluorouracil; Gestational Trophoblastic Disease; Humans; Lung Neoplasms; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Vincristine; Young Adult | 2009 |
Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study.
Topics: Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chorionic Gonadotropin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hysterectomy; Kaplan-Meier Estimate; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Pregnancy; Prognosis; Proportional Hazards Models; Retrospective Studies; ROC Curve; Survival Rate; Treatment Outcome; Trophoblastic Tumor, Placental Site; United Kingdom; Uterine Neoplasms; Vincristine | 2009 |
Incidence and outcome of patients with diffuse large B cell lymphoma with marrow involvement and preliminary experience of an adult acute lymphoblastic leukemia protocol (NEALL VI) in cyclophosphamide, doxorubicin, vincristine, and prednisolone--rituximab
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Female; Humans; Idarubicin; Ifosfamide; Incidence; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Mitoxantrone; Prednisolone; Prognosis; Registries; Retrospective Studies; Rituximab; Salvage Therapy; Survival Analysis; Treatment Outcome; Vincristine | 2009 |
Increased vulnerability of the spinal cord to radiation or intrathecal chemotherapy during adolescence: A report from the Children's Oncology Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dacarbazine; Dactinomycin; Etoposide; Female; Humans; Hydrocortisone; Injections, Spinal; Male; Meninges; Methotrexate; Myelitis; Neoplasm Invasiveness; Puberty; Radiation Injuries; Retrospective Studies; Rhabdomyosarcoma; Sarcoma, Ewing; Spinal Cord; Spinal Neoplasms; Vincristine | 2009 |
Placental site trophoblastic tumor (PSTT) with multiple metastases and extremely poor prognosis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cell Differentiation; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Fatal Outcome; Female; Humans; Magnetic Resonance Imaging; Methotrexate; Mitotic Index; Neoplasm Invasiveness; Pregnancy; Tomography, X-Ray Computed; Treatment Failure; Trophoblastic Tumor, Placental Site; Uterine Neoplasms; Vincristine | 2009 |
Rituximab combined with MACOP-B or VACOP-B and radiation therapy in primary mediastinal large B-cell lymphoma: a retrospective study.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Methotrexate; Middle Aged; Prednisone; Radiotherapy, Adjuvant; Retrospective Studies; Rituximab; Survival Rate; Treatment Outcome; Vincristine; Young Adult | 2009 |
Metastasis of gestational trophoblastic neoplasia to the spinal canal: a case report.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Dactinomycin; Etoposide; Female; Floxuridine; Gestational Trophoblastic Disease; Humans; Magnetic Resonance Imaging; Methotrexate; Pregnancy; Spinal Canal; Spinal Neoplasms; Uterine Neoplasms; Vincristine; Young Adult | 2009 |
The cytotoxic effects of gemtuzumab ozogamicin (mylotarg) in combination with conventional antileukemic agents by isobologram analysis in vitro.
Topics: Aminoglycosides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Etoposide; Gemtuzumab; HL-60 Cells; Humans; Idarubicin; Immunotoxins; Leukemia; Mercaptopurine; Methotrexate; Mitoxantrone; Sialic Acid Binding Ig-like Lectin 3; U937 Cells; Vincristine | 2009 |
Long term outcome of patients with localized aggressive non-Hodgkin lymphoma treated with PROMECE-CYTABOM plus involved-field radiation therapy: a study by the Gruppo Italiano Studio Linfomi.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Multivariate Analysis; Prednisone; Radiotherapy; Retrospective Studies; Treatment Outcome; Vincristine | 2010 |
Ongoing remission after intensive ALL-type chemotherapy in pediatric intestinal T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Etoposide; Humans; Intestinal Neoplasms; Lymphoma, T-Cell; Male; Mercaptopurine; Methotrexate; Methylprednisolone; Neoplasm Staging; Receptors, Antigen, T-Cell, gamma-delta; Remission Induction; Thioguanine; Vincristine | 2010 |
Etoposide induces more severe mucositis than CY when added to TBI as conditioning in allograft recipients receiving CsA and MTX.
Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Etoposide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Mucositis; Retrospective Studies; Severity of Illness Index; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation; Young Adult | 2010 |
Primary intra-osseous liposarcoma of the femur: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cisplatin; Combined Modality Therapy; Diagnosis, Differential; Doxorubicin; Etoposide; Femoral Neoplasms; Humans; Ifosfamide; Liposarcoma; Magnetic Resonance Imaging; Male; Methotrexate; Neoadjuvant Therapy; Radiography; Whole Body Imaging | 2009 |
Significance of myeloid antigen expression in precursor T lymphoblastic lymphoma.
Topics: Adolescent; Adult; Age Factors; Aged; Antigens, CD7; Antigens, Differentiation, Myelomonocytic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cyclin D3; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Male; Mercaptopurine; Methotrexate; Middle Aged; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Proportional Hazards Models; Remission Induction; Survival Rate; Transcription Factors; Vincristine; Young Adult | 2010 |
Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Celiac Disease; Combined Modality Therapy; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, T-Cell, Peripheral; Male; Methotrexate; Middle Aged; Prospective Studies; Scotland; Survival Rate; Transplantation, Autologous; Treatment Outcome; Vincristine | 2010 |
Successful treatment of extranodal natural killer/T-cell lymphoma, nasal type, complicated by severe hemophagocytic syndrome, with dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide chemotherapy followed by autologous stem cell transpl
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chemotherapy, Adjuvant; Combined Modality Therapy; Dexamethasone; Etoposide; Humans; Ifosfamide; Lymphohistiocytosis, Hemophagocytic; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome | 2010 |
Good prognosis for primary ovarian pure nongestational choriocarcinoma using the EMA/CO regime.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma, Non-gestational; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Ovarian Neoplasms; Prognosis; Vincristine; Young Adult | 2010 |
[Successful treatment with hyper-CVAD and highly active anti-retroviral therapy (HAART) for AIDS-related Burkitt lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Burkitt Lymphoma; Colonic Neoplasms; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Humans; Lymphoma, AIDS-Related; Male; Methotrexate; Prednisone; Treatment Outcome; Vincristine | 2010 |
A case of uterine pseudoaneurysm combined with gestational trophoblastic disease in a 30-year-old woman.
Topics: Adult; Aneurysm, False; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Cyclophosphamide; Dactinomycin; Dilatation and Curettage; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Trophoblastic Neoplasms; Ultrasonography, Doppler; Uterine Artery; Uterine Artery Embolization; Vincristine | 2011 |
Moyamoya in a child treated with interferon for recurrent osteosarcoma.
Topics: Antineoplastic Agents; Bone Neoplasms; Carotid Artery Diseases; Cerebral Arterial Diseases; Cerebral Infarction; Chemotherapy, Adjuvant; Child; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Interferon-alpha; Lung Neoplasms; Magnetic Resonance Angiography; Methotrexate; Moyamoya Disease; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Osteosarcoma; Thyroiditis, Autoimmune | 2010 |
Efficacy of high-dose methotrexate, ifosfamide, etoposide and dexamethasone salvage therapy for recurrent or refractory childhood malignant lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Dexamethasone; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Recurrence; Salvage Therapy | 2011 |
Infant ependymoma in a 10-year AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) experience with omitted or deferred radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Ependymoma; Etoposide; Female; Humans; Infant; Infratentorial Neoplasms; Italy; Male; Methotrexate; Neoplasm, Residual; Supratentorial Neoplasms; Treatment Outcome; Vincristine | 2011 |
Salvage chemotherapy with methotrexate, etoposide and actinomycin D in men with metastatic nonseminomatous germ cell tumors with a choriocarcinoma component: a preliminary report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Chorionic Gonadotropin; Choroid Neoplasms; Dactinomycin; Etoposide; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasms, Germ Cell and Embryonal; Salvage Therapy; Testicular Neoplasms; Treatment Outcome | 2010 |
Successful allogeneic hematopoietic stem cell transplantation for aggressive NK cell leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Female; Herpesvirus 4, Human; Humans; Ifosfamide; Injections, Spinal; Leukemia, Large Granular Lymphocytic; Leukemic Infiltration; Methotrexate; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Prednisone; Radiography; Remission Induction; Subarachnoid Hemorrhage; Transplantation Conditioning; Transplantation, Homologous; Vincristine | 2010 |
Midtreatment 18F-fluorodeoxyglucose positron-emission tomography in aggressive non-Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoxantrone; Monitoring, Physiologic; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Retrospective Studies; Rituximab; Survival Analysis; Time Factors; Vincristine; Young Adult | 2011 |
Vandetanib mediates anti-leukemia activity by multiple mechanisms and interacts synergistically with DNA damaging agents.
Topics: Acute Disease; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers, Tumor; Cell Cycle; Cell Proliferation; Cell Survival; DNA Damage; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Etoposide; HL-60 Cells; Humans; Inhibitory Concentration 50; Leukemia; Methotrexate; Piperidines; Protein Kinase Inhibitors; Quinazolines; Topoisomerase II Inhibitors | 2012 |
Etoposide, mitomycin, and methotrexate combination in heavily treated breast cancer: a retrospective study.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease-Free Survival; Etoposide; Female; Humans; Methotrexate; Middle Aged; Mitomycin; Retrospective Studies; Survival Rate | 2012 |
Rituximab in combination with CODOX-M/IVAC: a retrospective analysis of 23 cases of non-HIV related B-cell non-Hodgkin lymphoma with proliferation index >95%.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cell Proliferation; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Neoplasm Staging; Retrospective Studies; Rituximab; Treatment Outcome; Vincristine; Young Adult | 2011 |
Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Rituximab; Treatment Outcome; Vincristine; Young Adult | 2010 |
[Clinical analysis of patients with relapsed and chemo-resistant gestational trophoblastic neoplasia].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Lung Neoplasms; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pregnancy; Prognosis; Retrospective Studies; Time Factors; Treatment Outcome; Vincristine; Young Adult | 2010 |
Five Chinese pediatric patients with leukemias possibly arising from immature natural killer cells: clinical features and courses.
Topics: Adolescent; Adult; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cytarabine; Etoposide; Female; Humans; Immunophenotyping; Infant; Killer Cells, Natural; Leukemia, Lymphoid; Leukemia, Myeloid; Male; Methotrexate; Mitoxantrone; Remission Induction; Treatment Outcome | 2011 |
Metastatic placental site trophoblastic tumour successfully treated with hysterectomy and EMA/CO chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hysterectomy; Methotrexate; Pregnancy; Trophoblastic Tumor, Placental Site; Uterine Neoplasms; Vincristine | 2011 |
Characterisation of transient benign hCG elevations in women following chemotherapy for GTT.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin; Cisplatin; Cyclophosphamide; Dactinomycin; Estradiol; Etoposide; Female; Follicle Stimulating Hormone; Gestational Trophoblastic Disease; Humans; Ifosfamide; Leucovorin; Luteinizing Hormone; Methotrexate; Pregnancy; Retrospective Studies; Taxoids; Vincristine; Young Adult | 2011 |
Ovarian involvement of epithelioid trophoblastic tumor: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole; Immunohistochemistry; Methotrexate; Neoplasms, Second Primary; Ovarian Neoplasms; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms | 2011 |
Treatment with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone combined with cytarabine and methotrexate results in poor mobilization of peripheral blood stem cells in patients with mantle cell lymphoma.
Topics: Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Humans; Leukapheresis; Lymphoma, Mantle-Cell; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Time Factors; Transplantation, Autologous; Treatment Outcome; Vincristine | 2011 |
Reactive tonsillar enlargement with strong 18F-FDG uptake after chemotherapy for tonsillar diffuse large B-cell lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Humans; Hyperplasia; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Neoplasm Staging; Palatine Tonsil; Positron-Emission Tomography; Prednisolone; Radiopharmaceuticals; Tonsillar Neoplasms; Vincristine | 2011 |
Evaluation of the addition of rituximab to CODOX-M/IVAC for Burkitt's lymphoma: a retrospective analysis.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; HIV Infections; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Retrospective Studies; Rituximab; Secondary Prevention; Vincristine | 2011 |
Diffuse infiltrating retinoblastoma with central nervous system metastasis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Child; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Etoposide; Humans; Hydrocortisone; Infusions, Intravenous; Injections, Spinal; Magnetic Resonance Imaging; Male; Methotrexate; Retinal Neoplasms; Retinoblastoma; Vincristine | 2011 |
Treatment for relapsed Hodgkin lymphoma: refinement of chemotherapy or targeted treatment?
Topics: Child; Etoposide; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Ki-1 Antigen; Methotrexate | 2011 |
Treatment outcome of Korean patients with localized Ewing sarcoma family of tumors: a single institution experience.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Confounding Factors, Epidemiologic; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Odds Ratio; Prognosis; Republic of Korea; Retrospective Studies; Risk Factors; Sarcoma, Ewing; Time Factors; Treatment Outcome; Vincristine; Young Adult | 2011 |
[Standard CHOP immuno-chemotherapy for primary mediastinal lymphomas].
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Methotrexate; Middle Aged; Prednisone; Rituximab; Treatment Outcome; Vincristine | 2011 |
Age differences in temporal discounting: the role of dispositional affect and anticipated emotions.
Topics: Adult; Affect; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Choice Behavior; Emotions; Etoposide; Female; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Neuropsychological Tests; Wechsler Scales; Young Adult | 2011 |
Haemophagocytic lymphohistiocytosis: a case series from Mumbai.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Cyclosporine; Dexamethasone; Etoposide; Female; Humans; India; Infant; Lymphohistiocytosis, Hemophagocytic; Male; Methotrexate; Retrospective Studies | 2011 |
Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Humans; Infant; Leucovorin; Magnetic Resonance Imaging; Male; Medulloblastoma; Methotrexate; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Radiotherapy; Remission Induction; Survival Rate; Vincristine | 2011 |
Wipe sampling procedure coupled to LC-MS/MS analysis for the simultaneous determination of 10 cytotoxic drugs on different surfaces.
Topics: Antineoplastic Agents; Camptothecin; Chromatography, Liquid; Cyclophosphamide; Cytarabine; Deoxycytidine; Doxorubicin; Epirubicin; Etoposide; Gemcitabine; Ifosfamide; Irinotecan; Methotrexate; Organophosphorus Compounds; Surface Properties; Tandem Mass Spectrometry; Vincristine | 2012 |
A cohort study to evaluate the effectiveness of laparoscopic-guided local injection of etoposide in the management of women with unruptured tubal pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Adult; Antineoplastic Agents, Phytogenic; Cohort Studies; Etoposide; Fallopian Tubes; Female; Follow-Up Studies; Humans; Injections; Laparoscopy; Methotrexate; Pregnancy; Pregnancy, Tubal; Retrospective Studies; Treatment Outcome | 2011 |
Metastatic choriocarcinoma presenting and treated during viable pregnancy: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Leucovorin; Methotrexate; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prenatal Diagnosis; Tomography, X-Ray Computed; Uterine Neoplasms; Vincristine | 2011 |
Infantile choriocarcinoma in a neonate with massive liver involvement cured with chemotherapy and liver transplant.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Choriocarcinoma; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Liver Transplantation; Male; Methotrexate; Testicular Neoplasms; Treatment Outcome | 2011 |
Etoposide, cisplatin-etoposide, methotrexate, actinomycin-D as primary treatment for management of very-high-risk gestational trophoblastic neoplasia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dactinomycin; Disease Progression; Etoposide; Female; Gestational Trophoblastic Disease; Humans; India; Liver Neoplasms; Methotrexate; Middle Aged; Pregnancy; Retrospective Studies; Risk; Salvage Therapy; Survival Rate; Treatment Outcome; Young Adult | 2011 |
The effects of chemotherapeutic agents on differentiated chordoma cells.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Benzamides; Bone Neoplasms; Cell Differentiation; Cell Line, Tumor; Cell Lineage; Chordoma; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Imatinib Mesylate; Methotrexate; Piperazines; Pyrimidines; Vidarabine; Vincristine | 2011 |
Unexpected pancytopenia following treatment of acute lymphoblastic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Chromosomes, Human, Pair 6; Chromosomes, Human, Pair 9; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Daunorubicin; Erythropoiesis; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Maintenance Chemotherapy; Mercaptopurine; Methotrexate; Middle Aged; Neoplasms, Second Primary; Oncogene Proteins, Fusion; Pancytopenia; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Translocation, Genetic; Vincristine | 2012 |
The result of adjuvant chemotherapy for localized pT3 upper urinary tract carcinoma in a multi-institutional study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cytarabine; Databases, Factual; Doxorubicin; Etoposide; Female; Humans; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Mitoxantrone; Multivariate Analysis; Nephrectomy; Prognosis; Proportional Hazards Models; Retrospective Studies; Ureteral Neoplasms; Vinblastine | 2012 |
CNS disease in younger patients with aggressive B-cell lymphoma: an analysis of patients treated on the Mabthera International Trial and trials of the German High-Grade Non-Hodgkin Lymphoma Study Group.
Topics: Adolescent; Adult; Age of Onset; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Germany; Humans; International Cooperation; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Medical Oncology; Methotrexate; Middle Aged; Multicenter Studies as Topic; Neoplasm Grading; Neoplasm Invasiveness; Prednisolone; Prednisone; Rituximab; Societies, Medical; Vincristine; Young Adult | 2012 |
Adult T-cell lymphoma/leukemia presenting as pagetoid reticulosis of the palms and soles.
Topics: Adult; Antigens, CD; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Diagnostic Errors; Doxorubicin; Etoposide; Fatal Outcome; Foot; Hand; Humans; Interferons; Jamaica; Leukemia-Lymphoma, Adult T-Cell; Male; Methotrexate; Pagetoid Reticulosis; Prednisone; Skin Neoplasms; Vincristine; Zidovudine | 2011 |
Choriocarcinoma of the sigmoid colon: report of a case.
Topics: Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Colon, Sigmoid; Colonoscopy; Dactinomycin; Etoposide; Female; Humans; Leucovorin; Methotrexate; Middle Aged; Neoplasm Grading; Neoplasm Staging; Sigmoid Neoplasms | 2012 |
Treatment outcome of adult Burkitt Lymphoma in Japanese patients with modified LMB protocol : a single center retrospective analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Japan; Male; Methotrexate; Middle Aged; Prognosis; Retrospective Studies; Treatment Outcome; Vincristine; Young Adult | 2011 |
Minimally-aggressive gestational trophoblastic neoplasms.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chorionic Gonadotropin; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Pregnancy; Treatment Outcome; Vincristine | 2012 |
Ovarian hyperstimulation syndrome in a spontaneous pregnancy with invasive mole: report of a case.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Ascites; Biomarkers, Tumor; Chorionic Gonadotropin, beta Subunit, Human; Combined Modality Therapy; Cyclophosphamide; Dyspnea; Electrocoagulation; Etoposide; Female; Humans; Hydatidiform Mole, Invasive; Hysterectomy; Methotrexate; Ovarian Hyperstimulation Syndrome; Paracentesis; Parity; Polycystic Ovary Syndrome; Pregnancy; Radiography; Ultrasonography; Uterine Neoplasms | 2011 |
The roles of surgery and EMA/CO chemotherapy regimen in primary refractory and non-refractory gestational trophoblastic neoplasia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Half-Life; Humans; Methotrexate; Middle Aged; Pregnancy; Retrospective Studies; Uterine Neoplasms; Vincristine; Young Adult | 2012 |
Choriocarcinoma of the lung masquerading as a persisting pregnancy of unknown location (PUL).
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma, Non-gestational; Chorionic Gonadotropin; Cyclophosphamide; Dactinomycin; Diagnostic Errors; Etoposide; False Positive Reactions; Female; Humans; Leucovorin; Lung Neoplasms; Methotrexate; Pregnancy; Radiography; Treatment Outcome; Vincristine; Vitamin B Complex | 2012 |
Effect of chemotherapy in patients with resected small-cell or large-cell neuroendocrine carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Lymph Nodes; Male; Methotrexate; Middle Aged; Neoplasm Staging; Perioperative Care; Platinum; Pneumonectomy; Prognosis; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate | 2012 |
EP-EMA regimen (etoposide and cisplatin with etoposide, methotrexate, and dactinomycin) in a series of 18 women with gestational trophoblastic neoplasia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dactinomycin; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pregnancy; Prognosis; Retrospective Studies; Uterine Neoplasms; Young Adult | 2012 |
Treatment of high-risk gestational trophoblastic neoplasia with weekly high-dose methotrexate-etoposide.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Retrospective Studies | 2012 |
Human chorionic gonadotropin (hCG) regression normograms for patients with high-risk gestational trophoblastic neoplasia treated with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine) chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Pregnancy; Vincristine | 2012 |
[Organ-preserving interventions in combined therapy of children and adolescents with osteosarcoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Bone Transplantation; Chemotherapy, Cancer, Regional Perfusion; Child; Cisplatin; Cohort Studies; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Methotrexate; Neoadjuvant Therapy; Orthopedic Procedures; Osteosarcoma; Transplantation, Autologous; Treatment Outcome | 2012 |
Comparison of methotrexate, actinomycin D, and etoposide for treating low-risk gestational trophoblastic neoplasia.
Topics: Adult; Alopecia; Antineoplastic Agents; Chorionic Gonadotropin; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Leucovorin; Methotrexate; Nausea; Pregnancy; Prospective Studies; Remission Induction; Stomatitis; Vitamin B Complex; Vomiting; Young Adult | 2012 |
SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Clinical Trials, Phase II as Topic; Cohort Studies; Dexamethasone; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Survival Rate; Young Adult | 2012 |
Fatal cases of gestational trophoblastic neoplasia over four decades in the Netherlands: a retrospective cohort study.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Choriocarcinoma; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Guideline Adherence; Humans; Hydatidiform Mole; Hysterectomy; Methotrexate; Middle Aged; Neoplasm Metastasis; Netherlands; Practice Guidelines as Topic; Pregnancy; Retrospective Studies; Risk Assessment; Treatment Outcome; Uterine Neoplasms; Vincristine | 2012 |
Comparing cisplatin-based combination chemotherapy with EMA/CO chemotherapy for the treatment of high risk gestational trophoblastic neoplasia.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Netherlands; Pregnancy; Prognosis; Remission Induction; Risk Factors; Survival Rate; Vincristine | 2013 |
Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cranial Irradiation; Cranial Nerve Neoplasms; Drug Administration Schedule; Drug Evaluation; Drug Resistance, Neoplasm; Etoposide; Eye Neoplasms; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Recurrence; Remission Induction; Retrospective Studies; Rituximab; Salvage Therapy; Survival Analysis; Transplantation, Autologous; Treatment Outcome | 2013 |
Successful treatment of primary central nervous system lymphoma without irradiation in children: single center experience.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Infant; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Recurrence; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2012 |
Identification of transporters associated with Etoposide sensitivity of stomach cancer cell lines and methotrexate sensitivity of breast cancer cell lines by quantitative targeted absolute proteomics.
Topics: Biological Transport; Breast Neoplasms; Carrier Proteins; Cell Line, Tumor; Etoposide; Female; Humans; MCF-7 Cells; Membrane Proteins; Membrane Transport Proteins; Methotrexate; Multidrug Resistance-Associated Proteins; Propionates; Proteomics; Quinolines; Replication Protein C; Stomach Neoplasms | 2013 |
Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemoradiotherapy; Child, Preschool; Cranial Irradiation; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Male; Methotrexate; Neoplasm Grading; Neoplasm, Residual; Neuroectodermal Tumors, Primitive; Neuropsychological Tests; Pineal Gland; Pinealoma; Prognosis; Prospective Studies; Quality of Life; Survival Rate; Vincristine | 2013 |
Successful allogeneic stem cell transplantation for Lennert lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Female; Humans; Immunosuppressive Agents; Lymphoma, T-Cell, Peripheral; Melphalan; Methotrexate; Middle Aged; Nitrosourea Compounds; Pharyngitis; Prednisolone; Recurrence; Rituximab; Salvage Therapy; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Vincristine; Whole-Body Irradiation | 2013 |
EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cohort Studies; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Remission Induction; Retrospective Studies; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine | 2013 |
Primary central nervous system diffuse large B cell lymphoma transformed from orbital mucosa-associated lymphoid tissue lymphoma: complete response to combined intrathecal and systemic rituximab.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clarithromycin; Cranial Irradiation; Cyclophosphamide; Disease Progression; Etoposide; Humans; Immunophenotyping; Immunosuppressive Agents; Injections, Spinal; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Male; Meningeal Neoplasms; Methotrexate; Methylprednisolone Hemisuccinate; Orbital Neoplasms; Prednisolone; Remission Induction; Rituximab; Vincristine | 2013 |
Anti-Müllerian hormone as a marker of ovarian reserve following chemotherapy in patients with gestational trophoblastic neoplasia.
Topics: Adult; Anti-Mullerian Hormone; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Dactinomycin; Dilatation and Curettage; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Methotrexate; Ovary; Pregnancy; Young Adult | 2013 |
Pure nongestational choriocarcinoma of the ovary: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma, Non-gestational; Combined Modality Therapy; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Ovarian Neoplasms; Prognosis | 2013 |
Severe methotrexate toxicity due to a concomitant administration of ciprofloxacin.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bicarbonates; Bleomycin; Ciprofloxacin; Crystallization; Cyclophosphamide; Cytarabine; Diarrhea; Doxorubicin; Drug Eruptions; Drug Interactions; Etoposide; Female; Fluid Therapy; Fungemia; Humans; Hydrogen-Ion Concentration; Ifosfamide; Lymphoma, B-Cell; Mediastinal Neoplasms; Metabolic Clearance Rate; Methotrexate; Mucositis; Pancytopenia; Prednisone; Solubility; Urine; Vindesine | 2013 |
Impact of chemotherapy regimen and rituximab in adult Burkitt lymphoma: a retrospective population-based study from the Nordic Lymphoma Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Denmark; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Multivariate Analysis; Retrospective Studies; Rituximab; Sweden; Treatment Outcome; Vincristine; Young Adult | 2013 |
Outcome of infants and young children with newly diagnosed ependymoma treated on the "Head Start" III prospective clinical trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Ependymoma; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Male; Methotrexate; Prognosis; Prospective Studies; Radiotherapy Dosage; Survival Rate; Vincristine | 2013 |
New advances in the treatment of gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Docetaxel; Doxorubicin; Drug Combinations; Etoposide; Fluorouracil; Humans; Leucovorin; Levoleucovorin; Methotrexate; Organoplatinum Compounds; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur | 2004 |
Unsuspected metastatic choriocarcinoma presenting as unexplained severe anaemia.
Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Methotrexate; Neoplasm Metastasis; Pregnancy; Uterine Neoplasms; Vincristine | 2013 |
Quantification of circulating Epstein-Barr virus DNA in NK/T-cell lymphoma treated with the SMILE protocol: diagnostic and prognostic significance.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; DNA, Viral; Etoposide; Female; Herpesvirus 4, Human; Humans; Ifosfamide; Killer Cells, Natural; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Prognosis | 2014 |
Treatment outcome of relapsed/refractory primary central nervous system diffuse large B-cell lymphoma: a single-center experience of autologous stem cell transplantation.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Combined Modality Therapy; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome; Young Adult | 2013 |
Fatal neurological side-effects with necrosis of spinal cord following nelarabine treatment in a child with relapsed T-cell acute lymphoblastic leukemia.
Topics: Antimetabolites, Antineoplastic; Arabinonucleosides; Cerebellum; Child; Cyclophosphamide; Cytarabine; Etoposide; Fatal Outcome; Guillain-Barre Syndrome; Humans; Magnetic Resonance Imaging; Male; Medulla Oblongata; Methotrexate; Necrosis; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence; Seizures; Spinal Cord | 2013 |
Pilot study of modified LMB-based therapy for children with ataxia-telangiectasia and advanced stage high grade mature B-cell malignancies.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Ataxia Telangiectasia; Child; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Hydrocortisone; Leucovorin; Lymphoma, B-Cell; Male; Methotrexate; Neoplasm Staging; Pilot Projects; Prednisone; Prognosis; Prospective Studies; Vincristine; Young Adult | 2014 |
[Experimental study of remaxol as a drug for supportive therapy in traditional and high-dose treatment of tumors].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Deoxycytidine; Etoposide; Gemcitabine; Methotrexate; Mice; Neoplasms, Experimental; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Succinates | 2013 |
High-dose chemotherapy with autologous stem cell support as salvage therapy in recurrent gestational trophoblastic disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Prognosis; Remission Induction; Salvage Therapy; Stem Cell Transplantation; Transplantation, Autologous; Vincristine | 2013 |
Head and neck presentations of B-NHL and B-AL in children/adolescents: experience of the LMB89 study.
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Hydrocortisone; Infant; L-Lactate Dehydrogenase; Leucovorin; Leukemia, B-Cell; Lymphoma, B-Cell; Male; Methotrexate; Neoplasm Staging; Prednisone; Vincristine | 2014 |
Extranodal NK/T cell lymphoma, nasal type, presenting with meningeal infiltration in a Caucasian female.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carboplatin; Cerebrospinal Fluid; Dexamethasone; Etoposide; Female; Headache; Humans; Ifosfamide; Lumbar Vertebrae; Lymphoma, Extranodal NK-T-Cell; Magnetic Resonance Imaging; Methotrexate; Neoplasm Invasiveness; Pia Mater; Polyradiculopathy | 2013 |
Outcome of gestational trophoblastic neoplasia: experience from a tertiary cancer centre in India.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; India; Methotrexate; Middle Aged; Pregnancy; Salvage Therapy; Survival Analysis; Tertiary Care Centers; Treatment Outcome; Vincristine; Young Adult | 2014 |
Dimethylfumarate induces apoptosis in human mast cells.
Topics: Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Calcium; Caspase 6; Caspase 9; Cell Death; Cell Line; Dermatologic Agents; Dexamethasone; Dimethyl Fumarate; Etoposide; Fumarates; Humans; Interleukin-8; Maleates; Mast Cells; Methotrexate; Psoriasis; TNF-Related Apoptosis-Inducing Ligand | 2013 |
Angioimmunoblastic T cell lymphoma: an unusual presentation of posttransplant lymphoproliferative disorder in a pediatric patient.
Topics: Alveolitis, Extrinsic Allergic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Cyclophosphamide; Cytarabine; Etoposide; Heart Transplantation; Humans; Hydrocortisone; Immunoblastic Lymphadenopathy; Immunocompromised Host; Immunophenotyping; Immunosuppressive Agents; Kartagener Syndrome; Lymphoma, T-Cell; Methotrexate; Mycophenolic Acid; Oculomotor Nerve Diseases; Postoperative Complications; Prednisone; Remission Induction; T-Lymphocyte Subsets; Tacrolimus; Vincristine | 2014 |
[A case of a nonseminomatous germ cell tumor responding to MEA therapy].
Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Etoposide; Humans; Lung Neoplasms; Male; Methotrexate; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 2013 |
Diagnosis of brainstem involvement in NK/T cell lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Stem; Cerebrospinal Fluid; Cisplatin; Deoxycytidine; Dexamethasone; DNA, Viral; Etoposide; Gemcitabine; Herpesvirus 4, Human; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Neoplastic Stem Cells; Nose Neoplasms; Ophthalmoplegia; Trigeminal Nerve Diseases; Viral Load | 2014 |
Dexamethasone, methotrexate, ifosfamide, L-asparaginase and etoposide (SMILE) chemotherapy for relapsed or refractory adult lymphoblastic lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; Etoposide; Humans; Ifosfamide; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome | 2014 |
Extraskeletal Osteosarcoma: An International Rare Cancer Network Study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Cohort Studies; Deoxycytidine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Gemcitabine; Humans; Ifosfamide; Lower Extremity; Male; Methotrexate; Middle Aged; Mitomycin; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Osteosarcoma; Pelvic Neoplasms; Prognosis; Radiotherapy; Rare Diseases; Retroperitoneal Neoplasms; Retrospective Studies; Soft Tissue Neoplasms; Tumor Burden; Young Adult | 2016 |
[Successful treatment with high-dose methotrexate/cytarabine regimen in a patient in SMILE regimen-resistant extranodal natural killer/T-cell lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Dexamethasone; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Treatment Outcome | 2014 |
Characteristics and clinical evolution of patients with acute myeloblastic leukemia in northeast Mexico: an eight-year experience at a university hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Component Transfusion; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hospitals, University; Humans; Infant; Infusions, Intravenous; Injections, Spinal; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Male; Methotrexate; Mexico; Middle Aged; Mitoxantrone; Proportional Hazards Models; Retrospective Studies; Risk Factors; Treatment Outcome; Young Adult | 2014 |
Clinical outcomes of AIDS-related Burkitt lymphoma: a multi-institution retrospective survey in Japan.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Induction Chemotherapy; Japan; Kaplan-Meier Estimate; Lymphoma, AIDS-Related; Male; Methotrexate; Middle Aged; Prednisone; Retrospective Studies; Rituximab; Treatment Outcome; Vincristine | 2014 |
Therapy of HIV-associated lymphoma-recommendations of the oncology working group of the German Study Group of Physicians in Private Practice Treating HIV-Infected Patients (DAGNÄ), in cooperation with the German AIDS Society (DAIG).
Topics: Anti-HIV Agents; Antibiotic Prophylaxis; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Castleman Disease; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Interactions; Etoposide; Hematopoietic Stem Cell Transplantation; HIV Infections; Humans; Lymphoma, AIDS-Related; Methotrexate; Neoplasm Staging; Prednisolone; Prednisone; Radiotherapy, Adjuvant; Risk Assessment; Rituximab; Vincristine | 2014 |
Anaplastic lymphoma kinase-positive large B-cell lymphoma: description of a case with an unexpected clinical outcome.
Topics: Anaplastic Lymphoma Kinase; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Receptor Protein-Tyrosine Kinases; Remission Induction; Treatment Outcome; Vincristine | 2015 |
After the treated mole.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole; Immunophenotyping; Leukemia, Myeloid, Acute; Methotrexate; Neoplasms, Second Primary; Pregnancy; Trophoblasts; Vincristine | 2014 |
Upfront autologous stem-cell transplantation with melphalan, cyclophosphamide, etoposide, and dexamethasone (LEED) in patients with newly diagnosed primary central nervous system lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Cytarabine; Dexamethasone; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Methotrexate; Middle Aged; Remission Induction; Retrospective Studies; Stem Cell Transplantation; Survival Analysis; Transplantation, Autologous; Treatment Outcome | 2014 |
Reticulated hyperpigmentation following chemotherapy for radiation-induced osteosarcoma.
Topics: Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Eruptions; Etoposide; Humans; Hyperpigmentation; Ifosfamide; Male; Methotrexate; Middle Aged; Neoplasms, Radiation-Induced; Orbital Neoplasms; Osteosarcoma; Triamcinolone | 2014 |
Extracavitary primary effusion lymphoma initially presenting with hemophagocytic lymphohistocytosis.
Topics: Adrenal Cortex Hormones; Adult; Anti-HIV Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Diagnostic Imaging; Doxorubicin; Early Diagnosis; Epstein-Barr Virus Infections; Etoposide; Herpesviridae Infections; Herpesvirus 8, Human; Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoma, AIDS-Related; Lymphoma, Primary Effusion; Male; Methotrexate; Prednisone; Remission Induction; Rituximab; Vincristine; Viremia | 2014 |
A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma.
Topics: Acute Kidney Injury; Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Injections, Spinal; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Prednisone; Recurrence; Retrospective Studies; Risk Assessment; Rituximab; Survival Rate; Vincristine; Young Adult | 2014 |
Induction treatment with SMILE and consolidation with autologous stem cell transplantation for newly diagnosed stage IV extranodal natural killer/T-cell lymphoma patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cohort Studies; Combined Modality Therapy; Dexamethasone; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Induction Chemotherapy; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prospective Studies; Survival Rate; Transplantation, Autologous; Treatment Outcome; Young Adult | 2015 |
Etoposide, Methotrexate, and Dactinomycin Alternating With Cyclophosphamide and Vincristine (EMACO) for Male Patients With HCG-expressing, Chemoresistant Germ Cell Tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Humans; Male; Methotrexate; Neoplasms, Germ Cell and Embryonal; Retrospective Studies; Testicular Neoplasms; Vincristine | 2017 |
[Prognostic impact of anthracyclines in the treatment of aggressive lymphoma in patients over 70 years].
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Prognosis; Proportional Hazards Models; Retrospective Studies; Rituximab; Treatment Outcome; Vincristine | 2015 |
[Unusual antenatal gestational choriocarcinoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Chorionic Gonadotropin; Cisplatin; Dactinomycin; Etoposide; Female; Gestational Age; Humans; Male; Methotrexate; Pregnancy; Pregnancy Outcome; Prognosis; Seizures; Tomography, X-Ray Computed; Uterine Neoplasms | 2014 |
How I treat Burkitt lymphoma in adults.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Ifosfamide; Male; Methotrexate; Nasopharyngeal Neoplasms; Prednisone; Prognosis; Translocation, Genetic; Vincristine | 2014 |
Ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) plus L-asparaginase as a first-line therapy improves outcomes in stage III/IV NK/T cell-lymphoma, nasal type (NTCL).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Prednisolone; Prognosis; Retrospective Studies; Young Adult | 2015 |
Osteopontin upregulates the expression of glucose transporters in osteosarcoma cells.
Topics: Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Daunorubicin; Etoposide; Fluorouracil; Glucose Transport Proteins, Facilitative; Glucose Transporter Type 1; Glucose Transporter Type 3; Humans; Integrin alphaVbeta3; Membrane Transport Modulators; Methotrexate; Osteopontin; Osteosarcoma; Phloretin; Up-Regulation | 2014 |
Attempted conservative management of a placental site trophoblastic tumor: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Lymph Node Excision; Methotrexate; Paclitaxel; Pregnancy; Trophoblastic Tumor, Placental Site; Uterine Neoplasms; Vincristine | 2014 |
[Expression of C1QBP gene and its correlation with drug resistance in human resistance choriocarcinoma cell line].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Carrier Proteins; Cell Line, Tumor; Choriocarcinoma; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Female; Gene Expression; Humans; Lentivirus; Methotrexate; Mitochondrial Proteins; Pregnancy; RNA, Messenger; RNA, Small Interfering; Uterine Neoplasms | 2014 |
Gestational trophoblastic neoplasia: treatment outcomes from a single institutional experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Choriocarcinoma; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Hysterectomy; Liver Neoplasms; Lung Neoplasms; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Remission Induction; Retrospective Studies; Risk Factors; Salvage Therapy; Survival Rate; Uterine Neoplasms; Vaginal Neoplasms; Vincristine; Young Adult | 2015 |
Testicular germ cell tumors in adolescents - results of the protocol MAHO 98 and the identification of good risk patients.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Child; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Prognosis; Risk Adjustment; Testicular Neoplasms; Vinblastine; Young Adult | 2014 |
Temporal analysis of prostaglandin F2α receptor, caspase 3, and cyclooxygenase 2 messenger RNA expression and prostaglandin F2α receptor and cyclooxygenase 2 protein expression in endometrial tissue from multiparous Nelore (Bos taurus indicus) cows treate
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Caspase 3; Cattle; Cloprostenol; Cyclooxygenase 2; Endometrium; Etoposide; Female; Gene Expression; Ifosfamide; Immunohistochemistry; Luteolytic Agents; Methotrexate; Postpartum Period; Receptors, Prostaglandin; RNA, Messenger | 2015 |
Whole-scale neurobehavioral assessments of photothrombotic ischemia in freely moving mice.
Topics: Analysis of Variance; Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Infarction; Brain Ischemia; Disease Models, Animal; Etoposide; Exercise Test; Ifosfamide; Intracranial Thrombosis; Lasers; Locomotion; Male; Methotrexate; Mice; Mice, Inbred Strains; Movement Disorders; Rotarod Performance Test; Wakefulness | 2015 |
Resistance to single-agent chemotherapy and its risk factors in low-risk gestational trophoblastic neoplasms.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Iran; Methotrexate; Middle Aged; Pregnancy; Risk Factors; Vincristine; Young Adult | 2015 |
Effects of single-agent and combination chemotherapy for gestational trophoblastic tumors on risks of second malignancy and early menopause.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Cohort Studies; Cyclophosphamide; Dactinomycin; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Incidence; Kaplan-Meier Estimate; Menopause, Premature; Methotrexate; Middle Aged; Neoplasms, Second Primary; Odds Ratio; Pregnancy; Risk Assessment; Risk Factors; Uterine Neoplasms; Vincristine; Young Adult | 2015 |
High-dose Chemotherapy With Autologous Stem Cell Rescue in Saudi Children Less Than 3 Years of Age With Embryonal Brain Tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Etoposide; Female; Follow-Up Studies; Humans; Infant; Male; Methotrexate; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Saudi Arabia; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Vincristine | 2015 |
A case of clonally distinct relapse of Burkitt lymphoma 9 years after complete remission.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Genes, Immunoglobulin; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunoglobulin Heavy Chains; Male; Methotrexate; Molecular Sequence Data; Neoplasm Recurrence, Local; Remission Induction; V(D)J Recombination; Vincristine | 2015 |
Brain metastases in gestational trophoblast neoplasia: an update on incidence, management and outcome.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma, Non-gestational; Cisplatin; Cohort Studies; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Methotrexate; Middle Aged; Pregnancy; Treatment Outcome; Vincristine; Young Adult | 2015 |
Characterization of a unique cell population marked by transgene expression in the adult cochlea of nestin-CreER(T2)/tdTomato-reporter mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cochlea; Ear, Inner; Estrogen Antagonists; Etoposide; Female; Gene Expression Regulation; Ifosfamide; Ki-67 Antigen; Luminescent Proteins; Male; Membrane Proteins; Methotrexate; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nerve Tissue Proteins; Nestin; Neurons; Plant Lectins; Receptors, Estrogen; Tamoxifen | 2015 |
A rare case of primary high-grade large B-cell lymphoma of the sciatic nerve.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Methotrexate; Multimodal Imaging; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Prednisone; Rituximab; Sciatic Nerve; Tomography, X-Ray Computed; Vincristine | 2015 |
Outcome of Patients With Non-Hodgkin Lymphomas With Concurrent MYC and BCL2 Rearrangements Treated With CODOX-M/IVAC With Rituximab Followed by Hematopoietic Stem Cell Transplantation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Gene Rearrangement; Genes, bcl-2; Genes, myc; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Retrospective Studies; Rituximab; Survival Rate; Treatment Outcome; Vincristine | 2015 |
Use of combined chemotherapy with etoposide and methotrexate, both associated to lipid nanoemulsions for atherosclerosis treatment in cholesterol-fed rabbits.
Topics: Animals; Aorta; Atherosclerosis; Drug Therapy, Combination; Emulsions; Etoposide; Lipids; Male; Methotrexate; Nanostructures; Rabbits | 2015 |
Response to chemotherapy in overweight/obese patients with low-risk gestational trophoblastic neoplasia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Cohort Studies; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Staging; Obesity; Overweight; Pregnancy; Prognosis; Remission Induction; Vincristine; Young Adult | 2015 |
Evaluation of the drug sensitivity and expression of 16 drug resistance-related genes in canine histiocytic sarcoma cell lines.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cytarabine; Dog Diseases; Dogs; Doxorubicin; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Histiocytic Sarcoma; Melphalan; Methotrexate; Nimustine; Paclitaxel; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Vinblastine; Vincristine | 2015 |
Benefit of consolidative radiation therapy for primary bone diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cause of Death; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Prednisone; Proportional Hazards Models; Radiotherapy Dosage; Rituximab; Treatment Failure; Tumor Burden; Vincristine; Young Adult | 2015 |
Predictors of local recurrence after rituximab-based chemotherapy alone in stage III and IV diffuse large B-cell lymphoma: guiding decisions for consolidative radiation.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Selection; Prednisone; Recurrence; Regression Analysis; Risk; Rituximab; Treatment Failure; Tumor Burden; Vincristine; Young Adult | 2015 |
Relationship between race and clinical characteristics, extent of disease, and response to chemotherapy in patients with low-risk gestational trophoblastic neoplasia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asian; Black or African American; Chorionic Gonadotropin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Folic Acid; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Risk Factors; White People; Young Adult | 2015 |
High-dose methotrexate, etoposide, dexamethasone and pegaspargase (MEDA) combination chemotherapy is effective for advanced and relapsed/refractory extranodal natural killer/T cell lymphoma: a retrospective study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Polyethylene Glycols; Retrospective Studies; Treatment Outcome | 2015 |
A 30-year experience in using oral methotrexate as initial treatment for gestational trophoblastic neoplasia regardless of risk group.
Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Pregnancy; Risk Factors; Treatment Outcome; Vincristine; Young Adult | 2016 |
Human Chorionic Gonadotropin (hCG) Regression Curve for Predicting Response to EMA/CO (Etoposide, Methotrexate, Actinomycin D, Cyclophosphamide and Vincristine) Regimen in Gestational Trophoblastic Neoplasia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Chorionic Gonadotropin; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Nomograms; Pregnancy; Prognosis; Regression Analysis; ROC Curve; Vincristine; Young Adult | 2015 |
A Demyelinating Disease; What Lies Beneath?
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain; Central Nervous System Neoplasms; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Demyelinating Diseases; Diagnosis, Differential; Doxorubicin; Encephalomyelitis, Acute Disseminated; Etoposide; Humans; Hydrocortisone; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Methotrexate; Prednisone; Vincristine | 2016 |
Cavernous angioma after chemotherapy for desmoplastic/nodular medulloblastoma associated with anhidrotic ectodermal dysplasia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Cerebellar Neoplasms; Child, Preschool; Cisplatin; Cyclophosphamide; Ectodermal Dysplasia; Etoposide; Hemangioma, Cavernous, Central Nervous System; Humans; Infant; Intracranial Hemorrhages; Male; Medulloblastoma; Melphalan; Methotrexate; Neurosurgical Procedures; Peripheral Blood Stem Cell Transplantation; Vincristine | 2016 |
The Role of Computed Tomography Scanning of the Thorax in the Initial Assessment of Gestational Trophoblastic Neoplasia.
Topics: Administration, Intravenous; Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Lung Neoplasms; Methotrexate; Neoplasm Staging; Pregnancy; Radiography, Thoracic; Risk Assessment; Salvage Therapy; Tomography, X-Ray Computed | 2015 |
Highly effective reduced toxicity dose-intensive pilot protocol for non-metastatic limb osteogenic sarcoma (SCOS 89).
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Drug Substitution; Etoposide; Female; Follow-Up Studies; Hearing Loss; Humans; Ifosfamide; Kidney Diseases; Leucovorin; Male; Methotrexate; Osteosarcoma; Pilot Projects; Stroke Volume; Survival Rate; Treatment Outcome; Young Adult | 2015 |
A Hemophagocytic Lymphohistiocytosis Case with Newly Defined UNC13D (c.175G>C; p.Ala59Pro) Mutation and a Rare Complication.
Topics: Amino Acid Substitution; Amphotericin B; Aspergillosis; Bone Marrow Transplantation; Combined Modality Therapy; Cyclosporine; Debridement; Dexamethasone; Drug Therapy, Combination; Etoposide; Female; Humans; Immunocompromised Host; Infant; Lymphohistiocytosis, Hemophagocytic; Membrane Proteins; Methotrexate; Mutation, Missense; Nasal Septal Perforation; Opportunistic Infections; Palate, Soft; Point Mutation; Stomatitis | 2015 |
Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cardiotonic Agents; Child; Child, Preschool; Cisplatin; Dexrazoxane; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Methotrexate; Osteosarcoma; Treatment Outcome; Ventricular Dysfunction | 2016 |
Comparison of 5-day MTX and 5-day ETP treatment results and early predictors of drug resistance to 5-day MTX in patients with post-molar low-risk gestational trophoblastic neoplasia.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Chorionic Gonadotropin; Drug Administration Schedule; Drug Resistance, Neoplasm; Drug Substitution; Etoposide; Female; Humans; Hydatidiform Mole; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Retrospective Studies; Treatment Outcome; Uterine Neoplasms; Young Adult | 2015 |
Methotrexate-associated lymphoproliferative disorder presenting as extranodal NK/T-cell lymphoma arising in the lungs.
Topics: Antineoplastic Agents; Arthritis, Rheumatoid; Asparaginase; Diagnosis, Differential; Epstein-Barr Virus Infections; Etoposide; Female; Herpesvirus 4, Human; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Lymphoproliferative Disorders; Methotrexate; Middle Aged; Risk; Steroids | 2015 |
Concurrent Chemoradiation Therapy Followed by Consolidation Chemotherapy for Localized Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparagine; Chemoradiotherapy; Cisplatin; Consolidation Chemotherapy; Dexamethasone; Disease-Free Survival; Dose Fractionation, Radiation; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Nose Neoplasms; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Recurrence; Treatment Outcome | 2015 |
Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Burkitt Lymphoma; Central Nervous System Neoplasms; Cohort Studies; Cyclophosphamide; Cytarabine; Databases, Factual; Dexamethasone; DNA-Binding Proteins; Doxorubicin; Etoposide; Female; Gene Rearrangement; Genes, bcl-2; Genes, myc; Germinal Center; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Proto-Oncogene Proteins c-bcl-6; Rituximab; Survival Rate; Vincristine | 2016 |
The pharmacokinetics of high-dose methotrexate in people living with HIV on antiretroviral therapy.
Topics: Adult; Aged; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Etoposide; Female; Half-Life; HIV Infections; Humans; Ifosfamide; Kidney Function Tests; Male; Methotrexate; Middle Aged; Retrospective Studies; Tenofovir; Vincristine; Young Adult | 2016 |
Successful Treatment of Genetically Profiled Pediatric Extranodal NK/T-Cell Lymphoma Targeting Oncogenic STAT3 Mutation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chemoradiotherapy; Child; Cytarabine; Dexamethasone; DNA Mutational Analysis; Etoposide; Female; Humans; Hydrocortisone; Hydroxamic Acids; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; MAP Kinase Kinase 1; Methotrexate; Mutation; Positive Regulatory Domain I-Binding Factor 1; Precision Medicine; Repressor Proteins; STAT3 Transcription Factor; Vorinostat | 2016 |
[Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Leucovorin; Logistic Models; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Multivariate Analysis; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Retrospective Studies; Survival Rate; Vincristine | 2016 |
Conservative Chemotherapy in Gestational Trophoblastic Disease: Experience With Etoposide, Methotrexate, and Dactinomycin Chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Methotrexate; Neoplasm Invasiveness; Neoplasm Staging; Pregnancy; Prognosis; Salvage Therapy | 2016 |
L-asparaginase-based regimens followed by allogeneic hematopoietic stem cell transplantation improve outcomes in aggressive natural killer cell leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Combined Modality Therapy; Dexamethasone; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Outcome Assessment, Health Care; Prognosis; Transplantation, Homologous; Young Adult | 2016 |
Concomitant Presentation of Hemophagocytic Lymphohistiocytosis and Posttransplant Lymphoproliferative Disease-Like Lymphoma in a Mildly Immunosuppressed Leukemia Patient: An Unusual Association.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cyclosporine; Dexamethasone; Epstein-Barr Virus Infections; Etoposide; Female; Humans; Immunocompromised Host; Infant; Lymphohistiocytosis, Hemophagocytic; Male; Mercaptopurine; Methotrexate; Multiple Organ Failure; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Rituximab; Treatment Failure; Vincristine; Viral Load | 2016 |
Primary mediastinal choriocarcinoma with brain metastasis in a female patient.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma, Non-gestational; Cyclophosphamide; Dactinomycin; Etoposide; Fatal Outcome; Female; Humans; Mediastinal Neoplasms; Methotrexate; Middle Aged; Vincristine | 2016 |
Antimicrobial Use in Patients on a Comfort Care Protocol: A Retrospective Cohort Study.
Topics: Anti-Infective Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Humans; Intensive Care Units; Methotrexate; Palliative Care; Patient Comfort; Retrospective Studies | 2016 |
Spontaneous renal hemorrhage caused by invasive mole: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Doxorubicin; Etoposide; Female; Hemorrhage; Humans; Hydatidiform Mole, Invasive; Kidney Diseases; Leucovorin; Methotrexate; Pregnancy; Uterine Neoplasms; Vincristine | 2016 |
Prognosis of Patients with Gestational Trophoblastic Neoplasia and Obstetric Outcomes of Those Conceiving After Chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Dactinomycin; Etoposide; Female; Fertility Preservation; Gestational Trophoblastic Disease; Humans; Leucovorin; Methotrexate; Middle Aged; Pregnancy; Prognosis; Term Birth; Treatment Outcome; Uterine Neoplasms; Young Adult | 2016 |
Dose-Adjusted EPOCH-R and Mid-Cycle High Dose Methotrexate for Patients with Systemic Lymphoma and secondary CNS Involvement.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma; Methotrexate; Prednisone; Rituximab; Treatment Outcome; Vincristine | 2017 |
Isolation, Culture and Identification of Choriocarcinoma Stem-Like Cells from the Human Choriocarcinoma Cell-Line JEG-3.
Topics: AC133 Antigen; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Separation; Choriocarcinoma; Culture Media, Serum-Free; Etoposide; Female; Fluorouracil; Gene Expression; Humans; Hyaluronan Receptors; Methotrexate; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Proteins; Neoplastic Stem Cells; Tumor Burden; Xenograft Model Antitumor Assays | 2016 |
Is chemotherapy necessary for patients with molar pregnancy and human chorionic gonadotropin serum levels raised but falling at 6months after uterine evacuation?
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brazil; Case-Control Studies; Chemotherapy, Adjuvant; Chorionic Gonadotropin; Cohort Studies; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Leucovorin; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Retrospective Studies; Treatment Outcome; Uterine Neoplasms; Vacuum Curettage; Vincristine; Watchful Waiting; Young Adult | 2016 |
Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell Lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy; Leucovorin; Liver; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Methotrexate; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Prednisone; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Conformal; Recurrence; Rituximab; Statistics, Nonparametric; Vincristine; Young Adult | 2017 |
Ewing Sarcoma of the Bone With EWS/FLI1 Translocation After Successful Treatment of Primary Osteosarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Femoral Neoplasms; Humans; Ifosfamide; Limb Salvage; Methotrexate; Neoplasms, Second Primary; Oncogene Proteins, Fusion; Osteosarcoma; Proto-Oncogene Protein c-fli-1; Remission Induction; RNA-Binding Protein EWS; Sarcoma, Ewing; Vincristine | 2017 |
Nasal Type Extranodal Natural Killer/T (NK/T) Cell Lymphoma Presenting as Periorbital Cellulitis: A Case Report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Diagnosis, Differential; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Mesna; Methotrexate; Orbital Cellulitis; Paranasal Sinus Neoplasms; Prognosis; Treatment Outcome | 2016 |
Gestational choriocarcinoma with renal and pulmonary metastases lacking a primary uterine origin.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Hematuria; Humans; Kidney Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Methotrexate; Neoplasms, Unknown Primary; Pregnancy; Vincristine | 2016 |
Nonfunctioning Adrenocortical Carcinoma in Pediatric Acute Lymphoblastic Leukemia: A Case Report of a Rare Multiple Primaries Combination.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Fatal Outcome; Humans; Language Development Disorders; Lung Neoplasms; Mercaptopurine; Methotrexate; Mitoxantrone; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Nephrectomy; Pneumonectomy; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2017 |
Delayed Diagnosis of a Nasal Type Lymphoma Misdiagnosed as Persistent Sinusitis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chronic Disease; Delayed Diagnosis; Dexamethasone; Diagnostic Errors; Etoposide; Fistula; Humans; Ifosfamide; Leucovorin; Lymphoma, Extranodal NK-T-Cell; Male; Maxillary Sinusitis; Methotrexate; Mouth Diseases; Nose Diseases; Nose Neoplasms; Palatal Neoplasms; Radiotherapy | 2017 |
Extranodal NK/T cell lymphoma in a living donor liver transplant recipient.
Topics: Allografts; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; Drug Substitution; Etoposide; Humans; Ifosfamide; Immunosuppressive Agents; Liver Cirrhosis; Liver Transplantation; Living Donors; Lymphoma, Extranodal NK-T-Cell; Methotrexate; Methylprednisolone; Mycophenolic Acid; Postoperative Complications; Remission Induction; Tacrolimus; Transplant Recipients | 2017 |
Outcomes of adults with relapsed or refractory Burkitt and high-grade B-cell leukemia/lymphoma.
Topics: Adult; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Leukemia, B-Cell; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Methotrexate; Polyethylene Glycols; Prednisone; Recurrence; Remission Induction; Retrospective Studies; Rituximab; Salvage Therapy; Treatment Outcome; Vincristine | 2017 |
The added value of hysterectomy in the management of gestational trophoblastic neoplasia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Hysterectomy; Methotrexate; Middle Aged; Pregnancy; Retrospective Studies; Treatment Outcome; Vincristine; Young Adult | 2017 |
Salvage chemotherapy for gestational trophoblastic neoplasia: Utility or futility?
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Kaplan-Meier Estimate; Medical Futility; Methotrexate; Middle Aged; Pregnancy; Retrospective Studies; Risk Factors; Salvage Therapy; Vincristine; Young Adult | 2017 |
Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Prednisone; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-bcl-6; Proto-Oncogene Proteins c-myc; Recurrence; Remission Induction; Rituximab; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Vincristine | 2017 |
Comparison of Native Escherichia coli L-Asparaginase versus Pegylated Asparaginase, in Combination with Ifosfamide, Methotrexate, Etoposide, and Prednisolone, in Extranodal NK/T-Cell Lymphoma, Nasal Type.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Escherichia coli; Etoposide; Female; Humans; Ifosfamide; Length of Stay; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Polyethylene Glycols; Prednisolone; Treatment Outcome | 2018 |
[A Case of Long Survival in Aggressively Growing Small Cell Carcinoma of the Bladder Successfully Treated by Combined Chemotherapy of Methotrexate, Etoposide and Cisplatin].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Time Factors; Urinary Bladder Neoplasms | 2017 |
Role of chemotherapy and thrombolysis in treatment of choriocarcinoma accompanied with pulmonary embolism: A case report with literature review.
Topics: Adult; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Chorionic Gonadotropin, beta Subunit, Human; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Pregnancy; Pulmonary Embolism; Uterine Neoplasms; Vincristine | 2017 |
Treatment of grey zone lymphoma using the R-CODOX-M/R-IVAC protocol: Two case reports.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Treatment Outcome; Vincristine | 2017 |
Recombinant human erythropoietin prevents etoposide- and methotrexate-induced toxicity in kidney and liver tissues via the regulation of oxidative damage and genotoxicity in Wistar rats.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Catalase; Chemical and Drug Induced Liver Injury; DNA Damage; Erythropoietin; Etoposide; Glutathione; Kidney; Kidney Diseases; Lipid Peroxidation; Liver; Male; Malondialdehyde; Methotrexate; Protective Agents; Rats, Wistar; Recombinant Proteins | 2018 |
Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Carmustine; Cost-Benefit Analysis; Cyclophosphamide; Cytarabine; Etoposide; Female; HIV Infections; Humans; Ifosfamide; Male; Melphalan; Methotrexate; Middle Aged; Neoplasm Staging; Retrospective Studies; Rituximab; Survival Analysis | 2018 |
Reproductive Outcomes After Gestational Trophoblastic Neoplasia. A Comparison Between Single-Agent and Multiagent Chemotherapy: Retrospective Analysis From the MITO-9 Group.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Hysterectomy; Infant, Newborn; Italy; Male; Methotrexate; Multicenter Studies as Topic; Pregnancy; Pregnancy Outcome; Retrospective Studies; Vincristine; Young Adult | 2018 |
Analysis of the activity and safety of weekly low-dose bevacizumab-based regimens in heavily pretreated patients with metastatic breast cancer.
Topics: Adult; Aged; Albumins; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Etoposide; Female; Humans; Irinotecan; Methotrexate; Middle Aged; Neoplasm Metastasis; Paclitaxel; Pemetrexed; Progression-Free Survival; Treatment Outcome | 2018 |
Excellent real-world outcomes of adults with Burkitt lymphoma treated with CODOX-M/IVAC plus or minus rituximab.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Rituximab; Survival Rate; Time Factors; Vincristine | 2018 |
Successful treatment of multisite hemorrhage by several methods in brain metastasis of choriocarcinoma: A case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Brain; Brain Neoplasms; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Hemorrhage; Hemostatic Techniques; Humans; Magnetic Resonance Imaging; Methotrexate; Pregnancy; Tomography, X-Ray Computed; Uterine Neoplasms; Vincristine | 2018 |
Treatment results of the second-line chemotherapy regimen for patients with low-risk gestational trophoblastic neoplasia treated with 5-day methotrexate and 5-day etoposide.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Japan; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Remission Induction; Retrospective Studies; Risk Factors; Treatment Outcome | 2018 |
[Curative effects and influenced factors of EMA-CO as an initial regimen for the treatment of high-risk gestational trophoblastic neoplasia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Prognosis; Remission Induction; Retrospective Studies; Salvage Therapy; Vincristine | 2018 |
Is there uniformity in definitions and treatment of gestational trophoblastic disease in Europe?
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Europe; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Prognosis; Vincristine | 2019 |
Can carboplatin or etoposide replace actinomycin-d for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brazil; Carboplatin; Dactinomycin; Drug Resistance, Neoplasm; Drug Substitution; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Retrospective Studies; Treatment Outcome; Young Adult | 2019 |
Targeting of TMPRSS4 sensitizes lung cancer cells to chemotherapy by impairing the proliferation machinery.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cisplatin; Docetaxel; Etoposide; Fluorouracil; HEK293 Cells; Humans; Lung Neoplasms; Membrane Proteins; Methotrexate; Mice; Molecular Targeted Therapy; Pemetrexed; Serine Endopeptidases | 2019 |
Clinical Prognostic Factors and Outcome in Pediatric Osteosarcoma: Effect of Delay in Local Control and Degree of Necrosis in a Multidisciplinary Setting in Lebanon.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Infant; Lebanon; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Metastasis; Osteosarcoma; Prognosis; Retrospective Studies; Risk Assessment; Treatment Outcome | 2019 |
Paternal uniparental isodisomy of tyrosine hydroxylase locus at chromosome 11p15.4: spectrum of phenotypical presentations simulating hydatidiform moles.
Topics: Abortion, Missed; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chromosomes, Human, Pair 11; Cyclophosphamide; Dactinomycin; Etoposide; Female; Genetic Loci; Genetic Predisposition to Disease; Humans; Hydatidiform Mole; Male; Methotrexate; Phenotype; Pregnancy; Treatment Outcome; Tyrosine 3-Monooxygenase; Uniparental Disomy; Uterine Neoplasms; Vincristine | 2019 |
Topics: ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Dactinomycin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Humans; Methotrexate; Polymorphism, Single Nucleotide | 2019 |
Genetically Related Choriocarcinoma Developing 5 Yr After a Complete Hydatidiform Mole and Simulating a Cornual Ectopic Pregnancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Chorionic Gonadotropin; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Etoposide; Female; Genotype; Genotyping Techniques; Humans; Hydatidiform Mole; Methotrexate; Pregnancy; Pregnancy, Ectopic; Uterine Neoplasms; Vincristine | 2020 |
A role for ABCB1 in prognosis, invasion and drug resistance in ependymoma.
Topics: ATP Binding Cassette Transporter, Subfamily B; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Child, Preschool; Drug Resistance, Neoplasm; Drug Synergism; Ependymoma; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Infant; Methotrexate; Neoplasm Invasiveness; Neoplastic Stem Cells; Prognosis; Survival Analysis; Up-Regulation; Vardenafil Dihydrochloride; Verapamil; Vincristine | 2019 |
Strategy to minimize radiation burden in infants and high-risk medulloblastoma using intrathecal methotrexate and high-dose chemotherapy: A prospective registry study in Japan.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Humans; Injections, Spinal; Male; Medulloblastoma; Melphalan; Methotrexate; Prognosis; Prospective Studies; Registries; Survival Rate | 2020 |
Primary intraocular natural killer-cell lymphoma successfully treated using a multidisciplinary strategy.
Topics: Aged; Asparaginase; Combined Modality Therapy; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Injections, Intraocular; Intraocular Lymphoma; Killer Cells, Natural; Methotrexate; Radiotherapy, Adjuvant; Remission Induction; Vitreous Body | 2019 |
Metastatic Brain Choriocarcinoma in a Postmenopausal Woman: A Case Report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Postmenopause; Uterine Neoplasms; Vincristine | 2020 |
Small Cell Variant of Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma of the Dura Mimicking Tentorial Meningioma.
Topics: Adult; Anaplastic Lymphoma Kinase; Antineoplastic Agents; Cytarabine; Diagnosis, Differential; Etoposide; Humans; Lymphoma, Large-Cell, Anaplastic; Male; Meningeal Neoplasms; Meningioma; Methotrexate; Supratentorial Neoplasms | 2020 |
T Regulatory Cell Frequency During Maintenance Phase Chemotherapy for Pediatric Acute Lymphoblastic Leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Etoposide; Female; Humans; Hydrocortisone; Maintenance Chemotherapy; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; T-Lymphocytes, Regulatory; Vincristine | 2020 |
Prognostic factors, therapeutic approaches, and distinct immunobiologic features in patients with primary mediastinal large B-cell lymphoma on long-term follow-up.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; MicroRNAs; Middle Aged; Prednisone; Prognosis; Retrospective Studies; Rituximab; Transcriptome; Vincristine; Young Adult | 2020 |
EMA vs EMACO in the treatment of gestational trophoblastic neoplasia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dactinomycin; Doxorubicin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Leucovorin; Methotrexate; Mitoxantrone; Multivariate Analysis; Neoplasm Staging; Pregnancy; Retrospective Studies; Vincristine | 2020 |
Efficacy of salvage therapy with MTX-HOPE for elderly patients with heavily pretreated non-Hodgkin's lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Hydrocortisone; Lymphoma, Non-Hodgkin; Male; Methotrexate; Piperazines; Salvage Therapy; Treatment Outcome; Vincristine | 2020 |
Management of methotrexate-induced neurotoxicity with aminophylline plus dextromethorphan in a pediatric patient with pineoblastoma.
Topics: Adolescent; Aminophylline; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Bronchodilator Agents; Cisplatin; Cyclophosphamide; Dextromethorphan; Disease Management; Drug Therapy, Combination; Etoposide; Excitatory Amino Acid Antagonists; Female; Humans; Methotrexate; Neurotoxicity Syndromes; Pineal Gland; Pinealoma; Prognosis | 2020 |
How I treat adult T-cell leukemia/lymphoma.
Topics: Aged; Allografts; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Human T-lymphotropic virus 1; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Methotrexate; Middle Aged; Practice Patterns, Physicians'; Prednisone; Raltegravir Potassium; Recurrence; Remission Induction; Therapies, Investigational; Vincristine; Virus Activation; Zidovudine | 2021 |
Nivolumab Treatment of Burkitt Lymphoma: A Case Report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Ifosfamide; Male; Methotrexate; Nivolumab; Vincristine | 2021 |
M-EA (methotrexate, etoposide, dactinomycin) and EMA-CO (methotrexate, etoposide, dactinomycin / cyclophosphamide, vincristine) regimens as first-line treatment of high-risk gestational trophoblastic neoplasia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Risk Factors; Vincristine | 2021 |
Management and prognostic analysis of patients with gestational trophoblastic neoplasia (GTN) in FIGO stage IV and its special type.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dactinomycin; Disease Management; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Retrospective Studies; Survival Rate; Vincristine | 2021 |
Placental site trophoblastic tumour: five challenges of patient clinical management.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Chorionic Gonadotropin; Cisplatin; Consolidation Chemotherapy; Dactinomycin; Etoposide; Female; Humans; Hysterectomy; Lung Neoplasms; Lymph Node Excision; Methotrexate; Paclitaxel; Pregnancy; Puerperal Disorders; Salpingectomy; Trophoblastic Tumor, Placental Site; Uterine Neoplasms | 2021 |
MTX-HOPE is a low-dose salvage chemotherapy for aged patients with relapsed or refractory non-Hodgkin lymphoma.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Grading; Neoplasm Staging; Piperazines; Prognosis; Proportional Hazards Models; Recurrence; Salvage Therapy; Treatment Outcome; Vincristine | 2021 |
Uterine Rescue in High-Risk Gestational Trophoblastic Neoplasia Treated with EMA-CO by Uterine Arteries Embolization due to Arteriovenous Malformations.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arteriovenous Malformations; Cyclophosphamide; Dactinomycin; Embolization, Therapeutic; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Pregnancy, High-Risk; Ultrasonography, Prenatal; Uterine Artery; Uterine Hemorrhage; Vincristine; Young Adult | 2021 |
Gestational trophoblastic neoplasia after human chorionic gonadotropin normalization in a retrospective cohort of 7761 patients in France.
Topics: Adolescent; Adult; Aftercare; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Transformation, Neoplastic; Choriocarcinoma; Chorionic Gonadotropin; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; France; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Hysterectomy; Leucovorin; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Retrospective Studies; Trophoblastic Tumor, Placental Site; Uterine Neoplasms; Vincristine; Young Adult | 2021 |
Choriocarcinoma brain metastasis in a patient in the third trimester: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Pregnancy; Pregnancy Trimester, Third; Uterine Neoplasms; Vincristine | 2021 |
Rituximab, Methotrexate, Carmustine, Etoposide, and Prednisone (RMBVP) for the treatment of relapsed/refractory primary central nervous system lymphoma: a retrospective single-center study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System; Central Nervous System Neoplasms; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Retrospective Studies; Rituximab | 2022 |
Long-term outcomes and central nervous system relapse in extranodal natural killer/T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carboplatin; Central Nervous System; Dexamethasone; Etoposide; Humans; Ifosfamide; Killer Cells, Natural; Lymphoma, Extranodal NK-T-Cell; Methotrexate; Neoplasm Recurrence, Local; Retrospective Studies | 2022 |
Towards establishment of a plant-based model to assess the novel anti-cancerous lead molecule(s): An in silico, in vivo and in vitro assessment of some potential anti-cancerous drugs on Lathyrus sativus L.
Topics: Colchicine; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Etoposide; Fluorouracil; Humans; Lathyrus; Methotrexate; Pemetrexed; Plant Proteins; RNA; Topotecan | 2022 |
Recurrent Metastatic Choriocarcinoma Responsive to Etoposide and Cisplatin with Etoposide, Methotrexate, and Dactinomycin: A Case Report.
Topics: Brain Neoplasms; Choriocarcinoma; Cisplatin; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Placenta; Pregnancy; Trophoblastic Neoplasms | 2022 |
A Rare Case of Combined Choriocarcinoma and Placental Site Trophoblastic Tumor Presenting as Skin Lesion: A Case Report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cyclophosphamide; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pain; Placenta; Pregnancy; Trophoblastic Tumor, Placental Site; Uterine Neoplasms; Vincristine | 2022 |
Long-term results of the treatment of adolescents and adults with acute lymphoblastic leukemia with a pediatric-inspired regimen delivered on an outpatient basis: A single institution experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Etoposide; Humans; Mercaptopurine; Methotrexate; Outpatients; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Vincristine | 2022 |
Development and application of a liquid chromatography coupled to mass spectrometry method for the simultaneous determination of 23 antineoplastic drugs at trace levels.
Topics: Antineoplastic Agents; Busulfan; Carboplatin; Chromatography, Liquid; Cyclophosphamide; Cytarabine; Dacarbazine; Daunorubicin; Docetaxel; Doxorubicin; Epirubicin; Etoposide; Fluorouracil; Ganciclovir; Humans; Idarubicin; Ifosfamide; Irinotecan; Methanol; Methotrexate; Oxaliplatin; Paclitaxel; Pemetrexed; Tandem Mass Spectrometry; Topotecan; Vinblastine; Vincristine; Water | 2022 |
EMACO for treatment of gestational trophoblastic neoplasia: A multinational multicenter study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Retrospective Studies; Vincristine | 2023 |
Real-world efficacy of DA-EPOCH-R/HD-MTX regimen in CD5-positive diffuse large B cell lymphoma: a single-institute analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Prednisone; Retrospective Studies; Rituximab; Vincristine | 2023 |